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Abstract 
Background.  Stepped care is widely implemented as a means to organise 
depression treatment.  However, it is unclear how this system and the system it 
was designed to replace – long-term intensive psychotherapy for all – compare. 
Aim.  To further the development and evaluation of stepped care.  Specifically, 
assess the clinical effectiveness of stepped care and prepare for a fully-
powered evaluation of stepped care vs. high-intensity psychotherapy alone for 
depressed adults. 
Design.  A systematic review and mixed methods feasibility study 
encompassing a pilot randomised controlled trial and semi-structured 
interviews. 
Results of the systematic review.  Fourteen randomised controlled trials 
involving 4580 participants were included.  Relative to controls, there was 
significantly greater improvement in depression for adults treated with stepped 
care (d=0.34 at six months; 95% CI 0.20 to 0.48).   The quality of included 
studies was good and there was little evidence of publication bias.  All 
comparisons were with usual care. 
Results of the feasibility study.  66 patients were recruited to the pilot trial.  
The recruitment rate was 2.9% and follow-up data was obtained from 90.9% of 
participants.  A third of stepped care patients stepped up to high-intensity 
therapy.  Patients improved in both groups: the mean reduction in depressive 
symptoms was 13.4 in the stepped care group and 13.6 in the high-intensity 
therapy alone group.  Recruitment methods were appropriate to patients and 
therapists but only somewhat appropriate to IAPT staff.  Although the stepped 
care intervention was broadly acceptable to therapists, patient experience 
varied and some patients who demonstrated a low level of self-efficacy declined 
any therapy or dropped out of treatment.   
Conclusions.  The effectiveness of stepped care compared with long-term 
intensive psychological therapy for all has not yet been established.  A fully-
powered trial of stepped care vs. high-intensity therapy alone is feasible 
although pilot trial methods and procedures should be modified to improve 
recruitment and acceptability.  
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CHAPTER 1.  INTRODUCTION 
This thesis will help develop and prepare to evaluate stepped care for the 
treatment of depression in adults.  As a system for the organisation of 
depression treatment, stepped care requires that almost all patients start with 
an evidence-based therapy of low-intensity; progress is monitored 
systematically and patients who do not respond adequately go on to receive 
high-intensity treatment (Davison, 2000).  Compared with the provision of long-
term, intensive psychotherapy for all, stepped care is assumed to achieve 
equivalent clinical outcomes at reduced cost (Bower & Gilbody, 2005b); 
implemented in a publicly funded health care system, it is expected to increase 
access to depression treatment (Richards, 2012).  For these reasons, many 
clinical guidelines worldwide endorse stepped care for depression (Andrews & 
World Health Organisation Collaborating Centre for Classification in Mental 
Health, 2006; National Collaborating Centre for Mental Health, 2010; Spijker, 
van Vliet, Meeuwissen, & van Balkom, 2010).  In England stepped care has 
become the dominant model of treatment organisation as implemented by 
Improving Access to Psychological Therapies (IAPT) services.  Yet around a 
decade ago, Bower and Gilbody (2005b) cautioned that the acceptability of 
stepped care and the clinical and cost-effectiveness of this system vs. high-
intensity psychological treatment were untested.   To establish equivalence and 
efficiency with certainty, a fully-powered randomised controlled trial of stepped 
care compared with intensive psychological therapy alone will be required.  
Several trials of stepped care have been undertaken (Ell et al., 2008; 
Oosterbaan et al., 2013; Unutzer et al., 2002).  However, the strength of 
evidence on the effectiveness of stepped care vs. high-intensity psychological 
therapy alone has not been systematically appraised; patients’ and therapists’ 
views of stepped care remain important to establish. 
1.1 Thesis overview 
The aim of this thesis is to further the development and evaluation of stepped 
care treatment for depression in adults.   Two studies are presented which have 
been conducted in line with the Medical Research Council framework for the 
development and evaluation of complex interventions: (1) a systematic review 
of the effectiveness of stepped care treatment for depression in adults and (2) a 
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mixed methods feasibility study to prepare for a large randomised controlled 
trial of stepped care compared with intensive psychological therapy alone.   
Techniques for integrated mixed methods analysis are included in the feasibility 
study.  The potential for these techniques in the field of Health Services 
Research going forward is considered. 
1.2 Thesis structure and content 
This thesis is structured as follows: Chapter 2 provides a summary of 
depressive symptomatology, prevalence and impact followed by a description 
and discussion of evidence on (a) the origin and definition of stepped care; (b) 
the acceptability of this system and (c) effects of stepped care implemented in 
routine clinical practice. 
Chapter 3 describes the methodological framework and philosophy 
underpinning my programme of research.  The thesis is situated in the context 
of evidence-based medicine, the development and evaluation of complex 
interventions and the appropriateness of mixed methods for health services 
research. 
Chapter 4 identifies and assesses existing evidence on the effectiveness of 
stepped care treatment for depression in adults through a systematic review 
and meta-analysis (study 1).  The results of the review are used to determine, 
with confidence, whether current evidence is sufficient to conclude that stepped 
care is equivalent to long-term, intensive psychological therapy for all. 
Chapters 5 & 6 describe and report the methods and results of a feasibility 
study (study 2) to prepare for a fully-powered evaluation of stepped care vs. 
high-intensity psychological therapy.  Key clinical, methodological and 
procedural uncertainties associated with the conduct of a large trial are 
addressed.  The results of integrated mixed methods analysis are presented. 
Chapter 7 concludes this thesis with: (i) a summary of results in relation to the 
aim and objectives the systematic review and each of five research questions 
addressed in the mixed methods feasibility study, (ii) a discussion of the 
findings from each study comprising strengths and limitations, clinical 
implications and directions for future research, and (iii) a summary of key 
conclusions.  The value of integrated mixed methods analysis is considered. 
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1.3 Aims and objectives 
Study 1 - The aim of the systematic review of stepped care will be to assess 
the clinical effectiveness of stepped care treatment for depression in adults.  
Specific objectives are to: (1) determine whether existing evidence is sufficient 
to conclude, with confidence, that stepped care is equivalent to high-intensity 
psychological therapy for all; (2) investigate heterogeneity in the findings of 
relevant randomised controlled trials by exploring aspects of study design and 
elements of the intervention that are associated with more or less effect. 
Study 2 – The aim of the feasibility study will be to provide information to inform 
the design of a large randomised controlled trial that will evaluate the clinical 
and cost-effectiveness of stepped care vs. high-intensity psychotherapy alone 
for the treatment of depression in adults.  Specific objectives will be to: (1) 
gather enough information on recruitment, retention, the proportion of patients 
who step up from low- to high-intensity therapy and treatment effects to design 
a fully-powered clinical trial or to determine that such a trial is not feasible; (2) 
explore patients’ and therapists’ views of stepped care and the ways in which 
patients’ views relate to how much they engage in therapy to inform a stepped 
care clinical protocol for the large trial. 
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CHAPTER 2.  BACKGROUND 
The purpose of this chapter is to demonstrate the requirement for a programme 
of research on stepped care for the treatment of depression in adults. 
The chapter provides an overview of depressive symptomology, prevalence and 
impact followed by a summary of effective treatment for depression.  Work on 
improving care for depressed patients is described.  This is followed by a review 
of literature on (a) the origin and definition of stepped care, (b) a critique of this 
system and (c) how stepped care has been implemented in the UK.  Current 
evidence on the acceptability of stepped care, how patients’ views of this 
system might relate to attendance and the effects of stepped care in routine 
clinical practice is presented.  The key limitations of studies on the effects of 
stepped care in clinical practice are described; implications for future research 
are presented.  Chapter two culminates in a summary of my PhD programme of 
work; the aim and specific objectives of my thesis are provided. 
Material is organised into several sections.  Sections one to six are: (2.1) 
depression – symptoms, prevalence & impact; (2.2) treating depression; (2.3) 
improving access; (2.4) stepped care; (2.5) a critique of stepped care (2.6) the 
implementation of stepped care.  Sections 2.7 to 2.10 summarise existing 
research on acceptability, the relationship between acceptability and therapeutic 
attendance and the effect of stepped care in routine clinical practice.  
Limitations of the evidence on effect are presented in section 2.11.  Sections 
2.12 and 2.13 comprise ‘implications for future research’ and my ‘PhD 
programme of work’. 
2.1 Depression – symptoms, prevalence and impact 
Major depression is a common, recurrent and debilitating disorder which, for 
many, is a lifelong and chronic illness (Richards, 2011).  Two systems are 
predominantly used for the diagnosis of depression: the ICD-10 (World Health 
Organization, 1992) in Europe and DSM-V (American Psychiatric Association, 
2013) in the USA.   In both systems, diagnosis is primarily based on the 
presence of depressed mood or loss of interest or pleasure; other symptoms 
include insomnia, low self-esteem, reduced concentration and feelings of 
hopelessness. 
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Internationally, the World Health Organisation predicts that by 2030 depression 
will become the third leading cause of the global burden of disease (Mathers, 
Boerma, & Ma Fat, 2008).  In the UK, epidemiological studies demonstrate that 
depression is highly prevalent with the National Psychiatric Comorbidity Survey 
estimating a point prevalence rate of 8.8% for mixed anxiety and depression 
and 2.3% for depression (McManus, Meltzer, Brugha, Bebbington, & Jenkins, 
2009).  Lifetime and twelve month prevalence rates for depression, as 
estimated in the US, are higher at 16.6% and 6.7%, respectively (Kessler, 
Berglund, et al., 2005). 
For individuals, depression is often recurrent.  Between 40% and 60% of people 
who experience a first depressive episode will go on to have another where the 
risk of recurrence subsequently increases with successive episodes (Eaton et 
al., 2008; Moffitt et al., 2010; Solomon et al., 2000).  Rates of psychiatric co-
morbidity and risk for suicide are also high (Fava et al., 1997; Kasper, 
Schindler, & Neumeister, 1996; Kessler, Berglund, et al., 2005; Robins, Locke, 
& Regier, 1991) and comorbidity has been established between depression and 
physical conditions (Angst, Gamma, Rossler, Ajdacic, & Klein, 2009; Rosenthal, 
2003).  In the UK, the cost of depression and anxiety is significant at £17bn in 
lost output and direct health care costs to the economy annually and a £9bn 
impact on the Exchequer through benefit payments and lost tax receipts (The 
Centre for Economic Performance Mental Health Policy Group, 2006). 
2.2 Treating depression 
Effective pharmacological and psychological treatments for depression are 
available.  Different types of psychotherapy are efficacious including Cognitive 
Behaviour Therapy (CBT), Interpersonal Psychotherapy (IPT), Problem-Solving 
Therapy (PST) and Behavioural Activation (BA) with only small differences in 
effect between them (Cuijpers, Andersson, Donker, & van Straten, 2011).  
Psychological treatments have also been found to have an important role to 
play in the primary prevention of depression (Cuijpers, van Straten, Smit, 
Mihalopoulos, & Beekman, 2008).  For patients with mild to moderate 
depression, the efficacy of psychological treatments is about the same as the 
efficacy of pharmacotherapy (Cuijpers, van Straten, van Oppen, & Andersson, 
2008).   However, there may be advantages of psychotherapy over 
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pharmacological treatments in terms of relapse prevention (Cuijpers, Hollon, et 
al., 2013; Vittengl, Clark, Dunn, & Jarrett, 2007).  For example, patients who 
receive acute phase CBT are less likely to relapse than those who are 
withdrawn from pharmacotherapy (Cuijpers, Hollon, et al., 2013); although rates 
of relapse after acute phase CBT and continuation of pharmacotherapy 
following remission are similar (Cuijpers, Hollon, et al., 2013), advantages of 
acute phase CBT include an absence of medication side-effects. 
2.2.1 Problems in the detection and treatment of depression 
Despite the availability of effective pharmacological and psychological 
treatments, in the 1990s problems in the detection and treatment of depression 
were convincingly demonstrated through empirical research.   Data from the 
United States indicated that only half of depressed patients were accurately 
diagnosed in primary care (Public Health Service Agency for Healthcare Policy 
and Research, 1993).  Worldwide, approximately half of people presenting with 
psychiatric problems in primary care went unrecognised; one third of cases 
were misdiagnosed (Lecrubier, 2001).  More broadly, access to treatment, 
irrespective of setting, was poor (Katz et al., 1997; Robins et al., 1991).  Several 
studies found that only one in three patients with depressive disorders received 
treatment (Kessler, Demler, et al., 2005; Young, Klap, Sherbourne, & Wells, 
2001).  Among patients who were accurately diagnosed, 25% to 50% received 
guideline-level antidepressant medication however many patients treated with 
antidepressant medications in primary care had persistent symptoms (Katon et 
al., 1999).  With respect to psychological treatment, fewer than 10% of those 
diagnosed with depression received an evidence-based psychological therapy 
(Wells, Katon, Rogers, & Camp, 1994).  In these ways, care for depression was 
associated with problems in detection and recognition, unsatisfactory 
pharmacotherapy and a lack of access to any treatment, most notably evidence 
based psychotherapy.   
2.2.2 Problems in the organisation of treatment 
Reflecting on such problems, academics, clinical researchers and those 
responsible for the design and delivery of treatment for depression began to 
recognise that the structure and delivery of mental health services, as 
traditionally configured, prohibited high quality care for depression.  In the US, 
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Wagner and colleagues (2001) observed that care systems which had been 
designed for the efficient and effective treatment of acute illness were poorly 
suited to care for chronic illness including depression.  Failures of primary care 
to meet the growing demand from rises in chronic disease were attributed to 
poorly organised treatment and system level change was recommended 
(Institute of Medicine, 2001b; Wagner et al., 2001).   
2.2.3 Problems in the organisation of psychological therapies in the UK 
In the UK, the efficacy of CBT for common mental health problems was well 
established by the end of the 1990’s (Lovell & Richards, 2000).  The National 
Service Framework for Mental Health (Department of Health, 1999) had 
identified CBT as a major component of primary and secondary mental health 
care and CBT was central to government plans for modernising mental health 
services (Department of Health, 1997).  However, in the same way that health 
care for chronic illness was deemed inadequate in the US, Lovell and Richards 
(2000) argued that traditional systems for the delivery of CBT were inadequate: 
access to care was limited by the structure and supply of services. 
Traditional systems for the provision of CBT required patients to consult with 
their GP or a mental health specialist to secure a place on a waiting list; 
therapists then typically offered patients around six to twelve sessions of 45-60 
minutes face to face therapy.  However, the supply of trained CBT therapists 
was inadequate for the number of people estimated to be suffering from most of 
the major disorders for which CBT had been shown to be effective; as such, 
services were often characterised by lengthy waiting lists and wait times (Lovell 
& Richards, 2000). 
Importantly, Lovell and Richards (2000) also argued that CBT could be 
delivered more efficiently.  They contended that the typical duration of CBT 
sessions of between 45 and 60 minutes had been determined by tradition and 
convenience rather than evidence (Lovell & Richards, 2000).  The authors also 
cited research to suggest that a large number of people could and would 
respond to treatment in a relatively small number of sessions (Howard, Kopta, 
Krause, & Orlinsky, 1986); people improve more quickly when limits on the 
numbers of sessions are imposed (Barkham et al., 1996); although patients who 
receive 16 sessions ultimately improve more than those who receive eight, 
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gains are small in comparison to the additional effort from both the therapist and 
patient (Barkham et al., 1996).  Thus it was suggested that problems in access 
to CBT due to the structure of care and a lack of CBT therapists were 
compounded by inefficiencies in the treatment provided – ‘long term’, intensive 
CBT for all.  
2.3 Improving access 
Drawing on studies that had been designed to (i) explore elements of CBT that 
may be associated with good effect and (ii) compare CBT involving multiple 
components with less complex forms ,  Lovell & Richards (2000) proposed that 
the use of brief (or ‘low-intensity’) versions of CBT had potential to greatly 
improve access to evidence-based treatment for a wide range of disorders, 
including depression.  Since then, others have highlighted the potential for low-
intensity psychological therapies in general (including but not limited to low-
intensity CBT) to significantly increase access to depression treatment (Bilsker, 
Goldner, & Anderson, 2012; Bower & Gilbody, 2005a; Clarke, Lynch, Spofford, 
& DeBar, 2006). 
Low-intensity psychological therapies are typically defined as psychotherapies 
that require less time from a health care professional than conventional, or high-
intensity, psychological treatments (Bennett-Levy, Richards, & Farrand, 2010).  
However, intensity might also refer to the time required of patients and 
therapists’ level of expertise and it is possible for treatments to differ in one but 
not all of these dimensions (van Straten, Hill, Richards, & Cuijpers, 2014).  
Patients, for example, may spend similar amounts of time undertaking high- or 
low-intensity psychotherapies which require a different amount of time from a 
professional. 
In practice, low-intensity psychological treatment can be delivered in a very 
wide range of formats, including self-help, group therapy, and book- or internet-
based courses with support provided over the internet, by phone, email or face-
to-face (Bennett-Levy et al., 2010).  Key to the potential for low-intensity 
psychological treatments to increase access to psychological therapies is that, 
compared with conventional psychotherapies, low-intensity treatments cost less 
and are less reliant on scarce therapeutic resource.  In a publicly funded 
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healthcare system, the offer of such low-intensity psychotherapy can increase 
the number of people accessing psychological therapy for depression. 
2.3.1 Possible issue with low-intensity psychotherapy 
In the last decade, the effectiveness of low-intensity psychological therapies for 
depression, delivered in a variety of ways, has been demonstrated convincingly 
(Andrews, Cuijpers, Craske, McEvoy, & Titov, 2010; Cuijpers, Donker, van 
Straten, Li, & Andersson, 2010; Gellatly et al., 2007; Richards & Richardson, 
2012).  However, a potential shortcoming of such treatments is that they may be 
inappropriate and insufficient for some.  Low-intensity psychological treatments 
may not be acceptable to all; some patients might require more robust 
psychotherapy (K. E. Green & Iverson, 2009; Richards, 2012) and not everyone 
will require the same treatment (Patten, Bilsker, & Goldner, 2008). 
Access to healthcare can be conceived as more than the supply of services; for 
services to be truly accessible they must also be used by and effective for the 
population for whom they are provided (Gulliford et al., 2002).  Against this 
definition, the provision of low-intensity psychological treatments may be 
insufficient.  The challenge may be to retain the benefits of low-intensity 
psychotherapies  but incorporate them within a system for the allocation of 
psychological therapies that is sensitive to the different needs of different 
patients.  
2.4 Stepped care 
Stepped care represents one such attempt to titrate the provision of 
psychological (and pharmacological) treatment to need.  In 2000, Haaga 
introduced a series of papers in the Journal of Consulting and Clinical 
Psychology on the potential for and implementation of stepped care for common 
mental health disorders (Haaga, 2000).  In this series, the authors reflected on 
how to define and implement stepped care as a system for the organisation of 
treatment for a variety of mental health problems - Generalised Anxiety Disorder 
(Newman, 2000) , Panic Disorder (Otto, Pollack, & Maki, 2000), Eating 
Disorders (G. T. Wilson, Vitousek, & Loeb, 2000), and alcohol problems (Sobell 
& Sobell, 2000).  In the fifth paper, Davison appraised all four articles and the 
core principles of his description of stepped care have come to define this 
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system of treatment: almost all patients start with an evidence-based treatment 
of low intensity; only patients who require further treatment ‘step up’ to a 
treatment of higher intensity  (Davison, 2000).  In practice, low-intensity 
psychotherapies delivered in the variety of forms described above are often 
used as a first step in stepped care treatment for depression and for patients 
who do not respond, high-intensity psychological therapies delivered in a more 
conventional form can follow.   
Integral, to the definition of stepped care is the requirement for patient progress 
to be assessed to inform next treatment step.  This is an element of stepped 
care that has been made more explicit by other authors (Bower & Gilbody, 
2005b).  To determine which patients ‘step up’, response to treatment is 
systematically evaluated; patient progress is assessed using validated symptom 
checklists and the decision to end or continue treatment after low-intensity 
therapy is made using set criteria appraised at a pre-specified time interval (van 
Straten et al., 2014). 
Defined and implemented in this way, compared with offering almost all patients 
long-term intensive psychological therapies, stepped care as a system for the 
allocation of depression treatment has potential to improve access whilst 
reassuring those who may be concerned about the appropriateness and 
effectiveness of low-intensity psychological therapy for all (Scogin, Hanson, & 
Welsh, 2003). 
2.4.1 The role for clinical judgment 
The core principles of stepped care are arguably simple – offer patients the 
least intensive treatment first, monitor, and only ‘step up’ if required.  Yet the 
more detailed description by Davison (2000) and colleagues  (Newman, 2000; 
Otto et al., 2000; Sobell & Sobell, 2000; G. T. Wilson et al., 2000) incorporates 
a role for clinical judgment.  Davison argues that stepped care should be 
sufficiently flexible to offer patients non-validated treatment where it makes 
sense to do so, moreover that clinical judgment should be applied to identify the 
least intensive / intrusive treatment to which a patient is likely to respond 
favourably (Davison, 2000). Hence whilst advising that, wherever possible, 
clinical work is informed by empirical evidence (Davison, 2000), the finer detail 
of Davison’s description supports a definition of stepped care that is flexible 
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enough to allow patients to begin with high-intensity treatment and be offered 
non-validated treatment if judged appropriate by a suitably qualified health care 
professional (2000).  Others share this position (Katon, Von Korff, Lin, & Simon, 
2001; Von Korff & Tiemens, 2000). 
2.4.2 Progressive vs. stratified stepped care 
Whilst Davison and others support the role for clinical judgment in stepped care, 
their model is still one of ‘progression’: almost all patients start with low intensity 
treatment and move on to more intensive treatment if needed (Ekers & 
Webster, 2013). By comparison, Newman (2000) and G. T. Wilson et al. (2000) 
describe ‘stratified’ models of stepped care (Ekers & Webster, 2013).  In this 
form of stepped care, prior to treatment, patients are assessed and allocated to 
different treatment intensities; some patients begin with low intensity treatment, 
others ‘jump’ straight to high intensity treatment.  Initial allocation or ‘matching’ 
of patients therefore requires some judgment to be made as to the likely 
response individual patients will make to the treatments available (Richards et 
al., 2010).  In this way, there is overlap between stratified stepped care and 
‘personalised medicine’ where treatment choice is determined by individual 
patients’ characteristics that are (ideally) known to predict response to treatment 
(Simon & Perlis, 2010). 
2.4.3 Stepped care involving a change in the type or modality of treatment 
In one other respect, the definition of stepped care is varied: authors use the 
term to describe sequential treatments that are not organised in terms of 
increasing intensity.  Writing on stepped care for the treatment of alcohol 
problems, Sobell and Sobell (2000) suggest that ‘stepping up’ need not be 
limited to increasing the intensity of treatment – changing ‘type’ might also be 
justified where ‘type’ refers to treatments of different modalities 
(pharmacological, psychological etc.) but also qualitatively different treatments 
of the same modality and intensity (Sobell & Sobell, 2000).  Similarly, Otto et al. 
(2000) investigated the cost-effectiveness of CBT and medication for Panic 
Disorder: CBT was recommended as a first line treatment in a stepped care 
model; subsequent treatment could involve a combination of CBT and 
medication or medication alone (Otto et al., 2000).  Given that it is difficult to 
characterise pharmacological treatments as intensive or otherwise, stepped 
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care involving medication and psychological treatment cannot be easily defined 
in this way.  In these examples, the term stepped care is used to describe 
treatment that is organised in steps characterised by a switch in treatment or 
the augmentation of one treatment with another. 
There are several examples of stepped care for depression defined by no clear 
intensity order. Joffe and Levitt (1995) describe stepped care for patients with 
‘treatment resistant’ depression involving substitution, combination or 
augmentation of an antidepressant agent with a second agent.  For the same 
population, Sharan and Saxena (1998) refer to stepped care treatment that 
involved augmentation of and switching antidepressant agents; this could be 
combined with psychological therapy.  Stepped care for women with depression 
has encompassed pharmacological treatment followed by high intensity 
psychological therapy, if required (Katon & Ludman, 2003). 
Considering the widespread use of pharmacotherapy alongside psychological 
treatment for depression, it is perhaps unsurprising that the term stepped care 
has been used to describe treatment that is organised in steps defined by 
switching or adding treatments of different modalities (van Straten et al., 2014).  
This version of stepped care substantially departs from the model described by 
Davison (2000) but has a place in the literature. 
2.4.4 Stepped care as an ‘adaptive treatment’ 
Broadly defined, stepped care has been described as an example of ‘adaptive 
treatment’ (Murphy, Collins, & Rush, 2007).  Such strategies are based on 
decision rules that recommend when and for whom treatment should change; 
often they incorporate a sequence of treatments and patient characteristics, 
adherence and response to treatment are used to inform treatment 
recommendations (Murphy et al., 2007).  Progressive models of stepped care, 
stepped care involving initial stratification and allocation and stepped care 
defined by a change in treatment are captured by this umbrella term.  
2.4.5 Stepped and collaborative care 
Stepped care is also compatible with other systems that aim to improve care 
quality and within the literature stepped care is often combined with 
collaborative care in a single intervention.  Collaborative care is defined by 
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enhanced communication between primary and specialist care providers, a 
structured patient management plan and scheduled patient follow-ups provided 
by a dedicated ‘case manager’ working in primary care but supervised by a 
mental health specialist (Gunn, Diggens, Hegarty, & Blashki, 2006).  It is also 
deemed to be compatible with stepped care because the need for specialist 
involvement is often determined by a lack of response to first- and second-line 
treatments (Von Korff, Katon, Unutzer, Wells, & Wagner, 2001).  Combined, 
stepped care and collaborative care is labelled in a variety of ways: as 
collaborative care, stepped care or collaborative stepped care, for example.  For 
this reason, it can be difficult to identify as stepped care but nonetheless meets 
criteria for a definition of this system. 
2.5 Critique of stepped care 
The variety of ways in which stepped care has been defined and implemented 
can, in part, be thought of as a response to key criticisms of this way of 
organising treatment.   Concerns with stepped care have been highlighted by 
several authors and cover four themes: the appropriateness of low-intensity 
treatment; consequences of unsuccessful low-intensity treatment; reduced 
patient choice; monitoring and stepping. 
2.5.1 Inappropriate low-intensity treatment  
Despite credible evidence that low- and high-intensity psychological therapies 
have comparable effects (Cuijpers, Donker, et al., 2010), there is an assumption 
implicit in the language of stepped care that high–intensity treatment (of any 
kind) is in some way superior to low-intensity treatment (Williams & Martinez, 
2008).  With respect to depression treatment, patients and professionals may 
feel that the provision of low-intensity psychological therapy is inappropriate 
(Bilsker et al., 2012; Scogin et al., 2003).  Some people may be particularly 
committed to the view that low-intensity psychological treatments are 
inappropriate for those with more severe depression (Landreville, Landry, 
Baillargeon, Guérette, & Matteau, 2001).  Meta-analysis of individual patient 
data has found that patients with more severe depression show at least as 
much clinical benefit from low-intensity psychotherapies as less severely 
depressed patients (Bower et al., 2013).  However, treatment guidelines that 
clearly recommend stratified stepped care involving low-intensity psychological 
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therapy for patients with mild and moderate depression but more intensive 
psychotherapy for those with more severe symptoms (Spijker et al., 2010; Van 
Weel-Baumgarten et al., 2012) are likely to reinforce the belief that low-intensity 
psychological interventions are unsuitable for patients with more severe 
symptoms.  
2.5.2 Unsuccessful low-intensity treatment 
A second cause of concern with stepped care focuses on the consequences of 
unsuccessful low-intensity treatment in a stepped care framework.  
Paradoxically, assuming that high-intensity treatment alone may have led to 
improvement, the treatment of patients who receive unsuccessful low-intensity 
treatment followed by a high-intensity intervention may be unnecessarily 
burdensome and prolonged (Richards et al., 2010).  There is also a concern 
that patients who do not respond to minimal interventions may develop negative 
attitudes towards treatment and ultimately be deterred from further treatment 
(Kellett & Matthews, 2008; Scogin et al., 2003).  In addition, in terms of 
depression treatment, if severe depressive symptoms, including suicide 
ideation, are not promptly addressed with high-intensity psychotherapy, Scogin 
et al. (2003) worry that serious consequences could occur. 
2.5.3 Restricted patient choice 
Another issue of concern is the scope for patient choice in stepped care.  The 
importance of a health care service that offers patients more choice, 
personalised care and genuine empowerment has been at the forefront of the 
National Health Service agenda (Lovell & Bee, 2008).  Although patient 
attitudes to choice in the NHS are equivocal and complex (Ipsos MORI, 2006), 
the opportunity to select one’s own treatment may be important, at least for 
some patients (Bromley & Hewton, 2005).   The efficiency of stepped care 
services for depression may, to a degree, be determined by constraints on 
choice; allowing patients to choose between low- and high-intensity 
psychological treatment could negate the benefits of this system if most expect 
and would prefer the latter (Bower & Gilbody, 2005b; Richards et al., 2010).  
Whilst patients may be provided with a choice of treatment within steps even if 
the choice between steps is more constrained, the stepped care model could be 
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perceived as limiting, directing patients towards low intensity options and thus 
restricting choice (Lovell & Bee, 2008). 
2.5.4 Monitoring and stepping criteria  
The fourth criticism of stepped care concerns monitoring patients who are in 
receipt of a low intensity intervention to determine their next treatment step.  In 
the same way that the efficiency of stepped care is, in part, determined by a 
lack of patient choice, the cost of stepped care is also influenced by timely 
decisions to step up patients without any clear therapeutic gains to the next 
level of treatment (Delgadillo, Gellatly, & Stephenson-Bellwood, 2015).  
Qualitative evidence has suggested that the decision to step up depressed 
patients does not happen consistently or in line with clinical guidelines (Gellatly, 
2011).   Central to the difficulty faced by clinicians is a tension between the 
desire to tailor or individualise psychological treatment which is perceived to 
conflict with standardised measures and guidelines for deciding which patients 
have high intensity psychotherapy and when (Gellatly, 2011).  Congruent with 
the findings of Gellatly (2011), analysis of questionnaire data from 82 clinicians 
on factors associated with the decision to step up or refer patients for further 
treatment has demonstrated that  a range of idiosyncratic assumptions, 
perceptions and attitudes influence clinicians’ decision making processes  
(Delgadillo et al., 2015).  The use of clinical outcome measures and algorithms 
in order to reach timely decisions about who should remain in low-intensity 
psychological treatment or step up may not be wholly acceptable to 
professionals – or patients. 
2.6 The implementation of stepped care 
Notwithstanding commentators’ concerns about stepped care, many authors 
have remained focused on its potential to improve access to depression 
treatment (Gjerdingen, Katon, & Rich, 2008; Katon & Ludman, 2003; Richards, 
2012).  For this reason, several authors have recommended that stepped care 
should be widely adopted (Ormel, Bartel, & Nolen, 2003; ten Have, de Graaf, 
Vollebergh, & Beekman, 2004).  In practice, many depression treatment 
guidelines worldwide have endorsed this system for the treatment of depression 
in adults (Andrews & World Health Organisation Collaborating Centre for 
Classification in Mental Health, 2006; Spijker et al., 2010; Van Weel-
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Baumgarten et al., 2012).  In the UK, the National Institute for Health and Care 
Excellence (NICE) recommends that psychological therapies for depression are 
delivered using stratified stepped care (National Collaborating Centre for Mental 
Health, 2010; National Institute for Health and Care Excellence, 2009a, 2009b, 
2011).  Low-intensity psychological treatment is recommended for patients with 
mild to moderate depression – followed by high-intensity psychotherapy only if 
required; patients with moderate to severe depression can start with high-
intensity psychological therapy  (National Institute for Health and Care 
Excellence, 2009b, 2011). 
A little over a decade ago, economists and clinical researchers in the UK also 
argued strongly that increased access to psychological therapies would largely 
pay for itself (Clark, 2011).  The UK Government was receptive to these 
arguments (and to the recommendation of NICE) but also recognised that the 
English NHS could not possibly implement NICE guidelines without 
fundamental reform of therapy provision (Richards, 2012).  A political 
commitment to increase the availability of evidence-based psychological 
therapies was secured in 2005 (Clark, 2011) and the government set out to 
reform traditional services for depression (and anxiety) into new Improving 
Access to Psychological Therapies (IAPT) services (www.iapt.nhs.uk) that 
operated on stepped care principles in accordance with NICE guidelines. 
Two pilot projects (termed ‘Demonstration Sites’ – one each in Doncaster and 
Newham) were established to test the viability of such services and whether 
expected outcomes could be achieved (Clark, 2011, 2013).  Following the 
success of these sites (Clark et al., 2009; Richards & Suckling, 2009), in 2007 
the UK government announced funding for a phased national rollout of the IAPT 
initiative in the English NHS (Clark, 2013).  A national implementation plan was 
published in early 2008 (Department of Health, 2008) and funding for the first 
three years was allocated to train up to 3,600 new psychological therapists 
(Clark, 2011).  In February 2011, the UK government announced further 
investment to complete and extend the IAPT programme over the period 2011 
to 2015 and by Summer 2012, IAPT  services had been established in 99% of 
the then Primary Care Trusts across England (Clark, 2013). 
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2.7 Research on stepped care 
In support of the significant investment in IAPT, several studies were conducted 
to evaluate services and inform national roll-out  (Clark et al., 2009; Department 
of Health, 2012; Department of Health Mental Health Division Improving Access 
to Psychological Therapies Programme, 2008; Glover, Webb, & Evison, 2010; 
Gyani, Shafran, Layard, & Clark, 2013; Parry et al., 2011; Richards & Borglin, 
2011; Richards et al., 2012; Richards & Suckling, 2009; Richards et al., 2010).  
Studies were able to utilise the minimum data set on patient related outcomes 
which all IAPT services are required to collect (Department of Health, 2009).  
This included patient data on the nine item Patient Health Questionnaire (PHQ-
9) (Kroenke, Spitzer, & Williams, 2001).  Two studies also evaluated patients’ 
and therapists’ views of IAPT services (Parry et al., 2011; Richards et al., 2010).  
Other studies have investigated what patients and healthcare professionals 
think of stepped care delivered outside of IAPT  (Franx, Oud, de Lange, 
Wensing, & Grol, 2012; Hermens, Muntingh, Franx, van Splunteren, & Nuyen, 
2014; Mitchell, Dwyer, Hagan, & Mathers, 2011; van Beljouw et al., 2014).  
Collectively, this body of research provides evidence on: (i) the acceptability of 
stepped care, (ii) a possible relationship between acceptability and therapeutic 
attendance and (iii) the effects of stepped care in routine clinical practice. 
2.8 Evidence on the acceptability of stepped care 
Data are available on each of the four key concerns with stepped care 
described above: (a) the degree to which low-intensity psychological therapy is 
considered appropriate; (b) views and experiences of unsuccessful low-intensity 
psychotherapy; (c) patient choice; (d) monitoring and stepping. 
2.8.1 The appropriateness of low-intensity psychological therapy 
Qualitative studies suggest that low-intensity psychological therapy may indeed 
be perceived as inappropriate by some.  From semi-structured interviews 
conducted with 77 patients who had completed stepped care treatment at the 
newly established Doncaster and Newham IAPT services, Parry et al. (2011) 
reported a perception that low-intensity psychotherapy was too difficult given 
how unwell people felt; patients struggled to engage in treatment with relatively 
little therapeutic support (Parry et al., 2011).  Research by Franx et al. (2012) 
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also provides evidence to suggest that low-intensity psychological interventions 
delivered as part of stepped care is considered inappropriate by some 
healthcare professionals.  Semi-structured group interviews were conducted 
with 79 professionals including Primary Care Physicians (PCPs), mental health 
specialists, psychologists and mental health nurses working in The Netherlands.  
Among interviewees there was a perception that treatment for depression was 
difficult to standardise and several PCPs mistrusted the effectiveness of low-
intensity psychotherapies (Franx et al., 2012).  Similarly in a UK study, Farrand, 
Duncan, and Byng (2007) found that GPs and managers of Graduate Mental 
Health Workers (GMHW) felt that low-intensity psychological therapy was 
unsuitable for patients with more severe difficulties.  Together, these studies 
provide a small amount of evidence to suggest that some patients and 
healthcare professionals consider low-intensity psychotherapies inappropriate.   
Although low-intensity psychological therapy might sometimes be seen as 
inappropriate, it is possible that the mistrust expressed in the above research 
might not be shared by patients and professionals receiving and delivering 
stepped care in different contexts.  All three studies interviewed participants at a 
time when stepped care incorporating low-intensity psychotherapy for 
depression was uncommon; views may have changed as the use of low-
intensity psychological therapies has become more widespread.  In addition, 
studies did not obtain or clearly report the views of therapists who were 
responsible for the delivery of low-intensity treatment and whose opinion may 
be influenced by direct experience of the success or otherwise of low-intensity 
psychotherapy for patients with more and less severe depressive symptoms.  
Rather, negative views of the appropriateness of low-intensity psychotherapy 
were often expressed by Primary Care Physicians and GPs who may, 
consciously or otherwise, be motivated to defend their involvement in the 
treatment of patients with depression, and whose perspective may not be 
shared by other healthcare professionals. 
Other aspects of low-intensity psychological therapy 
It is also notable that although some patients and professionals might be 
concerned with the appropriateness of low-intensity psychotherapy for 
depression, patients’ dissatisfaction but also satisfaction with low-intensity 
36 
psychological treatment appears to be shaped by a wide range of other 
elements of that care.  Richards et al. (2010) conducted interviews with 14 
patients attending four services that had recently implemented stepped care as 
part of IAPT.  This study and that of Parry et al. (2011) identified a large number 
of elements of low-intensity psychotherapy (besides appropriateness) with 
which patients were unhappy.  They included phone calls, the duration of 
treatment, content that is too simple or superficial, patients’ ability to apply and 
use material, the therapeutic relationship and the qualifications and experience 
of low-intensity therapists (Parry et al., 2011; Richards et al., 2010). 
In the same studies, elements of low-intensity psychotherapy with which 
patients were satisfied included phone calls - for their anonymity, convenience 
and flexibility - and the structure of low-intensity therapy (Parry et al., 2011; 
Richards et al., 2010).  Farrand et al. (2007) also found a positive perception 
among twelve patients who were interviewed about the role of Graduate Mental 
Health Workers (employed, at the time of the research, to deliver low-intensity 
psychotherapy) that low-intensity psychological treatment helped you take 
control and be responsible for your own recovery.  Patients evidently hold 
different and perhaps mixed views of low-intensity psychotherapy that are 
shaped by a host of factors, not only the degree to which it is considered 
appropriate. 
A limitation of data on factors shaping patients’ views of low-intensity 
psychological therapy is that it is not possible to interpret what patients thought 
about different aspects of therapy in relation to the specific treatment that they 
received.  Parry et al. (2011) and Richards et al. (2010) recruited patients from 
several services; services differed in the form of stepped care provided and the 
treatment received by individual participants was not reported.  Negative views 
on low-intensity psychotherapy delivered in one form may not be a good guide 
to patients’ views of another.  Without more information it is not possible to 
appreciate which components or exactly what about those components was 
liked or caused most difficulty.  The views of patients in response to other forms 
of low-intensity psychotherapy may be somewhat difficult to gauge based on 
existing research. 
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2.8.2 Unsuccessful low-intensity psychological therapy  
Patients’ and professionals’ views of the consequences of unsuccessful low-
intensity psychotherapy have been explored in several studies.  Following 
interviews with 14 patients but also 18 members of IAPT staff (graduate 
workers, mental health practitioners / nurses, psychologists, a GP and 
counsellor), Richards et al. (2010) found that some patients experienced 
negative consequences following unsuccessful low-intensity psychological 
treatment; patients described feeling disillusioned.  Furthermore, some staff 
worried about the possibility of such consequences; there was a perception that 
patients might drop out of treatment following a lack of response to low-intensity 
psychotherapy (Richards et al., 2010). 
However, in a larger cohort of patients, Parry et al. (2011) found no evidence 
that negative consequences arose.  Following unsuccessful low-intensity 
psychotherapy, patients had been relieved and reassured to be offered further 
support; some patients who dropped out of therapy viewed this decision 
positively although it is unclear whether such views were expressed by patients 
who had dropped out following unsuccessful low-intensity psychotherapy.  
Among the small number of other qualitative studies of stepped care conducted 
with healthcare professionals (Farrand et al., 2007; Franx et al., 2012; Hermens 
et al., 2014; Mitchell et al., 2011; van Beljouw et al., 2014), there is no evidence 
that staff were particularly concerned for patients who did not respond to low-
intensity psychological treatment. 
Reasons for the discrepancies in findings are unclear.  It is possible that 
professionals’ views of unsuccessful low-intensity psychotherapy may not have 
been explored in studies conducted by Farrand et al. (2007), Franx et al. 
(2012), Hermens et al. (2014), and Mitchell et al. (2011).  Alternatively, it may 
not have been an issue about which staff felt strongly.  With respect to patients, 
although people might respond both negatively and positively to unsuccessful 
low-intensity psychotherapy, studies by Parry et al. (2011) and Richards et al. 
(2010) shed no light on features of treatment that could make patients’ transition 
into high-intensity psychotherapy easier.    From existing research, it is not 
possible to conclude with any degree of certainty that patients who receive 
stepped care delivered in other ways will respond positively to unsuccessful 
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low-intensity psychotherapy.  Nor is it possible to anticipate the views of 
healthcare professionals. 
2.8.3 Patient choice 
Concerns regarding a lack of choice in stepped care have focused on the 
acceptability of directing patients to low-intensity treatment as a first line 
intervention.   In this context, it is noteworthy that patients and health care 
professionals have endorsed stepped care for providing an alternative to 
antidepressant medication (Mitchell et al., 2011; Parry et al., 2011).  Concerns 
about directing patients to low-intensity psychotherapy could be attenuated 
where patients and healthcare professionals are focused on the increased 
choice available to patients compared with offering antidepressant medication 
alone. 
On the other hand, Parry et al. (2011) also found that patients were dissatisfied 
with the lack of choice in psychological therapies at Doncaster and Newham.   A 
key difficulty with the interpretation of this finding, however, is that it is unclear 
what patients objected to: being directed to low-intensity psychotherapy, a lack 
of alternative forms of low-intensity psychological therapies from which to 
choose or the similarity of low- and high-intensity psychotherapies on offer.  
Indeed, given that at the time of the study approximately half of all patients in 
Newham were allocated straight to high-intensity treatment (Parry et al., 2011), 
it is possible that some patients may have expressed dissatisfaction with the 
lack of choice of high-intensity psychological therapies or with being ‘denied’ 
low-intensity psychotherapy. 
It is also difficult to interpret qualitative research on the degree to which 
healthcare professionals dislike directing patients to low-intensity psychological 
therapy.  Franx et al. (2012) and Richards et al. (2010) both found that some 
staff were uncomfortable ‘forcing’ patients to conform to a stepped care model 
but it is unclear whether reservations related to perceptions regarding the 
clinical effectiveness of such a system, the lack of patient choice, or both.  
Practitioners may have been concerned less about patient choice but more the 
reduced role for clinical judgment. 
39 
The degree to which the above findings apply to stepped care delivered in other 
ways is also uncertain.  Franx et al. (2012) studied patients’ response to 
stratified stepped care; all four sites from which participants were recruited by 
Richards et al. (2010) implemented systems incorporating an element of 
stratification and in the study by Parry et al. (2011), only Doncaster operated 
stepped care in which the majority of patients received low-intensity 
psychological therapy.  The views of patients and healthcare professionals on 
patient choice in stepped care defined by increasing intensity have not been 
clearly established.  
2.8.4 Monitoring and stepping 
In addition to the research by Delgadillo et al. (2015) and Gellatly (2011) 
summarised in  section 2.5.4, information on views of monitoring is available 
from a small number of other studies.  Patient feedback was obtained by Parry 
et al. (2011); health care professionals’ views are described in research by 
Franx et al. (2012) and Hermens et al. (2014).  Studies by Franx et al. (2012) 
and Hermens et al. (2014) provide feedback on the use of symptom checklists 
by Primary Care Physicians (PCPs) implementing stratified stepped care in The 
Netherlands; Hermens et al. (2014) also conducted group interviews involving 
other healthcare practitioners e.g. mental health nurses, psychologists, social 
workers and physiotherapists. 
In all three studies patients and professionals held mixed views of monitoring.  
Being monitored was sometimes useful to patients (Parry et al., 2011); PCPs 
reported that it legitimised treatment decisions and gave structure and focus to 
patient consultations (Franx et al., 2012).  However, patients and professionals 
also distrusted scores (Franx et al., 2012; Parry et al., 2011) and had issue with 
the time taken to complete measures (Hermens et al., 2014; Parry et al., 2011).  
Some patients were uncomfortable being monitored (Parry et al., 2011) and, 
consistent with the findings of Delgadillo et al. (2015) and Gellatly (2011), PCPs 
rated their own judgement of patients’ wellbeing over scores on a symptom 
checklist (Franx et al., 2012).  There was also a perception that asking patients 
to complete a checklist was not in accordance with a PCP’s role, albeit more 
appropriate for others (Franx et al., 2012). 
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With respect to the decision to end or continue treatment following low-intensity 
psychotherapy, although Delgadillo et al. (2015) and Gellatly (2011) provide 
data to suggest that therapists might struggle to apply pre-defined stepping 
criteria, healthcare professionals’ views of specific criteria have not been 
explored.  Likewise, no data are available for patients.  Parry et al. (2011) and 
Richards et al. (2010) describe patients’ views of ending treatment but the point 
at which patients ended treatment (following low- or high-intensity 
psychotherapy) is unclear and patients’ views of how the decision was made to 
end treatment are not reported.  Other  limitations of the data on monitoring and 
stepping are that: results are based on one study with patients; Hermens et al. 
(2014) did not specify the measure(s) used; none of the studies conducted by 
Franx et al. (2012), Hermens et al. (2014) or Parry et al. (2011) clarified exactly 
how and when checklists were administered.  Thus, the extent to which findings 
will apply to monitoring conducted in other ways is unclear. 
2.8.5 Evidence on acceptability – summary 
Although a number of studies provide data on what people think of stepped 
care, the degree to which this system is acceptable to patients and 
professionals has not yet been fully understood.   Studies suggest that low-
intensity psychotherapy may indeed be perceived as inappropriate yet some 
patients also rate minimal interventions positively; negative consequences of 
unsuccessful low-intensity treatment might occur and be of concern to some 
professionals; choice may be an issue although exactly how is unclear; views of 
monitoring are mixed.  Data are limited in that findings may not apply to stepped 
care delivered at the current time and in different ways.  Results are also 
somewhat difficult to interpret and extrapolate and patients’ and healthcare 
professionals’ views of key elements of this system e.g. stepping criteria, have 
not yet been established. 
2.9 Evidence on how acceptability and attendance might relate 
In addition to research on the acceptability of stepped care, data are available 
from two studies which allow for the possibility that patients’ views of this 
system might relate to attendance at therapy. 
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IAPT data reveal that between 14% and 30% of patients who are referred do 
not attend an assessment and around a quarter of those assessed, offered or 
who commence treatment drop out or decline further contact (Parry et al., 2011; 
Richards & Borglin, 2011; Richards & Suckling, 2009).  In an investigation of 
differences between patients who had been referred to the Doncaster and 
Newham services and subsequently attended vs. not, Di Bona, Saxon, 
Barkham, Dent-Brown, and Parry (2014) found that people referred to Newham 
were more likely to attend than those referred to Doncaster.  Logistic regression 
revealed ‘site’ to be a statistically significant predictor of attendance and the 
authors concluded that patients’ views and opinions of stepped care in the 
different sites may have had a bearing on attendance (Di Bona et al., 2014). 
A key limitation of this work is that analyses were observational with results that 
are subject to confounding: differences in the attendance of patients at 
Doncaster and Newham might readily be explained by a variety of factors, 
unknown or known, such as the socio-demographic or clinical characteristics of 
sites’ local populations and other features of care.   Nonetheless it is possible 
that views of stepped care delivered in different ways might have influenced 
attendance. 
Qualitative research by van Beljouw et al. (2014) also allows for a possible 
relationship between the acceptability of stepped care and attendance.  
Qualitative and quantitative data were used to explore barriers and facilitators to 
the engagement of older adults who scored six or more on the PHQ-9 in a 
stepped care programme for the treatment of depression.  Perceptions of the 
appropriateness of high-intensity psychological therapy were an important 
influence on patients’ decision to step up; many people did not define 
themselves as depressed rather emotional distress was viewed as a normal 
part of ageing.  Patients’ lack of self-perceived depressive symptoms was 
decisive to refuse more intensive treatment (van Beljouw et al., 2014). Negative 
views of intensive psychological therapy appear to have influenced patients’ 
decision to drop-out of stepped care. 
Although patient decisions to drop out stemmed from views of high-intensity 
psychological therapy and not unique features of stepped care such as 
monitoring, stepping criteria or the offer of low-intensity psychotherapy prior to 
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the option of high-intensity treatment, results nonetheless suggest that 
objections to a component of this system could influence patients’ decision to 
end therapy.  For other patients and in other settings, it is possible that views of 
some of the unique features of stepped care might influence patients’ 
attendance.  However, to date, no research has focused on the relationship 
between the acceptability of stepped care and attendance. 
Evaluations of IAPT report better clinical outcomes for patients who complete 
stepped care treatment (Clark et al., 2009; Parry et al., 2011).  Thus, if patients’ 
views of stepped care have a bearing on attendance, what people think of this 
system could have important clinical implications.  From an increased 
understanding of how attendance and acceptability relate, it might be possible 
to deliver stepped care in ways that anticipate patients’ concerns and perhaps 
help retain patients in treatment.  In addition, research on the relationship 
between acceptability and attendance may help identify patients likely to decline 
treatment or who are at increased risk of dropping out and might benefit from a 
different system of treatment allocation. 
2.10 Evidence on the effect of stepped care in routine clinical practice 
Besides research on the acceptability of stepped care and how acceptability 
and attendance might relate, several studies provide data on the effects of 
stepped care in IAPT.  Studies report clinical and work-related outcomes for 
IAPT patients.  There has also been a small amount of work to benchmark 
clinical outcomes with the effects of high-intensity psychological therapy alone. 
2.10.1 Clinical outcomes 
Clinical outcomes associated with stepped care have been evaluated in 
Doncaster and Newham – IAPT ‘demonstration’ sites (Clark et al., 2009; Parry 
et al., 2011; Richards & Borglin, 2011; Richards & Suckling, 2009) as well as a 
broader cohort of IAPT services (Department of Health, 2012; Department of 
Health Mental Health Division Improving Access to Psychological Therapies 
Programme, 2008; Glover et al., 2010; Gyani et al., 2013). 
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Doncaster and Newham 
An analysis of the Doncaster and Newham services at the end of their first full 
year of operation (2006-07) indicated that stepped care is associated with 
reasonable effect.  Among patients who completed treatment, uncontrolled, pre-
post treatment effect sizes in terms of depressive symptoms were large: 1.26 
(Clark et al., 2009) and 1.39 (Richards & Suckling, 2009) in Doncaster and 1.09 
in Newham (Clark et al., 2009).  Recovery rates at both sites were also in 
excess of 50% (Clark et al., 2009). 
Favourable effects were also observed based on data collected over two years 
and using a more stringent assessment of clinical improvement:  41% of 
patients treated at Doncaster, studied to the point of exit from that service, 
achieved reliable and clinically significant change; uncontrolled pre-post 
treatment effect sizes were 1.07 in terms of depressive symptoms  (Richards & 
Borglin, 2011). 
Similarly, based on an analysis of Doncaster and Newham over three years 
(2006-2009), Parry et al. (2011) found that 40% of patients who received 
treatment achieved reliable and clinically significant change although this 
proportion fell to 36% among all patients accepted for treatment i.e. assessed 
and offered treatment but who may or not have received therapy.  For patients 
who completed treatment, recovery rates reported by Parry et al. (2011) of 56% 
in Doncaster and 66% in Newham, were at least as good as those reported by 
Clark et al. (2009) for the same sites during year one.  Thus, it appears that the 
clinical effects of stepped care at Doncaster and Newham observed during their 
first year of operation were maintained. 
Other services 
Data on the performance of a broader cohort of IAPT services indicates that 
stepped care implemented elsewhere has been associated with a similar level 
of clinical benefit to that observed in Doncaster and Newham.   Among eleven 
‘Pathfinder’ sites, uncontrolled pre-post treatment effect sizes for patients 
treated for depression were 1.25 (Department of Health Mental Health Division 
Improving Access to Psychological Therapies Programme, 2008) and during the 
first year of IAPT operation, across 32 services, the recovery rate among 
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patients treated for depression was  47% (Glover et al., 2010).  A report on the 
first three years of IAPT published by the Department of Health (2012) reported 
an overall recovery rate for the fourth quarter of 2011-12 of 46%. 
Whilst average levels of the effectiveness of stepped care delivered in a larger 
number of services pointed to good clinical outcomes, data also obscured 
considerable differences across sites (Glover et al., 2010; Gyani et al., 2013).  
Among 30 of the 32 services for which effects could be estimated, individual 
sites’ uncontrolled pre-post treatment effect sizes in terms of depressive 
symptoms ranged from 0.38 to 0.95 (Gyani et al., 2013) and whilst Gyani et al. 
(2013) identified a small number of service-level characteristics that predicted 
higher reliable recovery rates (e.g. the use of treatments recommended by 
NICE and higher rates of stepping) features of stepped care that are associated 
with more or less effect are not generally well understood. 
2.10.2 Employment-related benefits 
In addition to the clinical outcomes associated with stepped care delivered in 
routine practice, four studies provided an indication of effects on employment.  
Among patients attending Doncaster and Newham in year one, there was a 4% 
net increase in the number at work and a 10% net decrease in the number of 
patients receiving Statutory Sick Pay (Clark et al., 2009).  Across Pathfinder 
sites, the number of patients returning to work and off Statutory Sick Pay 
increased by 16% (Department of Health Mental Health Division Improving 
Access to Psychological Therapies Programme, 2008).  Effects on employment 
were evident but smaller among the 32 services established in year one of IAPT 
(Glover et al., 2010).   Data published by the Department of Health (2012) on 
the first three years of IAPT appeared to show an increase, quarter on quarter, 
in the number of IAPT patients off Statutory Sick Pay and other benefits.  
Across different services, to a greater or lesser extent, it appears that stepped 
care has been associated with employment-related patient benefit. 
2.10.3 Effect in routine clinical practice vs. high-intensity psychological 
therapy alone 
Whilst clinical and employment-related data indicate that stepped care 
implemented in routine clinical practice has been associated with good effect, in 
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no way does this information reveal whether stepped care is as clinically or 
cost-effective compared with offering patients high-intensity  psychological 
therapy alone. 
Stepped care in routine practice vs. trial data on the effectiveness of high-
intensity CBT alone 
To help address this question, two IAPT evaluations cited published research 
on the effectiveness of high-intensity CBT as estimated in randomised 
controlled trials alongside their primary data on the effectiveness of stepped 
care in IAPT.   Richards and Suckling (2009) reported that the magnitude of the 
uncontrolled, pre-post-treatment effect size in Doncaster (1.38) was smaller 
than the effect of high-intensity CBT for depression (1.46) stated in a non-
systematic review of CBT trials conducted by Pilling and Burbeck (2006).  
Likewise, across the first three years of operation, Parry et al. (2011) reported 
that uncontrolled, pre-post treatment effect sizes in Doncaster and Newham (in 
the region of 1.3) were smaller than the effect of high-intensity CBT alone (1.49) 
identified from a non-systematic review of RCTs conducted by the authors.  
Findings appeared to indicate that high-intensity CBT alone could be more 
effective than stepped care however Parry et al. (2011) argued that the modest 
differences provided very little support for the contention that stepped care is 
less effective; the magnitude of difference was consistent with the effects of 
psychological therapies estimated from randomised controlled trials vs. 
practice-based studies more generally (Barkham et al., 2008).  
Stepped care vs. high-intensity psychotherapy alone in routine clinical 
practice 
The same studies also cited published data on the effectiveness of high-
intensity psychological therapy that had been delivered in routine clinical 
practice.  Richards and Suckling (2009) reported that the uncontrolled pre-post 
treatment effect size in Doncaster following its first year of operation (1.38) was 
similar to that of high-intensity psychological therapy alone (1.34) in a review of 
cognitive-behavioural, person-centred and psychodynamic therapies delivered 
in UK primary care by Stiles, Barkham, Mellor-Clark, and Connell (2008).  
Similarly, Parry et al. (2011) cited data to suggest that recovery rates for 
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Doncaster and Newham in their first three years of operation fell within the 95% 
confidence interval of rates for patients with similar symptom severity seen at 24 
NHS sites delivering pre-IAPT primary care services.    Together, these studies 
provide a small amount of evidence to suggest that stepped care and intensive 
psychological therapies implemented in routine clinical practice might achieve 
similar effects. 
The cost-effectiveness of stepped care and high-intensity psychological 
therapy alone in routine practice 
In terms of the cost-effectiveness of stepped care compared with intensive 
psychological treatment alone, Parry et al. (2011) reported data on the cost of 
treatment and clinical outcomes for patients recruited from General Practices in 
Doncaster vs. patients recruited from GP practices in matched comparator sites 
- Wakefield and Barnsley.  Although details of the treatments offered and 
received in Wakefield and Barnsley were not described, it may be reasonable to 
assume that they operated traditionally configured psychological therapy 
services.  If this is correct, data on Doncaster, Wakefield and Barnsley 
represent data on the cost-effectiveness of stepped care and high-intensity 
psychological therapy alone in routine clinical practice. 
When Doncaster was compared to Wakefield and Barnsley, the incremental 
cost effectiveness ratio (ICER) was £37,571 per QALY.  This was calculated 
using the Short Form-6 dimensions (SF-6D) (Ware & Sherbourne, 1992).  In a 
sensitivity analysis based on ‘predicted’ EQ-5D values – a metric preferred by 
NICE for measuring health states – the ICER was £20,230 per QALY gained 
(Parry et al., 2011) .  The latter ICER falls within a decision-maker willingness to 
pay threshold of £20,000-£30,000 adopted by NICE (Parry et al., 2011) 
indicating that stepped care may be cost-effective compared with ‘traditional 
care’. 
However, limitations of the analysis include that it was substantially under-
powered.  Moreover, comparisons between participants’ PHQ-9 scores 
collected for this study and post-treatment scores in the larger cohort of 
Doncaster patients used by Parry et al. (2011) indicated that improvements for 
the cost-effectiveness evaluation may have been underestimated by up to 20% 
(Parry et al., 2011).  As such, results do not provide credible evidence on the 
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cost-effectiveness of stepped care and that of high-intensity psychological 
therapy alone in routine clinical practice. 
2.10.4 Effect in routine clinical practice – summary 
IAPT service evaluations provide evidence of the ‘real life’ effectiveness of 
stepped care that has been implemented in routine clinical practice (Richards & 
Suckling, 2009).  Collectively, they have found that stepped care is associated 
with favourable clinical and employment-related outcomes across a range of 
services and over a number of years.  However, services have varied in their 
performance and, despite a small amount of research on elements of stepped 
care that may be associated with more or less effect, optimal and sub-optimal 
components of this system are not yet well understood.  In terms of how 
stepped care and high-intensity psychological therapy alone compare, data is 
available to suggest that both are associated with good outcomes delivered in 
routine clinical practice but no credible evidence has been collected on the cost-
effectiveness of stepped care and more high-intensity psychotherapy. 
2.11 Key limitations of evidence on the effect of stepped care in IAPT 
IAPT service evaluations provide a large body of data on the effects of stepped 
care in routine clinical practice.  They are also an example of observational 
cohort studies: using routinely collected outcome data, authors observed how 
depressive symptoms changed among patients who received stepped care in 
IAPT.  A key limitation of such studies is that they do not establish causality.  
Although the evaluations might provide an indication of the effects of stepped 
care delivered in routine clinical practice, outcomes cannot be reliably attributed 
to that system; the direction and magnitude of effects may be due to other 
factors (confounders).   
The presence of confounding undermines the degree to which the data can be 
thought of as a valid estimate of the effect of stepped care on the patients under 
study.  Moreover, where confounders influence pre- and / or post-test data in 
ways that result in an under- or over-estimate of the difference between the two, 
outcomes are biased.  Sources of bias are commonly classified in terms of: (i) 
selection, (ii) performance, (iii) attrition, and (iv) measurement (Higgins & 
Altman, 2008).  Together with the role for ‘spontaneous remission’ and 
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‘regression to the mean’, risk of bias threatens the internal validity of 
observational cohort studies such that the effects of stepped care on IAPT study 
participants cannot be reliably attributed to stepped care. 
2.11.1 Spontaneous remission 
Many illnesses, including depression, tend to be self-limiting and left un-treated 
a proportion of patients will recover from any one episode.  From meta-
regression incorporating the results of 19 studies, it has been estimated that 
without intervention 23% of patients will remit within three months, 32% within 
six months and 53% within 12 months (Whiteford et al., 2013).  Across all of the 
IAPT evaluations, the role for natural recovery will have influenced outcomes 
and, in observational cohort studies, it is not possible to disentangle these 
temporal effects from that of the intervention. 
2.11.2 Regression to the mean 
The role for natural recovery can be exaggerated by the statistical phenomenon 
of regression to the mean which occurs when there is measurement error.   
When a group of people is assessed on a dimension and then re-assessed, 
individuals with ‘extreme’ scores on the first assessment will tend to score 
closer to the mean on the second (Torgerson & Torgerson, 2008).  This is 
because high levels of error in the measurement of extreme scores mean that, 
by chance, when someone is re-assessed, their second score will move closer 
towards his or her ‘true’ state.  In a group of people purposively selected for 
their high (or low) scores, this phenomenon will produce apparent improvement 
without any intervention.  In studies of IAPT patients, most of whom are likely to 
have presented with relatively high scores on the PHQ-9 (or GAD-7) that is 
itself, to a degree, unreliable (McMillan, Gilbody, & Richards, 2010), regression 
to the mean will confound estimates of the effect of stepped care. 
2.11.3 Selection bias 
In a study of two groups, selection bias refers to systematic differences in the 
baseline characteristics of each group that could help to explain differences in 
the effects of treatment (Higgins & Altman, 2008).  In an observational cohort 
study, threats to internal validity might arise if participants’ characteristics differ 
systematically before and after treatment.  Circumstances in which this might 
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apply may not be obvious or thought likely and, perhaps for this reason, authors 
of IAPT evaluations have tended to focus on threats to external validity in terms 
of selection i.e. the degree to which participants’ characteristics mean that 
results generalise. 
However, sources of confounding can be ‘known’ and ‘unknown’ and it is 
possible that the circumstances of IAPT patients may have changed during 
treatment in ways that could have a bearing on outcome but that may not be 
thought important.  Prognostic and prescriptive variables predict differential 
treatment outcomes for individuals with depression.  Some of the predictor 
variables are (potentially) transient e.g. marriage, employment and number of 
recent life events (Fournier et al., 2009).  Moreover, combinations of those 
variables (rather than any single predictor) are likely to have a bearing on 
treatment outcomes (DeRubeis et al., 2014).  Yet our understanding of how 
variables combine is in its infancy and we have a limited understanding of 
individual patient characteristics that predict treatment response (Cuijpers, 
Reynolds, et al., 2012).  As such, it may not be possible for us to spot 
potentially important changes in people’s circumstances which, if experienced 
by ‘enough’ participants, could confound treatment outcomes for the sample as 
a whole, yet confounding would still occur.  In the IAPT evaluations, selection 
bias remains a threat to internal validity although we may not be able to identify 
how. 
2.11.4 Performance bias 
Performance bias is defined as a threat to validity that arises from the way in 
which care is delivered to patients other than as part of the intervention (Higgins 
& Altman, 2008).  Sources of performance bias are also not discussed by the 
authors of IAPT evaluations but could include the prescription of antidepressant 
medication, other care provided by patients’ GPs and alternative forms of 
support or therapy accessed by patients - via employers or paid for privately, for 
example.  IAPT patients’ clinical and employment-related outcomes could be 
affected by any additional care that they may have received. 
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2.11.5 Attrition bias 
The significance of missing data (levels of attrition) on estimates of the effect in 
IAPT was explored by Clark et al. (2009). By comparing clinical outcomes in 
different sub-samples, Clark et al. (2009) found that effect sizes for patients with 
complete pre- and post-treatment data were larger than for patients with 
partially complete data.  Moreover, patients with complete data received more 
therapy than those without (Clark et al., 2009).  The authors therefore 
concluded that patients without post-treatment data would probably have worse 
outcomes than patients with post-treatment data.  Accepting this, levels of 
attrition are likely to bias estimates of the effect of stepped care in IAPT. 
2.11.6 Measurement bias 
The way in which treatment-related outcomes are assessed is another source 
of potential bias.  None of the IAPT evaluations used standardised diagnostic 
interviews to establish the presence or absence of depression.  Studies varied 
in the degree to which the metrics used took account of inherent unreliability of 
symptom measurement on the PHQ-9.  Clark et al. (2009) and Richards and 
Suckling (2009) reported recovery rates; other studies utilised reliable and 
clinically significant change criteria (Parry et al., 2011; Richards & Borglin, 
2011).  Moreover, a risk of measurement bias arose from the collection of 
outcome data by staff as part of their everyday clinical work rather than by 
independent assessors – a point noted by Richards and Borglin (2011).  
Estimates of the effect of stepped care in IAPT may have been biased by the 
way in which treatment outcomes were assessed. 
2.11.7 Comparison of stepped care vs. high-intensity therapy alone 
For being at high risk of bias, evaluations of IAPT do not prove, categorically, 
that stepped care delivers favourable outcomes.  In this regard, the data are 
limited.  In one other key respect, the data are also limited: none of the 
evaluations directly compared stepped care with high-intensity psychological 
therapy alone.  Parry et al. (2011) and Richards and Suckling (2009) cited 
published data on the effects of high-intensity psychotherapy from randomised 
controlled trials and routine clinical practice.  However, differences or similarities 
between the published data and the results of their primary data analysis are 
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not a robust indication of the difference between stepped care and high-
intensity psychotherapy.  In the same way that observational cohort studies are 
at risk of confounding, differences between studies might be explained by many 
factors other than treatment received e.g. sample characteristics, how 
outcomes were assessed and levels of attrition.    Without a direct comparison 
of the effect of stepped care vs. high-intensity psychological therapy alone that 
is at low risk of bias and therefore internally valid, we cannot conclude, with 
certainty, whether stepped care achieves similar patient benefit for less cost 
than traditionally configured systems of depression treatment. 
2.12 Implications for future research 
Over a decade ago, Bower and Gilbody (2005b) argued that a randomised 
controlled trial (RCT) of stepped care compared with high-intensity 
psychological therapy alone was required to establish the relative clinical and 
cost-effectiveness of these systems. 
2.12.1 The need for a randomised controlled trial 
The essence of an RCT is the random allocation of individuals (or groups) of 
people into two (or more) groups.  The major strength of random allocation is 
that it is the best method available for dealing with selection bias, regression to 
the mean and temporal changes (Torgerson & Torgerson, 2008).  In a large 
enough trial, provided that investigators enrolling participants cannot see the 
sequence in which participants will be allocated to different groups, random 
allocation will produce groups that, on average, have the same characteristics 
as each other (Schulz, Chalmers, Grimes, & Altman, 1994; Schulz, Chalmers, 
Hayes, & Altman, 1995).  Known characteristics of patients that could affect 
outcome will be present in both groups without bias and unknown 
characteristics that could affect outcome will also be unbiasedly present in both 
groups.  The equal presence of all patient characteristics that could affect 
outcome in both groups will cancel out their effects in analysis.  Likewise, 
through random allocation, the role for temporal change and regression to the 
mean will also be equally present in each group and their effects will similarly 
cancel out in analysis.  Thus, in a large enough RCT, we can be confident that 
any differences observed between groups are due to the effect of the 
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intervention or, depending on the nature of the control group, the relative 
difference in the effect of two interventions. 
Based on a well-conducted RCT to compare patients randomly allocated to 
stepped care vs. high-intensity psychological therapy alone, we could be 
confident that differences in the outcomes associated with each were due to the 
effect of the interventions.  A large RCT would establish the clinical 
effectiveness of stepped care vs. high-intensity psychological therapy alone, 
with certainty, and by incorporating established methods for the estimation of 
the relative costs and benefits of complex interventions (Drummond, Sculpher, 
Torrance, O'Brien, & Stoddart, 2005), it would also be possible to understand 
whether stepped care offers added value, and hence potential to genuinely 
increase access to treatment, relative to the system it was designed to replace. 
2.12.2 The need for a systematic review 
The most reliable means to establish whether an RCT of stepped care vs. high-
intensity psychological therapy alone has already been undertaken is a 
systematic review.  A systematic review attempts to collate all of the relevant 
empirical evidence on an intervention and, by using explicit, systematic 
methods, provides a reliable estimate of its effects on which to base defensible 
conclusions and make decisions (Antman, Lau, Kupelnick, Mosteller, & 
Chalmers, 1992; Oxman & Guyatt, 1993).  Five key features of a systematic 
review (S. Green et al., 2008) are: 
 A clearly stated set of objectives with pre-defined eligibility criteria for 
including studies 
 An explicit and reproducible methodology 
 A systematic search that attempts to identify all studies that would meet 
eligibility criteria 
 An assessment of the internal validity of the included studies 
 A systematic presentation and synthesis of the included studies’ 
characteristics and results 
Bower and Gilbody’s (2005b) recommendation to undertake an RCT of stepped 
care compared with high-intensity psychological therapy alone was based on a 
narrative review of the literature conducted over ten years ago.  Since then, 
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several RCTs of stepped care have been undertaken (Davidson et al., 2013; Ell 
et al., 2010; Seekles, van Straten, Beekman, van Marwijk, & Cuijpers, 2011; 
van Dijk et al., 2013).  Yet an initial search in the Cochrane Database of 
Systematic Reviews (CDSR) and Database of Abstracts of Reviews of 
Effectiveness (DARE) found no systematic review of stepped care as the 
primary intervention against which other systems for the allocation of 
depression treatment were compared.  Without a systematic review, we cannot 
establish, with confidence, whether a large trial of stepped care vs. high 
intensity therapy alone has been conducted. 
Performing a systematic review of RCTs on the effectiveness of stepped care 
treatment for depression in adults would clarify if such a trial exists but would 
also provide an opportunity to appraise and synthesise all of the relevant RCTs 
on stepped care.  Although randomised controlled trials represent the ‘gold 
standard’ method for drawing causal inference, individual RCTs can be 
methodologically flawed, time and context dependent, inadequately reported 
and biased (Moher et al., 2010; P. Wilson, Petticrew, Calnan, & Nazareth, 
2008).  Individual studies can also reach conflicting conclusions, sometimes 
simply by chance (Centre for Reviews and Dissemination, 2008).  If appropriate, 
combining the results of studies on stepped care in a meta-analysis as part of a 
systematic review and doing so using methods that reflect the quality of 
included studies will provide a more reliable and precise estimate of the 
effectiveness of this system than would be possible from any one study alone 
(L'Abbe, Detsky, & O'Rourke, 1987; Oxman, 1993; Sacks, Berrier, Reitman, 
Ancona-Berk, & Chalmers, 1987).  A systematic review and meta-analysis of 
stepped care can establish if the existing evidence base as a whole is sufficient 
to determine whether stepped care is equivalent to long term, high-intensity 
psychological therapy for all. 
Meta-analysis would also facilitate an exploration of differences across studies 
(Deeks, Higgins, & Altman, 2008; S. Green et al., 2008).  If a sufficient number 
of studies were available, by looking at the results of different groups of those 
studies, it would be possible to explore ways in which stepped care has been 
implemented that may be associated with more or less effect. 
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2.12.3 The need for a mixed methods feasibility study 
If the results of a systematic review reveal that the effectiveness of stepped 
care compared with high-intensity psychological therapy alone has not been 
established, a fully-powered RCT of stepped care vs. high-intensity 
psychological therapy will be required.  However, to maximise the success of 
such a trial and help ensure resource is not wasted on an evaluation which 
produces an invalid result, it would first be important to conduct a feasibility 
study (Giangregorio & Thabane, 2015; Thabane et al., 2010). 
Feasibility studies are an opportunity to gather information on potential 
problems that might compromise the success of a main evaluation and to 
collect information to inform study design (Giangregorio & Thabane, 2015).  The 
terms ‘feasibility study’ and ‘pilot study’ are often used synonymously.   Where 
they are defined as distinct entities (Arain, Campbell, Cooper, & Lancaster, 
2010), feasibility studies refer to research done before a main study that is used 
to gather key pieces of information needed to design the main study.  Feasibility 
research questions usually centre around discrete study processes for example 
on recruitment or retention although feasibility studies need not involve a 
randomised controlled trial (Arain et al., 2010).  On the other hand, the term 
‘pilot study’ is used to refer to a mini version of the main study to test whether all 
of the components of that study will work together; conducted in anticipation of 
a large RCT, it will employ the same design as the main trial (Arain et al., 2010).  
Together, these types of studies have a similar aim to inform the development 
and conduct of a planned research project. 
Feasibility and pilot studies can be very useful to prepare for trials of complex 
interventions that present additional complexity in design and procedures 
compared with the evaluation of a sole pharmacological agent (Giangregorio & 
Thabane, 2015).  In support of the importance of this phase of work, the UK 
Medical Research Council guidance on the development and evaluation of 
complex interventions recommends a stage of ‘feasibility and piloting’ prior to 
full evaluation (Craig et al., 2008).  Undertaken in anticipation of a large trial of a 
complex intervention, areas of uncertainty that feasibility studies can address 
include clinical, methodological and procedural (Giangregorio & Thabane, 
2015). 
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In terms of a feasibility study on stepped care, this chapter has highlighted our 
lack of understanding of the acceptability of this system but also its relationship 
with therapeutic attendance.  Thus, alongside methodological and procedural 
aspects of a large stepped care trial about which we may be uncertain, it will be 
important to test the acceptability of the intervention and how this might relate to 
the number of therapy sessions trial participants attend.  In this regard, 
qualitative but also mixed methods can be used to make an important 
contribution to addressing clinical uncertainties.  Moreover, by successfully 
completing a feasibility study that involves a pilot trial of stepped care vs. high-
intensity psychological therapy alone, it will be possible to determine if a fully-
powered evaluation of the same can be done.  A mixed methods feasibility 
study will provide all of the information required to design a large trial and 
improve the chances that the main trial will achieve its objectives so that valid 
inferences can be made about the clinical and cost-effectiveness of stepped 
care compared with traditionally configured systems for the provision of 
psychological therapies. 
2.13 PhD programme of work 
In response to the need for research on stepped care, the purpose of my PhD 
has been to pursue a programme of work that will advance our understanding of 
the effectiveness and acceptability of this system for the treatment of 
depression in adults. 
This programme of work has comprised: (1) a systematic review of existing 
evidence on the effectiveness of stepped care treatment for depression and (2) 
a mixed methods feasibility study incorporating a pilot trial of stepped care vs. 
high-intensity psychological therapy alone for the treatment of depression in 
adults plus in-depth, semi-structured interviews to explore what trial participants 
think of stepped care.  Techniques for integrated mixed methods analysis have 
also been used to investigate how patients’ views of the intervention and 
therapeutic attendance might relate.  
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2.13.1 Systematic review 
The aim of the systematic review of stepped care was to assess the clinical 
effectiveness of stepped care for the treatment for depression in adults.  
Specific objectives were to:  
(1) determine whether existing evidence is sufficient to conclude, with 
confidence, that stepped care is equivalent to high-intensity psychological 
therapy for all;  
(2) investigate heterogeneity in trial findings by exploring aspects of study 
design and elements of the intervention that may be associated with more or 
less effect. 
From a non-systematic reading of the available literature, it was thought unlikely 
that the effectiveness of stepped care compared with high-intensity 
psychological therapy alone for depression had been reliably established.  
Whilst a systematic review and meta-analysis was required to establish this with 
certainty, a mixed methods feasibility study was planned (and subsequently 
undertaken) to prepare for a fully-powered randomised controlled trial of 
stepped care vs. high-intensity psychological therapy alone. 
2.13.2 Feasibility study 
The aim of the mixed methods feasibility study was to provide information to 
inform the design of a large randomised controlled trial that will evaluate the 
clinical and cost-effectiveness of stepped care vs. high-intensity psychotherapy 
alone for the treatment of depression in adults.  Specific objectives of the mixed 
methods feasibility study were to:  
(1) gather enough information on recruitment, retention, the proportion of 
patients who step up from low- to high-intensity psychological therapy and 
treatment effects to design a fully-powered clinical trial or to determine that such 
a trial is not feasible;  
(2) explore patients’ and therapists’ views of stepped care and the ways in 
which patients’ views relate to how much they engage in therapy to inform a 
stepped care clinical protocol for the main study. 
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2.13.3 A brief summary of anticipated impact 
Together, the results of the systematic review and mixed methods feasibility 
study will provide new knowledge on stepped care and its evidence base that 
will inform future programmatic research on this system.  Results are also likely 
to be of immediate interest to those involved in the design and delivery of 
current stepped care services for depression treatment.  If used successfully, 
the innovative application of techniques for integrated mixed methods analysis 
will demonstrate new and systematic ways in which such techniques can be 
used to combine quantitative and qualitative data with rigour to address 
important research questions in the development and evaluation of complex 
interventions. 
  
58 
CHAPTER 3.  METHODOLOGICAL FRAMEWORK 
Chapter Two set out the need for a programme of research on stepped care 
treatment for depression and ended with an outline of my doctoral studies, 
specifically, a systematic review and mixed methods feasibility study.    Before 
describing these studies in full (see Chapters Four to Six) this chapter sets out 
the methodological framework and philosophy that underpin my doctoral 
research. 
The chapter is organised into four main sections.  Evidence-based medicine 
and the need for experimental research are described in section 3.1.  This is 
followed by a summary of the Medical Research Council framework for the 
development and evaluation of complex interventions in section 3.2.  In the third 
section (3.3), I consider the value of mixed methods in health services research.  
The chapter finishes with a description of the philosophy of pragmatism that 
underpins my doctoral studies (section 3.4). 
3.1 Evidence-based medicine 
By the beginning of the 20th century, medicine had started to differentiate 
between successful interventions (e.g. vaccination and antiseptic surgery) and 
those of less certain benefit (Spring, 2007).   Based on this differentiation, the 
concept of evidence-based medicine (EBM) began to take shape (Spring, 
2007).  Initial attention focused on increasing advocacy for and control over 
medical training.  Several decades later, towards the end of the 1900’s, a 
faculty group was established at McMaster University, Canada, with significant 
interest in clinical epidemiology - the study of the determinants and 
consequences of health care decisions.  This group has been credited with a 
pivotal role in the modern development of EBM (Spring, 2007). 
3.1.1 Defining evidence-based medicine 
David Sackett, a key member of the McMaster group, defined evidence-based 
medicine as:  
“The conscientious, explicit, and judicious use of current best 
evidence in making decisions about the care of individual 
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patients,” (Sackett, Rosenberg, Gray, Haynes, & Richardson, 
1996) p 71. 
Based on this definition, clinical decision making involves integrating individual 
healthcare professionals’ expertise with the best available evidence from 
systematic research (Sackett et al., 1996).  ‘Clinical expertise’ is described as 
the “proficiency and judgment” (p 71) that clinicians acquire from experience 
and clinical practice; ‘best available evidence’ entails clinically relevant 
research, especially research into diagnostic tests, prognostic indicators and the 
efficacy and safety of health care interventions (Sackett et al., 1996).  Sackett, 
Richardson, Rosenberg, and Haynes (1997) also advocated that the practice of 
EBM should involve clinicians acquiring skills that allow them to convert their 
information needs into answerable questions; to find, as efficiently as possible, 
the best evidence with which to address them; and to critically appraise and 
apply that evidence before evaluating the outcome.  Defined as such, EBM 
represents a way of practising medicine for which clinicians were encouraged to 
acquire skills that would allow them to change their way of working for the 
duration of their careers. 
Although the role of patients was not obviously demarcated in Sackett et al.’s 
(1996) definition of EBM, in their description of what it entailed, the authors 
emphasised the need to consider patients.  Clinical expertise was said to 
manifest in the, “Thoughtful identification and compassionate use of individual 
patients’ predicaments, rights and preferences in making clinical decisions,” (p 
71); patient-centred research was given credence as a source of ‘best available 
evidence’ (Sackett et al., 1996).  In 2001, the U.S. Institute of Medicine adopted 
a modified definition that gave more prominence to patients.  EBM was defined 
as, “The integration of best research evidence with clinical expertise and 
patients values,” (Institute of Medicine, 2001a) (p 147).  Similarly, in a statement 
by the American Psychological Association (APA), evidence-based practice 
(EBP) was defined as, “The integration of the best available research with 
clinical expertise in the context of patient characteristics, culture and 
preferences (A. P. A. Presidential Task Force on Evidence-Based Practice, 
2006) (p 273). 
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Thus, today, in recognition of the role of patients alongside that of evidence and 
clinical experience, EBP is typically denoted by three overlapping circles (Figure 
1).  Clinical decision making is made by tying together or integrating information 
from each (Lilienfeld, Ritschel, Lynn, Cautin, & Latzman, 2013; Spring, 2007). 
 
Figure 1.The ‘three legged stool’ of evidence based practice – adapted from 
Spring (2007) 
3.1.2 The evolving role of patients in evidence-based medicine 
Although changing definitions of EBM have made the role of patients more 
explicit, other recent developments in how patients utilise and are involved in 
research also shape the meaning of EBP.  In 1996, Sackett et al. described 
clinicians as responsible for sensitively enquiring about and coming to 
understand individual patients’ circumstances and preferences which they 
should allow for when reaching a clinical decision (Sackett et al., 1996).  In 
contrast, in ‘Testing treatments’, Evans, Thornton, Chalmers, and Glasziou 
(2011) strongly encourage patients to proactively, “Raise concerns, questions 
and what’s important to them; recognise that they have a right to be equal 
participants in their care; seek and use high quality health information” (p159).  
The description of patient involvement in EBP in these two statements is 
representative of a move away from a model of ‘medical paternalism’, where a 
doctor (or other healthcare professional) ultimately remains responsible for 
evidence-based clinical decision making albeit considering and encouraging 
patients to share their needs, to a model of shared decision making (Thornton, 
2009) in which patients as well as clinicians track down, discuss and use 
evidence to help make decisions together.  Thus, the interface between patients 
Evidence 
Clinical expertise 
Patients' values, 
characteristics, 
preferences and 
circumstances 
Clinical decision 
making 
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and clinicians but also patients and evidence is altering in ways that are 
significant and see patients as well as clinicians using research for mutually 
agreed benefit. 
Patient involvement in EBP has also evolved in one other key respect.  The 
critical importance of actively involving patients (and the public) in research has 
been recognised and supported by the emergence of relatively new 
infrastructure and guidance.  The James Lind Alliance 
(http://www.lindalliance.org) brings patients, carers and clinicians together on an 
equal footing to jointly identify priorities for research (Partridge & Scadding, 
2004); how to involve lay members and good practices for doing so is the 
subject of helpful guidance from INVOLVE (http://www.invo.org.uk); in the UK, 
the National Institute for Health Research will not grant funding for research 
unless there is a programme of patient and public involvement (PPI) built into 
the research programme (National Institute for Health Research, 2016; 
Richards, 2015b).  New methods for patients and researchers to work together 
are developing across the whole spectrum of research activities including 
formulating research questions, study design and the analysis and interpretation 
of research findings (Evans et al., 2011).  In these ways, not only are patients 
seeking out and using evidence to help inform healthcare decisions made in 
conjunction with their clinician, they are also involved in the generation of 
evidence.  
3.1.3 Why evidence matters 
The need for research to inform clinical decision-making stems from uncertainty 
that arises in the absence of robust evidence regarding which treatments are 
effective or which treatments might be best for which patients.  Without 
research, rarely are benefits and harms of a potential intervention so clear that 
there is no room for doubt; most treatments do not have dramatic effects (Evans 
et al., 2011).  Rather, the degree to which an intervention is effective and for 
whom it may work is usually uncertain.    
Furthermore, as noted in chapter two (section 2.11) in the absence of robust 
research, patients’ apparent response to treatment cannot be reliably attributed 
to an intervention.  Diseases improve or resolve without intervention; people get 
better by believing in their treatment; other temporal changes occur (Evans et 
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al., 2011; Lilienfeld et al., 2013; Torgerson & Torgerson, 2008) e.g. children 
acquire new skills and understanding through maturity (Torgerson & Torgerson, 
2008).  Other factors, that may be unrelated to treatment, such as increased 
social support, can also generate gains (Lilienfeld et al., 2013). Without 
sufficient evidence, it is not possible therefore to disentangle the effects of an 
intervention from other explanations of why people improve: positive gains in 
patients’ health and wellbeing are liable to be misattributed to treatment. 
Difficulty making sense of the effects of treatments in the absence of robust 
research is evident in the use of treatments which are believed to be both safe 
and beneficial but that cause harm or are ineffective.   Evans et al. (2011) 
provide a number of examples.  Following World War II, an epidemic of 
‘blindness’ among premature babies was found to be associated with the way 
supplemental oxygen had come to be used in their management  (Silverman, 
1985); in the 1950s, a form of synthetic oestrogen called diethylstilboestrol 
(DES) that had been prescribed to help pregnant women who had previously 
had miscarriages and stillbirths, was found to be ineffective (Chalmers, 1989) – 
twenty years later, evidence emerged of an increased frequency of rare cancers 
in both men and women who had been exposed to DES before they were born 
(Ulfelder, 1980).  In each example, treatments for which there was insufficient 
research caused harm or were ineffective. 
Taken together, errors in the attribution of cause and effect and the cost to 
individuals and societies when interventions are implemented without good 
quality research on their benefits and harms, speak to the need for high quality 
evidence to inform clinical decision making. 
3.1.4 The need for experimental research 
Descriptions of EBP emphasise that it involves drawing on the most appropriate 
evidence to address a given uncertainty (A. P. A. Presidential Task Force on 
Evidence-Based Practice, 2006; Sackett et al., 1996; Spring, 2007).  Qualitative 
studies are used to elicit people’s views and opinions of a disease and / or 
treatment; public health and ethnographic research can track the availability and 
utilisation of treatments; process evaluations can help to identify mechanisms 
and moderators of treatment effects (A. P. A. Presidential Task Force on 
Evidence-Based Practice, 2006).  However, to answer questions about 
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treatment efficacy (the ability of a treatment to work in ideal circumstances) and 
effectiveness (the degree to which a treatment works in practice), experimental 
research is needed that has the potential to provide credible information which 
can be trusted to inform clinical decision-making. 
As described in chapter two, the key benefit of experimental research - in which 
one or more factors is deliberately (or experimentally) manipulated - is that, 
relative to other forms of research, it has potential to establish causality with 
greater certainty.  Observational cohort studies that compare similar groups of 
patients who have received different treatments in the same timeframe and 
historical comparisons which investigate outcomes for patients who have 
received different treatments over different timeframes are more susceptible to 
selection and other biases (see section 2.11). 
In terms of different experimental approaches, randomised controlled trials 
(RCTs) comprise our most robust method for assessing treatment effects 
(Collins & MacMahon, 2001; Eccles, Grimshaw, Campbell, & Ramsay, 2003; 
Torgerson & Torgerson, 2008).  As previously argued (in section 2.12.1) in a 
large and well conducted RCT, allocation of individuals to two or more groups at 
random will produce groups that have, on average, the same characteristics as 
each other (Torgerson & Torgerson, 2008).  Known but also unknown and 
therefore unmeasured patient characteristics that might rival treatment as an 
explanation of effect, will be evenly distributed across groups (Torgerson & 
Torgerson, 2008).  The presence of all such variables that could affect outcome 
(including people’s experience of spontaneous remission, placebo effects and 
other temporal changes) will be present without bias in all groups and the 
effects of such characteristics will be cancelled out in analysis (Torgerson & 
Torgerson, 2008).   In this way, large and well conducted RCTs make it possible 
to arrive at healthcare decisions based on information that can be trusted to 
represent the effect of treatment. 
3.2 The development and evaluation of complex interventions 
In the last fifteen years, EBP encompassing a recognition of the requirement for 
experimental research, has gained increasing traction outside of medicine in 
fields including education, social work, psychology, and public health (Lilienfeld 
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et al., 2013).  Across all fields, options for intervening in people’s lives for better 
health and quality of life are examples of so called ‘complex interventions’.  
Interventions can be complex in terms of different parameters (Richards, 
2015a).  The Medical Research Council (Campbell et al., 2000; Craig et al., 
2008) emphasise characteristics of the intervention itself by suggesting that  
complex interventions comprise a number of components that may act 
dependently and / or inter-dependently to achieve effect; the greater the 
difficulty defining what the ‘active ingredients’ are and how they relate, the 
greater the likelihood that the intervention is complex (Campbell et al., 2000).  
Others define complexity with respect to the context in which an intervention is 
implemented and how an intervention might be implemented (Anderson et al., 
2013; Datta & Petticrew, 2013).  On whichever respect definitions focus, 
complex interventions present a number of challenges in terms of generating 
high quality research to inform decision-making (Craig et al., 2008; Richards, 
2015a). 
3.2.1 The MRC framework 
In response to such challenges, in 2000, the UK Medical Research Council 
(MRC) published a framework for researchers on how to investigate the effects 
of complex interventions (Campbell et al., 2000).  This document was 
subsequently updated (Craig et al., 2008) and the MRC framework has been 
widely used as tool for helping the research community improve the quality and 
value of complex interventions’ research.  Guidance covers four stages of 
research: develop, test, evaluate and implement.    
Develop 
The goal of the first stage of the MRC framework is to develop an intervention to 
the point where it can be reasonably expected to be effective (Craig et al., 
2008).  This involves acquiring a secure knowledge of the existing evidence for 
the intervention, becoming clear about its theoretical base, being able to 
describe how it will be implemented, and modelling in order to be sufficiently 
convinced that, should the intervention be proven effective, it will be adopted by 
those for whom it is intended.  At this stage, there is also an ethical and 
scientific imperative to establish whether further research is required at all and, 
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for this, relevant prior research must be properly identified (Robinson & 
Goodman, 2011). 
Test 
Once adequate development work has been undertaken, an intervention can 
then be evaluated.  However there may be a number of uncertainties that have 
the potential to undermine the success of the evaluation if they are not 
addressed (Richards, 2015a) – see Chapter Two, section 2.12.3.  These 
uncertainties often concern the feasibility of potential research methods and 
procedures and the degree to which an intervention is acceptable to the people 
who will deliver and receive it (Richards, 2015a).  Conducted prior to the main 
evaluation, feasibility testing and piloting encourages methodological rigour 
(Lancaster, Dodd, & Williamson, 2004) and can enhance the likelihood of 
success of the main evaluation (Thabane et al., 2010). 
Evaluate 
In the evaluation stage of the MRC framework, the main aim is to establish 
causality i.e. the link between the intervention and effect (Richards, 2015a).  
Minimising bias is critical and possible to achieve through randomisation.  
Nonetheless, in circumstances where randomisation may not be possible, 
criteria are available to help researchers consider other methods by which they 
can establish causality beyond reasonable doubt (A. B. Hill, 1965; Howick, 
Glasziou, & Aronson, 2009).  In parallel to the main evaluation, the 2008 
guidance also recommends  that two other forms of investigation are conducted 
– process and economic evaluations (Craig et al., 2008).  A process evaluation 
is designed to identify for whom, in what circumstances and how an intervention 
‘works’ (Moore et al., 2014); health economists have developed ways of 
estimating the economic value of treatments to individuals so that the benefits 
and costs of different interventions can be compared  (Bowling, 2005; Elliot & 
Payne, 2005).  
Implement 
In the last phase of the MRC framework, three forms of activity are suggested to 
help the results of evaluative studies translate into routine practice: (1) active 
dissemination of research findings; (2) ‘implementation research’ - focused on 
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how to successfully embed an intervention in routine practice; and (3) long-term 
follow-up and monitoring to identify the actual effects of an intervention in 
practice plus any unanticipated consequences (Craig et al., 2008).  In the last 
decade or so, the implementation of complex interventions and with it, the need 
for implementation research, has received increasing attention (van Achterberg, 
2015).  Strategic and systematic approaches to the identification of factors that 
facilitate and hinder the adoption of interventions have been developed 
(Helfrich, Li, Sharp, & Sales, 2009; May et al., 2009; McCormack, McCarthy, 
Wright, Slater, & Coffey, 2009).  In addition, methods for implementing 
interventions have themselves become the subject of a scientific approach 
(Boaz, Baeza, Fraser, & for the European Implementation Score Collaborative 
Group (EIS), 2011). 
In practice, developing, testing, evaluating and conducting implementation 
research into complex interventions can take a very wide range of different 
forms.  Moreover, despite the linear description of the MRC framework provided 
above, the order in which different stages of the process is undertaken is 
flexible and the stages, as summarised, are not necessarily discrete.  
Nonetheless, implemented in a variety of ways, by providing guidance to help 
researchers, the MRC framework has potential to support a better standard of 
research on the development and evaluation of complex interventions.  
3.2.2 Implications for research on stepped care 
Stepped care typifies a complex intervention.   As a system for the organisation 
of depression treatment, it contains several interacting components.  At the 
‘highest’ level these include low-intensity psychological therapy, a means to 
decide who ‘steps up’, high-intensity psychological therapy and the contribution 
of one or more therapists.  Stepped care is also implemented in diverse ways 
for different patient groups (Glover et al., 2010; Richards et al., 2012; Richards 
et al., 2010) and it is probable that the anticipated effects of stepped care will be 
modified by patient characteristics.  Thus, as a complex intervention, the MRC 
framework is available to inform the development and evaluation of this system 
for the allocation of depression treatment and, in response to the need for 
research described in chapter two, the MRC framework was used to guide my 
PhD programme of work    
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This programme of work covered two stages of the MRC framework: 
development and testing.  With respect to development, study one entailed a 
systematic review of the effectiveness of stepped care.  This was designed to 
avoid research waste and un-necessary burden on patients by ascertaining the 
need for further research on stepped care, specifically, whether a fully-powered 
RCT of this system vs. high-intensity psychological therapy alone was required.  
Other development work (e.g. to establish, as far as possible, whether the 
intervention was likely to be effective and modelling to help ensure that, if 
proven effective, the intervention could be implemented) was not undertaken for 
two main reasons: (1) at the beginning of my PhD, various forms of stepped 
care were already widely implemented; (2) the favourable effects of low- and 
high-intensity variants of Cognitive Behaviour Therapy (CBT) that would 
comprise the key therapeutic components of the stepped care intervention to be 
tested in study two had been convincingly demonstrated (Cuijpers, Berking, et 
al., 2013; Cuijpers, Hollon, et al., 2013; National Institute for Health and Care 
Excellence, 2009b).  With finite resource available, study two was therefore 
designed to test key methodological, procedural and clinical uncertainties 
associated with the conduct of a fully-powered evaluation of stepped care vs. 
high-intensity CBT.  Given the existing evidence base for and widespread use 
of high-intensity CBT for depression, this work did not include research to 
enhance the control intervention. 
3.3 Mixed methods for complex interventions 
As noted, my PhD studies comprised: (1) a systematic review of the 
effectiveness of stepped care and (2) a mixed methods feasibility study to 
prepare for a large RCT.  The mixed methods study incorporated a pilot trial 
and semi-structured interviews. 
3.3.1 Defining mixed methods research 
Studies that incorporate more than one type of method have been published 
from the late 1950’s.  However, in the late 1980s, there was a more systematic 
attempt to develop ‘mixed methods’ as a distinct approach to research 
(Creswell & Plano Clark, 2011).  Authors from different disciplines considered 
how to link, combine and integrate quantitative and qualitative data and several 
definitions of mixed methods research were proposed. 
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Tashakkori and Teddlie (1998) provided an early and straightforward definition 
of mixed methods as the combination of, “Qualitative and quantitative 
approaches in the methodology of a study,” (p ix).  Others have similarly 
focused on the use of both quantitative and qualitative methods but also  
emphasise how different data types might be combined (‘mixed’ or ‘folded 
together’) as well as the world view or philosophy that underpins data collection 
and analysis.  This is illustrated by Creswell and Plano Clark (2007) who have 
defined mixed methods as, “A research design with philosophical assumptions 
as well as methods of inquiry.  As a methodology, it involves philosophical 
assumptions that guide the direction of the collection and analysis of data and 
the mixture of qualitative and quantitative approaches...  As a method, it 
focuses on collecting, analysing and mixing both quantitative and qualitative 
data in a single study or series of studies…” (p 5). 
3.3.2 Types of mixed methods research 
In practice mixed methods are employed in a range of different forms and 
alongside attempts to define mixed methods, several approaches have been 
developed for characterising or classifying the design of mixed methods studies 
(Creswell, Plano Clark, Gutmann, & Hanson, 2003).  One such approach by 
Cresswell and Plano Clark (2011) offers six prototypes which differ according 
to: the order in which qualitative and quantitative elements of work are 
undertaken; the relative priority of each – which, if either, of the qualitative or 
quantitative strand is given precedence; and for what purpose and at what point 
the quantitative and qualitative elements are integrated – during data collection, 
analysis or the interpretation of results only.  Two of the prototypes are the 
‘embedded’ and ‘multi-phase’ designs. 
In the embedded design, one type of data is given priority while the other is 
used mainly in a supportive capacity.  Qualitative and quantitative elements are 
mixed from the outset in that the research is purposefully designed so that the 
supplemental data can inform what the major component may entail or be used 
to better understand or explain the results obtained from it; the collection of the 
supporting strand of data can occur before, during or after the major component 
(Creswell & Plano Clark, 2011).  In this design, mixed methods are employed 
within a single study. 
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The multi-phase design involves a series of connected studies.  Studies may be 
undertaken concurrently or sequentially; each study will comprise quantitative, 
qualitative or mixed methods; across all studies, both quantitative and 
qualitative methods are employed (Creswell & Plano Clark, 2011).  Importantly, 
successive studies build on what has already been learned and equal priority is 
afforded to the quantitative, qualitative (and mixed methods) elements (Creswell 
& Plano Clark, 2011). 
At the current time, multi-phase designs are most common in large funded 
studies where the purpose is to advance one programmatic objective by 
addressing a series of incremental research questions (Creswell & Plano Clark, 
2011).  In respect of my PhD, a systematic review followed by a mixed method 
feasibility study can be considered to comprise two stages (development and 
testing) of a multi-phase design that has been organised in line with the MRC 
complex interventions framework (2008).  The mixed methods feasibility study 
employs an embedded design.  
3.3.3 The value of mixed methods in the development and evaluation of 
complex interventions 
From the description of the multi-phase and embedded designs, it is possible to 
appreciate ways in which mixed methods are suited to the development and 
evaluation of complex interventions.  
Mixed methods and complexity 
For research on complex interventions to be of value to patients, professionals 
and others who deal with multiple uncertainties when making decisions about 
service provision or healthcare for individuals, researchers also need to address 
multiple uncertainties (Borglin, 2015; Griffiths & Norman, 2013).  In this respect, 
there is growing recognition that mixed methods may be ‘fit for purpose’ 
(Wisdom, Cavaleri, Onwuegbuzie, & Green, 2012).  Quantitative or qualitative 
research alone may not be appropriate to address different research questions.  
Indeed, by describing a phased and potentially iterative approach to 
researching complex interventions and by providing examples of good practice 
involving both qualitative and quantitative methods, the MRC framework (2008) 
highlights the potential of different methods.  The multi-phase design described 
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by Creswell and Plano Clark (2011) is particularly suited to the ‘develop, test, 
evaluate, implement’ stages of complex interventions research.  Mixed methods 
designs that capitalise on the strengths of both methodologies by combining 
them in a single study to increase breadth and depth of understanding  
(Johnson, Onwuegbuzie, & Turner, 2007) offer potential at all stages of the 
MRC framework (Borglin, 2015). 
Advantages of gathering quantitative and qualitative information 
Collecting quantitative and qualitative data in single study or programme of 
research in the development and evaluation of complex interventions offers 
potential to offset the limitations of both types of information (Borglin, 2015; 
Creswell, 2003; Creswell & Plano Clark, 2011).  Moreover, the use of different 
data types may strengthen the credibility of research (Creswell, 2003).  Where 
the results of quantitative and qualitative analysis concur, data might be 
considered more trustworthy; where different data types conflict, this might raise 
important questions warranting further investigation.  Mixed methods also offer 
potential to help answer research questions that lend themselves to the 
integration of quantitative and qualitative data.    
In this regard, Creswell and Plano Clark (2011) advise researchers to identify 
separate research questions for quantitative and qualitative methods and a 
mixed methods question that frames the integration of the results from both.  
This approach raises the possibility of answering specific questions relating to 
the ‘mixing’ of the quantitative and qualitative data.  Examples of mixed 
methods questions include, “In what ways do the qualitative data help explain 
the quantitative results?” and, “To what extent do the quantitative and 
qualitative results converge?” (Creswell & Plano Clark, 2011) (p 166). 
Such questions require researchers to explore the relationship between 
quantitative and qualitative phenomena.  At present, the most well-known form 
of mixed methods comprises the simultaneous collection of quantitative and 
qualitative data that are integrated only at the point of discussion (Kettles, 
Creswell, & Zhang, 2011).  In contrast, mixed methods can also be used to 
address mixed methods research questions by ‘merging’ quantitative and 
qualitative data at the point of analysis (Creswell & Plano Clark, 2011).  In this 
way, it is possible that mixed methods might support a novel, potentially deeper 
71 
understanding of phenomena than may be possible from quantitative or 
qualitative analysis alone. 
Helping avoid research waste  
One other advantage of mixed methods is advanced by Creswell (2003) which 
also applies to their use in the development and evaluation of complex 
interventions.  Specifically, mixed methods support an incremental or stepwise 
increase of knowledge.  By conducting mixed methods, sequentially or 
concurrently, it is possible to build in ‘feedback loops’: knowledge from one 
strand of research can inform another (Cresswell 2003).  By providing such 
opportunities, the use of mixed methods may help to reduce levels of avoidable 
waste in studies that fail to provide appropriate, credible and useful information 
due to correctable problems e.g. in the formulation of research questions and 
study design (Chalmers & Glasziou, 2009).  For example, in a multi-phase 
design, results from a systematic review might determine what, if any, 
qualitative research is required to help develop a new intervention; in an 
embedded mixed methods study, feedback from qualitative interviews set in a 
pilot trial might provide important insights regarding the acceptability of an 
intervention – the interviews may suggest that a main evaluation is not 
warranted.    By using what has been learnt from one methodological strand of 
research to inform another, mixed methods can help minimise unnecessary 
research waste in the development and evaluation of complex interventions. 
3.4 Philosophical assumptions 
All forms of research, mixed methods included, are underpinned by a set of 
implicit or explicit beliefs and assumptions about the nature of our world and our 
ability to know it (Greene & Caracelli, 1997).  Collectively, those assumptions, 
variably called a paradigm (Greene & Caracelli, 1997) philosophy or worldview 
(Creswell & Plano Clark, 2011) warrant different types of methods.  Two such 
philosophies, constructivism and positivism, are typically associated with 
qualitative and quantitative methods.  For purists, these worldviews are 
incompatible: they encompass different assumptions that cannot be reconciled 
with the logical result that it is not possible to combine mixed methods in a 
single study or programme of work.  For researchers who employ mixed 
methods, a different perspective is required. 
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3.4.1 The pragmatic perspective 
From a pragmatic perspective, different philosophies can be upheld.  Those 
who support this philosophy argue that, in the real world, studies rarely 
exemplify a paradigm in full but embody different worldviews in how they are 
conducted; moreover, contradictions between different paradigms do not need 
to be resolved (Patton, 1988).  Thus, researchers who adopt a pragmatic 
philosophy reject the need to choose between positivism and constructivism; 
methods which are typically associated with each of these worldviews can be 
combined (Borglin, 2015).  Pragmatism is also characterised by one other key 
feature: the primary importance given to the research question (Creswell & 
Plano Clark, 2011).  When deciding on and planning how to approach an 
investigation, the research question is more important than a philosophy or 
method in determining how that inquiry takes shape.    The emphasis is on the 
objective or purpose of the research and ultimately doing ‘what works’ to 
address it.  At this time, pragmatism is commonly associated with mixed 
methods research (Creswell & Plano Clark, 2011; Johnson & Onwuegbuzie, 
2004; Johnson et al., 2007).  It also underpins my PhD programme of research. 
3.4.2 Pragmatism and my PhD 
In conducting elements of a multi-phase programme of research on stepped 
care, I have afforded highest priority to the research questions to be addressed.  
For example, starting with the question, ‘What is the existing evidence on the 
effectiveness of stepped care treatment for depression in adults?’, I selected the 
most appropriate method (a systematic review) to address this question.  
Similarly, to prepare for a fully-powered trial of stepped care vs. high-intensity 
psychological therapy alone, a mixed methods design was chosen to address 
key methodological, procedural and clinical uncertainties associated with the 
conduct of that trial.  By attaching primary importance to the research questions, 
my approach is consistent with a pragmatic worldview. 
Congruent with pragmatism, my research also embodies multiple philosophies.  
In conducting a pilot RCT, I have upheld a positivist paradigm: I have sought, 
for example, to measure the effect of stepped care compared with CBT alone 
on symptoms of depression to inform the sample size calculation required for a 
main evaluation.  This is illustrative of the ‘determinism’ or ‘cause and effect’ 
73 
thinking which characterises positivism.  I have also subscribed to a 
constructivist worldview: the results of qualitative interviews on the acceptability 
of stepped care have been analysed allowing for multiple participant meanings, 
accepting that those meanings are shaped by social interaction with others, 
including myself as the researcher, and participants’ own personal histories.  By 
upholding positivism and constructivism, but also by attaching primary 
importance to the research questions to be addressed, I have illustrated how 
my doctoral thesis embodies a pragmatic perspective. 
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CHAPTER 4.  SYSTEMATIC REVIEW OF STEPPED CARE FOR 
DEPRESSION 
Earlier in this thesis, several observational cohort studies were described which 
found that stepped care implemented in routine clinical practice is associated 
with favourable patient outcomes (see Chapter Two).  Although the results of 
such studies assess the ‘real life’ effectiveness of this system, they do not 
establish causality: outcomes cannot be reliably attributed to stepped care.  
Moreover, whilst two of the observational studies cited published findings on the 
effects of high-intensity psychological therapy alongside their primary data on 
the effect of stepped care in routine clinical practice (Parry et al., 2011; 
Richards & Suckling, 2009), none directly compared these systems. 
To determine the relative effectiveness of stepped care vs. high-intensity 
psychological therapy alone with greater certainty requires a fully-powered 
RCT.  Although several large trials of stepped care have been conducted 
(Davidson et al., 2010; Katon et al., 2004; Unutzer et al., 2002), a systematic 
review is needed to determine, with confidence, if this body of work provides 
sufficient evidence to determine whether stepped care is equivalent to high-
intensity psychological therapy for all – the system it was designed to replace.  
As such, this chapter reports a systematic review encompassing a meta-
analysis of randomised controlled trials of stepped care; meta-analyses also 
allowed for an exploration of the features of this intervention that may be 
associated with more or less effect. 
4.1 Chapter structure 
This chapter is organised into three main sections.  Section one summarises 
the methods, results and conclusions of a systematic review and meta-analysis 
of stepped care conducted between September 2012 and March 2013.  The 
results of this work have been published and the article is reproduced in section 
one with additional information provided: 
van Straten A, Hill J, Richards DA, Cuijpers P. (2014) Stepped care treatment 
delivery for depression: a systematic review and meta-analysis. Psychological 
Medicine, 45 (2): 231-246. 
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Section two comprises an update of the original review conducted between 
November and December 2015.  The method underpinning the update is 
described; results reported are those combined with data from the original 
review.  Section three comprises a succinct description of key conclusions.  
(Results are discussed in full in Chapter Seven.) 
4.2 Part I - Original systematic review and meta-analysis 
The original review (undertaken from September 2012 to March 2013) was 
conducted by myself (JJH) in collaboration with Professors van Straten (AVS), 
Richards (DR) and Cuijpers (PC).  The study team were responsible for 
different activities: the scope of the review, search strategy and study inclusion 
criteria were defined by AVS, DR and PC; JJH and AVS were jointly responsible 
for study identification and data extraction – DR acted as a third reviewer.  Risk 
of bias assessment and narrative synthesis of included studies were produced 
by JJH.  Meta-analyses were performed by AVS.  Methods are described 
further in section 4.2.2. 
4.2.1 Aim and specific objectives 
The aim of the original systematic review of stepped care was to assess the 
clinical effectiveness of stepped care for the treatment for depression in adults.  
Specific objectives were to: (1) determine whether existing evidence is sufficient 
to conclude that stepped care is equivalent to long term, intensive psychological 
therapy for all; (2) investigate heterogeneity in trial findings by exploring aspects 
of study design and elements of the intervention that may be associated with 
more or less effect.  
4.2.2 Method 
Search strategy 
A comprehensive literature search was conducted in PubMed, PsycINFO, 
EMBASE, and the Cochrane Central Register of Controlled Trials. Terms 
indicative of depression were combined with those of stepped care (Box 1).  
Literature was searched up to April 2012 without any language restrictions.  
Identified protocol papers published before April 2012 were followed up to 
determine if the researchers had subsequently published their findings before 
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May 2013. Two researchers (AVS and JJH) reviewed all of the abstracts and 
titles of retrieved references for eligibility. Full papers were retrieved for all of 
the references that had been judged as potentially eligible and were examined 
independently by two of AVS, DR and JJH.  In case of disagreement the paper 
was discussed with the third reviewer until a consensus was achieved. 
Reference lists of the included papers and a recent meta-analysis on 
collaborative care (Archer et al., 2012) were checked. 
 
Box 1. Systematic review search terms 
 
Cochrane Central Register of Controlled Trials 
MeSH descriptor: Depression OR Mood Disorders OR Depressive Disorder 
AND 
Free text in title, abstract and keywords: stepped AND care 
 
Embase 
Major descriptor: Depression OR Major Affective Disorder (search terms exploded) 
AND 
Free text: stepped AND care 
 
PsycINFO 
From the thesaurus: Depression OR Major Depression OR Affective Disorders (search terms exploded) 
AND 
Free text: stepped AND care 
 
PubMed 
MeSH descriptor: depression OR depressive disorder OR mood disorders 
AND 
Free text search in all fields: stepped AND care 
 
 
 
Inclusion criteria 
Inclusion criteria were as follows: (1) the study had to be a randomised 
controlled trial (2) aimed at adults (3) with a recognised depressive disorder 
(meeting criteria set by the World Health Organization or American Psychiatric 
Association) identified through a diagnostic interview, or with depressive 
symptoms established by scoring above a cut-off on a depression questionnaire 
and, (4) investigating ‘stepped care’ as one of the randomised trial arms.  
Randomised controlled trials could be of any type e.g. cluster, stepped wedge.  
The definition of stepped care was developed to reflect the widespread use of 
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pharmacotherapy alongside psychological treatment and the use of the term to 
refer to both the organisation of psychological therapies in order of intensity but 
also treatment where at each ‘step’ patients switch or add treatments of 
different modalities (pharmacological, psychological).  Stepped care was 
defined accordingly i.e. as the availability of more than one psychological 
treatment of different intensities and / or the availability of more than one 
treatment modality (pharmacological and psychological treatments).  Treatment 
had to include psychological therapy.  The intensity of psychological treatments 
was defined with respect to the time to deliver; non-psychological 
(pharmacological) treatments were not characterised in this regard.  We did not 
require treatments to be organised in a hierarchy of low- to high-intensity.  
Decisions about stepping up had to be based on a systematic clinical evaluation 
undertaken by a clinician or through questionnaire assessment, performed at a 
pre-specified time interval and with an explicit aim to determine the next 
treatment step.  Studies were included in which only a proportion of patients 
were depressed, for example studies including patients with a common mental 
health disorder and a subgroup of patients specifically diagnosed with 
depression.  Physical and psychiatric comorbidity with other disorders was 
allowed. Studies were included regardless of their setting or control group. 
Data extraction 
General characteristics of the studies were extracted as follows: year of 
publication, country, randomisation level (patient or cluster), number of trial 
arms, features of the control group (e.g. treatment as usual, waiting list), setting, 
how depression or depressive symptoms were established (e.g. diagnostic 
interview or scoring above a cut-off on a questionnaire), participants’ diagnosis / 
symptom profile in terms of depression and anxiety as an inclusion criteria, 
possible comorbidity as an inclusion criterion (e.g. cancer patients, diabetes), 
age, total number of patients included in the study.  Features of the stepped 
care interventions that were coded were: number of steps, the content of the 
interventions in each step, stepping criteria, treatment providers (e.g. mental 
health nurses, psychologists) and total duration of the programme.  Extracted 
outcome data were: primary and secondary outcome measures relevant to the 
review, continuous (e.g. means, standard deviations) and / or dichotomous (e.g. 
proportion ‘recovered’) data for each measure at each time point.  Two 
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independent assessors coded each study; differences were discussed by JJH, 
DR and AVS until consensus was reached.  
Risk of bias assessment 
The internal validity of studies was assessed using criteria as suggested by the 
Cochrane Handbook (The Cochrane Collaboration, 2011): adequate sequence 
generation; concealment of allocation; blinding of participants, study personnel 
and outcome assessors; intention to treat (defined as whether participants were 
analysed in the groups to which they had been allocated) and handling 
incomplete outcome data; selective outcome reporting; other potential threats to 
internal validity. Two reviewers conducted the quality assessment 
independently of each other.   Summary assessments were made for individual 
studies by counting the number of domains in which the study was considered 
at low and high risk of bias. 
Meta-analyses 
Between-group effect sizes (Cohen’s d) were calculated for all individual 
studies.  The effect size represents the difference between two groups in 
number of standard deviations (Cooper & Hedges, 1994; Hedges & Olkin, 1985; 
Lipsey & Wilson, 1993).  Available statistics as published in the papers (means 
and standard deviations, mean difference score and 95% confidence interval, or 
proportions of patients improved or recovered) were used to calculate between-
group effect sizes.  Effects were subsequently pooled across treatment trials; 
data from prevention trials and treatment trials reporting insufficient outcome 
data for meta-analyses were excluded.  Missing data were not imputed.  When 
more than one outcome was reported (e.g. more than one depression 
questionnaire or more than one cut-off score) sensitivity analyses of post-test 
effects were performed: effects were pooled using (a) the highest reported post-
test effect size for each study, (b) the lowest reported post-test effect size for 
each study and (c) the combined post-test effect size for each study.  (The 
combined effect size averaged the between-group differences from the various 
measures used in a given study.) 
Individual effect sizes as well as the pooled effects were calculated using the 
computer program Comprehensive Meta-analysis version 2.2.046 for Windows, 
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developed for support in meta-analysis (www.metaanalysis.com).  Statistical 
heterogeneity i.e. variability in the intervention effects being evaluated in the 
different studies (The Cochrane Collaboration, 2011) was tested under the 
fixed-effect model using the statistics I2 and Q.  This model assumes that there 
is one true effect size underlying all of the studies included in the analysis 
(Borenstein, Hedges, Higgins, & Rothstein, 2009).  Pooled effects are hence 
interpreted as an estimate of that true effect (Deeks et al., 2008).  I2 describes 
the proportion of variance between studies that is due to heterogeneity rather 
than sampling error (The Cochrane Collaboration, 2011): a value of 0% 
indicates no observed heterogeneity; larger values were interpreted as 
evidence of heterogeneity - 25% suggested a low degree of heterogeneity, 50% 
moderate and 75% high. The statistical significance of the heterogeneity was 
tested with the Q statistic. A significant Q value rejects the null hypothesis that 
observed differences between studies are compatible with chance alone (The 
Cochrane Collaboration, 2011). All results in which the p-value was less than 
0.05 were marked.  In the presence of statistical heterogeneity, pooled effect 
sizes were calculated using the random effects model.  In contrast to the fixed-
effect model, under this model the true effect of the intervention is assumed to 
vary from study to study (Borenstein et al., 2009).  Pooled effects represent an 
‘average’ of systematically different intervention effects (Deeks et al., 2008).  
Formulae for the basic meta-analyses (i.e. calculation of Cohen’s d, pooled 
effects using the random effects model, the Q statistic and I statistic) are 
provided at Appendix I. 
Sub-group analyses investigated heterogeneity and were performed to explore 
characteristics of the stepped care interventions and study design that may be 
associated with more or less effect.  Significant differences between the effect 
sizes in different categories of studies were tested.  The mixed effects model 
was used which pooled studies within subgroups using the random effects 
model but tested for significant differences between them using the fixed effects 
model.  Publication bias was tested by inspecting the funnel plot, and by Duval 
and Tweedie’s trim and fill procedure that yields an estimate of the effect size 
after publication bias has been taken into account - as implemented in 
Comprehensive Meta-Analysis  (Duval & Tweedie, 2000). 
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Summary of outcomes among studies excluded from meta-analysis 
The effects of stepped care as reported in prevention studies and treatment 
trials with insufficient data to include in meta-analyses were summarised.  
Between-group effect sizes (Cohen’s d) were calculated for individual treatment 
trials; incidence rate ratios were derived from published data on the prevalence 
of depression in the prevention studies.  A pooled incidence rate ratio was 
calculated for indicated prevention trials. 
4.2.3 Results 
Inclusion of studies 
A total of 343 unique records were identified from electronic databases and 
other sources (Figure 2).  After screening, 61 full text papers were retrieved and 
reviewed; 47 did not fulfil study inclusion criteria and were excluded.  Fourteen 
studies on stepped care treatment for depression were included: Unutzer et al. 
(2002) [study number 13]; Araya et al. (2003) [2]; Katon et al. (2004) [10]; Ell et 
al. (2008) [7]; van't Veer-Tazelaar et al. (2009) [14]; Bot, Pouwer, Ormel, Slaets, 
and de Jonge (2010) [3]; Davidson et al. (2010) [4]; Ell et al. (2010) [8]; Patel et 
al. (2010) [11]; Seekles et al. (2011) [12]; Apil, Hoencamp, Haffmans, and 
Spinhoven (2012) [1]; Dozeman et al. (2012) [6]; Davidson et al. (2013) [5]; 
Huijbregts et al. (2013) [9].  The results of one trial [3] were not published in full: 
post-test data were only available for the intervention and control arms 
combined; data was not reported at each time point.  The authors were 
contacted to obtain the (unpublished) research protocol and additional results. 
Ten of the 14 studies were included in quantitative meta-analyses on the 
treatment of depression in which outcomes were expressed as the reduction of 
depressive symptoms. One treatment trial [3] was excluded because the 
authors did not provide post-test results but long-term follow-up data only.  The 
three remaining trials were aimed at prevention of depression either as 
indicated prevention [6, 14] or relapse prevention [1] with the incidence of 
depressive disorders as the main outcomes. 
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Figure 2. Study identification and selection for meta-analyses 
 
 
Characteristics of the included studies 
The 14 studies included a total of 5194 patients of whom 2560 were 
randomised to stepped care and 2634 to a control condition.  For the ten 
studies included in the quantitative meta-analyses, the total number of included 
patients was 4580 with 2243 in the stepped care arms and 2337 in the control 
(Table 1). 
Twelve of the included trials were patient-randomised [studies 1-8, 10, 12-14]; 
two were cluster-randomised [9, 11]. Six trials were conducted in the US [4-5, 7-
8, 10, 13], six in The Netherlands [1, 3, 6, 9, 12, 14], one in Chile [2] and one in 
India [11].  Participants were recruited mainly from primary care [2, 9-11, 12-14] 
or secondary care [3-5, 7]. All studies compared stepped care to usual care, 
either standard [1-6, 9-10, 12-14] or ‘enhanced’ [7-8, 11]. 
Of the eleven treatment trials, six [3-5, 7-8, 10] included patients scoring above 
a cut-off on a self-rated depression questionnaire only; two of those [7, 8] also 
used the core symptoms of Major Depressive Disorder (MDD).  Five others [2, 
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9, 11-13] performed diagnostic interviews to include patients with MDD; one 
study [12] also included patients with minor depression and two [12, 13] also 
included patients with dysthymia. The three prevention trials [1, 6, 14] used a 
diagnostic interview to exclude patients with existing MDD.  Six of the studies 
were aimed at depressive symptoms among patients with either co-morbid 
acute coronary syndrome [4-5], cancer [7] or diabetes mellitus [3, 8, 10].  Five 
trials, including the three prevention studies, were specifically aimed at older 
adults [1, 3, 6, 13, 14]. 
 
 
 
Table 1 overleaf
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Table 1. Characteristics of included studies (continued overleaf) 
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Table 1. Characteristics of included studies (continued from previous page) 
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Notes:  1 not included in quantitative meta-analysis; 2 total N in this trial is 2796 but only results from the depressed subsample were 
included in meta-analyses; 3 age in- and exclusion criteria ‘not specified’; 4 no particular feature of usual care described; 5 oncologists 
may have attended a depression treatment didactic session by the study psychiatrist at the start of the study and yearly thereafter and 
have been informed of patients' depression status although it is unclear whether these features applied to patients in the Enhanced Usual 
Care group.  
Abbreviations: GP – General Practitioner; PCP - Primary Care Physician; MDD – Major Depressive Disorder; ACS – Acute Coronary 
Syndrome; GHQ – General Health Questionnaire; other abbreviations refer to depressive symptom checklists (CES-D, BDI, PHQ, SCL) 
and diagnostic interviews for depression (MINI, CIS-R, SCID, CIDI) 
 
Continued overleaf 
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Characteristics of the stepped care interventions 
There were considerable differences between studies in numbers of steps (two, 
three or four), types of treatments offered at each step and duration of the total 
intervention (between three and 12 months; Table 2). 
IMPACT vs. progressive intensity 
The stepped care interventions in seven studies [4, 5, 7-10, 13] (six of which 
were undertaken in the U.S.) were based on the ‘IMPACT’ model and used 
Problem Solving Treatment (PST) and antidepressant medication (ADM) as the 
core of the intervention.  The IMPACT intervention is primarily a collaborative 
intervention in which a dedicated team works together to provide optimal 
depression care, meeting inclusion criteria as a stepped care approach because 
patients were evaluated at pre-determined time intervals according to defined 
improvement criteria and care was adjusted or augmented if the patient did not 
improve sufficiently.  Treatments were provided according to patients’ needs 
and preferences.  In all seven ‘IMPACT’ studies and one other [study 22] 
involving both psychological treatment (psycho-education) and ADM, there was 
no progression of increasing therapeutic intensity.  
In contrast, care was delivered in the other six trials [1, 3, 6, 11-12, 14] through 
steps of increasing intensity. Five of these studies started with watchful waiting 
although two [12, 14] only included patients after the watchful waiting period 
while the other three [1, 3, 6] included watchful waiting as part of their stepped 
care model.  The first therapeutic component included psycho-education or 
bibliotherapy alone or combined, offered either as self-help (with online, 
telephone or face-to-face support), in a group, or as individual sessions.  The 
next step in these six studies varied widely and included psychological therapy 
(CBT, life review, IPT, PST, Coping with Depression Course) [1, 3, 6, 12, 14] or 
a psychological therapy (IPT) combined with ADM [11]. The last step typically 
consisted of referral to specialists, a GP or mental health services.  Only two 
[11, 12] of the six studies which used steps of increasing intensity were included 
in the quantitative meta-analysis.  As described above (see Inclusion of Studies) 
one study was excluded because of unavailability of post-test data [3] and three 
were excluded for being aimed at prevention [1, 6, 14]. 
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Healthcare providers 
In twelve studies [1-2, 4-13] more than one healthcare professional was 
involved in stepped care including nurses [1-2, 4-6, 10, 12-13], psychiatrists [4-
5, 7-11, 13], General Practitioners [2, 5, 8, 9, 11, 13], social workers [2, 4, 7-8], 
psychologists [4-5, 12-13] and relatively less qualified staff (residential home 
staff [6], an assistant patient navigator [8], lay health counsellor [11] and study 
researcher [1]).  In two studies, treatment was provided by one healthcare 
professional: a nurse or psychologist [3] or a nurse only [14].  No details are 
available for external professionals providing treatment after referral outside the 
core stepped care team.  
Stepping criteria 
Patient progress was assessed using one [1-7, 9-11, 13-14], two [8] or three 
[12] self-rated instruments.  In five studies the decision to ‘step up’ was 
contingent on patients’ score relative to a specific cut-off on the HDRS [2], CES-
D [1, 14], PHQ-9 [7] or HADS, IDS and WSAS [12].  In five studies the decision 
to ‘step up’ was dependent on improvement (relative to baseline or the last 
assessment) on the PHQ-9 [4-5, 10, 13] or CES-D [6]. Three studies used a 
combination of improvement and a specific cut-off on the CES-D [3], PHQ-9 [9] 
or PHQ-9 and SCL [8].  In one study [11] improvement was assessed by health 
counsellors following application of the GHQ with no further detail specified. 
 
Table 2 overleaf 
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Table 2. Characteristics of the stepped care interventions for depression 
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Table 2. Characteristics of the stepped care interventions for depression (continued from previous) 
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Notes: 1 ‘Providers’ includes the role of all health care professionals involved in the stepped care intervention except for professionals 
who cared for patients ‘on referral’. 
Abbreviations: ADs =antidepressants; CBT = cognitive behavioral therapy; CDCS = cancer depression clinical specialist; CES-D = 
Center for Epidemiological Studies Depression Scale; CGI-S= Clinical Global Impression Severity Scale; CWD = Coping With 
Depression; HADS-A = Hospital Anxiety and Depression Scale-Anxiety; HDRS = Hamilton Depression Rating Scale; IPT = interpersonal 
psychotherapy; MDD = major depressive disorder; PST = problem solving treatment; PE = psycho-education; WSAS = Work and Social 
Adjustment Scale 
 
Please see over 
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Risk of bias 
In one study [3] all criteria were rated as either unclear or at high risk of bias 
and in a second [1], five of the six criteria were rated as unclear or at high risk of 
bias (Table 3).  For the remaining twelve studies, risk of bias on most criteria 
was low.  Across these trials, the description of the randomisation sequence 
generation was adequate although four studies [4, 10, 11 & 14] did not clearly 
report methods of allocation concealment.  None of the 12 studies were able to 
blind patients or clinicians but all studies used assessors to measure outcomes 
who were unaware of the randomisation status of the patients or collected data 
using measures that were self-report.  Post-intervention study drop-out ranged 
between 8.0% [5] and 49.6% [3] and one study [9] was rated at high risk of bias 
with respect to handling incomplete outcome data.  All twelve studies used 
intention-to-treat analyses.  None of the twelve were considered at high (or 
unclear) risk of bias from selective reporting.  Three were at high risk of other 
biases because of the potential for contamination between trial arms [6, 8, 13] 
or because patients were recruited in different ways in the intervention and 
control groups [9]. 
 
Table 3. Risk of bias in included studies 
 
Notes: 
1 
Blinding of participants and personnel was not possible in any study; included ratings are with respect to the 
blinding of outcome assessors  
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Effects of stepped care 
Post-intervention effect sizes 
The overall (pooled) post-intervention effect size calculated from the combined 
effect size in each individual study was d = 0.38 (95% confidence interval 0.18 
to 0.57; Table 4).  Sensitivity analyses estimating overall effects using the 
measure in each study with the highest and lowest post-test effect size 
produced pooled effect sizes of d = 0.42 (95% CI 0.22 to 0.62) and d = 0.33 
(95% CI 0.13 to 0.52), respectively.  All of the pooled effect sizes were 
significantly in favour of stepped care. 
Effect sizes at various time points  
The stepped care interventions varied in duration between three and 12 
months.  Overall effect sizes at different time points estimated using the 
combined effect size in individual studies were as follows: d=0.57 at two to four 
months (95% confidence interval 0.21 to 0.94); d=0.34 at six months (95% CI 
0.20 to 0.48); d=0.43 at nine to 12 months (95% CI 0.20 to 0.65); d=0.26 at 18 
months (one study only; Table 4).  All effects were significantly in favour of the 
stepped care intervention with the exception of the 18 month result. 
 
Table 4 overleaf 
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Table 4. Pooled effect sizes (Cohen’s d) across treatment trials examining the 
effects of stepped care treatment for depression compared with usual care 
 
Notes: 
1
 Ncomp = number of comparisons; 
2
 * = p < 0.01; 
3
 pooled effect sizes for different time points were calculated 
using the combined outcomes effect sizes for individual studies 
Abbreviations: 95% CI = 95% confidence interval; ES = Effect Size 
 
Statistical heterogeneity 
Heterogeneity, as indicated by I2, was high for the post-intervention effect sizes 
as well as for the effect sizes at the different time points (Table 4).   From Figure 
3 it can be observed how the six month effect sizes varied between the different 
studies. 
 
Figure 3 overleaf 
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Figure 3. Effects of stepped care vs. care as usual at six months 
 
 
Sub-group analysis and publication bias 
The association of the six months outcomes estimated using combined effect 
sizes (overall d=0.34; Table 5) with the following variables was explored: 
country in which the study was undertaken (USA, Netherlands, or other), 
treatment based on IMPACT protocol (yes or no), stepped care treatment using 
progressive intensity (yes or no), physical health comorbidity (present or 
absent), and diagnostic status at inclusion (diagnosis assessed or not).  The 
overall effect of the eight studies on stepped care models without progressive 
intensity (d=0.41) was significantly higher than the effect of the two studies 
examining stepped care models with progressive intensity (d=0.07; p < 0.01).  
None of the remaining variables were significantly related to the effect size.  
There was no indication of publication bias in the funnel plot of the six month 
outcomes or in Duval and Tweedie’s trim and fill procedure. 
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Table 5. Sub-group analyses on overall effect of stepped care compared with 
usual care at six months (calculated using combined outcomes; effect size 
d=0.34; 95% CI 0.20 to 0.48) 
 
Notes: 
1
 Ncomp = number of comparisons; 
2
 * = p < 0.01 
Abbreviations: d = Cohen’s d; 95% CI = 95% confidence interval 
 
Effect of stepped care in studies excluded from meta-analysis 
The treatment study by Bot et al. (2010) [3] only provided two year follow-up 
data for the complete cases (49.6%) and reported no difference between the 
groups (d=-0.12; 95% CI -0.62 to 0.39). Both of the trials on indicated 
prevention [6, 14] showed results in favour of stepped care. One [6] 
demonstrated 12 month MDD rates of 6.5% in the intervention group and 14.1% 
in the control group (Incidence Rate Ratio = 0.46; 95% CI 0.17 to 1.21). The 
other [14] demonstrated 12 month prevalence rates of combined MDD and 
anxiety disorders of 11.6% in the intervention group and 23.8% in the control 
group (Incidence Rate Ratio = 0.49; 95% CI 0.24 to 0.98). The pooled rate ratio 
of the two studies was 0.48 (95% CI 0.27 to 0.83; I2 = 0).  The study on relapse 
prevention [1] reported no difference in the 12 month MDD incidence rate 
between stepped care and care-as-usual.  
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4.2.4 Summary of key findings from the original review and meta-analysis 
Fourteen trials on stepped care for depression were identified, ten of which 
could be used in meta-analyses of treatment outcomes.  Stepped care had a 
moderate effect on depression (d=0.34 at six months and d=0.38 post-
intervention). Stepped care interventions based on progressive treatment 
intensity performed worse (n=2; d=0.07) than those without a clear intensity 
order (n=8; d=0.41; p < 0.01). In most trials, risk of bias on the majority of 
criteria was low.  There was no indication of publication bias.  The stepped care 
interventions were extremely heterogeneous with different numbers of steps, 
different treatment components, different duration of the steps, different rules 
about stepping up and different professionals involved.   All of the included 
studies compared stepped care with care as usual. 
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4.3 Part II – Updated systematic review and meta-analysis 
The original systematic review and meta-analyses were completed by June 
2013.  Work to update the review was undertaken from November to December 
2015 by myself with the assistance of Professors Richards and van Straten.  
Responsibilities were as follows: study identification, data extraction, narrative 
synthesis and meta-analysis were undertaken by JJH; DR and JJH appraised 
the full text of potential papers for in- or exclusion; AVS provided a third opinion 
where JJH and DR did not agree.  Methods are described further in section 
4.3.2. 
4.3.1 Aims and objectives 
The aim and specific objectives of the review update were as for the original i.e. 
to assess the clinical effectiveness of stepped care treatment for depression in 
adults and thus: (1) determine whether existing evidence is sufficient to 
conclude that stepped care is equivalent to long-term, intensive psychological 
therapy for all; (2) explore aspects of study design and elements of the 
intervention that may be associated with more or less effect. 
4.3.2 Method 
Methods for updating the review replicated those of the original.  A 
comprehensive literature search was performed in PubMed, PsycINFO, 
Embase and the Cochrane Central Register of Controlled Trials using the 
search terms described in Box 1, section 4.2.2.  Searches were limited to 
studies published from January 2012 onwards.  JJH reviewed all abstracts and 
titles of retrieved references; full text papers were examined by JJH and DAR.  
In case of disagreement, the paper was discussed with AVS.  Reference lists of 
included papers were checked and JJH contacted the authors of protocol 
papers that met study inclusion criteria but for which there were no published 
results to request available data.   In-and exclusion criteria were identical to 
those used previously.  As per the original review, studies were included in 
which only a proportion of patients were depressed, for example studies 
including patients with a common mental health disorder and a sub-group of 
patients specifically diagnosed with depression.  Data on the characteristics of 
the included studies and the stepped care interventions were extracted by JJH. 
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Risk of bias was assessed using the criteria as suggested by the Cochrane 
Handbook (The Cochrane Collaboration, 2011).  Summary assessments were 
made for individual studies by counting the number of domains in which the 
study was considered to be at low and high risk. 
Meta-analyses 
Meta-analyses were performed using data from all of the eligible and included 
studies i.e. studies identified in the original review and update.  Pooled effects 
of stepped care in the sub-set of new studies alone were not estimated.   
Individual study effects 
Between-group effect sizes (Cohen’s d) were calculated for all individual studies 
included in analyses using the available data as published in the papers (means 
and standard deviations, proportions of patients improved etc.).  For studies in 
which only a proportion of patients were depressed and where the publication of 
results allowed, individual study effect sizes were also calculated for the 
depressed sub-sample.  
Pooled effects – primary and secondary analyses 
Effects were subsequently pooled across treatment trials.  Data from prevention 
studies, treatment trials reporting insufficient outcome data and trials comparing 
two active treatments were excluded.  Primary analyses estimated the effect of 
stepped care on patients with depression: effects were pooled across studies 
that only included patients with depression and, when available, from the 
estimate of the effect of stepped care in the depressed sub-sample in studies in 
which only a proportion of patients were depressed.  Secondary analyses 
estimated the effects of stepped care on depressive symptoms in patients with 
depression and other common mental health problems: effects were pooled 
across studies that included patients with depression only and studies that 
included patients with common mental health problems, including but not limited 
to depression. 
In primary and secondary analyses, pooled post-intervention effects were 
calculated using the highest reported effect size in each study, the lowest and 
the average or combined; pooled intervention effects at a variety of other time 
99 
points were calculated using the combined effect in each study.  Statistical 
heterogeneity was tested under the fixed-effects model using the statistics I2 
and Q2.  Pooled effects were calculated with the random-effects model.  Missing 
data were not imputed.  Computational formulae for basic meta-analyses are 
provided at Appendix I. 
Sub-group analyses 
Planned sub-group analyses investigated heterogeneity in the effects of 
stepped care across studies that included patients with depression only and the 
depressed sub-samples in studies in which only a proportion of patients were 
depressed.  As per the original review, analyses tested whether there were 
significant differences between the effect sizes in different categories of studies, 
specifically studies: set in different countries; adopting an IMPACT based 
stepped care clinical protocol (yes/no); that organised stepped care using 
progressive treatment intensity (yes/no); that recruited patients with a co-morbid 
physical health condition (yes/no); and that in- or excluded potentially eligible 
patients by assessing their diagnostic status using a diagnostic interview 
(yes/no). 
Publication bias 
Publication bias was tested by inspecting the funnel plot and Duval and 
Tweedie’s trim-and-fill procedure (Duval & Tweedie, 2000) for primary and 
secondary analyses of the effects of stepped care immediately after treatment 
and at six to nine months estimated using the average (combined) effect in 
individual studies. 
4.3.3 Results 
Inclusion of studies 
Two hundred unique records were identified from electronic databases and 
other sources (Figure 4).  After screening, 48 full text papers were reviewed; 28 
did not fulfil study inclusion criteria and were excluded.  Seven new studies 
were included: J. J. Hill, Kuyken, and Richards (2014) [study number 15]; 
Krebber et al. (2015) [16]; Oladeji et al. (2015b) [17]; Oosterbaan et al. (2013) 
[18]; Stoop, Nefs, Pommer, Pop, and Pouwer (2015) [19]; van der Aa et al. 
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(2015) [20]; D. X. Zhang et al. (2014) [21].  One other study met inclusion 
criteria (Van Beljouw et al., 2015) but was excluded from the review due to 
problems which rendered the study invalid: part-way through the trial and in 
response to high drop-out rates, the intervention was substantially altered such 
that more than half of participants did not receive stepped care; in their results, 
the authors did not distinguish between participants who had stepped care vs. 
the modified intervention.  Three of the new studies were included in 
quantitative meta-analyses.  One treatment trial [19] was excluded because the 
authors did not report outcome data with sufficient clarity for results to be 
useable; one study [15] (conducted by myself as part of my doctoral studies) 
was excluded for comparing two active treatments - stepped care and high-
intensity psychological therapy alone; the two remaining trials [20, 21] were 
aimed at the indicated prevention of depression.  
Papers providing supplementary information and data for studies already 
included in the review 
Six papers were also included that provided supplementary information or data 
for three studies that were included in the original review.  Apil, Spinhoven, 
Haffmans, and Hoencamp (2014) reported 24 month outcomes for Apil et al. 
(2012) [study no. 1].  Bosmans et al. (2014) and van Schaik et al. (2014) 
reported cost-effectiveness data, ten and 22 month outcomes for Dozeman et 
al. (2012) [study 6].  Three papers provided additional information for the 
IMPACT study by Unutzer et al. (2002) [13]: Hunkeler et al. (2006) reported 18 
& 24 month outcomes; Tang, Song, Belin, and Unutzer (2005) described a 
comparison of imputation methods using the 12 month IMPACT data; Unutzer 
et al. (2008) published the results of cost-effectiveness analyses. 
None of the six papers were included in meta-analyses.  Three papers (Apil et 
al., 2014; Bosmans et al., 2014; van Schaik et al., 2014) provided additional 
data or supplementary information for prevention trials [1, 6].  The cost-
effectiveness analysis by Unutzer et al. (2008) did not report new clinical 
outcome data; longer-term outcome data reported by Hunkeler et al. (2006) was 
not reported in a format suitable for meta-analysis; 12 month outcome data 
(using all available data) that had been extracted for the original review was 
incorporated in the update. 
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Figure 4. Review update: study identification and selection for meta-analyses 
 
Notes: 
1
 n=5 refers to (i)  three papers reporting the study design and results of a trial by Stoop et al. where the results 
were not provided in a format suitable for analysis, (ii) results of a cost-effectiveness analysis and longer-term outcome 
data for Unutzer et al. (2002) where the cost-effectiveness paper included no new clinical data and longer term outcome 
data was not reported in a format suitable for meta-analysis; 
2
 n=1 refers to imputed 12 month outcome data for Unutzer 
et al. 2002 – 12 month outcomes using ‘all available cases’ were included as per the original review. 
 
Characteristics of the included studies  
Characteristics of the seven new studies are summarised in Table 6.   
Combined with the 14 studies included in the original review, the 21 studies 
encompassed a total of 6364 patients of whom 3202 were randomised to 
stepped care and 3157 to a control condition.  For the 13 studies included in the 
quantitative meta-analyses, the total number of included patients was 5133 with 
2577 in the stepped care arms and 2551 in the control conditions.  (The 
allocation of five patients in one study [18] was not reported.  For this reason, 
the number of patients randomised to stepped care and the control condition do 
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not equal the total number of participants included in the review or meta-
analysis.) 
Of the 21 included trials, 17 were patient randomised [studies 1-8, 12-16 and 
19-21] and four were cluster randomised [ 9, 11, 17-18]; six were conducted in 
the USA [4, 5, 7, 8, 10 and 13], eleven in Europe, specifically The Netherlands 
[1, 3, 6, 9, 12, 14, 16, 18, 19], The Netherlands and Belgium [20] and the UK 
[15]; four were conducted in other countries (Chile [2], India [11], Nigeria [17] 
and Hong Kong [21]).  Participants were mainly recruited from primary care 
[studies 2, 9-11, 12-15, 17-19, 21] or secondary care [3-5, 7, 16 & 20].  All 
studies bar one compared stepped care with usual care, either standard [ 1-6, 
9, 10, 12-14, 16, 18-21] or ‘enhanced’ [ 7, 8, 11, 17]; one study compared 
stepped care with high-intensity psychological therapy alone [15]. 
Of the 16 treatment trials, eight included patients scoring above a cut-off on a 
self-rated depression questionnaire [3-5, 7, 8, 10, 16 and 19]; two also used the 
core symptoms of MDD [7 & 8] while eight others performed diagnostic 
interviews to include patients with MDD [6, 9, 11-13, 15, 17, 18].  Two also 
included minor depression [12, 18] and three also included dysthymia [12, 13, 
18].  The five prevention trials [1, 6, 14, 20 and 21] used a diagnostic interview 
to exclude patients with existing MDD. 
Nine studies included patients with a common mental health problem that could 
include but was not limited to depression.  Of those, eight included patients with 
anxiety [6, 11, 12, 14, 16, 18-21] and one study included patients with stress 
[18] alongside depressed sub-samples.  Nine studies were aimed at depressive 
symptoms among patients with co-morbid acute coronary syndrome [4 & 5], 
cancer [7 & 16], diabetes [3, 8, 10, 19] or visual impairment [20].  Six trials, 
including four of the prevention studies, were specifically aimed at older adults 
[1, 3, 6, 13, 14 and 20].  
 
Table 6 overleaf
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Table 6. Characteristics of the new studies (n=7) 
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Notes: 1 The allocation of five patients who did not complete baseline questionnaires was not specified – numbers of intervention and 
control participants do not equal the total; 2 Response and remission data were reported for a subset of patients who presented with a 
primary diagnosis of depression; the sub-set of data (comprising information on response and remission for n=71 (I:46/C:25) and n=69 
(I45/C:24) patients, respectively) were included in primary meta-analyses – data from all participants (numbers as reported in the table) 
were included in secondary meta-analyses; 3 The protocol paper for this study was published in 2012 – outcome data were extracted 
from a manuscript currently under review provided to JJH by the authors; 4 age in- and exclusion criteria ‘not specified’; 5 no particular 
features of usual care described 
Abbreviations: CBT – Cognitive Behaviour Therapy; GP – General Practitioner; PCP - Primary Care Physician; MDD – Major Depressive 
Disorder; GAD – Generalised Anxiety Disorder; COPD – Chronic Obstructive Pulmonary Disease; other abbreviations refer to depressive 
symptom checklists (HADS-D,  PHQ-9, CES-D) and diagnostic interviews for depression (MINI, CIS-R, SCID, CIDI) 
 
Continued overleaf 
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Characteristics of the stepped care interventions 
Consistent with the original review, with respect to the seven new studies, there 
was considerable between-study heterogeneity in numbers of steps (two, three 
or four), types of treatments offered at each step and duration of the total 
intervention (between 14 weeks and 12 months; Table 7).  In six of the seven, 
the stepped care intervention was offered in steps of increasing intensity [15, 
16, 18-21].  Three studies started with watchful waiting [16, 20, 21]; the first 
therapeutic component included psycho-education [19], counselling [21] or 
bibliotherapy alone [20, 21] or combined with one session of counselling [16] or 
medication [18] and offered as self-help with email, telephone or face to face 
support.  The next step typically comprised CBT or PST either alone [15, 16, 20, 
21] or combined with ADM [18].  The last step often consisted of referral to a 
GP [16, 20, 21].  In one other study psycho-education was followed by 
bibliotherapy (based on the Coping With Depression / Anxiety course); 
thereafter patients received six booster sessions of the same and were advised 
to discuss medication with their GP [19].  There was no progression of 
increasing therapeutic intensity in one study predominantly involving PST and 
ADM [17].  None of the new studies implemented stepped care based on the 
IMPACT model. 
All included studies   
Combining data from the update and original review, care was delivered in 
steps of increasing intensity in 12 studies [1, 3, 6, 11, 12, 15, 16, 18-21].  There 
was no progression of increasing therapeutic intensity in nine studies [2, 4, 5, 7-
10, 13, 17], seven of which were based on the IMPACT model [4, 5, 7-10, 13]. 
Consistent with studies’ inclusion criteria, in twelve studies the stepped care 
intervention was aimed at depression alone [1-5, 7-10, 13, 15, 17] whereas nine 
studies sought to treat or prevent both depression and anxiety [6, 11, 12, 14, 
16, 18-21] and one study also treated stress [18]. 
In 19 studies, more than one healthcare professional was involved in delivering 
stepped care.  Professionals included nurses [1, 2, 4-6, 10, 12, 13, 15-19], 
psychologists  [4, 5, 12, 13, 15, 19, 20], psychiatrists [4, 5, 7-11, 13], GPs [ 2, 5, 
8, 9, 11, 13, 15, 17, 19, 21], social workers [2, 4, 7, 8, 20, 21], an occupational 
therapist [20] and relatively less qualified staff (study researcher [1], residential 
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home staff [6], an assistant patient navigator [8], lay health counsellor [11], care 
co-ordinator /  trained coach [16], and community mental health workers and 
officers [17]).  In two studies treatment was provided by one healthcare 
professional: a nurse or psychologist [3] or nurse [14].  No details were 
available in any study for external professionals providing treatment on referral 
outside the core stepped care team. 
Across all studies, patient progress was assessed using one [1-7, 9-11, 13-15, 
17, 18], two [8, 16, 19-21] or exceptionally three [12] self-rated instruments.  In 
four of the six studies using more than one instrument, stepped care was aimed 
at anxiety in addition to depression and progress was monitored using symptom 
checklists for each condition [12, 16, 19-21].  In the study using three 
instruments, progress was monitored using checklists for anxiety, depression 
and a measure of social function and function at work [12].  In the sixth study, 
stepped care was aimed at the treatment of depression only; patient progress 
was assessed using two depressive symptom checklists [8]. 
In ten studies, the decision to step up was contingent on patients’ score relative 
to a specific cut-off on a symptom checklist [1, 2, 7, 12, 14, 16, 18, 19-21]; in 
five studies the decision to step up was dependent on improvement on a 
checklist  (relative to baseline or last assessment) [ 4, 5, 6, 10, 13]; five studies 
used a combination of improvement and a specific cut-off [3, 8, 9, 15, 17].  In 
one study, improvement was assessed by health counsellors following 
application of the General Health Questionnaire with no further detail specified 
[11]. 
Checklists typically used to assess progress were the Patient Health 
Questionnaire-9 [used in studies 4, 5, 7-10, 13, 15, 17, 19], the Centre for 
Epidemiological Studies Depression Scale [1, 3, 6, 14, 20, 21] and the Hospital 
Anxiety and Depression Scale [12, 16, 20 and 21].  Other less utilised measures 
were: the Hamilton Depression Rating Scale [2], Symptom Checklist [8], 
Inventory of Depressive Symptomatology [12], Work and Social Adjustment 
Scale [12], Clinical Global Impression – Severity scale [18] and the Generalised 
Anxiety Disorder questionnaire [19]. 
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Table 7. Characteristics of the stepped care interventions for depression in the new studies (n=7) 
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Notes: 1 ‘Providers’ includes the role of all health care professionals involved in the stepped care intervention except for 
professionals who cared for patients ‘on referral’; 2 the professional group of persons involved in the delivery of specialist 
mental health services was not specified. 
Abbreviations: ADs =antidepressants; CBT = cognitive behavioral therapy; CES-D = Center for Epidemiological Studies 
Depression Scale; CGI-S= Clinical Global Impression - Severity Scale; CWD/A = Coping With Depression / Anxiety; GAD-7 = 
General Anxiety Disorder questionnaire; GP = General Practitioner; HADS-A / HADS-D = Hospital Anxiety and Depression 
Scale-Anxiety / -Depression; PHQ-9 = Patient Health Questionnaire-9; PST = problem solving therapy; PE = psycho-
education; WB = Wellbeing Course 
 
Please see over 
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Risk of bias 
In one study [3], all criteria were rated as either at unclear or high risk of bias; in 
a second [1] five of the six criteria were rated at unclear or high risk of bias.  In 
two of the new studies, three criteria were rated at high or unclear risk of bias 
[17, 18] (Table 8).  Across the remaining 17 trials, most criteria were rated at 
low risk of bias.   
The description of the randomisation sequence generation was adequate 
except for in four studies where methods were not clearly reported [1, 3, 18, 21]; 
seven studies did not clearly report methods of allocation concealment [1, 3, 4, 
10, 11, 14, 17).  No studies were able to blind patients or study personnel 
(clinicians) but the large majority (n=19) used self-report data and / or assessors 
to measure outcomes who were unaware of the randomisation status of their 
patients; two studies did not clearly report blinding [1, 3].  With respect to 
handling incomplete outcome data, three studies were rated at high risk of bias 
[1, 3, 9] and another at unclear risk [18].  All studies used intention to treat 
analyses i.e. analysed patients according to the group to which they had been 
allocated.  In terms of selective reporting, five studies were rated at high risk of 
bias [1, 3, 17-19] and one at unclear risk [21].  Three studies were rated at high 
risk of other biases because of the potential for contamination between trial 
arms [6, 8, 13], because patients were recruited differently in the intervention 
and control groups [9] and because data collection in the intervention and 
control groups occurred at different time points post baseline – the authors did 
not allow for this in their analysis [16]. One study was rated at high risk of other 
biases because a sub-set of analyses had not been undertaken according to 
protocol and was therefore not reported [3]. 
 
Table 8 overleaf 
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Table 8. Risk of bias in the new studies (n=7) 
 
Notes: 
1 
Blinding of participants and personnel was not possible in any study; included ratings are with respect to the 
blinding of outcome assessors.  
 
Effects of stepped care 
Primary analyses 
Eleven comparisons reported post-intervention outcomes for patients with 
depression.  The pooled post-intervention effect size from the combined effect 
size in each individual study was d=0.40 (95% confidence interval 0.22 to 0.57; 
Table 9).  Sensitivity analyses estimating overall effects using the measure in 
each study with the highest and lowest post-test effect size produced pooled 
effect sizes of d=0.45 (95% CI 0.27 to 0.63) and d=0.33 (95% CI 0.15 to 0.52), 
respectively.  Levels of heterogeneity (indicated by I2) were high.  All of the 
pooled effect sizes were significantly in favour of stepped care.  Corresponding 
forest plots are provided in Figure 5. 
 
Table 9 & Figure 5 overleaf 
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Table 9. Pooled post-intervention effects (Cohen’s d) across treatment trials 
examining the effects of stepped care compared with usual care in patients with 
depression 
 
 
 
 
 
Notes: 
1 Ncomp = number of comparisons; 2 * = p < 0.01.  
Abbreviations: d = Cohen’s d; 95% CI = 95% confidence interval; ES = Effect Size 
 
 
Figure 5. Forest plots of stepped care vs. usual care: post-intervention 
improvement among patients with depression calculated using the combined, 
highest and lowest effect size in individual studies. 
i) Multiple outcomes in individual studies combined:  
 
 
Continued overleaf 
  
Post intervention effect sizes Ncomp 
1
 d 95% CI I
2
 
 
 Outcomes combined 
 Outcomes with highest ES 
 Outcomes with lowest ES 
 
 
11 
11 
11 
 
0.40 
0.45 
0.33 
 
0.22 to 0.57 
0.27 to 0.63 
0.15 to 0.52 
 
78.09* 
2
 
74.88* 
82.49* 
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ii) Highest effect size in individual studies: 
 
iii) Lowest effect size in individual studies: 
 
 
The effect of stepped care on patients with depression at different time 
points 
The stepped care interventions varied in duration between three and 12 
months.  Overall effect sizes at different time points estimated using the 
combined effect size in individual studies were as follows: d=0.69 at three to 
four months (95% confidence interval 0.46 to 0.93); d=0.36 at six to nine 
months (95% CI 0.23 to 0.49); d=0.40 at 12 to 18 months (95% CI 0.20 to 0.61; 
Table 10).  Levels of heterogeneity (indicated by I2) were high except for in the 
analysis of improvement at three to four months.  All effects were significantly in 
favour of the stepped care intervention.  Forest plots of the analysis at each 
time point are provided in Figure 6. 
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Table 10. The pooled effect (Cohen’s d) of stepped care vs. usual care at 
different time points among patients with depression 
 
 
 
 
Notes: 
1
 Ncomp = number of comparisons; 
2
 * = p < 0.01; 
3
 pooled effect sizes for different time points were calculated 
using the combined outcomes effect sizes for individual studies 
Abbreviations: d = Cohen’s d; 95% CI = 95% confidence interval; ES = Effect Size 
 
 
Figure 6. Forest plots of stepped care vs. usual care: improvement among 
patients with depression at three to four, six to nine and 12-18 months - effect 
sizes estimated using the combined effect in each study 
i) Effects of stepped care at three to four months: 
 
 
Figure continued overleaf  
 Ncomp 
1
 d 95% CI I
2
 
Effect sizes for different time points 
3
 
 3-4 months 
 6-9 months 
 12-18 months 
 
4 
11 
6 
 
 
0.69 
0.36 
0.40 
 
 
0.46 to 0.93 
0.23 to 0.49 
0.20 to 0.61 
 
 
38.30 
61.22* 
67.75* 
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ii) Effects of stepped care at six to nine months: 
 
iii) Effects of stepped care at 12 to 18 months: 
 
Secondary analyses 
Thirteen studies reported effects of stepped care on depressive symptoms in 
patients with a common mental health disorder that could include but was not 
limited to depression.  The pooled post-intervention effect size from the 
combined effect size in each individual study was d=0.37 (95% confidence 
interval 0.20 to 0.54; Table 11).  Sensitivity analyses estimating overall effects 
using the measure in each study with the highest and lowest post-test effect 
size produced pooled effect sizes of d=0.41 (95% CI 0.23 to 0.59) and d=0.32 
(95% CI 0.15 to 0.49), respectively.  Levels of heterogeneity (indicated by I2) 
were high.  All of the pooled effect sizes were significantly in favour of stepped 
care but smaller than the equivalent effects estimated for patients with 
depression only.  Forest plots of improvement immediately after stepped care 
relative to usual care are provided in Figure 7. 
115 
Table 11. The pooled post-intervention effect (Cohen’s d) of stepped care vs. 
usual care on patients with common mental health problems including 
depression 
 
 
 
 
Notes: 
1
 Ncomp = number of comparisons; 
2
 * = p < 0.01.  
Abbreviations: d = Cohen’s d; 95% CI = 95% confidence interval; ES = Effect Size 
 
 
Figure 7. Forest plots of stepped care vs. usual care: post-intervention 
improvement in depressive symptoms among patients with common mental 
health problems including depression - calculated using the combined, highest 
and lowest effect size in individual studies 
i) Multiple outcomes in individual studies combined:  
 
 
Figure 7 continued overleaf  
 Ncomp 
1
 d 95% CI I
2
 
Post intervention effect sizes 
 Outcomes combined 
 Outcomes with highest ES 
 Outcomes with lowest ES 
 
 
13 
13 
13 
 
0.37 
0.41 
0.32 
 
0.20 to 0.54 
0.23 to 0.59 
0.15 to 0.49 
 
85.29* 
2
 
84.59* 
86.87* 
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ii) Highest effect size in individual studies: 
 
iii) Lowest effect size in individual studies: 
 
 
The effect of stepped care on patients with common mental health 
problems at different time points 
Six comparisons reported outcomes at two to four months for patients with a 
common mental health problem that could include but was not limited to 
depression; 13 comparisons reported six to ten month outcomes and seven 
comparisons reported effects at 12 to 18 months.  Overall effect sizes at 
different time points estimated using the combined effect size in individual 
studies were as follows: d=0.55 at two to four months (95% confidence interval 
0.34 to 0.77); d=0.32 at six to ten months (95% CI 0.19 to 0.45); d=0.35 at 12 to 
18 months (95% CI 0.15 to 0.55; Table 12).  Levels of heterogeneity (indicated 
by I2) were high.  All effect sizes were significantly in favour of the stepped care 
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intervention but smaller than the equivalent estimates for patients with 
depression only.  Corresponding forest plots are provided in Figure 8. 
 
Table 12. The pooled effect (Cohen’s d) of stepped care vs. usual care at 
different time points among patients with common mental health problems 
including depression 
 
 
 
 
Notes: 
1
 Ncomp = number of comparisons; 
2
 * = p < 0.05; 
3
 pooled effect sizes for different time points were calculated 
using the combined outcomes effect sizes for individual studies 
Abbreviations: d = Cohen’s d; 95% CI = 95% confidence interval; ES = Effect Size 
 
Figure 8. Forest plots of stepped care vs. usual care: improvement among 
patients with common mental health problems, including depression, at two to 
four, six to ten and 12-18 months - effect sizes estimated using the combined 
effect in each study 
i) Effects of stepped care at two to four months: 
 
 
Continued overleaf 
  
 Ncomp 
1
 d 95% CI I
2
 
Effect sizes for different time points 
3
 
 2-4 months 
 6-10 months 
 12-18 months 
 
6 
13 
7 
 
 
0.55 
0.32 
0.35 
 
 
0.34 to 0.77 
0.19 to 0.45 
0.15 to 0.55 
 
 
64.05* 
2
 
73.93* 
71.41* 
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ii) Effects of stepped care at six to ten months: 
 
iii) Effects of stepped care at 12 to 18 months: 
 
Publication bias 
Although there was no marked evidence of asymmetry in funnel plots of the 
effect of stepped care vs. usual care immediately after treatment or at six to 
nine months on patients with depression (Figure 9 – primary analyses) Duuval 
and Tweedie’s Trim and Fill procedure removed three studies from the estimate 
of the pooled effect at six to nine months.  The adjusted effect size was d=0.28 
(95% CI 0.15 to 0.42); the magnitude of the observed effect was d=0.36 (95% 
CI 0.23 to 0.49).  With respect to secondary analyses, there was some evidence 
of asymmetry in funnel plots of the effect of stepped vs. usual care immediately 
after treatment and at six to ten months on patients with common mental health 
problems that included but were not limited to depression (Figure 9).   However, 
in both cases, Duuval and Tweedie’s Trim and Fill procedure did not remove 
any study from analysis; observed and adjusted estimates of effects were 
identical.  
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Figure 9. Funnel plots for the primary and secondary analyses of the effects of 
stepped care immediately after treatment and at six to nine months estimated 
using the average (or combined) effect in each study 
i) Primary analysis – post-intervention effects on patients with 
depression: 
 
ii) Primary analysis – effects on patients with depression at six to nine 
months: 
 
 
Figure 9 continued overleaf  
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iii) Secondary analysis – post-intervention effects on patients with 
common mental health problems: 
 
iv) Secondary analysis – effects on patients with common mental health 
problems at six to ten months: 
 
Sub-group analysis 
The effect of stepped care at six to nine months among patients with depression 
(overall d = 0.36, 95% CI 0.23 to 0.49) was significantly higher in nine studies 
[2, 4, 5, 7-10, 13, 17] examining models of no clear intensity order (d = 0.40) 
than in two studies [11, 18] on stepped care of increasing intensity (d = 0.15; 
Table 13).  None of the other analysed variables (country, stepped care 
treatment based on IMPACT protocol, physical health comorbidity and patients’ 
diagnostic status at inclusion) were significantly related to effect size. 
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Table 13. Sub-group analyses on overall effects of stepped care compared with 
controls at six to nine months among patients with depression - pooled effects 
calculated using combined outcomes; effect size d = 0.35; 95% CI 0.22 to 0.47 
 
Notes: 
1
 Ncomp = number of comparisons; 
2
 * = p < 0.01 
Abbreviations: d = Cohen’s d; 95% CI = 95% confidence interval 
 
Effect of stepped care in studies excluded from meta-analysis 
In all, eight studies were excluded from primary and secondary meta-analyses 
including one on relapse prevention [1], four indicated prevention trials [6, 14, 
20, 21] and three treatment trials [3, 15, 19].  The treatment study by Stoop et 
al. (2015) [19] appeared to show results in favour of stepped care but did not 
report outcome data with sufficient clarity for results to be useable.  In another 
treatment study, Bot et al. (2010) [3] only provided two-year follow-up data for 
complete cases (49.6% of participants) and reported no difference between the 
groups (d=-0.12; 95% CI -0.62 to 0.39).  The treatment study by J. J. Hill et al. 
(2014) [15] (presented in full in Chapters Five and Six) comprised a pilot trial of 
 
Effects at six to nine months by: 
Ncomp 
1
 d 95% CI I
2
 p value 
Country 
 USA 
 Europe 
 other 
 
6 
2 
3 
 
0.37 
0.54  
0.39 
 
0.29 to 0.45 
0.13 to 0.95 
-0.05 to 0.83 
 
0.00 
0.00 
88.94* 
2
 
 
0.19 
IMPACT based 
 yes 
 no 
 
7 
4 
 
0.38 
0.40 
 
0.29 to 0.46 
0.03 to 0.77 
 
0.00 
83.78* 
 
0.13 
Progressive treatment intensity 
 yes 
 no 
 
2 
9 
 
0.15 
0.40 
 
-0.15 to 0.45 
0.28 to 0.51 
 
32.20 
39.56 
 
< 0.01 
Physical co-morbidity 
 present 
 absent 
 
5 
6 
 
0.31 
0.41 
 
0.18 to 0.44 
0.19 to 0.64 
 
0.00 
78.07* 
 
0.53 
Inclusion based on diagnosis 
 yes 
 no 
 
6 
5 
 
0.41 
0.31 
 
0.19 to 0.64 
0.18 to 0.44 
 
78.07* 
0.00 
 
0.53 
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stepped care compared with high-intensity psychological therapy alone.  For 
patients allocated to receive stepped care, the mean difference in depressive 
symptoms from baseline to follow-up measured using the Beck Depression 
Inventory version 1.0 (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) was -
13.4 points; for patients allocated to CBT alone, the mean difference was -13.6.  
Three of the four indicated prevention studies showed results that were in 
favour of stepped care.  As reported in section 4.2.3, one study [6] reported 12-
month MDD rates of 6.5% in the intervention and 14.1% in the control group; 
the second study [14] demonstrated 12-month prevalence rates of combined 
MDD and anxiety disorders of 11.6% in the intervention and 23.8% in the 
control.  The pooled rate ratio of the two studies was 0.48 (95% CI 0.27 to 0.83, 
I2 = 0).  The third study [20] reported 24-month MDD, dysthymia and anxiety 
rates of 29% in the intervention and 46% in the control (incidence rate ratio = 
0.63, 95% confidence interval 0.45 to 0.87).  The other prevention trial [21] 
found no difference between stepped care and care as usual: 12 month MDD 
and GAD rates were 6.4% in the intervention and 6.5% in the control (incidence 
rate ratio = 0.99, 95% confidence interval 0.30 to 3.27).  The study on relapse 
prevention [1] reported no difference in the 12 month MDD incidence rate 
between stepped care and care as usual. 
4.3.4 Summary of key findings from the updated review and meta-analysis 
Twenty-one trials on stepped care for depression were identified, eleven of 
which were used in primary meta-analyses and 13 of which were used in 
secondary meta-analyses.  All of the included studies except for one compared 
stepped care with care as usual.  The results of primary analyses showed that 
stepped care had a moderate effect on depressive symptoms among patients 
with depression (d=0.36 at six to nine months and d=0.40 post-intervention).  
Secondary analyses found that stepped care had a moderate effect on 
depressive symptoms in patients with common mental health problems that 
included but were not limited to depression (d=0.32 at six to ten months and 
d=0.37 post-intervention).   Interventions were extremely heterogeneous; those 
based on progressive treatment intensity performed worse (n=2; d=0.15) than 
those without (n=9; d=0.40; p < 0.01).  In most trials, risk of bias on the majority 
of criteria was low.  There was little evidence of publication bias.  
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4.4 Key conclusions 
This study involved a systematic review undertaken and updated with the aim to 
assess existing evidence on the effectiveness of stepped care treatment for 
depression in adults. The results of the original and updated review were 
consistent.  Relative to care as usual, stepped care was found to be efficacious.  
Sub-group analyses indicated that interventions without a clear intensity order 
may produce greater gains than those defined by progressive intensity.  
However, the review did not find sufficient evidence to establish whether 
stepped care is equivalent to long-term intensive psychological therapy for all.   
All of the studies in the original review compared stepped care with treatment as 
usual.  Meta-analyses incorporated trials of stepped care with treatment as 
usual only; it was not possible to estimate the relative effectiveness of stepped 
care vs. high-intensity psychological therapy.  Although the systematic review 
update included a pilot trial of stepped care vs. intensive psychotherapy it also 
confirmed that a definitive evaluation of the same has not yet been undertaken.  
In the absence of at least one well conducted fully-powered RCT comparing 
stepped care vs. high-intensity psychological therapy for all, there remains 
insufficient evidence to determine the relative effectiveness of these systems. 
At this time, it is not possible to determine whether the assumption underpinning 
the widespread implementation of stepped in the UK and elsewhere holds. 
Commensurate with MRC guidance for the development and evaluation of 
complex interventions (Craig et al., 2008), prior to a fully-powered evaluation, 
preparatory work is needed to determine feasibility and inform trial design.   On 
completion of the original systematic review, it was concluded that a feasibility 
study to inform a fully-powered evaluation of stepped care compared with 
intensive psychological therapy alone was required.  The resulting study, 
‘STEPS’, is now described: methods are summarised in Chapter Five; results in 
Chapter Six.  The findings of the systematic review are discussed in full in 
Chapter Seven.  
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CHAPTER 5.  THE STEPPED CARE VS. HIGH-INTENSITY THERAPY 
(STEPS) FEASIBILITY STUDY: METHODS 
This chapter describes the methods of a feasibility study undertaken to prepare 
for a fully-powered randomised controlled trial of stepped care compared with 
high intensity psychological therapy alone for the treatment of depression in 
adults.  Study results are described in Chapter Six.  The need for the study was 
established following a systematic review of randomised controlled trials on the 
effectiveness of stepped care (see Chapter Four).  Feasibility study methods 
have been reported in J. J. Hill et al. (2014).  This chapter is based on the 
published article; additional information is provided. 
The chapter is organised into eight main sections: aim, objectives and research 
questions (5.1); study overview (5.2); pilot randomised controlled trial of 
stepped care (5.3); embedded semi-structured interviews (5.4); analysis - 
quantitative, qualitative and mixed methods (5.5); ethical issues (5.6); patient 
and public involvement (5.7); study set-up and management including execution 
dates (5.8). 
5.1 Aim, objectives and research questions  
The aim of the feasibility study was to test the feasibility of and provide 
information to inform the design of a large clinical trial that will investigate the 
effectiveness and efficiency of stepped care treatment of depression in adults.  
Specific objectives were to: (1) gather enough information on recruitment, 
retention, step ups and treatment effects to design a fully-powered clinical trial 
or to determine that such a trial is not feasible; (2) explore patients’ and 
therapists’ views of stepped care and the ways in which patients’ views relate to 
how much they engage in therapy to inform a stepped care clinical protocol for 
a proposed randomised trial. 
There were five related research questions: 
1. What is the quantifiable performance of recruitment and retention methods 
which may be used in a fully powered trial?  (Objective 1) 
2. What proportion of people who receive stepped care step up from low-
intensity to high-intensity treatment or are discharged following low-intensity 
psychological therapy? (Objective 1) 
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3. What is the variability in patient-related outcomes following stepped care or 
intensive psychological therapy alone and how do they correlate with 
patients’ baseline scores? (Objective 1) 
4. To what extent are potential recruitment methods considered appropriate by 
trial participants (patients), study therapists and other health professionals 
and how do people’s views combine with numeric data on the performance 
of trial recruitment methods? (Objective 1) 
5. How acceptable is stepped care to patients and therapists and how do 
patients’ views explain variability in the number of treatment sessions they 
attend? (Objective 2) 
5.2 Study design 
The study employed a mixed methods embedded design (Creswell & Plano 
Clark, 2011) in which semi-structured interviews with patients, therapists and 
IAPT staff were embedded in a pilot randomised controlled trial of stepped care 
versus intensive psychological therapy alone for adults with depression.  
Quantitative data were used to assess the feasibility of trial recruitment, 
retention and clinical procedures and to inform the sample size calculation that 
is required for a full-scale evaluation.  Semi-structured interviews with patients, 
therapists and other IAPT staff were embedded in the pilot trial and undertaken 
concurrently to explore what interviewees thought of (i) trial methods and 
procedures and (ii) the acceptability of the stepped care intervention.  
Quantitative and qualitative data on trial methods and procedures were 
combined so that one type of data could be interpreted in the context of the 
other for a more informed understanding of feasibility and appropriateness.  By 
integrating qualitative and quantitative data on the acceptability of stepped care 
I sought to generate hypotheses regarding how acceptability and treatment 
adherence might relate. 
5.3 Pilot randomised controlled trial 
5.3.1 Setting and participants 
Participants were recruited from an Improving Access to Psychological 
Therapies (IAPT) service serving a city population.  Eligible participants were 
aged 18 years and older with DSM Major Depressive Disorder identified by 
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standard clinical interview (Clinical Interview Schedule – Revised, CIS-R) 
(Lewis, Pelosi, Araya, & Dunn, 1992).  In line with the current operating criteria 
for IAPT services to determine who they treat and to reflect the pragmatic 
nature of this trial (and the fully-powered evaluation), at interview patients were 
excluded who were alcohol or drug dependent, acutely suicidal or cognitively 
impaired, had bipolar disorder or psychosis/psychotic symptoms.  Participants 
were eligible whether they were in receipt of antidepressant medication or not.   
Patients were subsequently treated at the Mood Disorders Centre AccEPT 
Clinic facilities (http://www.exeter.ac.uk/moooddisorders/acceptclinic/).  The 
AccEPT Clinic is part of the School of Psychology at the University of Exeter.  It 
provides psychological therapies as part of the Mood Disorders Centre’s 
mission to develop, test and make accessible effective treatments for 
depression and other disorders.  Although the AccEPT Clinic has been 
commissioned by the NHS, it is separate to and not an IAPT Service. 
5.3.2 Randomisation, allocation concealment and blinding 
Participants were allocated in a 1:1 ratio to either the stepped care or intensive 
psychological therapy arms stratified according to their symptom severity on the 
Beck Depression Inventory – version I (BDI-I: minimal (0-9), mild (10-18), 
moderate (19-29), severe (30-63)) (Beck et al., 1961).  Allocation was 
minimised to maximise the likelihood of balance in stratification variables across 
the two study arms.  Concealment was ensured by use of an externally 
administered, password-protected randomisation website and retaining a 
stochastic element to the minimisation algorithm.  The computer-based 
allocation and website were developed and maintained by the accredited 
Peninsula Clinical Trials Unit, independent of the trial.  Participants’ details were 
sent to the AccEPT Clinic Administrator to alert them to assign the patient a 
study therapist and contact the patient to arrange treatment. 
All research measures were applied equally to both groups of participants.  At 
baseline, the study researcher (JJH) was blind to group allocation which 
occurred after this assessment.  At follow-up, I was un-blinded to allow me to 
interview patients who had been allocated to receive stepped care; interviews 
were conducted prior to follow-up.  Follow-up and baseline data were self-
reported. 
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5.3.3 Recruitment 
The Increasing Access to Psychological Therapies (IAPT) service from which 
participants were recruited wrote to all patients who were offered an initial 
assessment appointment to invite them to take part.  Letters were sent out by 
the Administrative Team and were an amended version of the service’s 
standard appointment letter. A study summary sheet and ‘permission for 
researcher to contact’ form accompanied each letter - see Appendix II.  
Interested patients were asked to bring their completed ‘permission to contact’ 
form to their initial assessment and hand it to their therapist.  Therapists placed 
completed forms in a clearly marked box in the IAPT service reception for the 
study researcher to collect.  When a therapist met with patients at a local GP 
practice, completed forms were placed in the box on return to the IAPT service.  
In the interim, therapists were asked to send form information to the IAPT 
Admin Team via secure email. 
Assessing eligibility 
Patients who completed and returned a form were telephoned by the study 
researcher who used a standard two-question case-finding instrument for 
depression (Whooley, Avins, Miranda, & Browner, 1997) to assess possible 
eligibility.  Baseline interviews were arranged with potentially eligible and willing 
participants.  Interviewees were sent a full study information sheet and flow-
chart (provided at Appendix II).  At interview, the study was explained in full and 
eligibility was assessed using the Mini-Cog (Borson, Scanlan, Brush, Vitaliano, 
& Dokmak, 2000) to screen for cognitive impairment and the CIS-R (Lewis et 
al., 1992) to establish a diagnosis of depression.  Self-report data was used to 
establish if patients were alcohol or drug dependent, had been diagnosed with 
Bipolar Disorder, Schizophrenia or had psychotic symptoms.  Patients who 
were acutely suicidal were identified by self-report; good clinical practice was 
employed in monitoring risk (see section 5.6.3).   
Action on end of interview 
Ineligible and / or unwilling patients continued with usual care at IAPT.  If 
eligible, fully informed and consenting, patients entered into the study.  For each 
new participant, the study researcher completed an ‘Information for Clinic’ form 
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(see Appendix II).  This comprised a description of the participant’s diagnosis on 
the CIS-R (Lewis et al., 1992), demographics, risk status and other relevant 
clinical information.  Forms were passed to the AccEPT therapists via the Clinic 
Administrator.  The study researcher also contacted the IAPT Admin Team to 
let them know if patients were ‘in’ or ‘out’ of the study. The IAPT Admin Team 
wrote to patients who were no longer in their care to confirm that they had been 
discharged; returning patients were contacted by their IAPT therapist to 
schedule their first treatment session.  Towards the end of the study, this 
procedure was revised.  At initial assessment, IAPT therapists scheduled a 
telephone call with their patient for two weeks forth i.e. when the outcome of 
recruitment would be known.  The purpose of the call was to acknowledge that 
the patient had joined the study and wish them well or to arrange the patient’s 
first IAPT treatment session.  
Treatment delay 
Two procedures were implemented so that patients’ treatment was not delayed 
and to enable the IAPT service to meet a key performance target to commence 
treatment within 28 days of patients’ initial assessment: the study researcher 
completed recruitment procedures within five working days of an individual’s 
IAPT assessment appointment; for people who returned a permission form, the 
IAPT service activated a ‘patient delay’.  This delay remained in place until the 
outcome of recruitment was known.  The period of delay did not count towards 
the 28 days from assessment to first treatment session. 
Logging study involvement 
Patients’ involvement in the study was logged by the IAPT service as follows.  
Individuals’ entry on IAPT-us (www.iaptus.co.uk), an electronic patient record 
keeping system, was updated to record when people were sent study 
information.  The Admin Team and study researcher maintained a list of 
patients who completed and returned permission forms; individuals’ interest was 
noted on IAPT-us.  When a patient joined the study or continued treatment with 
IAPT, both the list and IAPT-us entry were updated; the date on which the 
decision had been communicated was recorded on the list.  Systems allowed 
the IAPT service to monitor whether recruitment had been completed within five 
working days and to avoid sending patients study information twice - this could 
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happen when patients had been invited to take part, received and completed 
treatment at IAPT or the AccEPT Clinic and returned to IAPT for further 
treatment whilst recruitment was ongoing. 
5.3.4 Trial interventions 
Clinical procedures in both arms of the feasibility trial were Cognitive Behaviour 
Therapy (CBT) in both low- and high-intensity variants.   
Stepped care 
Stepped care involved initial low-intensity CBT in the form of Guided Self Help 
and subsequently, dependent on treatment response, high-intensity CBT.  
Guided Self Help (GSH) encompassed delivery of an off-line version of the 
internet delivered Wellbeing Course developed by the Centre for Emotional 
Health at Macquarie University, Sydney, Australia 
(http://www.ecentreclinic.org/).  For some patients, the Centre for Emotional 
Health supplies course material by post and patients are supported by a 
therapist via the internet or by phone.  The Wellbeing Course was utilised in this 
study for two main reasons: course effectiveness has been established (Titov et 
al., 2013; Titov et al., 2014; Titov, Dear, Johnston, & Terides, 2012); the course 
content is highly structured and relatively prescribed such that all patients 
receive similar treatment.   
With the permission of Macquarie, Wellbeing Course material was adapted for 
UK patients.  Culturally specific information and references were replaced with 
equivalent for the UK.  Course material was otherwise unchanged.  Weekly 
delivery of the course material was replicated in how patients were provided 
with pdf or paper documents.  Each week for five weeks, the AccEPT Clinic 
Coordinator emailed or posted patients a Lesson, Do It Yourself (DIY) Guide, 
Stories and Additional Resources. 
Lessons were ‘core reading’.  The first lesson comprised material about anxiety, 
low mood and depression.  Lessons two to four covered unhelpful thoughts 
(lesson two), physical symptoms of depression and anxiety (lesson three) and 
unhelpful behaviours (lesson four).  The fifth lesson encompassed information 
on relapse prevention.   DIY Guides provided patients with the opportunity to 
further their understanding of and begin to implement key concepts which were 
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covered in the Lessons.   Stories provided examples of how two people who 
had read the Wellbeing Course material learnt and practised concepts therein.  
Additional Resources were optional reading; they provided further information 
on specific topics that may have been helpful to patients e.g. sleep, 
communication skills.   
Patients were supported in their reading and application of the Wellbeing 
Course material by weekly contact with their therapist involving up to six 30-
minute consultations.  The first consultation was face to face; the remainder 
were by phone although patients’ request for some or all of these to be face to 
face could be accommodated. 
Stepped care participants’ progress was monitored using the nine item Patient 
Health Questionnaire (PHQ-9) (Kroenke et al., 2001). At session six of low-
intensity therapy, the decision to discharge patients or offer high-intensity 
psychological treatment was informed by a clinical algorithm (Table 14) that was 
designed to reflect the degree to which the PHQ-9 has been found to correctly 
identify depressed patients (sensitivity) and distinguish between depressed and 
non-depressed individuals (specificity) using different thresholds for recovery 
(Gilbody, Richards, & Barkham, 2007).  Patients who unambiguously scored 
below the accepted PHQ-9 threshold for recovery (<=9) (Kroenke et al., 2001) 
were discharged.  This score has a 94.4% sensitivity for depression (highly 
sensitive) and a 73.3% specificity (reasonable although subject to some false 
positives) (Gilbody et al., 2007).  
Compared with a threshold for recovery of <=9, cut-off scores of between 10 
and 12 are associated with slightly reduced sensitivity (91.7% for all scores) 
albeit each additional point in the scale confers increased specificity (10=78.3%, 
11=81.7%, 12=85.0%) (Gilbody et al., 2007).  These three scores, therefore, 
represent a certain amount of ambiguity in terms of recovery from depression.  
For this reason, the decision to step up or discharge patients who scored 10-12 
at week six of GSH was guided both by their PHQ-9 score at follow up and by 
their progress from baseline.  Discharge was suggested to patients who had 
made around 50% improvement on the PHQ-9 from week one to six.  For 
patients who had made less than 50% improvement, therapists suggested 
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progression to high-intensity therapy.  Patients who scored unambiguously 
above the cut-off i.e. 13-27 were offered high-intensity therapy. 
Table 14. Stepping criteria 
 
 
In almost all cases, high-intensity psychological therapy was delivered by a 
different therapist to the person who had provided low-intensity treatment.  
High-intensity CBT was delivered by therapists following a treatment protocol 
based on the standard manuals published by Beck et al. (Beck, Rush, Shaw, & 
Emery, 1979) and used in two other recent trials led by or in which the study 
researcher’s supervisors were involved (Rhodes et al., 2014; Wiles et al., 2013). 
Early sessions focused on agreeing problems to be addressed, therapeutic 
goals and learning about the CBT model and techniques for behaviour change.  
Patients subsequently worked on negative automatic thoughts, maladaptive 
beliefs and, where indicated, underlying core beliefs.  Later sessions helped 
patients anticipate and practice managing their response to stressors which 
could lead to future relapse.  Specific CBT techniques available for the 
therapists to use included scheduling activity and mastery behaviours and the 
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use of thought records.  All sessions were face to face and consistent with NICE 
recommendations for duration and frequency i.e. between eight and 20, 50 
minute consultations over a maximum of 16 weeks (National Institute for Health 
and Care Excellence, 2009b).  Patients could be offered up to two ‘booster’ 
sessions. 
Intensive psychological therapy alone 
High-intensity psychological therapy for participants in the control arm of the 
trial was identical to the high-intensity treatment for patients in stepped care 
except that patients only had intensive CBT; they were not offered Guided Self 
Help first.   
The decision to offer control patients high-intensity psychological therapy alone 
was made for the following reasons.  Although the National Institute for Health 
and Care Excellence (NICE) has made a specific recommendation to conduct a 
fully-powered trial of stepped care versus matched care (National Institute for 
Health and Care Excellence, 2009b), prior to the conduct of this study, there 
were no published prognostic indicators, including severity of depression itself, 
with sufficient power to predict response to treatment and therefore the specific 
treatment required for matched care (Fournier et al., 2009).  In terms of severity, 
a recent Individual Patient Data meta-analysis of 2470 patients with depression 
receiving low-intensity treatment found that patients with severe symptoms 
show at least as good clinical benefit from low-intensity interventions as less 
severely ill ones (Bower et al., 2013).  Moreover, as described in Chapter Two 
(sections 2.3 and 2.4) stepped care was conceived and implemented as an 
alternative to long-term, high-intensity psychological therapy for all.   High-
intensity CBT  has been found effective against a number of comparators, in 
patients with a range of severity of depressive symptoms, in group and 
individual settings and for both relapse prevention and treatment of a current 
episode (National Institute for Health and Care Excellence, 2009b).  Compared 
with matched care, there are fewer uncertainties associated with it.     Thus, 
prior to the conduct of the study, it was logically decided that the most 
appropriate and robust test of the equivalence and efficiency of stepped care 
would be a fully-powered RCT against high-intensity CBT alone; the pilot trial 
comparator was selected accordingly. 
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All trial treatments were delivered by Mood Disorders Centre AccEPT Clinic 
therapists with considerable experience of CBT.  Two of the therapists (a 
Clinical Psychologist and specialist mental health nurse) were accredited by the 
British Association of Behavioural and Cognitive Psychotherapy.  The Clinical 
Psychologist, who had no prior experience of stepped care, had previously 
been employed as a CBT therapist for over ten years; the specialist mental 
health nurse had previously worked in IAPT as a low-intensity therapist.  The 
third therapist had received expert training in high-intensity CBT as part of his 
doctoral studies in Clinical Psychology at the University of Calgary, Canada, of 
which he was in his final year and on placement at the Mood Disorders Centre.  
All three therapists delivered both low- and high-intensity CBT for the current 
study.  Prior to the start of recruitment, the study researcher organised a Trial 
Orientation Day for AccEPT staff.  Therapists were briefed on: the background 
to the study; trial treatments and related clinic procedures; patients’ transition 
into therapy on randomisation; risk and adverse / serious adverse event 
protocols (see sections 5.6.3 & 5.6.4); embedded qualitative interviews.  
Supervision and training in the delivery of clinical treatments was provided by 
senior academic and clinically qualified experts in high-intensity Cognitive 
Behaviour Therapy and mental health. 
5.3.5 Outcomes 
As this was a feasibility study with a range of different aims to inform a fully-
powered evaluation of stepped care, there was no single primary outcome 
measure.  Rather a variety of patient-related data were collected at baseline 
and six months post randomisation: severity of depressive symptoms (BDI-I) 
(Beck et al., 1961), worry and anxiety (Generalised Anxiety Disorder-7; GAD-7) 
(Spitzer, Kroenke, Williams, & Lowe, 2006) and health related quality of life 
(Short Form Health Survey-36 version 2.0; SF-36 v2) (Ware et al., 2007).  A 
copy of the baseline Case Report Form is provided at Appendix III.  At six 
months post randomisation, it was expected that patients’ treatment, including 
for people randomised to stepped care and stepped up to CBT, would be 
complete.   However, for a sub-set of participants, the actual duration of 
treatment was greater than six months and follow-up data was consequently 
obtained prior to the end of patients’ treatment. 
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Data were also collected on: trial participants’ baseline demographic and clinical 
characteristics including age, sex, ethnic group, employment, history of 
depression and use of anti-depressant medication; the flow of participants 
through the trial i.e. numbers of patients at each step; the number and 
proportion of people who stepped up and were discharged from stepped care 
following low-intensity psychological therapy.   For the duration of recruitment, 
the IAPT Admin Team recorded the number of patients to whom they sent study 
information; this data was collated and sent to the study researcher weekly.  
Numbers of patients who had been offered and then attended IAPT 
assessments was provided by the mental health trust responsible for the IAPT 
service.  With the help of a University of Exeter colleague (see 
Acknowledgements), a trial database was developed in which the details of all 
patients who completed and returned a permission form were entered.  
Patients’ recruitment status e.g. declined telephone screen, ineligible at 
baseline was recorded therein.  Patient-related outcome data was entered in 
the same database. 
Therapists collected data on treatment adherence and content: patient contacts 
were recorded on a Participant Contact Log; key themes covered at each 
treatment session were recorded using semi-structured Session Record Forms 
(see Appendix III).  Patients’ PHQ-9 scores at each treatment session were 
recorded on the Participant Contact Log and Session Record Form for Guided 
Self-Help. 
5.3.6 Sample Size 
A conventional power calculation is inappropriate for a pilot RCT (Arain et al., 
2010; Thabane et al., 2010).  As such, the sample size required was calculated 
(with the assistance of a University of Exeter Medical School statistician – see 
Acknowledgements) based on the margins of error associated with the key 
parameters of interest, specifically: recruitment and retention rates; the standard 
deviation of the primary outcome (and other continuous outcomes);  the 
correlation between baseline and six month follow-up outcome scores – which 
can be used to refine the sample size calculation for the fully-powered 
evaluation to take into account the added precision gained from adjusting for 
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baseline scores when comparing the follow-up outcome scores between the 
trial arms.  
It was expected that a total of 1500 patients would need to be approached to 
participate in the pilot trial.  This was large enough to estimate a participation 
rate (as percentage of subjects approached) of 5% with a margin of error of +/- 
1.1% or to estimate a participation rate of 10% with a margin of error of +/- 1.5% 
based on 95% confidence intervals.  However, if it was necessary to approach a 
higher number of potential participants (2000) and a lower participation rate of 
2% was achieved, it was calculated that the associated margin of error would 
be +/- 0.7% based on 95% confidence intervals.   
Assuming the participation rate would be 5% of 1500 people approached, the 
feasibility trial would recruit 75 participants.  It was calculated that this would be 
sufficient to: (i) estimate a follow-up rate (as percentage of participants 
recruited) of 80% with a margin of error of +/- 9%; (ii) estimate the standard 
deviation of the continuous primary outcome to within 22% of its true value 
based on the upper limit of the 95% confidence interval; (iii) estimate the 
correlation between the baseline and follow-up outcome scores with a margin of 
error of 0.12 (based on the lower limit of the 95% confidence interval) if the true 
correlation was 0.8.  Assuming a participation rate of 2% of 2000 people 
approached, this would be sufficient to: (i) estimate a follow-up rate of 80% with 
a margin of error of +/- 10.1% and (ii) estimate the correlation between the 
baseline and follow-up outcome scores with a margin of error no greater than 
0.13 (based on the lower limit of the 95% confidence interval). 
The margins of error associated with the recruitment of 75/1500 people and 
60/2000 approached were considered to be acceptable.  A range of between 60 
and 75 was therefore selected as the target sample size. 
5.4 Semi-structured interviews 
Semi-structured interviews were embedded in the pilot trial to explore what 
patients, therapists and IAPT staff thought of (i) trial methods and procedures, 
(ii) the acceptability of stepped care. 
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5.4.1 Sample and setting 
Recommendations by qualitative methodologists on the number of interviews 
required for qualitative research vary (Bertaux, 1981; Corbin & Strauss, 2008; 
Morse, 1994).  Numbers differ by type of inquiry (e.g. six for phenomenological 
studies (Morse, 1994); 20 to 30 for Grounded Theory (Creswell, 2013)) and in 
ways that are unexplained; there is almost no evidence to substantiate 
recommendations.   Prior research on stepped care provides limited guidance 
on what may be an appropriate number of interviews for the current study.   For 
example, Parry et al. (2011) interviewed 77 patients.  However, the authors did 
not provide a rationale for their sample size; benefits were not described.  
Sample sizes for qualitative studies of other systems of care also differ (Coupe 
et al., 2014; Gask, 2005; Johnston et al., 2007).  The number of interviews for 
the current study was therefore selected with thought to the purpose of the 
current research, the degree to which the population of interest was 
homogenous, researcher experience and resource constraints. 
Number of patient interviews  
The aim of the patient interviews was, in part, to help understand what people 
thought of the stepped care intervention and how this might relate to treatment 
adherence.   Data was not required to test this relationship, provide definitive 
evidence of acceptability or (necessarily) represent the views of patients who 
may have experience of other forms of stepped care.  Very large numbers of 
interviews were not therefore required.  However, the population of interest (trial 
participants) was non-homogenous; it was anticipated that patients would have 
different treatment (GSH alone or GSH and CBT) and vary in the number of 
treatment sessions they would attend.  Thus, the researcher aimed to interview 
all of the trial participants who had been allocated stepped care.  A minimum 
sample size of 24 was selected to include patients with varied receipt of and 
adherence to low- and high-intensity therapy within the stepped care protocol.  
(See section 5.5.2 for a related explanation of numbers of patient interviews 
analysed.) 
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Number of therapist and IAPT interviews 
The number of therapist interviews was limited to the number who had provided 
stepped care treatment in the pilot RCT i.e. three.   The IAPT Team Manager, a 
Psychological Wellbeing Practitioner (PWP) and Team Administrator were also 
interviewed.  The Team Manager and Administrator had been closely involved 
in the set-up and design of recruitment procedures; the Administrator and PWP 
had good experience of how procedures worked in practice.  It was considered 
that this number of IAPT interviews would provide reasonable and informed 
feedback on the feasibility and appropriateness of recruitment methods and 
procedures. 
Patient interviews were undertaken at AccEPT Clinic facilities or by phone 
depending on interviewees’ preference.  Therapist interviews were held at the 
Mood Disorders Centre.  Interviews with IAPT staff were conducted at IAPT 
facilities. 
5.4.2 Recruitment 
Patients’ informed consent to be interviewed was determined at trial 
participants’ baseline interview.  On completion of stepped care treatment, 
patients were telephoned to establish that they were still willing to be 
interviewed; patients were reminded what an interview would involve and 
questions were answered.   For patients who remained willing, interviews were 
arranged no sooner than 48 hours later and confirmation of arrangements was 
sent in writing.  The opportunity to rearrange or cancel the interview was 
mentioned in the letter.  Therapists were given details of the therapist interviews 
at the Trial Orientation Day when their willingness to be interviewed was 
established.  Therapists’ interviews were arranged shortly before the end of 
their involvement in the pilot RCT.  IAPT personnel were invited for interview 
shortly before the end of the trial recruitment period; interviews were arranged 
on end recruitment. 
5.4.3 Interview process and questions 
Semi-structured interviews were employed to enable the interviewer to explore 
the meaning of participants’ responses and elicit more detail on themes that 
arose during the interviews as well as explore what people thought of pre-
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defined topics of interest (Taylor, 2011).  Individual semi-structured interviews 
were also utilised as they allowed participants to describe their views in 
confidence. 
Topic guides 
Interview schedules were developed for patients, therapists and IAPT staff. 
(Final versions are available at Appendix III).  People were asked for their views 
and experience of stepped care and trial methods and procedures in relation to 
their study involvement.   Questions about the acceptability of stepped care 
were designed to explore what people thought of its underpinning principles and 
implementation.  Questions on the feasibility and appropriateness of trial 
procedures aimed to identify procedures which facilitated the efficient running of 
the trial but also any that were perceived to be problematic. 
Patients 
Patient interview schedules were structured as follows.  Interviewees were 
asked why they had sought treatment, how they felt on being offered stepped 
care, what they thought of GSH and CBT and their symptoms of depression 
being monitored.  Interviews also explored patients’ views of stepping ‘up’ or 
‘out’ of treatment following GSH, ending treatment and the extent to which 
therapy helped.  The latter (and smaller) part of the interview focused on what 
people thought about trial methods and procedures specifically recruitment, the 
transition to therapy and the administration of treatment (scheduling 
appointments and receipt of the Wellbeing Course material for example).  
Patients were invited to suggest what, if anything, could have been done to 
improve how the study was run.  At the end of the interview, patients could 
share views and opinions not already discussed. 
An early version of patient interview schedule was shared with two members of 
the Mood Disorders Centre Lived Experience Group (LEG) for review and 
comment.  (Members of the group have direct or indirect experience of living 
with depression and are available to advise on all research activity at the Centre 
– see section 5.7.)  Changes were consequently made to the schedule to help 
make the interview feel more personal.  Consistent with standard practice in 
qualitative fieldwork (Arthur, Mitchell, Lewis, & McNaughton Nicholls, 2014), 
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successive versions of the topic guide were also amended to help participants 
provide more relevant information and to facilitate the smooth running of the 
interview; new questions were included based on what had been discussed at 
previous interviews. 
Therapists 
The therapist interview schedule was predominantly focused on what people 
thought of stepped care.  Interviewees were asked for their definition of this 
system of treatment, their view of GSH, monitoring patients, stepping criteria 
and high-intensity therapy.  The interviewer tried to elicit how the option to offer 
patients CBT influenced therapists’ delivery and views of GSH and similarly, 
how patients’ prior experience of GSH impacted delivery of CBT.  Questions on 
the feasibility and appropriateness of trial procedures sought feedback on study 
set up, patients’ transition to therapy on randomisation, the administration of 
treatment, record-keeping and clinic procedures for managing risk, reporting 
Serious Adverse Events and supervision. 
IAPT staff 
Interviews with IAPT staff were tailored depending on how the interviewee had 
been involved in recruitment.  The Team Manager, Administrator and PWP 
were all asked what they thought of research in general and the role for the 
NHS / their service.  Interviews with the Team Administrator and PWP 
subsequently explored their initial reaction to the prospect of being involved in 
this study, how patients were invited to take part, receiving and passing on 
completed permission forms, logging patients’ involvement in the study and 
continuing care for people who were ineligible / unwilling to take part.  The IAPT 
Team Manager was asked for her views and opinions of negotiation to agree 
recruitment procedures as well as how well they had worked in practise.  
Interviewees were asked to consider what had worked well or caused difficulty 
from their own and patients’ perspectives. 
Process 
Interviews lasted between forty-five and sixty minutes and were audio-recorded 
with participant’s permission.  Prior to the start of the interview, the therapists 
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and IAPT staff were reminded that they were one of three people interviewed 
hence their anonymity could not be guaranteed. 
Field notes 
Field notes were made on completion of each patient interview.  (See Appendix 
IIIV for an example.)  Notes included the study researcher’s summary of: what 
the patient thought of stepped care; main themes arising on trial methods and 
procedures; thoughts or new hypotheses on the acceptability of stepped care; 
potential questions for future interviews.  Field notes were primarily used to help 
inform changes to the patient topic guide (see above) and select interviews for 
analysis (see section 5.5.2, below). 
5.5 Analysis 
There were three strands of analysis: quantitative, qualitative and mixed 
methods.  First, quantitative trial data and the qualitative data from the semi-
structured interviews were analysed separately.  Next, quantitative and 
qualitative data were integrated in a mixed methods analysis (Creswell & Plano 
Clark, 2011). 
5.5.1 Quantitative analysis 
Recruitment and outcome data were downloaded from the trial database in a 
format suitable for import into STATA v.13, STATA, StataCorp LP, 4905 
Lakeway Drive, College Station, Texas 77845-4512, USA.  To check for 
inaccuracies, outcome data were double-data entered by an undergraduate 
Psychology student as part of a six month internship.   Treatment data 
(participant contact logs and session records) were collated and entered into an 
Excel spreadsheet (Microsoft 2010, Microsoft Excel, Redmond, Washington: 
Microsoft).  All data were imported into STATA v.13.  Following published 
guidance (Ware et al., 2007), Physical and Mental Health Component Scores 
were calculated from raw scores on the SF-36v2.  All of the variables to be 
analysed were cleaned by generating descriptive statistics and frequency data. 
Recruitment and retention  
To address the first research question, “What is the quantifiable performance of 
recruitment and retention methods which may be used in a fully powered trial?” 
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count data were used to enumerate the flow of the participants through the 
trial.  Data were expressed both as a percentage of the total number of 
participants approached and in relation to the preceding step in recruitment.   
Margins of error were estimated for each parameter. For each of the 
interventions, the number of participants who withdrew, could not be contacted 
or did not provide six month follow up data for another reason was quantified. 
Numbers were expressed as a percentage of the total number of participants in 
each of the stepped care or high-intensity group.  CONSORT guidelines 
(Schulz, Altman, & Moher, 2010) on reporting the number of participants who 
exit the trial at each step of recruitment and from whom it was not possible to 
collect follow up data were followed. 
Baseline characteristics 
Descriptive statistics were calculated to describe trial participants’ baseline 
demographic and clinical characteristics.  Frequency and percentage 
information was calculated from categorical data on patients’ sex, ethnic group, 
education, marital status, employment, home ownership, diagnostic status, 
history of depression and use of antidepressant medication.  Means and 
standard deviations were estimated to describe continuous data on patients’ 
age and CIS-R total score at baseline. 
Receipt of the intervention 
The number and proportion of people who received stepped care and stepped 
up from low- to high-intensity treatment or were discharged following low-
intensity therapy (Question Two) was quantified.  Quantitative data on patients’ 
therapeutic attendance (Question Five) was analysed as follows.  For each of 
the interventions descriptive statistics were generated to describe the number 
and proportion of total available sessions attended where the total number of 
available sessions was six for patients who had GSH alone, 20 for patients who 
had CBT alone and 26 for patients who had GSH and CBT.  The number and 
proportion of participants who declined any treatment, dropped out early or 
completed treatment was quantified.  For stepped care participants, the number 
and proportion that dropped out prior to low-intensity therapy, before high-
intensity therapy having been stepped up, and during each treatment step was 
quantified.  The total number of hours in treatment was estimated assuming that 
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each GSH and CBT session lasted 30 and fifty minutes respectively.  Dates of 
patients’ first and last treatment sessions were used to calculate the number of 
weeks in therapy.  
Outcomes 
To measure the variability in patient-related outcomes following stepped care or 
intensive psychological therapy alone and the correlation with patients’ baseline 
scores (Question Three) estimates were made of the standard deviation around 
mean BDI-I, GAD-7 and SF-36 scores at baseline and six months for both 
groups.  Estimates were then made of the correlation between participants’ 
scores on the BDI-I, GAD-7 and SF-36 at baseline and at six months. 
Sensitivity analyses 
The effect of six month follow up data that had been obtained prior to the 
completion of patients’ therapy was analysed in sensitivity analyses by 
excluding this data from estimates of the variability in patient-related outcomes 
and correlations between participants’ scores at baseline and six months. 
Planned sub-group analyses 
Several additional exploratory analyses were undertaken.  Analyses did not 
address the study research questions but were undertaken in anticipation of 
broader interest in the outcome data and in response to a specific concern with 
the stepping criteria for patients who had a relatively high pre-treatment PHQ-9 
score of 19-27, scored 10-12 at the end of low-intensity treatment and were 
subsequently discharged due to good progress.   Given that the severity of 
patients’ first / index episode of depression has consistently been found to 
relate to rates of recurrence, although a causal relationship has not been 
established (Burcusa & Iacono, 2007), it is possible that discharging  patients 
with relatively high levels of depressive symptoms before treatment who were 
not unambiguously below cut-off on end GSH, was premature.   
Thus, to explore the impact of the stepping criteria on patients with more severe 
pre-treatment depressive symptoms, six month outcome data was described for 
patients with a mild to moderate versus severe diagnosis of mental health 
problems on the CIS-R at baseline.  Other analyses described: levels of 50% 
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improvement on the BDI-I and GAD-7 from baseline to six months and 
associated margins of error; six month treatment outcomes for stepped care 
patients who were discharged on end GSH versus progressed to CBT. 
Underpinning principles 
All analyses were undertaken on an intention to treat basis i.e. participants were 
analysed in their original assigned groups.  Emphasis was on quantification and 
estimation rather than hypothesis testing.  Missing data was reported but not 
imputed; as far as possible reasons for missing outcomes were stated.   All 
analyses were conducted using STATA v.13. 
5.5.2 Qualitative analysis 
Interviews on the acceptability of stepped care and the appropriateness of trial 
recruitment were analysed to inform answers to Research Questions Four & 
Five.  Interviews were transcribed verbatim by the study researcher, University 
of Exeter colleagues and a specialist in qualitative research.  Transcribers were 
briefed by the study researcher and used a common template for transcription 
(see Appendix IV).  Transcripts were checked for consistency of style and 
accuracy. 
Analytic sample 
All of the IAPT and therapist interviews were analysed.  A sub-set of the patient 
interviews was purposively selected for analysis.  Transcripts were chosen to 
include patients with a range of treatment experience (GSH alone and GSH + 
CBT).  Compared with the proportion of trial patients who were offered stepped 
care and had progressed to high-intensity therapy, a larger proportion of the 
analytic sample (50%) had GSH and CBT.  The experiences of this group were 
considered particularly important.  To facilitate the mixed methods analysis (see 
section 5.5.3), all of the interviews completed with patients who had declined 
any treatment or dropped out early were included.  The remainder of the 
analysed interviews were conducted with patients who had completed 
treatment.  Given the potential for what people think of stepped care to be 
confounded by the degree to which they improved, patients who had stepped 
up and completed treatment were selected to include a range of treatment 
outcomes.  (All of the patients who had GSH alone had responded to therapy.)  
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The study researcher’s record of the quality of the interview and whether the 
interviewee expressed notable (potentially distinctive) views was also 
considered. 
In total, 18 interviews were analysed, 12 with patients, three with the study 
therapists and three with IAPT staff.  This number was chosen for two main 
reasons: to ensure that all of the qualitative analysis could be completed by the 
study researcher in the period planned (the time available was limited within the 
context of a three year programme of work and needed to allow good time for 
the mixed methods analysis) and for the potential to achieve saturation.  
Although saturation (the point at which no new information are observed in the 
data (Glaser & Strauss, 1967; Schensul & Le Compte, 2010)) has become the 
gold standard by which the size of purposive sample sizes is determined 
(Guest, Bunce, & Johnson, 2006), there are no practical guidelines or tests of 
adequacy for estimating what this means in practice (Guest et al., 2006; Morse, 
1995). 
In response, Guest et al. (2006) systematically documented the degree of data 
saturation achieved over the course of analysis of sixty in-depth interviews with 
women from two countries on their sexual behaviours.  Seventy-three percent of 
the thematic codes generated from analysis of all thirty interviews with women 
in one of the countries were identified in the first six transcripts; 92% of the 
codes were identified from twelve.  The authors therefore posited that data 
saturation had, for the most part, been achieved from the analysis of twelve 
interviews (Guest et al., 2006).  Whilst it is hard to say how generalizable this 
finding might be (Guest et al., 2006), it suggests that analysis of twelve patient 
interviews on stepped care could provide a largely ‘complete’ understanding of 
what trial participants think of this system; the analysis of six interviews with 
patients who had GSH alone and six interviews with patients who had 
GSH+CBT might provide a reasonable insight into the experiences of these 
different patient groups. 
Framework 
A series of framework analyses (Spencer, Ritchie, Ormston, O'Connor, & 
Barnard, 2014)  were conducted using an abductive approach.  Analyses 
explored the acceptability of stepped care to patients and therapists, the 
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feasibility and appropriateness of trial methods and procedures to patients and 
therapists, the feasibility and appropriateness of recruitment to IAPT staff. 
Transcripts were coded at the level of individual participants but analysed 
thematically across datasets as well as in the context of each participant’s 
interview, using a constant comparison approach (Miles & Huberman, 1994).  
Thematic frameworks were developed from a combination of interview topics 
and data collected from participants.  Data were indexed (applied to the 
thematic frameworks) and reviewed. Initial thematic frameworks were modified; 
themes were merged, split or re-defined.  Data were re-coded (indexed) 
accordingly.  Coded data were subsequently charted, abstracted and 
interpreted to distil, structure and make sense of what people said (Spencer, 
Ritchie, O'Connor, Morrell, & Ormston, 2014), the original transcripts being 
frequently revisited to check and clarify contextual meaning.  Examples of 
thematic frameworks, charts and abstraction are provided at Appendix IV.  
Frameworks were comprised of themes and sub-themes that were very 
descriptive.  Interviewees’ views and experiences of stepped care and trial 
recruitment were captured in detail.  A small number of (cross-cutting) 
interpretive themes on the acceptability of stepped care to patients were also 
derived (see below). 
Framework applied to acceptability 
Data on the acceptability of stepped care to patients was summarised in a 
number of charts.  Two charts were developed to capture what patients said 
across all of the major themes in the modified thematic framework.   This 
information was used to help develop typologies of the acceptability of stepped 
care to patients.   Additional charts were generated to summarise in more detail 
what interviewees said on each major theme: a chart was created for each 
theme; therein data were summarised by sub-theme.  For each sub-theme, 
common elements across all patients were identified and abstracted into 
dimensions and where appropriate higher order classifications.  This information 
was used to write summaries of patients’ views and experiences of stepped 
care in relation to each sub-theme.  Emergent cross-cutting themes that 
seemed to shape patients’ views and experiences of more than one component 
of stepped care were identified.  At the end of analysis, mini-summaries were 
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written (in the first person but not using quotes) of what each interviewee 
thought of stepped care as a whole; analogous summaries were written to 
encapsulate what each patient thought of GSH and CBT.  Summaries were 
presented in tables on patients’ views and experiences of low-intensity therapy, 
high-intensity therapy and the stepped care intervention as a whole. 
Data on the acceptability of stepped care to therapists was similarly analysed: a 
chart was developed for each major theme; therein data was summarised by 
sub-theme; for each sub-theme, common elements across all therapists were 
identified and abstracted; this information was incorporated in a summary of 
therapists’ views on each sub-theme. 
Framework applied to recruitment 
Compared with data on the acceptability of stepped care, less (complex) data 
was gathered on the feasibility and appropriateness of recruitment.  Data was 
consequently analysed using a modified framework approach.  Indexed data 
were charted by sub-theme and case.  Where helpful, common elements were 
abstracted and organised into dimensions; this information was used to write 
summaries of what patients, therapists and IAPT staff thought of recruitment.  
However, where it was possible to distil meaning without this level of 
abstraction, summaries were written directly from charts; within charts, 
summaries of what people thought of each sub-theme were sometimes 
organised by dimensions. 
Software 
NVivo version 9.0 (www.qsrinternational.com/products_nvivo.aspx ) was used 
to organise the data and help ensure systematic analysis. 
Patient and public involvement 
Prior to analysis, six patient interview transcripts were sent to two members of 
The University of Exeter Mood Disorders Centre Lived Experience Group.  
Members were asked for their ‘first impressions’ of how the interviewees had 
found stepped care.  Each member returned a short description of what each 
interviewee had said about being offered stepped care, GSH, CBT, being 
monitored and ending treatment.  The study researcher compared her 
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interpretation with LEG members’.  Where discrepancies arose, the study 
researcher returned to the original transcripts to check her understanding of the 
interview.  If needed, summaries of patients’ views (entered in Framework 
charts) were updated.  The study researcher was alert to any ‘type’ of 
discrepancy that was common to more than one transcript so that she could be 
mindful of this in her interpretation of interviews that were not shared with the 
LEG. 
5.5.3 Mixed methods analysis 
Mixed methods analysis was undertaken to integrate qualitative and quantitative 
data.  The choice of specific techniques was guided by the nature of the 
quantitative and qualitative data that was ultimately obtained and the inferences 
that arose from the separate analysis of both.   Techniques were developed 
based on three methods for merged data analysis summarised by Creswell and 
Plano Clark (2011).  Specifically: (1) a side-by-side comparison of quantitative 
and qualitative data presented in a summary table or as part of a discussion; (2) 
a joint display of quantitative and qualitative findings whereby qualitative data 
are presented for categories of people defined on a quantitative dimension (a 
category/theme display) or the presentation of quantitative data for typologies of 
people defined using qualitative information (a typology/statistics display); (3) a 
case-oriented display that positions cases (individuals) on a quantitative scale 
along with qualitative data about those cases (Creswell & Plano Clark, 2011).    
Techniques were also developed with reference to examples of the use of such 
methods (Li, Marquart, & Zercher, 2000; McEntarffer, 2003; Mendlinger & 
Cwikel, 2008; Wittink, Barg, & Gallo, 2006) cited by Creswell and Plano Clark 
(2011).  
Acceptability and attendance 
To investigate how patients’ views on the acceptability of stepped care might 
help explain variability in the number of treatment sessions they attend 
(Research Question Five), data were merged in three ways.  Two approaches – 
(1) & (2) below – examined how patients’ views of stepped care as a whole 
might relate to the total number of therapy sessions people attend.  The third 
approach (3) was used to explore how patients’ views of low-intensity treatment 
might relate to the number of GSH sessions they attend and how what people 
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thought of high-intensity therapy might relate to the number CBT sessions 
attended. 
(1) Typology / statistics display.  Categories of patients were defined using 
the typologies of patients’ views on stepped care.  Categories therefore 
represented groups of people for whom stepped care was more and less 
acceptable.  For each patient in each category, data were presented on the total 
number of therapy sessions attended and the number of low- and high-intensity 
sessions received.  
(2) Category / theme display.  Groups of patients were identified by the 
percentage of total available sessions attended - groups were defined to 
demarcate clusters of people who had more or less therapy.  For each group, 
treatment adherence data and mini-summaries of what people thought of 
stepped care were displayed jointly.  Mini-summary statements were highlighted 
to illustrate how patients’ views of stepped care were shaped by the cross-
cutting themes identified from qualitative analysis. Data were examined for 
similar and different views on acceptability within and between attendance 
categories and how cross-cutting themes might relate to attendance. 
 (3) Case-oriented display.  Cases (patients) were positioned on two scales of 
treatment adherence (number of low- and high-intensity sessions attended).  
Corresponding qualitative data (mini-summaries) were presented on the 
acceptability of GSH and CBT.  Qualitative data on the acceptability of low- and 
high-intensity treatment were reviewed for similarities and differences across 
the number of GSH and CBT sessions attended. 
Given the potential for what people think of their treatment to be confounded by 
its success or otherwise, outcome data (change in and improvement on the 
PHQ-9 pre- to post-treatment) were incorporated in the display of results from 
(1) to (3).  (Analyses were not designed to explore how what people thought of 
stepped care and treatment outcome relate.)  The results of (1) to (3) were 
ultimately used to develop hypotheses on the relationship between acceptability 
and treatment attendance for testing in a fully-powered evaluation of stepped 
care. 
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Recruitment 
For an improved understanding of the feasibility and appropriateness of 
recruitment (Research Question Four), qualitative data on appropriateness and 
numeric data on the performance of recruitment methods and procedures was 
presented in a side-by-side summary table so that one type data could be 
compared to the other.   Included data were a sub-set of all the available 
quantitative and qualitative information on recruitment: qualitative data were key 
findings from the patient, therapist and IAPT staff interviews considered helpful 
to interpret the quantitative data; numeric data (from STEPS’ CONSORT 
diagram) was included that was thought helpful to place what people thought of 
recruitment in context. 
Data were organised by stage of recruitment e.g. initial approach to patients, 
handling permission forms and telephone screening.  Synergy and disparity 
between quantitative and qualitative data were highlighted.  In terms of a fully-
powered evaluation of stepped care, it was suggested that procedures which 
elicited positive feedback and appeared to perform well could remain 
unchanged; procedures which elicited negative feedback and did not perform 
well according to numeric data, could be modified, and; procedures for which 
there was disparity between quantitative and qualitative data e.g. positive 
patient feedback and numeric data to suggest poor performance, required 
further thought. 
5.6 Ethical issues 
The pilot trial and embedded interviews were conducted in such a way to 
protect the human rights and dignity of the participants as reflected in the 
Helsinki Declaration (World Medical Association General Assembly, 2013).  
Participants were not paid to participate.  The study was approved by the 
National Research Ethics Service South West – Frenchay (reference 
13/SW/0140).  National Health Service Research and Development permission 
was obtained from Devon Partnership Trust (reference DPT 0258) to identify 
and recruit patients.  The School of Psychology Ethics Committee at the 
University of Exeter approved the study (reference 2012/500).  Copies of 
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approval letters are provided at Appendix V.  To conform to data protection and 
freedom of information acts, all data was stored securely and anonymised 
wherever possible.  No published material contained (or will contain) identifiable 
patient information. 
5.6.1 Obtaining informed consent from patients 
Patients’ informed consent was determined in two stages.  As described in 
section 5.3.3, potential participants were sent a one page study summary sheet 
and a form seeking their permission to be contacted by a member of the study 
team, not at this stage to give consent to taking part.  Patients who were 
interested in taking part returned their form to the study team (via IAPT staff).  
Interested patients could also telephone the study researcher.  Potential 
participants were telephoned by the study researcher to assess their possible 
eligibility and to answer any questions.  For those who were willing and possibly 
eligible, the study researcher sent a Patient Information Sheet and arranged a 
baseline interview.  The study summary and information leaflets were produced 
using the current guidelines for researchers on writing information sheets and 
consent forms, posted on the UK ethics website 
(www.nres.nhs.uk/applications/guidance/consent-guidance-and-forms/) and 
informed by consumer/lived experience user representatives.  Full informed 
consent was only obtained at interview by the study researcher.  She assessed 
eligibility in full, fully explained the study and answered outstanding questions.  
The opportunity to participate in a semi-structured interview was optional; 
patients could consent to participate in the pilot RCT only.  It was explained that 
a decision not to be interviewed would not affect patients’ participation in the 
trial.  Consent to record and transcribe interviews was established.   The 
opportunity to withdraw from the pilot trial and / or interview was explained.  The 
study researcher was fully trained and supervised by senior academic and 
clinically qualified staff.  Communication and recording systems enabled the 
study team to monitor and act on participants’ wishes to withdraw. 
5.6.2 Risks and benefits 
No treatment was withheld from participants taking part in this study.  
Interventions comprised active psychological treatments with previously 
demonstrated efficacy and no known iatrogenic effects.  By participating in the 
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study, participants received an intensive level of monitoring such that any 
participants worsening or at suicidal risk were identified and directed to 
appropriate care.  The participant information leaflet provided potential 
participants with information about the possible benefits and risks of taking part 
in the trial.  Participants were given the opportunity to discuss this with the study 
researcher prior to consenting.  The study researcher committed to inform the 
participants if new information came to light that may affect persons’ willingness 
to participate; information did not arise. 
5.6.3 Managing risk of suicide 
Good clinical practice in monitoring the risk of suicide to patients was adhered 
to during all clinical and research appointments with study participants.  Where 
any risk to participants due to expressed thoughts of suicide was encountered, 
this was reported directly to the patient’s General Practitioner (GP) (with the 
participant’s expressed permission) or, if an acute risk was present, immediate 
advice was sought from the GP.   All of the study therapists and members of the 
research team were familiar with established protocols for if a participant 
indicates that they are having thoughts of self-harm or suicide. A copy of the 
Risk Protocol for Researchers is provided at Appendix V.  Clinicians and 
researchers were specifically trained in risk assessment and management and 
supervised by experienced clinicians.  Senior academic and clinically qualified 
members of the study team were notified on detection of any risk to patients’ 
safety. 
5.6.4 Serious Adverse Events 
Following instruction by the National Research Ethics Service South West – 
Frenchay, Serious Adverse Events (SAEs) were defined as any untoward or 
unintended medical occurrence, related to the trial treatments or not, that could 
be further classified as: fatal; life threatening; requiring hospitalisation or 
prolonging existing hospitalisation; resulting in significant, persistent disability or 
incapacity; resulting in congenital abnormality or birth defect; leading to any 
other condition judged significant by a clinician.  Serious Adverse Events were 
reported to the study sponsor (University of Exeter) within 24 hours of coming to 
light.  Within 15 days and consistent with the SAE standard operating procedure 
(see Appendix V) a more detailed report was reviewed by an external advisor 
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(academic psychiatrist) and sent to the National Research Ethics Service South 
West – Frenchay Committee. 
5.7 Patient and public involvement 
The proposal for this study arose from a research prioritisation process in the 
NIHR CLAHRC South West Peninsula (PenCLAHRC, http://clahrc-
peninsula.nihr.ac.uk/).  PenCLAHRC has a well-developed patient and public 
involvement process through a funded group of representatives – the Peninsula 
Public Involvement Group (PenPIG).  PenPIG members are involved in 
research topic identification and prioritisation.  Patient and public 
representatives from both PenPIG and the University of Exeter Mood Disorder 
Centre’s Lived Experience Group (LEG) were involved at all stages in 
identification and preparation of the proposal for this study and in the early work 
conducted to underpin it.  As described above (see 5.4.3 and 5.5.2) two LEG 
members were subsequently involved in the design and analysis of the semi-
structured patient interviews. National good practice guidance for researchers 
on public involvement in research and the paying of PPI representatives at 
www.invo.org.uk was followed. 
5.8 Study set up and management 
The study researcher was responsible for study design, set-up and 
management and was the named Principal Investigator in all communications 
with the National Research Ethics Service South West – Frenchay committee.  
IAPT and AccEPT Clinic Handbooks were developed on recruitment, clinic and 
research procedures.  Handbooks were circulated, updated and available 
throughout the trial.  Prior to the start of recruitment, the study researcher 
organised a Trial Orientation Day for AccEPT staff (see section 5.3.4).  Senior 
and appropriately qualified academics provided clinical supervision; the study 
researcher handled all other study related questions, was in regular 
communication with the AccEPT Clinic therapists and attended monthly 
AccEPT Clinic meetings.  Recruitment procedures were agreed in close 
communication with senior IAPT staff.  The researcher attended several IAPT 
team meetings to brief therapists on their study involvement, answer questions 
and provide an update on progress.  Outside of meetings, regular contact was 
maintained with the IAPT Team Administrator and Team Manager. 
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Execution dates 
The preparatory period for this study started in April 2013.  Recruitment ran 
from September 2013 for a period of approximately one year.  Follow-up and 
qualitative data were collected from April 2014 to March 2015.  Data analysis 
was conducted from April 2015 for six months.  The study protocol paper (J. J. 
Hill et al., 2014) was published following submission in June 2014.  
154 
CHAPTER 6.  THE STEPPED CARE VS. HIGH-INTENSITY THERAPY 
(STEPS) FEASIBILITY STUDY: RESULTS 
This chapter describes the results of STEPS - a mixed method feasibility study 
encompassing a pilot RCT and embedded qualitative interviews undertaken to 
prepare for a fully-powered trial of stepped care compared with high intensity 
psychological therapy alone for the treatment of depression in adults.  The 
requirement for this study was described in Chapters Two and Four; Chapter 
Five set out study design, methods and procedures.  
Research questions 
STEPS addressed two specific objectives and five related research questions.  
Specific objectives were to: (1) gather enough information on recruitment, 
retention, step ups and treatment effects to design a fully-powered clinical trial 
or to determine that such a trial is not feasible; (2) explore patients’ and 
therapists’ views of stepped care and the ways in which patients’ views relate to 
how much they engage in therapy to inform a stepped care clinical protocol for 
a proposed randomised trial. 
Research questions were: (1) What is the quantifiable performance of 
recruitment and retention methods which may be used in a fully powered trial?; 
(2) What proportion of people who receive stepped care step up from low-
intensity to high-intensity treatment or are discharged following low-intensity 
psychological therapy?; (3) What is the variability in patient-related outcomes 
following stepped care or intensive psychological therapy alone and how do 
they correlate with patients’ baseline scores?; (4) To what extent are potential 
recruitment methods considered appropriate by trial participants (patients), 
study therapists and other health professionals and administrators and how do 
people’s views combine with numeric data on the performance of trial 
recruitment methods?; (5) How acceptable is stepped care to patients and 
therapists and how do patients’ views explain variability in the number of 
treatment sessions they attend? 
This chapter describes the results obtained in response to each question as 
well as the results of several exploratory and planned sub-group analyses that 
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were undertaken in anticipation of broader interest in the outcome data (see 
Chapter Five, section 5.5.1). 
Chapter structure 
The chapter is divided into four parts.  Part I presents the results of the 
quantitative analysis of pilot trial data.  Part II encompasses qualitative and 
mixed methods data on recruitment.  The results of qualitative and mixed 
methods analysis on the acceptability of stepped care are presented in Part III.  
Part IV summarises key results in relation to each research question.   
Across Part I to IV, material is further organised into fourteen sections: patient 
flow and retention (6.1); baseline characteristics (6.2); receipt of the intervention 
and control (6.3); treatment outcomes (6.4); the appropriateness of recruitment 
(6.5) – to patients (6.6), therapists (6.7) and IAPT personnel (6.8); comparing 
quantitative and qualitative data on recruitment (6.9); the acceptability of 
stepped care (6.10) – to patients (6.11) and therapists (6.12), and; the 
relationship between acceptability and attendance (6.13).  Section 6.14 
provides a brief summary of key findings. 
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Chapter 6. PART I 
 
Quantitative analysis of pilot trial data 
 
Comprising sections: 
6.1 Patient flow and retention 
6.2 Baseline characteristics 
6.3 Receipt of the intervention and control 
6.4 Treatment outcomes  
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6.1 Patient flow and retention  
6.1.1 Recruitment 
Over an eleven month period, 2299 IAPT patients were approached via written 
invitation to participate in STEPS (Figure 10).  Of those approached, 7.8% 
(179/2299) ‘opted in’ i.e. completed and returned a ‘permission for researcher to 
contact’ form.  Nine percent (179/19801) of patients who attended an initial IAPT 
assessment appointment returned a form.  The potential eligibility of 67.6% 
(121/179) of patients who returned a form was assessed via a telephone 
screen; baseline interviews were completed with 46.9% (84/179) – or 69.4% 
(84/121) of patients screened.  A total of 63.1% (113/179) of patients who opted 
in did not join the study.  Reasons for attrition were that: it was not possible to 
recruit 21.8% (39/179) of patients who returned a permission form due to limited 
therapist capacity at the AccEPT Clinic – therapists were unable to take on new 
patients; recruitment procedures could not be completed in five days with 
15.1%% (27/179) of persons; 12.8% (23/179) of patients were ineligible; 12.2% 
(22/179) of patients declined or did not attend a telephone screen or baseline 
interview; 1.1% (2/179) were randomised in error.  Overall, 2.9% (66/2299) of 
patients invited to take part, were recruited. 
Based on the 95% confidence interval for the recruitment rate, it is estimated 
that in a future trial the proportion of patients invited who were willing, eligible 
and randomised without error would be between 2.2% and 3.5%; the proportion 
invited who returned a permission form would be between 6.7% and 9.0%. 
6.1.2 Retention 
STEPS’ six month retention rate was 91%; 60 of the 66 patients randomised 
without error completed a six month follow-up assessment.   The same number 
and proportion of participants were retained in each of the control and 
intervention arms: 91% (30/33).  Across groups, five patients were lost to follow 
up because they could not be contacted; one patient (randomised to receive 
                                            
1
 The figure of 1980 was an estimate based on data supplied by IAPT on the number of patients (i) 
invited to book and (ii) who subsequently attended an initial assessment appointment.  The proportion 
of patients invited to book who attended the assessment was calculated.  This percentage was applied 
to the number of patients sent study information to obtain an estimate of the number who 
subsequently attended an IAPT assessment appointment. 
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stepped care) withdrew from the study.  From the 95% confidence interval 
around the retention rate, it can be inferred that in a future trial the proportion of 
randomised participants who would complete a six month follow-up assessment 
would be between 83.8% and 97.8%. 
 
Figure 10. CONSORT diagram 
 
Notes: The number of patients who were sent study information and completed an IAPT assessment (1980) has been 
estimated – see footnote, section 6.1.1. 
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6.2 Baseline characteristics 
Participants’ baseline characteristics are summarised in Table 15.  Prior to 
treatment, half (50.0%) met criteria for a moderately severe depressive episode, 
with a further 41% meeting criteria for severe depression, 9% mild depression, 
and 67% having had depression in the past.  The majority of participants (64%) 
were in full or part time paid employment, the mean age was 43.3 years 
(standard deviation 12.8) and 62% were women.  A small minority of 
participants (3%) had no educational qualification, 24% were qualified at GCSE 
or O’ Level, 46% post GCSE or O’ Level, and 27% had a degree or higher. Less 
than half (46%) were married or cohabiting.  Most participants (74%) had a 
secondary diagnosis of an anxiety disorder, the most common being 
generalised anxiety disorder.  Half (50.0%) of participants reported a 
longstanding illness or disability.  At baseline, 53% of participants had been 
prescribed antidepressant drugs by their primary care doctor. 
 
Table 15 overleaf 
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Table 15. Participant baseline characteristics 
 
 
Notes: data are number (%) unless stated otherwise; SD=standard deviation; percentages may not always total 100 due 
to rounding. 
 
6.3 Receipt of the intervention and control 
6.3.1 Receipt of stepped care 
Proportion of step ups 
The proportion of stepped care participants who progressed to high-intensity 
therapy following low-intensity treatment was 33.3% (11/33; Table 16).  Based 
on the 95% confidence interval for this percentage, it is estimated that in a 
future trial, the percentage of patients who would step up from low- to high-
intensity treatment would be between 17.9% and 51.8%. 
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Table 16. Progression through stepped care 
 
 
Number and proportion of available sessions received 
Stepped care patients received a mean number of 9.0 therapy sessions 
(standard deviation 7.8, range 0 to 27; Table 17); figures encompass the 
number of sessions attended by patients who had GSH alone and those who 
received both GSH and CBT.  The mean number of GSH sessions received by 
all stepped care patients (irrespective of next treatment step) was 4.6 (SD 2.2, 
range 0 to 6).  Stepped care patients who had low-intensity therapy alone 
received a mean number of 4.4 (standard deviation 2.5, range 0 to 6) GSH 
sessions.  Patients who progressed to high-intensity therapy received a mean 
number of 5.9 GSH sessions (0.3, range 5 to 6).  The mean number of CBT 
sessions received by stepped care patients who had high-intensity treatment 
after GSH was 12.9 (standard deviation 4.5, range 5 to 21). 
Of the maximum number of sessions available (n=26, 6 GSH and up to 20 
CBT), the mean proportion attended was 34% (standard deviation 30%, range 
0% to 100%).  On average, stepped care patients attended 78% (37%, range 
0% to 100%) of available GSH sessions and 65% (23%, range 25% to 100%) of 
the maximum number of CBT sessions.   
Treatment adherence 
Twelve percent (4/33) of stepped care participants declined to attend GSH and 
thus did not receive any therapy; none of the stepped care patients who 
stepped up declined CBT (Table 17).  Twelve percent (4/33) of patients started 
but subsequently ended treatment prior to the point at which their therapist 
believed they were ready; three such patients dropped out of therapy during 
GSH and one whilst in receipt of CBT. 
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Duration of treatment 
The mean total time in stepped care was estimated to be 5.9 hours (standard 
deviation 6.1) over a period of 12 weeks (SD 11.8; Table 17) and among 
patients who attended at least one session, the mean total time in treatment 
was 6.7 hours (SD 6.0) over a period of 13.5 weeks (SD 11.7).  (All of the 
preceding figures reflect the total time in treatment among stepped care patients 
who had GSH alone and GSH plus CBT.)  The mean total time in low-intensity 
therapy was 2.3 hours (SD 1.1) over a period of 4.9 weeks (SD 2.7) irrespective 
of next treatment step.  Among patients who progressed to CBT, the mean total 
time in high-intensity therapy was 10.8 hours (SD 3.8) over 19.3 weeks (SD 
6.5). 
6.3.2 Receipt of CBT alone 
Patients randomised to receive high-intensity therapy alone attended a mean 
number of 8.8 therapy sessions (standard deviation 5.4, range 0 to 20) - 44% of 
the maximum number (n=20) available (standard deviation 27%, range 0% to 
100%); Table 17).  Six percent (2/33) of patients declined any treatment; 42% 
(14/33) started but subsequently dropped out of therapy.  The mean total time in 
treatment was estimated to be 7.3 hours (standard deviation 4.5) over a period 
of 13 weeks (SD 9.8). 
 
Table 17 overleaf 
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Table 17. Receipt of the intervention and control 
 
Notes: 
1
 Percentage of available sessions attended has been calculated based on a total of six available GSH sessions, 
20 CBT and 26 stepped care. 
2 ‘
Dropped out’ is defined as ending treatment prior to a point at which the therapist 
believed the patient was ready to do so; 
3
 ‘Hours’ spent in treatment has been estimated assuming 0.5 hrs per GSH 
contact and 0.83 hours per CBT session as detailed in Chapter Five, section 5.5.1. 
 
6.4 Treatment outcomes 
This study was not powered to detect clinically meaningful differences in the 
effectiveness of stepped care vs. high-intensity psychological therapy alone.  
Similarly, it was not powered to detect differences in outcomes between 
stepped care patients who were discharged from treatment following GSH vs. 
‘stepped up’ or those with a mild to moderate vs. severe level of baseline 
depression.  Inferences regarding the relative effectiveness of stepped care and 
CBT alone cannot be drawn.  The study does not provide robust evidence on 
the effectiveness of stepped care for different patient groups. 
6.4.1 Variability in outcomes 
The pooled standard deviation around the mean BDI-I score for all patients at 
baseline was 6.9; equivalent figures for the intervention and control groups were 
6.4 and 7.4 (Table 18).  At follow-up, the pooled standard deviation around 
mean BDI-I scores across groups was 10.0; the standard deviation around 
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mean six month depression scores for stepped care patients and patients who 
had CBT alone was 9.6 and 10.5, respectively. 
Ninety-five percent confidence intervals indicate that, in a future trial, the pooled 
standard deviation around the mean BDI-I score at baseline for all patients 
would be between 5.9 and 8.3; standard deviations around mean baseline 
depression scores for the intervention and control groups would be from 5.1 to 
8.5 and from 5.9 to 9.8, respectively.  At follow-up, it can be inferred that the 
standard deviation around the mean BDI-score for all patients would be 8.0 to 
12.2; standard deviation around the mean BDI-I score for patients in the 
stepped care arm would be 7.6 to 12.9.  Equivalent six month figures for the 
control group would be between 8.3 and 14.2.   
Standard deviations around mean scores on the GAD-7 and physical and 
mental component scales (PCS, MCS) of the SF-36 at baseline and six months 
are provided in Table 18.  Ninety-five percent confidence intervals around the 
standard deviations are also provided. 
 
Table 18. Variability in outcomes at baseline and six month follow up 
 
Notes: 
1
 SD = standard deviation of the mean; 
2
 95% CI = 95% confidence intervals around the standard deviation. 
 
6.4.2 Correlation between baseline and six month scores 
The size of the correlations between stepped care participants’ BDI-I, GAD-7, 
PCS and MCS scores at baseline and six months ranged from small 
(Spearman’s Rho 0.19) to large (Rho 0.59) according to commonly used 
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guidelines (Cohen, 1988); Table 19. For patients who were randomised to 
receive CBT alone, correlations in depression, anxiety, physical and mental 
health scores were medium to large (Spearman’s Rho 0.39 to 0.52).  The 
margin of error (based on the lower limit of the 95% confidence interval) 
associated with each correlation is provided in Table 19.  
 
 
Table 19. Correlation between participant scores at baseline and six months 
 
Notes: 
1
 Rho = Spearman’s Rho; 
2
 margins of error associated with Rho have been estimated based on the lower limit of 
the 95% confidence interval. 
 
6.4.3 Reduction in depressive symptoms  
From baseline to six months, symptoms of depression reduced in both groups: 
the mean reduction in depression scores for patients in the stepped care arm 
was 13.4 points (standard deviation 8.6); the mean reduction for patients who 
had CBT alone was 13.6 points (standard deviation 9.1; Table 20).  Patients’ 
symptoms of anxiety and mental health function (as measured on the mental 
component scale, MCS, of the SF-36) also improved in both arms.  The mean 
reduction in GAD-7 scores from baseline to six months was 7.2 points (standard 
deviation 5.6) among stepped care patients and 7.3 points (SD 5.9) among 
those who had CBT alone.  The mean increase in stepped care participants’ 
MCS scores was 21.2 points (SD 10.7); for patients who had CBT alone the 
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mean increase was 21.3 points (SD 14.2).  (Higher scores on the MCS and 
Physical Component Scale, PCS, represent better function (Ware et al., 2007).)  
From baseline to six months, patients’ physical health function did not improve.  
The mean reduction in stepped care participants’ PCS scores was -1.4 (SD 
10.7); the mean reduction in PCS scores among patients who had CBT alone 
was -2.6 (SD 11.6). 
 
Table 20. Treatment outcomes at baseline and six month follow-up 
 
 
6.4.4 Improvement in depression and anxiety 
Participants’ depressive symptoms reduced by 50% or more from baseline to 
six months for 63% (19/30) of stepped care patients and 44.8% (13/29) of 
patients receiving CBT alone (Table 21).  The majority of patients in both trial 
arms experienced a reduction in symptoms of anxiety of at least 50%: this was 
true for 60.0% (18/30) of stepped care patients and 80.0% (24/30) of patients 
who had CBT alone.  
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Table 21. Treatment response (>=50% reduction in symptoms from baseline to 
six months) 
 
 
 
6.4.5 Outcomes for patients discharged vs. stepped up 
Relative to baseline, at six months symptoms of depression among stepped 
care patients who were either discharged following GSH or who subsequently 
had CBT, were reduced: the mean reduction in symptoms of depression for 
patients who were discharged was 15.4 points (standard deviation 9.5); the 
mean reduction in depressive symptoms for patients who stepped up was 10.1 
points (standard deviation 5.8; Table 22).  Levels of anxiety and mental health 
function improved for both groups.  At six months, the mean reduction in anxiety 
symptoms was 8.2 points (SD 5.8) for stepped care patients who had GSH 
alone and 5.6 points (SD 5.1) among patients who had GSH and CBT.  The 
mean increase in MCS scores was 22.3 (SD 10.5) for stepped care patients 
who had GSH alone and 19.5 (SD 11.2) among those who ‘stepped up’.  
Physical health function did not improve in either group: relative to baseline, the 
mean decrease in PCS scores was 0.1 points (SD 10.6) at six months for 
patients who had GSH alone and -3.4 points (SD 11.0) among patients who 
progressed to CBT. 
 
Table 22 overleaf 
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Table 22. Outcomes for stepped care patients who were discharged or ‘stepped 
up’ following GSH 
 
 
6.4.6 Outcomes for patients with mild to moderate vs. severe depression 
Relative to baseline and across groups, at six months there was a reduction in 
symptoms of depression for patients who had a mild to moderate episode of 
depression at baseline and for patients who had a severe level of baseline 
depression (Table 23).  The mean reduction in symptoms of depression among 
patients who had a mild to moderate depressive episode was 12.3 points 
(standard deviation 6.5) in the stepped care arm and 14.1 points (standard 
deviation 7.9) among patients randomised to receive CBT alone.  The mean 
reduction in symptoms of depression among patients who had a severe 
depressive episode at baseline was 15.4 points (SD 11.5) in the stepped care 
group and 13.1 points (SD 10.9) in the CBT alone arm.   
Across groups and relative to baseline, at six months there was also a reduction 
in anxiety symptoms for patients with a mild to moderate level of baseline 
depression and for those with a severe depressive episode (Table 23).  The 
mean reduction in GAD-7 scores among patients who had a mild to moderate 
episode was 6.4 points (SD 4.9) in the stepped care group and 7.9 points (SD 
3.9) in the CBT alone arm.  Among patients who had a severe depressive 
episode at baseline, the mean reduction in symptoms of anxiety at six months 
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was 8.6 points (SD 6.5) for stepped care participants and 6.6 points (SD 7.8) 
among those who had CBT alone. 
 
Table 23. Depression and anxiety at baseline and six months for participants 
with a mild to moderate vs. severe depressive episode 
 
 
6.4.7 Sensitivity analyses 
Six month outcome data was collected from 15% (10/66) of patients prior to the 
end of their treatment.   Sensitivity analyses excluding this data produced 
estimates of the variability in treatment outcomes (standard deviation around 
mean scores on the BDI-I, GAD-7, PCS and MCS) at six months that were 
similar to those estimated from all of the available data (Table 24).  The strength 
of correlations between patients’ baseline and six month data estimated using 
all of the available data vs. excluding follow up data collected from patients prior 
to the end of treatment, were also similar: the strength of the correlations 
estimated using all available data ranged from 0.19 to 0.59; the size of 
correlations estimated excluding data ranged from 0.24 to 0.59 (Table 25). 
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Table 24. Means and standard deviations estimated using all available data and 
excluding data collected from (n=10) patients prior to the end of treatment 
 
Notes: 
1
 Means and standard deviations (SD) estimated using all available data;
 2 
Means and standard deviations 
estimated excluding six month outcome data collected from ten patients (eight in stepped care, two CBT alone) prior to 
the end of treatment. 
 
Table 25. Correlation between baseline and six month scores estimated using 
all available data and excluding data from patients with whom a six month 
follow-up was conducted prior to end treatment 
 
Notes: 
1
 n, Spearman’s Rho and p estimated using all available data; 
2
 n, Spearman’s Rho and p estimated excluding 
data from patients with whom a six month follow up was conducted prior to end treatment; 
3
 Spearman’s Rho 
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Chapter 6. PART II 
 
Qualitative and mixed methods analysis on recruitment 
 
Comprising sections: 
6.5 Appropriateness of recruitment 
6.6 Appropriateness of recruitment to patients  
6.7 Appropriateness of recruitment to therapists 
6.8 Appropriateness of recruitment to IAPT personnel 
6.9 Comparing quantitative and qualitative recruitment data  
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6.5 Appropriateness of recruitment  
Interviews were conducted with 30 trial participants (patients), three study 
therapists and three IAPT personnel.  All of those approached consented to be 
interviewed.  Data from 12 patient interviews and all of the therapist and IAPT 
personnel interviews were analysed.   A description of the patient sample is 
provided in Part II, section 6.10.  Qualitative analysis aimed to describe the 
degree to which recruitment methods and procedures were considered 
appropriate.  It covered patients’ views and experiences of each stage of 
recruitment as well as what therapists and IAPT staff thought of the elements in 
which they had been involved.  The results of the qualitative analysis of the 
patient data are presented first (section 6.6) followed by the views of the 
therapists (section 6.7) and IAPT personnel (section 6.8).  The results of mixed 
methods analysis to compare interviewees’ views of recruitment with numeric 
data on the performance of recruitment methods and procedures are presented 
in section 6.9.  The aim of the mixed methods analysis was to help understand 
the implications of combining quantitative and qualitative data on recruitment in 
terms of a future trial. 
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6.6 Appropriateness of recruitment to patients 
Qualitative analysis showed patients’ views of recruitment methods and 
procedures could be understood in terms of three themes: ‘initial approach and 
further information’, ‘pace of recruitment’ and the ‘baseline interview’. 
6.6.1 Theme one - initial approach and further information 
The theme ‘initial approach and further information’ describes what patients 
thought of how they were first contacted about the study and the written 
information that they received.  It covers patients’ views of being sent a study 
summary sheet with their initial IAPT assessment appointment letter, returning a 
‘permission for researcher to contact’ form and the Patient Information Sheet. 
In terms of what patients thought about being sent a study summary sheet, 
people responded to it in the context of what was important to them and 
recollections of the experience were mixed.  Some patients could recall the 
summary and received it positively: it represented a source of much needed 
help, was clear and interesting and the location of the study was convenient.  A 
few patients decided to take part directly on reading the summary.  Other 
patients could not (much) remember the summary and were uncertain whether 
they had received it at or prior to their assessment.  Patients were sometimes 
critical of layout and content. 
I read the short summary and thought sounded quite interesting and 
fascinating and was happy with that [laugh].   (Patient 027) 
Interviewer: At what point did you decide to take part? 
Pretty much, I mean, as soon - so once I saw the leaflet.  (Patient 
028) 
I think I remember feeling like there was quite a lot of information, so 
maybe a little bit too much at the top of the sheet.  (Patient 039) 
There was also a small amount of feedback to suggest that patients were not 
troubled by being asked about their interest in STEPS at assessment.  Some 
patients decided to take part at this appointment. 
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I just said yes to [my therapist] when she said, ‘Might you be 
interested?’…  That was fine, nothing wrong with that at all.  (Patient 
007)  
Responses to the Patient Information Sheet (PIS) were similar to the study 
summary sheet: people responded to the PIS in the context of what was 
important to them and experiences were mixed.  Some of the interviewees read 
and found the PIS useful.  It was thorough; nothing stood out as missing; 
included information was appropriate and informative.  Reading the PIS also 
reinforced patients’ decision to get involved in the study and that STEPS was a 
means to access help.  In contrast, other patients did not read or only skimmed 
the PIS.  There was a perception that it was too long and dense; a leaflet may 
have been more accessible. 
[The PIS was] absolutely fine really, just, you know, appropriate and 
informative… what more do I want from information like this?  (Patient 
023) 
It gave a lot more of the background and allowed me to understand 
what it entailed… It helped reinforce … if I’m selected, this would be a 
good thing for me to do.’  (Patient 053) 
If somebody knows they need help and then they get these thick 
pages and think, ‘Oh God I’ve got to read through these now!’ it 
might, like, feel a bit too much.  You know, they know they need help 
but then they’ve got to get through all these pages.  (Patient 039) 
Summary – initial approach and further information 
Views on being sent study information were mixed.  Some patients could 
recall the study summary sheet and received it positively.  Likewise, some 
patients read and found the PIS useful.  Other patients could not 
remember the summary sheet and some of the interviewees thought that 
the summary sheet and PIS contained too much information.  Data 
indicated that patients were not troubled by being asked about STEPS at 
their IAPT assessment.  
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6.6.2 Theme two – pace of recruitment 
In the theme ‘pace of recruitment’ patients described their views and 
experiences of how long it took the research team to make contact once they 
had returned their ‘permission for researcher to contact’ form.  Patients also 
described how they felt about the length of time between their telephone screen 
and baseline interview and their views of the length of time for treatment to 
commence post-baseline. 
With respect to how long it took the study researcher to make contact, patients 
responded positively.  The speed of contact impressed on people that the 
research was well organised and that their problems were recognised as such; 
it maintained a sense of momentum (once people had decided to seek help) 
and for one person, was important in retaining her in treatment. 
Oh it was very good, it was perfect, if it had been any longer I 
probably wouldn’t have carried on.  (Patient 014)  
Had it been, you know, a month before I had heard anything¸ then 
you’d suddenly start to think, ‘Oh,’ – because I think, you know, 
having reached the point where you want to… Thinking, ‘I just want to 
get on with it now!’ you know, the importance of maintaining 
momentum and actually feel that you’re moving forward towards 
some help and therapy is, naturally, is useful.  (Patient 053) 
Fewer people commented on the length of time to pass from when the research 
team made first contact to their baseline interview but those that did 
predominantly felt that it had not been long and were pleased with this.   
Patients were also pleased with the length of time between their baseline 
interview and the start of treatment.  At a time when they were low, confirmation 
that they would start treatment quickly was welcome; patients expressed a 
sense that when you ask for support (which can be difficult) it is important that 
help soon follows.  The treatment of one patient (who was deaf and required an 
interpreter) took longer than average to arrange; this person had found the wait 
difficult but acceptable. 
It was just you know, nice to- well actually because you know, having 
been seen by [IAPT Service] previously, and then it takes them, you 
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know, three weeks to do anything pretty much. I guess because of 
staffing and- and- and busy-ness. It was, you know, yeah. It was nice 
to know, you know to- to, get quick responses.  (Patient 023) 
Summary – pace of recruitment 
The speed of recruitment was very well received.  Patients welcomed how 
quickly the study researcher made contact and arranged their baseline 
interview.  Patients were also pleased to begin treatment shortly after 
meeting with the study researcher. 
6.6.3 Theme three – the baseline interview 
The theme ‘baseline interview’ encompassed patients’ views on attending a 
baseline interview shortly after an initial assessment appointment at IAPT as 
well as experiences of the interview itself.   
Views on attending a baseline interview shortly after meeting with a DAS 
therapist for an assessment varied.  For some patients having two assessments 
(an initial IAPT appointment and baseline interview) close together was 
acceptable, without issue.  The baseline interview was seen as part of a due 
research process and the need for it was understood.  One patient described it 
as a good opportunity to better phrase thoughts, feelings and experiences that 
they had not put across very well at their initial IAPT assessment. 
It was, it was good because I think the first time I went away thinking, 
Oh, I could have phrased that better or I could have answered that 
better,’ and it was basically getting a do-over umm opportunity ...  
Yeah, to have like a practice, yeah to have a practice one… and then 
have time to think about it… personally I thought that was good.  
(Patient 027) 
Other patients described difficulty having their baseline after an IAPT 
assessment.  After a difficult experience at IAPT, one patient was nervous 
about her baseline interview; this person had been grateful for the opportunity to 
complete it by phone.  Another interviewee had been disheartened at the 
prospect of going over thoughts, feelings and experiences already discussed at 
IAPT although, in practice, the patient found that she was not bothered by this 
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at interview.  In these ways, difficulties for patients around scheduling baseline 
interviews shortly after an IAPT assessment were resolved or did not 
materialise as feared. 
I think I did feel a bit, kind of like ‘Oh I’ve got to go through it all 
again!’, ’cause I had already been through all the information with the 
DAS Service, so I think it was a bit like, ‘Oh, I’ve got to go through it 
again’…  But then when I was here it didn’t really bother me.   
(Patient 039) 
Patients expressed a range of views about the baseline interview itself.  Direct 
comparison between the baseline interview and IAPT assessment sometimes 
reflected less favourably on the baseline.  One patient found the baseline less 
personal.  Another patient thought that it was harder to complete for being more 
in-depth than the IAPT assessment although the same patient also viewed this 
positively. 
Well in many ways it [sighs] this was a lot more in depth, particularly 
completing the questionnaires…  it was a lot more intensive, a lot 
more soul searching and in a lot more depth in the way that we went 
through the process here than the relatively superficial level of 
interview that I had through the NHS.  So yes, it was a bit harder, but 
– it made me look at things a lot more, a lot more soul-searching and 
actually looking at some of the issues and was the start of the 
process from my point of view. (Patient 053) 
Other negative feedback about the baseline interview was mainly focused on 
the CIS-R: closed questions were disliked; the CIS-R was found to be repetitive 
and difficult to understand; the CIS-R failed to include questions about gambling 
(a problem that was perceived to be widespread and had affected one patient 
personally).  An older person observed that questions did not take into account 
people’s life stage / age.  In contrast, positive opinions of the baseline interview 
were that it was more personal than the IAPT assessment; at interview, 
treatment was very well explained; a patient had been reassured about starting 
therapy having met with the researcher.  Some patients decided to take part in 
the study at their interview. 
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Summary – the baseline interview 
Patients’ views on attending a baseline interview shortly after their IAPT 
assessment were mixed: for some patients it presented no issue; other patients 
felt nervous about the interview and did not want to go over what had already 
been discussed at IAPT.  The option to complete the baseline by phone helped.  
Views of the baseline interview itself were also mixed.   Some patients were 
critical of the CIS-R and found the interview less personal than their IAPT 
assessment.  Other patients thought that the baseline was more personal than 
their IAPT assessment and that treatment had been very well explained. 
6.6.4 A summary of the appropriateness of recruitment to patients 
Patients shared their views and experiences of being sent study information, the 
pace of recruitment and the baseline interview.  The study summary sheet and 
PIS were well received by some patients but not very memorable and thought to 
contain too much information by others.  A small amount of feedback suggested 
that patients were happy to be asked about STEPS at their IAPT assessment 
appointment.  The speed of recruitment was very well received although some 
patients found the prospect of attending a baseline interview after their IAPT 
assessment, difficult.  This had been helped by the offer to complete the 
baseline by phone.  In terms of the baseline interview itself, some patients were 
critical of some elements e.g. the CIS-R.  Others viewed the same features, 
positively. 
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6.7 Appropriateness of recruitment to therapists 
The study therapists were relatively uninvolved in recruitment.  Their views on 
its appropriateness were encapsulated in two themes: ‘study inclusion criteria’ 
and ‘patients’ transition into therapy’. 
6.7.1 Theme one – study inclusion criteria 
One therapist deliberated whether the criteria by which the eligibility of patients 
was determined should have been more closely defined.  One of his patients 
had bulimia; another was dependent on alcohol.  The therapist speculated that 
had he known of their problems prior to the start of therapy, he would not have 
accepted them into his care.  He suggested that stricter inclusion criteria may 
be required to help make sure that patients presenting with problems which may 
be more appropriate to treat in other services, did not join the study. 
‘Cause I wouldn’t have taken the bulimic into the CBT if I’d known she 
was bulimic... and I certainly wouldn’t have had an alcoholic at that 
level had it not sort of been diagnosed earlier on… So I suppose that 
goes to inclusion and I suppose when other things, if it was a [fully-
powered] randomised controlled trial would the inclusion have been 
stricter?  (Therapist 02) 
Summary – study inclusion criteria 
Study inclusion criteria may need to be more closely defined or implemented to 
exclude patients who are unsuitable for treatment. 
6.7.2 Theme two – patient transition to therapy 
Therapists were pleased with how quickly patients entered treatment after their 
baseline interviews.  There was a perception that the transition was handled 
efficiently and represented good care.  However, there was a concern that 
relevant information from a patient’s baseline which had been summarised for 
clinical use was not always reliably passed on via the AccEPT Clinic 
Administrator.   One of the therapists wanted more information from the 
baseline interview.  This additional information would be used to avoid asking 
patients the same questions at baseline and the start of treatment; it would also 
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be used to inform conversations with patients about the nature of their 
difficulties.   
When you assess people [at baseline] you clearly get a whole wealth 
of information from them that seems somehow a bit of a waste if we 
don’t have that, because then a). there’s a risk of total repetition a lot 
of the time, as in a person may come in for a CBT assessment and 
they’ll be having to recount the same material over again… [And] I 
suppose, for me, if I had more detail of what you’d gathered, I would 
be taking my lines of enquiry perhaps to unpack some of this or, you 
know, what does that anxiety look like?  Is it kind of generalised 
across all areas of life?  Is it more specific?  (Therapist 03) 
Another therapist thought that it would be useful to have an idea of what had 
been learned about the patient from their IAPT assessment.   However, he 
cautioned against sharing this information for patients who were randomised to 
stepped care as it may make it harder for the GSH therapist to work as an 
‘educator’ rather than a therapist. 
Summary – patients’ transition to therapy 
Therapists thought that patients’ transition to therapy worked well and 
represented good care.  However clinical information that had been 
summarised by the study researcher for the therapists was not always reliably 
passed on.  One therapist thought that it may have been helpful to receive more 
information; another warned that this may make it difficult for them to perform 
their role in low-intensity therapy. 
6.7.3 A summary of the appropriateness of recruitment to therapists 
Therapists described what they thought of the study inclusion criteria and 
patients’ transition into therapy.  There was a perception that study inclusion 
criteria may need to be more closely defined or carefully implemented.  The 
transition into therapy worked well although clinical information from patients’ 
baseline interview was not always reliably passed on.  One therapist thought 
that it may have been helpful to receive more information although another felt 
that this may not be beneficial.   
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6.8 Appropriateness of recruitment to IAPT personnel 
Analysis of the interviews conducted with IAPT personnel found that their views 
of recruitment could be described by five themes: ‘views of research and 
research in the NHS, ‘initial approach to patients’, ‘handling permission forms’, 
‘post-baseline’ and ‘administrative systems, workload and support’.  Four of the 
five themes comprised several sub-themes.  Themes and sub-themes were 
descriptive and are summarised in Box 2. 
 
Box 2. Key themes (numbered 1 to 5) and sub-themes describing the 
appropriateness of recruitment to IAPT personnel 
1. Views of research and research in the NHS 
2. Initial approach to patients 
Booking an assessment 
Written approach to patients 
3. Handling permission forms 
Changing the format of an assessment 
appointment 
Asking for permission forms 
Responding to patient questions 
Handling forms for potentially ineligible 
patients 
4. Post-baseline 
Joining STEPS 
Returning to IAPT 
Therapist capacity 
5. Administrative systems, workload and support 
Record-keeping 
Workload 
Staff briefing and support 
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6.8.1 Theme one - views of research and research in the NHS 
The theme ‘views of research and research in the NHS’, describes what the 
IAPT interviewees thought of research and the role of the NHS in research.  It 
also covers interviewees’ views of the role for research in their service. 
All of the IAPT interviewees were supportive of research and believed that 
research should be undertaken in the NHS.  The IAPT Manager felt that the 
involvement of her service in research was very important.  
If you didn’t have research then you’d sort of fall behind all other 
health authorities around the world, wouldn’t you really?  You’ve got 
to be sort of leading your way in new ideas, new ventures and – else 
you’d just get left behind really.  (IAPT Administrator) 
I’d see it as being very important, and we’re obviously a service that’s 
driven by the evidence base, so actually adding to the evidence base 
is a really valuable thing to do, otherwise it’s static isn’t it?  So I’d get 
the value of that, I would think it a really important thing to do.   (IAPT 
Manager) 
However, support for research was tempered.  The Administrator and Service 
Manager foresaw difficulty when the needs of research and those of an IAPT 
service driven by performance targets were different.  The Administrator was 
clear that involvement in research should not compromise patient care.  The 
IAPT Manager’s views of the current study were also influenced by her team’s 
involvement in another (larger) trial.  Although the larger trial was seen as 
important, she felt that it had left the IAPT service somewhat depleted of 
therapists.  There was a perception that this may have made it harder to 
negotiate and implement STEPS’ recruitment method and procedures.  
I guess the negatives are that services are under quite a lot of 
pressure to meet their own performance targets and research hasn’t 
necessarily got the same agenda, so those things sometimes can feel 
a little bit competing.  (IAPT Manager) 
I would think of them [the larger trial and current study] as both being 
really good, valid bits of research.  The fact that they’ve come along 
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at the same time is probably not great, because they’re both 
completely different, and obviously [this study] has not taken any 
resource out of the team in terms of therapists, but [the larger trial] 
has… So I suppose that makes me feel a bit depleted then, as the 
manager, and… it can make you feel a little bit overwhelmed by 
research requests, demands etc.  So I’d see them as both really valid 
and valuable, but quite intensive in terms of effort, resource, I 
suppose, from our point of view.  (IAPT Manager) 
Summary – views of research and research in the NHS 
Although all of the IAPT interviewees were supportive of research this was 
tempered.  There was a perception that research should not compromise 
patient care and the IAPT Manager and Administrator foresaw difficulty 
when the needs of research conflicted with IAPT service performance 
targets.   Involvement in another trial affected how staff felt about STEPS.   
6.8.2 Theme two - initial approach to patients 
In this theme, the IAPT interviewees described their views and experiences of 
the initial approach to patients.  The theme covered what the interviewees 
thought of a member of the Admin Team mentioning STEPS to patients when 
they rang to book their initial IAPT assessment appointment.  It encompassed 
interviewees’ views of subsequently referring to STEPS in the letter to confirm 
patients’ appointment and including a study summary sheet alongside other 
standard information sent to patients with their letter. 
Booking an assessment appointment 
The Admin Team’s mention of STEPS when patients rang to book their initial 
assessment was endorsed by the IAPT Manager who felt that this helped 
patients.  The Administrator was also comfortable with this procedure.  In 
response to queries (e.g. ‘what’s the study about?’) the IAPT Administrator 
referred patients to the study summary sheet and contact telephone number 
therein.  This was viewed as entirely appropriate.   Interviewees’ main concern 
had been to avoid confusing patients and there was a sense that the Admin 
Team was successful in this.  The IAPT Administrator mentioned STEPS briefly 
and sometimes not at all.  Only a handful of people declined to receive study 
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information. 
The script was such that, ‘Sent you out a questionnaire – erm, the 
letter, confirming the appointment, there will be a questionnaire that 
you need to fill in from the DAS Service, there’ll also be information 
about the STEPS project that’s taking place’, so we would mention 
that in the letter.  We had a few, very few, a handful of people who 
said, ‘Don’t bother sending me out that information’.  But that is, you 
know, a handful at most.  (IAPT Administrator) 
I think… if you went into [describing STEPS] at a very early stage, 
you would have just got people even more confused because a lot of 
people will phone us up saying, ‘My doctor’s told me to phone this 
number, I need to see a counsellor.’  So we don’t even go into 
whether it’s counselling or whatever, ‘cause they don’t know, they just 
want to come and see someone and then decide when they see 
someone.  So if you then went on to explain a bit more about the 
project and stepped care and – it would have just confused them 
even more.   (IAPT Administrator) 
Written confirmation and information 
In terms of sending patients the study summary sheet with the letter to confirm 
their initial assessment plus other IAPT information, one of the interviewees 
observed that this did not overcome difficulty recruiting patients with poor 
literacy skills and / or for whom English was not their first language.  Moreover, 
all of the IAPT interviewees felt that patients may have been overwhelmed by 
the amount of material sent.   The Administrator felt that the majority of people 
would have ignored the study information.  The PWP suggested that, at 
assessment, patients were sometimes stressed and may not have understood 
all of the paperwork that they had received; at assessment patients sometimes 
changed their mind about returning a completed permission form.  The PWP 
wondered if the accompanying appointment letter could be clearer that patients 
were not required to fill in the form. 
For patients, I think we send them an overwhelming amount of 
information in the post already, so more information I think was 
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probably a bit of information overload for them.  I think it’s really good 
that we amalgamated it into the letter and that we got the admin staff 
to tell people on the telephone… So that was helpful, gave a little 
clarity to patients, but still an overwhelming amount of information 
that people get landing on their doorstep.  They’re anxious about 
coming to the appointment.  Hard to know, really, what you could do 
about that, because we did streamline the information down as much 
as we could.  (IAPT Manager) 
Summary – initial approach to patients 
The IAPT Admin Team mentioned STEPS when patients rang to book their 
initial assessment appointment.  This was seen as helpful to patients and 
was competently handled by the Admin Team who had been comfortable 
with this procedure.  On the other hand IAPT personnel were 
uncomfortable sending patients study information.  Information was 
included with a letter to confirm patients’ assessment appointment that also 
enclosed a large amount of paperwork sent as standard by the IAPT 
service.   Interviewees felt that this may have overwhelmed and confused 
patients. 
6.8.3 Theme three – handling permission forms 
The theme ‘handling permission forms’ describes interviewees’ views and 
experiences of IAPT therapists receiving completed ‘permission for researcher 
to contact’ forms at patients’ initial assessment appointment.  The theme covers 
four ways in which the procedure caused difficulty or uncertainty: changing the 
format of the assessment appointment; the degree to which PWPs were 
proactive in asking patients for forms; responding to patients’ questions; 
passing on forms for patients who were potentially ineligible for STEPS. 
Changing the format of an assessment appointment 
Receiving permission forms required PWPs to change how they handled 
patients’ initial assessment appointments.  Outside of the study, it was usual for 
therapists to conclude the appointment with a discussion about IAPT treatment 
options and to give patients a booklet about treatment.  Receiving the booklet 
was defined as initiating IAPT treatment.  For this reason, therapists were asked 
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not to give the booklet to patients who returned a permission form.   They were 
also asked not to discuss IAPT treatment options with patients who were 
interested in the current study.  Changing the format of assessment 
appointments to accommodate these differences was difficult.  Whilst most 
patients presented their form at the start of an appointment, sometimes it was 
only mentioned at the end, perhaps when IAPT treatment options had already 
been discussed.  When forms were presented at the end of appointments, the 
PWP described how there was little time to prepare not to discuss IAPT 
treatment; remembering not to talk about treatment options was very much ‘out 
of habit’.  
We do quite a lot of high volume work and we get used to our habits 
around, perhaps assessments and just remembering not to discuss 
treatment options if a patient’s interested in the trial… that took a little 
bit of getting used to.  (IAPT PWP)  
When we do introductions assessment, we would say, ‘The 
assessment will take around about thirty five, forty minutes.  After the 
assessment I’ll talk to you a little bit about what we offer from our 
service.’  Now, there were instances when – I… said that and then 
had to [renege]… ‘cause actually at the end I then realised that the 
patient’s presented me with a STEPS form, so I’d have to then retract 
what I’d said by saying, ‘I said I was going to talk to you about 
treatment options from our service, but actually I notice that you’re 
interested in the STEPS research so I’m deliberately not going to talk 
about treatment options at this stage.’  (IAPT PWP)   
Asking for permission forms 
There was a perception that therapists varied (and hence may have been 
uncertain) regarding how proactive they were required to be in asking for 
permission forms.  At the start of the study, the IAPT Manager asked her team 
to accept forms when they were returned but not to enquire about patients’ 
interest in STEPS if forms were not readily presented.  Nonetheless, the PWP 
interviewee routinely asked people for their questionnaires (to include IAPT and 
STEPS’ forms) at the start of their assessment appointments.  Furthermore, the 
IAPT Manager described a variety of reasons why some PWPs may be more 
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proactive in asking for permission forms than others: some therapists may be 
more organised, oriented to research, motivated to reduce their workload; 
PWPs may have got better at asking for forms as the trial progressed – it 
became more routine to do so. 
I encouraged them to not be overly proactive, so if people come with 
a form, to accept that form and then do the thing, you know, the 
process, but if people didn’t readily come with the form I did not ask 
the PWPs to proactively check whether they wanted to be involved in 
the study.  (IAPT Manager) 
Some of the PWPs may have been more clued in to the study and 
therefore the permission forms… I would think some PWPs may have 
said about the study, ‘Did you get the form?’ and other ones wouldn’t 
have, so I think some people could have been more active than 
others about it.  (IAPT Manager) 
Responding to patient questions 
PWPs may not have been entirely comfortable with how they responded to 
patients’ questions and concerns about STEPS. As well as asking therapists not 
to ask patients for their forms, early on in the study, the IAPT Manager 
reminded the therapists not to dissuade patients from taking part.  This 
communication followed feedback from one patient to suggest that her therapist 
had said she should not take part in the current study as it would ‘cut her off’ 
from IAPT treatment.  As such, PWPs were minded to be ‘neutral’ in how they 
handled permission forms.  This instruction may have influenced how the PWPs 
responded to queries about STEPS.  At interview, the PWP described how he 
said very little in response to questions.  He queried whether this was the right 
approach and whether he should have had more information to share with 
patients.  
I felt very conscious about not influencing, like having any influence 
over, you know, encouraging the patient to take part or not.  And I 
suppose I was fairly reticent to actually give too much information.  
Whether that’s helpful of whether, you know, I should have been 
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more primed to be more specific or have more information about how 
the research worked or -?  (IAPT PWP) 
Handling forms for potentially ineligible patients 
Passing on forms for patients who PWPs did not believe would be accepted 
onto the trial caused considerable difficulty.  Such patients included people who 
were not depressed or who did not present with depression as their primary 
problem but also patients who may have difficulty engaging in any treatment as 
well as those for whom the PWP perceived CBT may be less helpful.  PWPs 
passed on the permission forms for people who they did not think would be 
accepted but to do so was frustrating and seen as a waste of time.  This 
frustration may have been compounded by experience: most of the people who 
the PWP interviewee anticipated would be ineligible for the study returned to 
IAPT.  A potential solution proposed by the PWP was to be given more 
information such that when it was very clear that patients were ineligible, he 
could let them know.  Indeed, he felt that he had a duty to do so. 
Patients who I felt maybe there was some complexity with problems 
they were presenting with and I just felt fairly certain they were not 
gonna meet the criteria, but it wasn’t my place to say, ‘You’re not 
gonna be – I don’t think you’re gonna be taken on for this research.’  
And I guess I had some misgivings about that because I felt actually, 
the likelihood is that this patient is not going to be taken on and that’s 
wasting time, ‘cause actually they’re probably not going to be taken 
on.  (IAPT PWP) 
Reflecting on the same issue, the IAPT Manager surmised that high-intensity 
therapists would not follow the recruitment procedure.  Rather, she thought that 
they would more likely take an independent decision not to pass on permission 
forms for such patients. 
I think the PWPs would have done that, because they’re fairly black 
and white in their practice, so if they’re kind of told to do something 
they would then generally then carry that out.  I think it would be 
really interesting to ask the high intensive therapists when they were 
doing… assessments, which they will do sometimes, how they would 
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have handled the form, because they will be more likely to make an 
independent clinical decision.  (IAPT Manager) 
Summary – handling permission forms 
Handling permission forms presented several difficulties for IAPT 
therapists.  When a patient returned a form, it was hard for PWPs to 
remember not to give the patient a booklet about treatment or to discuss 
treatment options.  Moreover PWPs felt very uncomfortable passing on 
forms for patients who they anticipated would be unsuitable or ineligible for 
STEPS, specifically, patients who were not depressed, did not present with 
depression as their primary problem, had difficulty engaging in treatment or 
would not benefit from CBT.  To pass on forms for patients who would not 
be accepted was seen as a waste of time; the IAPT Manager thought that 
high-intensity therapists may not return forms.  The PWP interviewee also 
wanted to give patients more information in response to study-related 
questions.  Therapists varied in the degree to which they were proactive in 
asking people for their form. 
6.8.4 Theme four – post-baseline 
The theme ‘post-baseline’ encompassed what IAPT personnel thought of 
patients joining STEPS, remaining under the care of IAPT and returning to IAPT 
due to a lack of therapist capacity at the AccEPT Clinic. 
Joining STEPS 
The prospect of discharging patients from IAPT to join STEPS was initially met 
with some enthusiasm by the PWP who, somewhat jokingly, described it as an 
opportunity to reduce his caseload.  The PWP also commented that the Admin 
Team worked very well to let therapists know when a patient joined (or was 
ineligible for) STEPS.  However, the IAPT Manager described a conflict of 
interest for her service and the study when patients joined STEPS.  At the time 
of the study, the service had not met a key performance target to treat 15% of 
the local population estimated to have depression and anxiety.  Patients who 
joined STEPS did not count towards the target.  Although this did not pose a 
substantial problem given the small number of people involved, it was 
anticipated that the same issue would affect a large stepped care trial and be 
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more problematic.  The same problem had arisen around the service’s support 
of another large mental health trial.  For trial patients to count towards the 
service’s performance target people would be required to complete the same 
measures necessary of all patients who enter IAPT services - to date, this had 
not been possible. 
Your trial did not impact much, because it was small but there is a 
competing demand for us to increase our prevalence… we have 
fifteen percent of the prevalence target that we have to see.  So 
whilst on the one hand I’d think research really important to be doing 
this, to find out what we’re doing, I’ve also got a competing demand 
that actually do I want our patients to go elsewhere because I’ve got 
to increase my prevalence of people entering treatment.  (IAPT 
Manager) 
Returning to IAPT 
In terms of the interviewees’ views of the experience of patients with whom 
recruitment procedures could not be completed or who were ultimately ineligible 
for STEPS and thus returned to IAPT, these were mixed.  Positive views were 
that recruitment procedures enabled the IAPT service to meet another of its key 
performance targets i.e. to see patients for their first treatment appointment 
within 28 days of their initial assessment.  By determining whether patients were 
in or out of STEPS within five working days of their assessment and by enacting 
a ‘patient delay’ (a mechanism by which days spent waiting for treatment do not 
count towards the 28 days), the target was not compromised.  On the other 
hand, the IAPT Manager’s description of how she handled patients’ questions 
about STEPS indicated that, in her experience, the treatment of patients who 
were interested in the study and came back to IAPT was still delayed compared 
with the treatment of patients who were not interested.  She had not felt able to 
tell patients otherwise.  There was also a perception that, despite best efforts to 
explain the recruitment procedure to patients, it was confusing for people to 
attend an IAPT assessment, meet elsewhere with the STEPS team and 
(potentially) return to IAPT.  
I can’t say it [interest in STEPS] won’t delay it, because there is a 
delay.  So it’s short, but there is a delay, so ordinarily, if we see 
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someone we’d see them the next week for treatment at Step Two to 
start, so there is a very short inbuilt delay, isn’t there?  If they come 
across, find that they’re not coming into the trial and then come back, 
potentially there’s a couple of weeks’ delay built into that: a bit from 
you and a bit from us then fitting them back into our diaries.  (IAPT 
Manager) 
The confusion, complexity for patients, I’m still not quite sure we 
resolved that throughout the trial, I still think patients felt quite 
confused by -the process to us was very clear, but I think if you’re a 
depressed person coming into the service then even though we all try 
to make it really clear, I still think it’s quite confusing for people to 
come to one place, to go to another, to potentially come back to the 
place that you started off from. (IAPT Manager) 
Another issue caused considerable concern: a worry that patients who returned 
to IAPT would not commence treatment.  This was thought possible for two 
reasons.  Patients who were unsuitable for STEPS may feel ‘rejected’ and 
hence disinclined to continue treatment at IAPT.  Second, it took more PWP 
resource and time to book patients into their first treatment session on return to 
IAPT than usual; returning patients might ‘slip off’ therapists’ radar.  This worry 
was significant enough to warrant a change to recruitment procedures: at the 
outset of the trial, arrangements for future therapy were left open at the end of 
the IAPT assessment appointment; during the second half of STEPS, on end 
assessment therapists arranged a telephone call with patients for in two weeks.  
The purpose of the call was to discuss and schedule treatment if the patient 
was returned to IAPT or to wish them well if they were not.  This was seen as a 
good but imperfect solution.  Interviewees still feared that some patients would 
drop out of therapy on return to IAPT. 
When people came back, because they’re out of the flow of the 
normal PWP work, so they’d normally see somebody and book an 
appointment, for second appointment, but they weren’t doing that, so 
that could mean that the person would then come back, and the PWP 
would get an email and it would slip off their radar, because it’s not in 
their normal working practice, so for that reason I suspect some 
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people will have then missed their second twenty eight day 
appointment.  (IAPT Manager) 
It also makes sense, that people who come to us, then go to you and 
then come back, if people are struggling with – I mean it’s hard to 
engage with the Mental Health Service, isn’t it – that, that process of 
coming to one place and going to another and coming back, 
inevitably, people will drop out because of that. (IAPT Manager) 
I’d at least a couple of patients who, when they were not taken on for 
STEPS I wasn’t then able to re-engage with them and that, so I’ll 
never really know whether they dropped out, whether they would 
have dropped out of treatment if STEPS wasn’t offered anyway, or 
whether they dropped out of treatment because of how they felt about 
not being taken on for the research or whether it was just difficulties 
with engagement anyway.  And was sort of a question mark which, 
you know, was quite frustrating really.  (IAPT PWP) 
Therapist capacity 
Continuing to send patients study information, collect forms and pass patients to 
STEPS whilst recruitment was ‘slow’ or ‘on hold’ because of a lack of capacity 
at the AccEPT Clinic also raised questions.  During this period the Administrator 
and PWP implemented recruitment procedures as usual.  However, to do so 
had felt a ‘bit of a waste’.  There was also a concern that patients who returned 
to IAPT due to a lack of AccEPT capacity might feel rejected and be at 
increased risk of drop out.  The PWP wondered if patients could be forewarned 
(perhaps in the Patient Information Sheet) that they may not be ‘taken on’.  
Us kind of sending people over even though the trial’s full, so 
knowing that they’re going to come back.  So that bit of the process 
created some question marks, I think.  (IAPT Manager) 
I mean, I understood there were some instances where I think the 
patient had expressed interest in STEPS and the reason they weren’t 
taken on was because there weren’t researchers available at the 
time.  I think I’ve got that right…. I just wonder whether, perhaps, with 
the information the research for patients, whether, you know, whether 
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that’s something which can happen, so there’s not – just so a patient 
has an understanding of the nature of research, about how, you 
know, there has to be certain time constraints, this could happen to 
them.  (IAPT PWP) 
Summary – post-baseline 
The experiences of patients following the baseline interview raised several 
concerns for IAPT personnel: patients who joined STEPS did not count 
towards a service target to treat 15% of the local population estimated to 
have depression and anxiety; although patients who returned to IAPT were 
seen for their first treatment session within 28 days of their initial 
assessment, their treatment was still delayed compared with that of 
patients who did not return a permission form; some patients may have 
been confused by attending an IAPT assessment, meeting with the study 
researcher and then returning to IAPT.  A fourth issue was particularly 
troubling.  Therapists could fail to re-engage patients who returned to IAPT 
in treatment and patients may drop out of therapy.  In addition, sending out 
and collecting permission forms when recruitment was ‘on hold’ had 
seemed wasteful. 
6.8.5 Theme five – administrative systems, workload and support 
The theme ‘administrative systems, workload and support’ reflected IAPT 
interviewees’ views and experiences of systems for recording patients’ interest 
and involvement in STEPS.  It also covered what the IAPT personnel thought of 
the workload STEPS entailed and the support they were given. 
Record-keeping 
The IAPT Administrator was confident in the method used to record how many 
patients were sent a study summary sheet.  Procedures for keeping track of 
patients who returned a permission form worked well.  Maintaining a paper list 
of the names of patients who returned a permission form together with the date 
of their IAPT assessment was particularly helpful.  The list was simple to 
complete and from it, the Admin Team knew at a glance which patients the 
research team had yet to confirm were in or out of STEPS.  
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The yellow [permission for researcher to contact] forms were put in a 
box once they’d erm, the therapist would bring them down or they 
would email us about them if they were based at a different location 
and weren’t able to get into the service and then one of your 
colleagues would come over, get the information and write it down on 
a list.  And I think that list really worked well, we then knew, could tell 
how many people had yet to – you needed to inform us about, really, 
as to whether they were in or out of the project.   (IAPT Admin) 
Problems arose only for a time half way through the study when the 
Administrator had been on sick leave and several admin staff left.  Temporary 
personnel were employed.  The Admin Team stopped recording on IAPT-us (an 
electronic database of patient records – see Chapter Five, section 5.3.3) when 
a patient was invited to take part and whether the patient joined STEPS.  
Potential consequences included that patients who returned to IAPT for a 
second time could be sent study information twice despite a lack of interest.  
The Administrator thought that a ‘step by step guide’ to recruitment could have 
been written for new / temporary staff but she was uncertain if the Admin Team 
would have had time to read it.  Administrative systems were re-introduced 
when the IAPT Administrator returned to work. 
I was off sick and then people were just having to mend and make-do 
with whatever they could, because bank staff were being brought in, 
they were just covering the bare bones.  So that is when we stopped 
recording that people had been invited… That was just about our staff 
resources and lack of training on new people coming because we 
didn’t have the staff to train them.  (IAPT Administrator) 
Whether we should have written sort of an idiot’s guide to what we 
needed to do, a step-by-step approach, but then would they have had 
time to have read that?  (IAPT Administrator) 
Workload 
All of the interviewees felt that the workload created by STEPS was relatively 
small.  Nonetheless, the IAPT Manager was concerned for the Admin Team on 
whom the burden of work fell.  There was a perception that they coped well but 
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were frustrated by their involvement in STEPS alongside all else they had to do.  
The IAPT Administrator’s initial reaction to supporting STEPS was consistent 
with this view: she had been concerned at the prospect of more work.  
However, once procedures were up and running, although the Admin Team 
noticed the additional work, at no time did the Administrator feel that it was 
unmanageable. 
I think probably [the IAPT Administrator] has done the most towards 
the trial in terms of holding the process around it, and that’s quite a 
lot.  The amount of work around the STEPS trial is not huge, it’s not 
massive, it’s that their overall work volume is so massive and their 
fairly stretched, and it’s like ‘another thing’.  (IAPT Manager) 
It’s just another ball, really [laughs].  You just sort of think ‘Oh’ 
because the role in our office is so, quite manic and there’s so many 
things going on, you get approached by a therapist and this, that and 
the other.  You just sort of take it in your stride, really, it’s just 
something else to, er, it didn’t affect me at all, it was just another 
process we had to deal with and get on with it, really.  (IAPT 
Administrator) 
The IAPT Manager also thought that the therapists may have reacted a little 
negatively to STEPS given that it was ‘something else to do’.  The IAPT PWP 
felt that difficulties mainly arose around changing practices.  For herself, the 
IAPT Manager described how STEPS similarly felt like ‘another thing to juggle’.  
During the period of staff illness in the Admin Team, the IAPT Manager took on 
some of STEPS’ administrative responsibilities which had been difficult.  The 
IAPT Manager suggested that, ideally, the trial would have provided some 
additional financial, administrative support. 
I guess the only thing you can do is to provide some additional admin 
support, which would have been, I guess, would have been financial, 
wouldn’t it, in terms of money to increase our admin capacity.  (IAPT 
Manager) 
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Staff briefing and support 
IAPT interviewees generally felt well supported by the study researcher.  There 
was a perception that therapists’ involvement in the study had been clearly 
explained at the outset and the study researcher’s presence at team meetings 
was welcome.  The IAPT Administrator also felt that day to day liaison with the 
researcher worked well.  The researcher was endorsed for being easy to 
contact and quick to respond, persistent and open. The IAPT Manger also let 
her team know what was required of them for STEPS.  This happened via 
email, staff meetings and a more direct approach with the IAPT Administrator.  
The IAPT Manager’s involvement in negotiation between the IAPT Administrator 
and study researcher, as required, did not present any problems.  
I mean, yeah, it was helpful to get an update on the last meeting you 
came to just about how many people had been taken on and the 
quotas.  I thought that was quite helpful.  (IAPT PWP) 
I think we’ve kept dialogue going on, we’ve kept, I think we’ve spoken 
quite a lot if there was a problem either end I think we were fairly 
open and sort of said ‘Well, this isn’t working I can’t do this, I can’t do 
that’ and I think that’s why it seemed to work quite smoothly really.  
(IAPT Administrator) 
I think you communicated really well with us, it was quite easy to get 
hold of you by email, you know, you responded pretty quickly, you 
know, just some concerns we had about the process like contacting 
the patient to see if they’d been taken on, that was really helpful to 
have that dialogue with you.  (IAPT PWP) 
Summary – administrative systems, workload and support 
Administrative systems for recording when patients were sent study 
information and tracking those who returned a permission form were 
manageable and worked well.  However, they represented more work for 
an Admin Team that was already very busy.  Ideally, STEPS would have 
provided financial support to assist.  STEPS also represented additional 
work for the IAPT Manager and, to a degree, therapists although the main 
challenge for PWPs had been to change working practices (see Theme 
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three – Handling permission forms).  Interviewees felt well supported by 
the study researcher. 
6.8.6 A summary of the appropriateness of recruitment to IAPT personnel 
The appropriateness of STEPS’ recruitment methods and procedures to IAPT 
personnel has been described by five themes covering what staff thought of 
research, STEPS initial approach to patients, handling permission forms, the 
experience of patients after a baseline interview and administrative systems, 
workload and support.  In terms of interviewees’ views of research, IAPT 
personnel were wary of the potential for conflict with patient care and service 
targets but still felt that research was important to support.  Moreover, the 
service supported STEPS despite being involved in another trial which had 
depleted clinic resource. 
Feedback on STEPS methods and procedures indicated that one aspect 
worked very well, specifically, the Administrative Team’s involvement in 
recruitment.   Systems for recording when patients were sent study information 
and monitoring their involvement the study were effective.  There was also a 
perception that patients benefited from the Admin Team mentioning STEPS 
when they rang to book an assessment appointment.  However, most of the 
workload associated with STEPS fell on the administrators who were already 
very busy and extra financial support to assist would have been welcome.  
Qualitative analysis also highlighted problems with recruitment methods and 
procedures.  Two were particularly troubling for IAPT personnel and may 
represent key barriers to the success of recruitment in a future trial.  They are 
(1) a concern that patients who return a permission form but ultimately remain 
under the care of IAPT could drop out of therapy or might not be contacted by 
their PWP and (2) a reluctance to pass on permission forms for patients who 
may be unsuitable or ineligible to take part.  A third problem was also identified 
that could affect the degree to which IAPT services may be willing to support a 
future trial: patients who joined STEPS did not count towards a key 
performance target to treat 15% of the local population estimated to have 
depression and anxiety. 
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Other ways in which recruitment was considered less appropriate were similarly 
motivated by a concern for patient wellbeing i.e. the view that sending patients 
study information may have overwhelmed and confused people and that some 
patients may have been confused by attending an IAPT assessment, meeting 
with the study researcher and then returning to IAPT.  The PWP interviewee 
also identified several issues around handling patient permission forms for 
which it may be possible to offer more support in a future trial: changing the 
format of an assessment to collect forms, responding to patient questions, the 
degree to which therapists should be proactive in asking people for their form. 
  
199 
6.9 Comparing quantitative and qualitative recruitment data 
Table 26 presents quantitative and qualitative data on recruitment.  Numeric 
information on the performance of pilot trial recruitment methods is displayed 
next to a summary of the views of patients, therapists and IAPT personnel.  
Data are organised according to each main stage of recruitment.  Synergy and 
conflict between the different data types is highlighted as follows (Box 3): 
 
Box 3. Key to disparity and synergy between quantitative and qualitative 
recruitment data 
Quantitative and qualitative data highlighted green: synergy – numeric 
and qualitative data are mostly positive indicating an element of 
recruitment that might remain unchanged in a fully-powered evaluation 
Quantitative and qualitative data highlighted red: synergy – numeric 
and qualitative data are fairly negative indicating a recruitment 
procedure that could be modified for a fully-powered evaluation 
Quantitative and qualitative data highlighted yellow: disparity – numeric 
and qualitative data hold different valence with implications for a fully-
powered evaluation that may require further thought 
 
Key findings with respect to congruence or divergence are noted in the final 
column.  Results are described in section 6.9.1 
 
Table 26 overleaf 
.
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Table 26. Quantitative and qualitative data on the appropriateness and performance of recruitment methods and procedures 
Theme Qualitative data from semi-structured interviews Numeric data Key finding 
 
Sending study 
information 
with patients’ 
initial IAPT 
assessment 
appointment 
letter 
 
 
 
 
Sending study information with patients’ appointment letter is appropriate 
 Patients generally liked the study summary sheet 
 The IAPT Manager and Administrator endorsed and were happy for the Admin Team to mention STEPS during 
telephone calls to arrange patients’ assessment appointments 
 The Administrator felt that patients were not confused when told they would receive study info 
 Only a handful of patients declined to receive study info 
Being sent study info need not deter people from assessment 
 Patients did not always recall receiving study info with their IAPT appointment letter 
 Some were uncertain when they had received it or thought that they had received it at their assessment 
appointment 
 
Being sent study info with an appointment letter is less appropriate 
IAPT personnel were concerned that patients: 
 May have been overwhelmed by the amount of information  they received  
 Did not always understand all of the paperwork 
 Were sometimes unclear what they were signing up to 
 With poor literacy skills & / or for whom English was not their first language may have been excluded 
 
 
1980/2299 (86.1%) of 
patients sent study info 
attended an assessment 
 
 
Sending study information 
with patients’ appointment 
letter is acceptable enough 
to most patients and did not 
obviously deter patients from 
attending an IAPT 
assessment 
 
Handling 
permission 
forms at 
assessment 
 
 
Receiving and passing on forms is less appropriate 
 Passing on forms for patients whom therapists did not believe would be eligible / suitable caused considerable 
tension  
 IAPT personnel were uncomfortable referring patients to STEPS knowing recruitment was slow or on hold. 
There may be scope to improve the number of patients returning forms 
 Therapists were asked not to enquire about people’s forms if patients did not readily present them 
 Therapists varied in how proactive they were in asking patients for their forms  
 The PWP was uncomfortable with his response to patients’ questions: he felt that he should offer little 
information in reply but was not happy with this. 
 When asked if interest in STEPS would delay someone’s treatment, the Team Manager did not feel that she 
could tell patients there would be no delay 
 
Receiving and passing on permission forms is appropriate 
 Patients were happy to be asked if they were interested in STEPS 
 The PWP was not precious about ‘referring’ patients  
 The PWP had initially seen the study as an opportunity to reduce his caseload 
 Completed permission forms were usually passed to the Admin Team without delay 
 Procedures for logging when patients returned a form worked well 
 
 
179/2299 (7.8%) of  
patients returned a 
permission form 
 
 
 
Handling permission forms at 
assessment caused some 
difficulty for IAPT staff – but 
not patients – and may have 
contributed to the relatively 
low number of forms 
received 
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Telephone 
screens – first 
contact with a 
researcher 
 
The brief amount of time between patients returning a permission form and the telephone screen was 
appropriate 
 Patients welcomed how quickly they were contacted 
 It impressed patients that the research was well organised and their problems were taken seriously; it 
maintained a sense of momentum once people decided to seek help.  For one person, it kept her in treatment 
following a difficult experience at IAPT. 
 Successful implementation of the five day turnaround (along with use of a ‘patient delay’) enabled the IAPT 
service to meet its 28 day target from assessment to first treatment appointment for patients who were 
returned to its care. 
 
Telephone screens could 
not be completed with a 
total of 58/179 (32.4%) 
patients who returned a 
permission form. 
 
Of those, it was not 
possible to screen 18/58 
(31.0%) patients in five 
days. 
 
The brief amount of time 
between returning a 
permission form was 
appreciated but led to a loss 
of potential participants 
 
 
Baseline 
interviews 
 
 
Attending a baseline interview - after initial assessment at IAPT - is acceptable 
 When asked how they felt about attending a baseline interview after their initial assessment at IAPT, some 
patients said this was not a problem 
 Patients were pleased by how quickly their baseline interview had taken place 
 Positive views about the baseline were that treatment had been well explained; having met with a researcher, a 
patient had been reassured about starting therapy; the baseline provided a welcome opportunity to reflect. 
 
Attending a baseline interview - after initial assessment at IAPT - is less acceptable 
 One patient had been disheartened at the prospect of discussing thoughts and feelings that had already been 
voiced at IAPT  
 Compared with their initial assessment, the baseline interview sometimes felt impersonal (although patients 
understood why) 
 
 
84/121 (69.4%)  patients 
screened completed a 
baseline interview 
 
 
 
 
17/121 (14.0%) patients 
declined or did not attend 
a baseline interview 
 
 
Baseline interviews were 
seemingly acceptable 
enough to the majority.   
 
 
 
However, difficulties 
associated with the baseline 
interview may have 
contributed to the decision by 
a minority of patients not to 
attend. 
 
Joining STEPS / 
returning to 
IAPT 
 
 
‘Losing’ patients to STEPS was not considered entirely appropriate by IAPT staff 
 The IAPT service had a key performance target to treat 15% of the local population with depression and 
anxiety; at the time of the study, the target had not been met; patients who joined STEPS did not count 
towards the target 
 
Returning patients to IAPT was not considered wholly appropriate by IAPT personnel 
 The IAPT Manager felt that it was confusing for people to attend an initial assessment, go to another location to 
meet with the researcher and return to IAPT. 
 Staff were worried that patients who came back to IAPT would be more likely to drop out of therapy 
 Compared with patients who were not interested in STEPS, it took more PWP resource and time to book in 
people’s first treatment session 
 
 
68/2299 (3.0%)  patients 
invited to take part were 
randomised, two in error 
 
 
111/179 (62.0%) patients 
who completed a 
permission form, 
continued treatment with 
IAPT 
 
 
Target numbers were 
recruited but this was 
somewhat problematic for 
the IAPT service. 
 
A large number of patients 
who completed forms 
remained under the care of 
IAPT which presented some 
difficulty. 
 
Transition to 
STEPS therapy 
 
 
Patients’ transition from baseline into therapy was managed appropriately 
 Patients and STEPS therapists were very pleased with how soon people began treatment 
 Discharging people from DAS on joining STEPS did not seemingly confuse or concern patients 
 
Elements of the transition were found to be less appropriate 
 One patient was disappointed to learn that he would not see the researcher for therapy 
 
 
62/68 (91.1%) randomised 
patients attended 
treatment. 
 
 
 
Patients transition into 
therapy following their 
baseline interview appeared 
to work well 
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6.9.1 Combined data at each main stage of recruitment 
Sending patients study information with their IAPT assessment 
appointment letter 
The majority of patients (1980/2299, 86.1%) who were sent study information 
with their IAPT assessment appointment letter attended an initial assessment 
appointment indicating that receiving a study summary sheet did not deter the 
majority from pursuing therapy.  This interpretation of the numeric data is 
consistent with positive patient feedback on the study summary sheet and IAPT 
interviewees’ views that mentioning STEPS during telephone calls to arrange 
patients’ assessment was helpful.  Concerns that patients may have been 
overwhelmed by information, did not understand all of the paperwork or had not 
fully understood what they were signing up were not obviously problems 
enough to deter most patients from pursuing therapy.  Indeed, qualitative data 
suggest that for some (even patients who join the research), receiving study 
information with an assessment letter may be fairly irrelevant in their decision to 
attend an assessment; patients did not (much) remember the study summary 
sheet or recall when it had been received.  Implications are that, with respect to 
a fully-powered evaluation of stepped care, the procedure of sending study 
information with patients’ initial IAPT appointment letter could remain 
unchanged. 
Receiving and passing on permission forms 
Qualitative data on therapists’ handling of permission forms suggests that, at 
assessment, patients were happy to be asked about STEPS and PWPs did not 
obviously obstruct their interest in the study. Procedures for passing on forms to 
the Admin Team worked.  Nonetheless, the number of patients who completed 
and returned a form was relatively small (179/2299 (7.8%) of those sent study 
information).  Interviews with IAPT staff also indicated that it may be possible to 
increase the number of permission forms received as well as the degree to 
which handling forms is considered appropriate.  Implications for a large trial are 
that it may be advantageous to modify procedures:  IAPT personnel might be 
encouraged to routinely ask patients for forms; it may be desirable to offer 
PWPs more support to help them respond to patients’ questions. 
203 
Telephone screening 
Telephone screens were not completed with 58/179 (32.4%) of patients who 
returned a permission form and, of those, 18/58 (31.0%) patients could not be 
contacted within five working days of their initial IAPT assessment.  In this way, 
the limit of five working days contributed to attrition in recruitment.   On the other 
hand, patients welcomed how quickly they were contacted.  Moreover, 
successful implementation of the five day turnaround enabled the IAPT service 
to meet a key performance target.  Implications for a fully-powered evaluation 
are that allowing more time to complete telephone screens could increase the 
participation rate but may be unpopular with patients and IAPT services.  
Whether to modify this procedure may require further thought. 
Baseline interviews 
Baseline interviews were completed with the majority of patients screened 
(84/121; 69.4%) indicating that completing an interview was broadly acceptable 
to most patients.  This interpretation is consistent with patients’ positive views of 
the baseline including that attending an interview shortly after a similar (initial) 
assessment at IAPT was generally not a problem.  However, qualitative data 
also revealed that scheduling the interview after an IAPT assessment caused 
some difficulty for some people and a minority of patients screened, declined a 
baseline or did not attend (17/121; 14.0%).  With respect to a large trial, it would 
be possible to leave procedures for the baseline interview unchanged but it 
might also be helpful to reflect on what further could be done to offset difficulties 
associated with arranging an interview after patients’ IAPT assessment. 
Joining STEPS or returning to IAPT 
In terms of patients ‘joining’ STEPS, although target numbers of participants 
were recruited, patients who were successfully recruited did not count towards 
the IAPT service target to treat 15% of the local population with depression and 
anxiety.  Whilst this was not a problem in the current study (due to the small 
number of people taking part), the IAPT manager anticipated that the same 
issue could threaten services’ willingness to be involved in a fully-powered 
evaluation.   Whether and how to address this conflict may require further 
consideration.  
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Qualitative analysis also found that returning patients who expressed an interest 
in STEPS to IAPT was not considered wholly appropriate.   A key concern was 
that patients who returned to IAPT would be less likely to attend their first 
treatment session although no data was available to help establish the degree 
to which the concern was justified.  The number of patients returning to IAPT 
was large; 111/179 (62.0%) of patients who completed a permission form 
ultimately continued treatment with IAPT.   In terms of a large trial, it may be 
advantageous to reduce the number of patients who returned to IAPT and 
obtain data on the number who returned a permission form but continued 
treatment with IAPT and subsequently dropped out. 
Trial participants’ transition to therapy  
Post baseline, only a minority of patients randomised (6/68; 8.8%) declined or 
did not attend any treatment.  Qualitative data also suggest that patients’ 
reasons for declining treatment are unlikely to be related to trial procedures: 
patients and therapists were very pleased with how quickly patients began 
therapy following their baseline interview and patients were not confused when 
they were discharged from IAPT.  On this basis, in terms of a large trial, it would 
be possible to leave procedures for patients’ transition from baseline into 
therapy unchanged. 
6.9.2 A summary of combined quantitative and qualitative recruitment 
data 
A side-by-side summary table was used to compare quantitative and qualitative 
data on each main stage of recruitment.  Synergy and disparity between 
different data types pointed to elements of recruitment that might remain 
unchanged in a large trial, be modified or require further consideration.  
Procedures that could remain unchanged are sending study information with 
patients’ initial IAPT appointment letter, the administration of the baseline 
interview and patients’ transition to therapy on randomisation.  Aspects that 
could be refined include support for IAPT staff handling permission forms, 
offsetting difficulties associated with scheduling a baseline interview following 
an IAPT assessment appointment and collecting data on the treatment received 
by patients who are interested in taking part but ultimately remain under the 
care of IAPT.   The brief amount of time (five working days) to complete 
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recruitment and the potential conflict between recruitment and IAPT services’ 
target to treat 15% of the local population with depression and anxiety may 
require further consideration. 
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Chapter 6. PART III 
 
Qualitative and mixed methods analysis on the 
acceptability of stepped care 
 
Comprising sections: 
6.10 Acceptability of stepped care 
6.11 Acceptability of stepped care to patients  
6.12 Acceptability of stepped care to therapists 
6.13 The relationship between acceptability and attendance  
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6.10 Acceptability of stepped care 
Qualitative data on the acceptability of stepped care was collected from 
interviews with 30 stepped care patients and three therapists.  All of the patients 
and therapists who were asked to participate consented to be interviewed.  
Data from 12 patient interviews were analysed.  Six patients received GSH 
alone of whom two declined any treatment, one ended therapy prior to the point 
at which her therapist believed she was ready (‘dropped out’) and three 
completed treatment; six patients received low-and high-intensity therapy of 
whom one dropped out (of intensive CBT) and five completed treatment (Table 
27).  From patients’ first to last treatment session, levels of depressive 
symptoms improved by at least 50% for half of the patients who received GSH 
alone and half of the interviewees who had progressed to CBT. 
 
Table 27. Treatment offered, adherence to therapy and outcomes for patients 
interviewed and analysed 
 
Notes: 
1
 Therapy offered to stepped care patients; 
2
 Patients’ adherence to treatment;
 3 
difference in PHQ-9 scores 
between patients’ first and last treatment session; 
4
 whether patients’ PHQ-9 scores between their first and last 
treatment reduced by 50% or more – yes / no; 
5
 Not Applicable. 
 
Analysis of the qualitative data on stepped care aimed to describe the degree to 
which the intervention was acceptable to patients and therapists.  It covered 
interviewees’ views of key components of the intervention including e.g. low-
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intensity therapy (Guided Self-Help; GSH), monitoring and stepping, high-
intensity therapy (Cognitive Behaviour Therapy; CBT).  Interviewees’ views 
were described by several themes and sub-themes.   
The results of the patient data analysis are presented first (section 6.11).  
Patients’ views were understood in terms of six major themes described in sub-
sections 6.11.1 to 6.11.6; results on each theme are summarised at the end of 
each sub-section. 
The summary of patients’ views of low-intensity therapy incorporates mini-
summaries of what each patient thought of GSH (see 6.11.2).  Similarly, the 
summary of patients’ views of high-intensity therapy incorporates mini-
summaries of what each patient thought of CBT (see 6.11.5).  Individual 
summaries of what each patient thought of stepped care as a whole are 
provided in section 6.11.7 and patients’ views of stepped care are also depicted 
in a number of typologies.  Ways in which patients talked about a variety of 
different elements of the intervention that appeared to influence the degree to 
which it was acceptable to them are described in the form of three ‘cross cutting 
themes’ (see 6.11.8). 
Patient data is followed by a description of what the therapists thought of 
stepped care (section 6.12).  Therapists’ views were understood in terms of four 
themes described in sub-sections 6.12.1 to 6.12.4; results on each theme are 
summarised at the end of each sub-section.  An overview of what the therapists 
thought of stepped care as a whole is provided in section 6.12.5. 
Section 6.13 presents the results of mixed methods analysis on the relationship 
between acceptability and therapeutic attendance.  Results include a 
description of findings based on: (1) a joint typologies / statistics display of 
treatment adherence data for patients for whom stepped care is more and less 
acceptable (see section 6.13.1); (2) a case-oriented display of the number of 
GSH and CBT sessions attended and patients’ views of low- and high-intensity 
therapy (6.13.2); (3) a joint categories / themes display of views of stepped care 
among patients who attended more and less therapy (6.13.3).  A summary of 
the results of the mixed methods analysis on acceptability and attendance is 
provided in section 6.12.4. 
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6.11 Acceptability of stepped care to patients 
Analysis of the patient interviews found that trial participants’ views of stepped 
care could be described by six descriptive themes: ‘thoughts and feelings 
before treatment’; ‘Guided Self-Help’; ‘monitoring’; stepping’; ‘Cognitive 
Behaviour Therapy’ and ‘ending therapy’.  Five themes comprised several sub-
themes.  Themes and sub-themes are summarised in Box 4. 
 
Box 4. Key themes (numbered 1 to 6) and sub-themes describing the 
acceptability of stepped care to patients 
1. Thoughts and feelings before treatment 
2. Guided Self-Help 
Wellbeing Course material 
Reading and using material 
Phone calls 
Therapeutic support 
Timings 
Influence of the option to have CBT 
3. Monitoring 
Being monitored and the use of information to inform 
stepping decisions 
Responding to and using scores 
Critique of the PHQ-9 
4. Stepping 
Thoughts and feelings following unsuccessful GSH 
Going on to CBT 
The transition 
5. Cognitive Behaviour Therapy 
CBT as a whole 
Therapy in person and the therapeutic relationship 
Timings 
6. Ending therapy 
Feelings about ending treatment 
Benefits of treatment and residual difficulties 
Reasons for dropping out 
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6.11.1 Theme one – thoughts and feelings before treatment 
The theme ‘thoughts and feelings before treatment’ describes patients’ 
response to being offered stepped care treatment for depression.  It describes 
how patients felt at the prospect of beginning therapy with GSH knowing CBT 
could follow.  
Views on starting treatment with GSH were divided.  For some patients, it hadn’t 
at all been what they wanted - they would have (much) preferred CBT.  
However, the contrasting view was much more positive; patients viewed GSH 
as good opportunity, useful in its own right (e.g. as a means to acquire tools that 
patients could apply) but also favourable knowing that CBT could follow if 
needed.   
I was generally happy that I was given the self-guided, the GSH first, 
knowing the back-up, CBT, could follow.  I mean hoping it wouldn’t at 
that point.  (Patient 027) 
More moderate views were also expressed.  They entailed some reservation(s) 
or uncertainties about starting treatment with GSH or a more open-minded 
stance.  Patients who held a more negative view of starting with GSH were both 
prepared to try it and anticipated that they would probably decline treatment. 
[Chuckles] Maybe at first I was thinking, ‘Really?  Is that going to be 
enough for me? Maybe I do need the in depth CBT.’  I remember sort 
of thinking, ‘Hold on, I don’t know which one’s best,’ then I thought, 
‘I’ll just give it a go’.  (Patient 039) 
I think I knew then [at baseline] that if it was going to be step one, I 
probably wouldn’t do it. (Patient 007) 
Reasons for feeling negative or cautious about starting therapy with GSH were 
a lack of knowledge of GSH compared with an understanding of CBT, having an 
interest in CBT and prior experience of unsuccessful low-intensity / successful 
high-intensity treatment.  Some aspects of the GSH course (principally the idea 
of ‘homework’) did not appeal and some people expressed a preference for face 
to face therapy.  Patients were also worried about ‘relying on oneself’ and were 
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concerned that GSH may not be enough given how they were feeling or 
because they thought that they were already quite self-aware. 
When you said ‘self-help’ I was probably slightly, again, put off by the 
fact that it might have felt like the emphasis was only on me, I don’t 
know, I don’t know.  And maybe I felt I needed that face-to-face or 
whatever it was, someone external to really help me, that’s how 
vulnerable I was feeling at the time, that maybe I thought that 
wouldn’t quite be enough, just to be getting a few things through the 
post.  (Patient 063) 
Summary – thoughts and feelings before treatment 
Views on starting therapy with GSH were mixed.  Some patients wanted 
CBT; others were content to start treatment with GSH and, in this regard, 
patients were reassured that CBT could follow.  Elements of GSH that did 
not appeal included homework and phone calls; patients thought that they 
may need more support and were uncertain about relying on themselves. 
6.11.2 Theme two – Guided Self-Help 
In the theme ‘Guided Self Help’ patients reflected on their actual experience of 
low-intensity treatment.  Patients described what they thought of the Wellbeing 
Course material, how they found reading and using course material, therapy by 
phone, therapeutic support and the timings of low intensity treatment (session 
duration (30 mins), pace (weekly) and the total length of treatment (six weeks)).  
The theme also encompassed patients’ description of how the option to have 
CBT influenced their experience of low-intensity treatment. 
Wellbeing Course material 
Views of the Wellbeing Course material varied.  One view was that it was very 
good.  Those who spoke positively gave generic feedback e.g. the course was 
brilliant.  Patients also said that the course material was well-structured and laid 
out, materials worked well together and they had been given the right amount of 
material each week.  Patients felt that they knew where they were with the 
Wellbeing Course, knew what they were doing; repetition in the material helped.  
For some patients, selected elements of the course stood out as ‘spot on’ e.g. 
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the stories, lessons & DIY guides, material on unhelpful thoughts and thought-
challenging. 
The couple of bits that really stood out for me were the stories about 
other people that have umm had you know like periods in their life 
when they’ve been depressed or really low.  Umm.  And that was… 
like, wow, I’m not the only one out there that has like these you know, 
sort of, like weird thoughts or feelings n, n things like that.  And it was, 
I suppose it was just a bit of an awakening really that.  I don’t know, I 
suppose when you’re feeling a bit low you just think it’s all about you.  
(Patient 031) 
The contrasting view was that the course material was poor.  Material was 
patronising; patients did not relate to it or it did not relate to them; material was 
inadequate for their needs.  In particular, stories were mentioned as something 
patients did not relate to and, for a similar reason, case studies were disliked. 
I mean, I do remember the people’s stories and I just thought both 
those people’s stories, for me they were – I think they were both 
married, they both had families, and because of that I couldn’t relate 
really, as a single person, having relationship difficulties and, you 
know, huge abandonment issues and all the rest of it.  I couldn’t really 
relate…  I don’t think it affected my understanding of the material but 
it just made me feel [sighs] different, that I needed something else.  
(Patient 062) 
Reading and using material 
Patients’ experience of reading and using course material ranged from 
engaging with the material very little (if at all) to reading quite intensively.  In 
general, the more acceptable patients found reading and using material, the 
more they read.  However, some people who found reading and using material 
much less acceptable nonetheless described reading and applying what they 
had learnt. 
Those for whom reading was more acceptable felt motivated to apply what they 
were learning and were able to read in a way to suit themselves e.g. by 
focussing on elements of the course that particularly resonated.  Patients also 
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reported that they had received material in good time prior to their forthcoming 
therapy session and being able to read before speaking with a therapist helped 
patients to work with material and prepare to meet with their therapist. 
Well I actually had a really positive reaction to the materials because I 
think I’m quite a, I think I’m more the thinking type as well, so 
sometimes I actually benefit from thinking things over and I suppose 
the only downside of the sort of face-to-face, unless you’re given 
materials to take away, which I suppose is an option, is that, you 
know, everything’s said and then you go home and think, ‘Oh, I wish 
I’d talked about that or that,’ whereas maybe with materials to work 
through for a week I was able to think what I wanted to get out of the 
next session by working through the materials and maybe prepping 
for it, almost.  (Patient 063) 
 In contrast, patients who found reading and using course material less 
acceptable were not motivated to read.  Participants perceived that they were 
too poorly and did not want to do ‘homework’.  There was also a perception that 
there was not enough time to read.  Practical issues sometimes made reading 
difficult including patients’ reading ability and lack of organisational skills. For 
some, reading the course material elicited a negative emotional response that 
deterred them from remaining in therapy. 
‘Cause every time you picked it up it brought something back that I 
was ill, you know, and it was like, although I don’t ever, ever regret 
doing what I did, it was still in the back of your mind that I did let 
people down, I did let myself down, and I was an ill person and it was 
like, ‘I can’t be bothered with it… and I was thinking ‘I don’t need this 
work.  I can get through this myself.’  (Patient 058) 
Phone calls 
In the same way that views of the Wellbeing Course material and the degree to 
which patients read and used material varied, there was a range of opinion 
about receiving therapy by phone.  This encompassed a strong dislike for calls, 
a dislike but tolerance of therapy by phone and finding calls really useful, 
completely normal and without issue.  Opinions could change over the course of 
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treatment: some respondents settled into calls after some uncertainty or found 
that they did not mind phone calls after disliking therapy by phone. 
Patients were unhappy with phone calls in three respects: therapy by phone 
was thought to be unsuitable or at least less helpful for the individual given their 
needs; practical issues arose with calls including problems with reception; 
participants felt less cared for.   
I think it’s mostly sort of, I mean, particularly for me who – I have 
problems with disconnecting from things.  If, you know, there’s a face 
to the voice… then it actually can be a lot more useful.  (Patient 028) 
The other thing was I’ve got one of these phones that the battery 
wants to suddenly die on, so I had to get home, charge it up and 
sometimes I was speaking to her while – so that was limiting me from 
where I could reach from the plug to the phone.  In the early days, 
you know, in the first two, three weeks, that used to really rattle me 
that, and I’d find myself getting sweaty and thinking, you know, I’d be 
having a conversation and we’d lose contact and me thinking, ‘What 
the hell, why am I doing this?’ and then she’d phone back and in the 
mean time I’d be thinking, ‘Well, at least she’s phoning me, it’s not 
costing me money’…  but every time it happened I just thought, ‘Why 
can’t we just have a one-to-one?  Why can’t they just come into the 
office and have a one-to-one?’  (Patient 058) 
I guess it’s a question of distance really with the whole, you know, the 
- the material being generalised and the conversations happening on 
the phone. It just seemed slightly sort of removed, you know, 
compared to meeting first face to face and then getting, what I 
presume to be tailored materials, and then meeting face to face 
again. (Patient 023) 
The main benefit of calls was perceived to be their convenience.  Having an 
element of face to face therapy at the start of low-intensity treatment (session 
one was in person) and sending people course material in advance helped. 
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Therapeutic support 
The therapeutic support that people had received in low-intensity therapy was 
viewed negatively and positively.  A small number of criticisms were not 
obviously related to GSH e.g. preferring a female therapist.  Others were and 
included that the support was impersonal, as if the therapist had done their job 
but had not been there for the patient.  Patients wondered if there was scope to 
‘move away from the material and there was a desire for ‘closer’ support – more 
involvement on the part of a therapist. 
Sometimes I wanted to talk more about one particular subject and it 
was as though, like, she had a list in front of her that she has to ask, 
and it was like, ‘No, we’ve got to go on to the next question, we’ve got 
to go on to the next stage’ and it was like, ‘Oh right, if you can’t be 
bothered, then why should I be bothered.’  (Patient 058) 
Positive views of therapeutic support in GSH were that it had a clear purpose, 
helped people to use, understand and engage with the course material, 
supported patients’ own learning and in direct contradiction to others’ opinion, 
that it had never felt impersonal. 
You've got the support in the background and you've got the support 
on paper but you're doing it alone, but you're not alone… It didn't feel 
like a business but actually it was important that everything was 
talked about and that the time for me it was important what I was 
going through and what was happening and that was, that was the 
main feeling of it.  (Patient 027) 
Timings 
With respect to session duration, there was a perception that contacts were 
(sometimes) too brief, felt rushed and prevented patients sharing important 
thoughts and feelings.  For one interviewee, this had led to adverse behaviour 
following a session.  Patients also reported that sessions sometimes over ran 
and that this was helpful.  The contrasting view was that 30 minutes was 
sufficient and had been appropriate for the type of therapy involved (where you 
were not encouraged to ‘open up’).  This amount of time was also perceived to 
help people focus.  Views on the total length of the course also varied.  At one 
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extreme, patients felt that the course had been too long; others wanted it to be 
longer or implied that six weeks may have been too brief without the option to 
proceed to individual CBT.  Patients liked the pace of treatment.  Interviewees 
remarked that scheduling sessions weekly gave them time to think, reflect and 
try out ideas that they had discussed with their therapist and that, in these ways, 
they had been encouraged to help themselves.  However, people also 
commented that it was (sometimes) difficult to read all of the material they had 
been sent within one week. 
Influence of the option to have CBT 
Most of the ways in which patients described how the option to have CBT 
influenced GSH appeared to make stepped care more acceptable:  it took the 
pressure off the need to get well in just six weeks; people felt reassured / 
happier to start treatment with GSH; they were pleased not to be left without 
another option if low-intensity therapy failed.  This compared with a fear that if 
they had been offered intensive CBT alone, should this ‘gold standard’ 
treatment option fail, they would not know what else to do.  The option to have 
CBT also became a motivation to continue GSH and it avoided difficulty around 
choosing between treatments where there was a risk that the patient might want 
whatever they didn’t have (choose). 
It took a lot of pressure off, to be honest… I was definitely happy that 
I was having a lot of available weeks.  If someone had told me it was 
only five weeks, I would have thought, ‘Ugh, that’s not going to be 
enough for me.’  So to know that it would be five weeks, an 
assessment and then possibly another ten weeks and then it would 
be face-to-face (which is obviously something I wanted at the time) 
that was reassuring.   (Patient 063) 
I mean, if it had just been CBT alone and without the Self-Help, I 
mean, CBT always sort of feels like it’s fairly comprehensive because 
it is individual and you are - it is tailored to you - so my feeling was 
always that if that doesn’t work then you’re a bit stuck.   (Patient 028) 
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If the course had been you’re, you know, doing just the coursework or 
you’re doing CBT then I would have been like, ‘Oh I don’t want to do 
this, I want to do that.’ (Patient 031)  
A more exceptional view was that, as a consequence of the option to have CBT, 
GSH became instrumental, necessary to complete in order to access CBT. 
I knew kind of what I felt that I needed was the CBT, so I kind of went 
through the process with the - [Guided Self Help].  (Patient 062) 
Summary – Guided Self Help 
Views of the Wellbeing Course material, reading and using material, 
therapy by phone, therapeutic support and how the option to have CBT 
influenced GSH combined to determine the degree to which low-intensity 
therapy was acceptable to patients.  Acceptability varied.  Views of GSH 
ranged from wholly negative to positive; in-between patients expressed 
opinions that were predominantly but not completely negative, or 
predominantly positive (Table 28).  The views of patients who had a 
negative or cautious view of GSH prior to treatment were sometimes but 
not always confirmed during therapy: some patients found that they 
disliked GSH; others came to view it more positively.  For patients who had 
a negative view of GSH both prior to and after treatment, the option to 
have CBT sometimes meant that GSH became a ‘means to an end’; for 
others it both reassured and motivated.  
Table 28 overleaf 
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Table 28. Summary – patient experience of low-intensity therapy 
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Table 28. Summary – patient views and experiences of low-intensity therapy (continued from previous) 
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6.11.3 Theme three – monitoring 
The theme of ‘monitoring’ describes what patients thought about their 
symptoms of depression being systematically assessed throughout treatment.  
It covers their views of being monitored and this information being used to 
inform stepping decisions.  It also encompasses patients’ description of how 
they responded to and used their scores as well as their critique of the PHQ-9.  
Being monitored and the use of information to inform stepping decisions 
When asked how they felt about their symptoms of depression being assessed 
at each therapy session and this information being used to inform stepping 
decisions, patients said that the process made sense and was useful.  
However, difficulties sometimes arose around being honest.  Patients described 
how they had downplayed their symptoms of depression believing that it was 
important not to waste therapists’ time; a patient had contemplated lying in 
order to receive CBT and one interviewee wondered if patients would want to 
please their therapist with lower scores. 
An exceptional view was that monitoring was wholly unacceptable.  This view 
was upheld for two reasons: using numbers and boxes to capture emotions felt 
completely inappropriate; there was a concern that information on ‘risk to self’ 
identified using the PHQ-9 and consequently shared with the patient’s GP 
would become known to the local community.  One patient raised a very 
specific criticism: whilst symptoms of depression had been assessed, anxiety 
was not.  This had caused confusion and raised an important issue about the 
design of the current study: STEPS was described as an evaluation of stepped 
care treatment for depression; symptoms of depression were used to make 
stepping decisions yet the Wellbeing Course supported patients with depression 
and anxiety. 
I remember you saying it’s mainly aimed at depression, and again, 
you know, this is a bit of a question mark about all this for me is how 
much is this mainly aimed at depression and how much is it 
depression and anxiety?  And I felt the stepped care [low-intensity 
therapy] was very much both, but I was under the impression, I think, 
that after that it [high-intensity] would be mainly focused on 
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depression, and of course, the week by week scores were only based 
on depression, not on anxiety.  So that, for me, remains a little bit of 
an issue about this whole treatment.  (Patient 063) 
Responding to and using scores 
Descriptions of how people responded to and used their PHQ-9 scores were 
positive.  Scores were often trusted e.g. made sense to patients and mattered, 
sometimes a great deal.  
It was the clarification.  ‘Cause you could just say, ‘Right, well you’ve 
had your nine session, well done, you’ve done very well, you look and 
sound a lot better, thanks very much.’  But, like I say, it was almost 
like getting good marks in an exam, not just that you’d passed, but 
you got an A!  (Patient 014) 
When scores came down, people felt good; when they went up, patients 
commented that this was useful, if not heartening.  On occasion when scores 
did not tally with how people felt, scores were sometimes dismissed or ignored.  
This did not necessarily undermine the acceptability of being monitored; 
patients continued to trust scores with which they agreed.  An example of how 
patients used scores was to identify specific difficulties rather than persist in 
seeing all aspects of themselves and their lives as awful. 
[Completing the PHQ-9] was helpful in helping me to identify the 
areas where I might need help, as well, because, you know, when 
you generally feel rubbish, well, fine, how do you feel rubbish, what 
should you be doing, what should you be targeting to make you feel 
less rubbish as opposed to just going, ‘Well, I feel rubbish.’ [Laughter]  
It forced me to start defining some of the things, some of the ways in 
which I felt bad, as opposed to just, as I said, going ‘I feel bad.’   
(Patient 028) 
Other patients responded to their scores in ways that were more negative.  
Some patients had been sceptical about their scores i.e. thought they were 
inaccurate; patients described feeling frustrated when their scores did not come 
down or dropped a little only.  For one patient, facing a difficult set of family 
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circumstances, being monitored was especially problematic: the patient felt that 
their scores were both irrelevant and misleading given the situation they faced. 
It felt irrelevant to be filling out forms in comparison to how I felt the 
week before or the two weeks before when considering how 
something so serious and life-changing had happened between when 
I saw him and when I filled out the form before.  It was just like he just 
wanted to get a comparison but I didn’t think that the comparison 
would be fair to how my mental state really is.  (Patient 031) 
Critique of the PHQ-9 
Although the use of symptom checklists to monitor symptoms of depression 
was generally endorsed, the PHQ-9 was heavily criticised.  Comments included 
that it failed to fully capture patients’ experience of living with depression; 
questions and response options lacked detail; some items were a poor measure 
of depression and more likely reflected patients’ broader circumstances and 
difficulties; some difficulties were over-emphasised, others omitted.  When 
completing the PHQ-9 patients also found it difficult to remember how things 
had been and there was a perception that scores were overly influenced by 
what had happened on the day the measure was administered. 
Summary – monitoring 
Monitoring symptoms of depression made sense and was useful to most 
patients.  Patients felt good when their scores came down albeit frustrated when 
their scores went up or stayed the same.   The PHQ-9 was heavily criticised but 
the acceptability of monitoring was not necessarily undermined when scores did 
not tally with how people felt: scores were sometimes ignored.  One patient 
raised an important issue, specifically, why monitor symptoms of depression but 
not anxiety.    
6.11.4 Theme four – stepping 
The theme of ‘stepping’ covered patients’ views and experiences following 
unsuccessful low-intensity treatment.  It describes patients’ response to 
unsuccessful GSH; how they felt about going on to CBT; how the transition 
worked in practice and what patients thought about changing therapists. 
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Thoughts and feelings following unsuccessful GSH 
Patients’ thoughts and feelings following unsuccessful GSH were predominantly 
negative.  Interviewees felt fed up, frustrated, and that GSH had become a 
chore.   There was an element of self-recrimination; some patients felt that they 
had failed – they should have been able to succeed - and were worried that 
they had not responded to GSH because there was something wrong with 
them.  Not responding to GSH also compounded a loss of faith in trained 
professionals and there was a concern that if those trained to do so had been 
unable to help, who could? 
You do start to lose faith, and you’re thinking, OK, so professionals 
have designed this, and you start to lose faith in the professionals 
and think – do they actually know what they’re talking about, and then 
you think, ‘Oh God!  Well, if they don’t know what they’re talking 
about, who’s going to help me?’ [Laughs]  It’s like, ‘Is anyone going to 
be able to help me?’  Or maybe it’s me, you know maybe it’s’, ‘cause 
I’ve been told that it’s worked for other people, so maybe there’s 
something wrong with me.  (Patient 047) 
A more exceptional response to unsuccessful low-intensity therapy was to be 
more objective.  Non-response was seen as simply that, viewed without 
emotion. 
It was kind of like OK, I’ve done that now, got that out of the way, I 
can move on to what I really need.  (Patient 062) 
Going on to CBT 
Patients’ views about going on to high-intensity CBT varied.  At one extreme, 
patients were excited, keen and positive at the prospect of having CBT.  In 
contrast, others felt frustrated, defensive and dubious about how effective it 
would be.  Doubts either focused on oneself (am I the right person for CBT) or 
therapy (will CBT help).  However, doubts were ultimately replaced by more 
positive feelings.  In this transition, patients described a role for therapists.  By 
giving patients time and space, patients were able to reflect on the chance to 
have CBT and speak with family and friends.  Therapists also provided helpful 
information about what CBT would entail and its potential benefits.  Patients 
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came to see CBT as an opportunity or at least something they were prepared to 
try. 
He [my therapist] said that, you know, if I obviously, if I went into the 
CBT I could still stop at any point, and I figured ‘Well’, you know, 
‘Give it a try, give it a few sessions’, I don’t have to have, you know, 
twenty sessions if I don’t feel I’m getting anywhere, but let’s at least 
give it a spin and see.  (Patient 028) 
In terms of the ‘link’ between how patients’ felt about unsuccessful GSH and 
having CBT, feelings about the former did not predict the latter: despite negative 
thoughts, patients were to a greater or lesser degree, keen to have CBT – albeit 
after a time and following discussion with family and friends. 
The transition   
The practical transition from GSH to CBT was criticised in a small number of 
ways.  On occasion patients were unhappy with the length of time from low- to 
high-intensity treatment although this was, in part, attributed to how awful the 
patient felt and less to do with the actual amount of time passed.  There was 
also a suggestion that it would help to provide more information about CBT at 
the end of unsuccessful GSH.   
Changing therapist 
Changing therapists from GSH to CBT was generally not a problem.  Patients 
tended to speak of this positively even when they described a lack of rapport 
with their new CBT therapist.  Advantages of having a new therapist were that 
patients did not feel pre-judged and that this person could provide a fresh start. 
I think it’s good in a way to have that sort of fresh, refresher point, to 
sort of go, ‘Oh all right, well, we tried one thing and it didn’t go 
anywhere, so let’s start again in some ways,’ and actually have 
someone come in who doesn’t know you and doesn’t know how 
you’ve, what you’ve said or what you’ve done about the previous 
things you’ve seen.  (Patient 028) 
  
225 
Summary – stepping 
Patients’ thoughts and feelings following unsuccessful GSH were often 
negative e.g. some patients lost faith in health care professionals and felt 
that they had failed.  However, negative feelings did not determine how 
people felt about having CBT.  Some patients felt excited at the prospect of 
high-intensity therapy.  For others, helped by therapists, friends and family, 
doubts were replaced with a more positive outlook.  Changing therapists 
from low- to high-intensity therapy was not a problem. 
6.11.5 Theme five – Cognitive Behaviour Therapy 
The theme ‘Cognitive Behaviour Therapy’ describes what patients thought 
of high-intensity treatment delivered as part of the stepped care 
intervention.  It includes patients’ reflections on CBT as a whole, therapy in 
person and the therapeutic relationship, and how they found the length of 
sessions and the total length of CBT. 
CBT as a whole 
Views and experiences of Cognitive Behaviour Therapy divided patients 
who had stepped up into three groups: patients who had predominantly 
negative, predominantly positive and mixed opinions.  Criticisms of CBT 
held by those who had a negative or mixed opinion were that it did not 
contain anything new and that patients had been unable to understand 
what it was.   CBT had a negative impact on self-esteem; sessions felt as if 
they perpetually highlighted one’s weaknesses.  Other criticisms were that 
it did not address long-standing, difficult issues and that (from a patient 
who did not step up but reflected on what CBT would entail) that it was 
mainly focused on depression whereas help with anxiety was very 
important too. 
Someone says ‘So what do you do in CBT?’ and I don’t know!  I talk 
about how horrible I’ve been during the week and then get told to do 
something nice for myself or breathe.  (Patient 047) 
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Positive descriptions of CBT were around what the therapy entailed e.g. being 
taught how to deal with the here and now, benefits to individual patients such as 
increased self-awareness and generic statements – CBT was enjoyed. 
Therapy in person and the therapeutic relationship 
Views and experiences of therapy in person and the therapeutic relationship in 
CBT also divided patients.  One group found therapy in person positive, they 
liked their therapist and had a good rapport with them; a second group criticised 
the therapeutic relationship heavily, felt unsupported, and wanted more 
empathy, understanding and guidance.   Some patients who stepped up 
explicitly said that they preferred the face to face delivery of CBT to phone calls.  
However, patients who preferred face to face did not always rate the therapeutic 
relationship positively.  Benefits of CBT that were directly attributed to it being in 
person included that face to face therapy was a welcome opportunity for 
patients to ‘get away’ from their home surroundings and everyday environments 
and that, face to face, a therapist could tell when the patient avoided things 
which was not always possible by phone. 
Being one-to-one, being face-to-face, being away from my home and 
my situation, you know, actively going – actually getting a break from 
work, to be honest, as well…  Just having a break, change, different 
situation, different person, it just felt a positive, so much more positive 
in a way and helped by the physical action of moving out of the 
situation, I felt freer, felt literally like I had more control,  (Patient 062) 
[My therapist] pretty quickly caught up on the fact that I avoid things if 
I don’t like doing them.   If you see someone and talk to them it’s a lot 
easier to call up on than if it’s done over a phone call… So that was 
quite, that was quite comforting to have someone there look at you 
and go, like, ‘So you’re avoiding again.’  (Patient 027) 
Timings 
In terms of the duration of CBT sessions and the total length of time patients 
spent in high-intensity therapy, patients held different views.  One view was that 
the duration of sessions was good and, together with how individual sessions 
had been planned, helped patients avoid trawling over difficulties in a way that 
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was unconstructive.  On the other hand, sessions were found to be too short 
and when they did over run (beyond the allotted 50 minutes) this was 
considered useful.  The total length of CBT did not necessarily feel too long, 
especially in the context of how long people had lived with depression; 
conversely, sessions seemed as if they went on and on. 
Summary – Cognitive Behaviour Therapy 
Patients’ views of CBT delivered as part of stepped care varied.  Some patients 
did not understand CBT and had a poor relationship with their therapist.  There 
was also a perception that sessions were too brief and the total number more 
than required.  Other patients enjoyed CBT, including face to face therapy; the 
length of individual sessions and the total duration of CBT were perceived as 
appropriate.  Patients who preferred face to face therapy did not always rate the 
relationship with their CBT therapist, positively.  Patients’ views of CBT and 
stepping (theme four) are combined in Table 29.  The table illustrates that some 
patients who experienced negative feelings following unsuccessful low-intensity 
treatment nonetheless liked CBT. 
228 
Table 29. Summary – patient experience of high-intensity therapy as part of the stepped care intervention 
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6.11.6 Theme six – ending therapy 
The theme ‘ending therapy’ covered how patients felt about ending treatment 
(following GSH alone or GSH + CBT), benefits of treatment and any residual 
difficulties and, for patients who ended a treatment before their therapist 
believed they were ‘ready’, why patients ‘dropped out’. 
Feelings about ending treatment 
Faced with the prospect of ending treatment, patients had mixed feelings.  This 
was true for patients who ended treatment following GSH alone and GSH plus 
CBT.  Patients at once understood and accepted that treatment had to end but 
also felt uncertain about doing so.  Negative feelings about ending therapy 
included worries around the loss of support and coping with ongoing difficulties.  
Patients who had high-intensity treatment following GSH did not always feel 
ready or expect to stop CBT. Patients were sometimes reassured knowing they 
could return to their local IAPT service if they required more treatment.  
However, patients did not normally want such support directly on ending 
therapy – one GSH patient wanted to be ‘checked up on’ at a later date.   
Benefits of treatment and residual difficulties 
When reflecting on the benefits of therapy, patients who had GSH alone but 
also those who stepped up described how low-intensity therapy helped them 
with the way they were thinking and feeling.  
I think it’s changed my mind set, the literature has, quite considerably, 
and, which is really positive, it’s really good.   (Patient 051) 
It was bringing me to terms with life again.  You know, these people 
in the book, they’d gone through worse, you know, losing their wife, 
having a car crash, losing a limb, and they got up and got on with it 
and it was like ‘You know what, someone up there’s looking over me, 
they’ve given me another chance and I [knew that]… nobody could 
do that for me, there was only me that could do that.  (Patient 058) 
I think it [GSH] made me give myself a bit more slack.  Because a lot 
of the time I would kind of berate myself with ‘Oh, you’re so lazy’ and 
it’s like, well, no, I’m tired for a reason.  (Patient 047) 
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Interviewees described benefits of having the GSH material to return to when 
needed.  This was important for patients who had GSH alone and those who 
had GSH and CBT.  Patients varied in the degree to which they actually used 
the material: some suggested that they had re-read it; others were reassured to 
know it was there but had not actually picked it up since ending therapy.  
I… love, think it’s amazingly useful that I have… all the paperwork 
from the self-guided work.  That was one of the first things I packed 
and make sure I got it handy, so if I feel like I need it, I can have it.  
Umm.  And knowing that I have this material and if I ever feel like I 
need to read it, I can.  I thought that was just, I think that was brilliant.  
(Patient 027) 
I have sort of put the course to one side, for the time being, but I’ve 
still got it mulling over in the back of my mind, but I haven’t actually 
looked at the stuff, I’ve just left that to the side.   (Patient 039) 
The self-help literature was brilliant, is brilliant, because I still have 
referred to it. (Patient 051) 
Both patients who had GSH alone and low- and high-intensity therapy 
described residual difficulties or problems in their lives which they anticipated 
would continue to be difficult beyond therapy and which treatment may not have 
addressed. 
Reasons for ‘dropping out’ 
For patients who had declined any treatment or ‘dropped out early, reasons 
given for doing so were both treatment related and not.  Two patients had 
declined any GSH.  The prospect of ‘homework’, a strong preference for face to 
face therapy or CBT and a belief that the Wellbeing Course material was not 
appropriate or relevant to them contributed to this decision; one of the patients 
also understood that he could access high-intensity CBT without first being 
referred for low-intensity treatment, on return to his local IAPT service.  A third 
patient who had significant difficulty with the idea of homework and being 
monitored and who had ended GSH treatment after one session, attributed her 
decision to end treatment primarily to a family crisis combined with work-related 
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demands.  A fourth stepped care patient ended CBT when she moved location 
for employment. 
Summary – ending therapy 
Patients who had GSH alone and GSH + CBT described ways in which 
treatment had helped but also residual problems at the end of therapy.  Both 
groups of patients had mixed feelings about ending treatment.  Patients who 
had CBT after GSH did not always expect or feel ready to end high-intensity 
therapy.   Both those who responded and did not respond to GSH were pleased 
to have GSH material at the end of treatment and said that they referred to it.  
Patients declined or dropped out of low-intensity therapy because of treatment 
and for other reasons. 
6.11.7 A summary of the acceptability of stepped care to patients 
Patients’ views and experiences of being offered stepped care, low-intensity 
treatment and (where applicable) unsuccessful GSH, going on to CBT and 
actual CBT as well as ending treatment combine to determine the degree to 
which the intervention was acceptable.  In this regard, patients divided into 
three groups: those for who stepped care was wholly or largely unacceptable; 
patients who found stepped care somewhat acceptable and a group for whom 
stepped care was acceptable (Table 30).  The views of patients for whom 
stepped care was unacceptable were often based on their response to GSH 
alone but could also reflect a dislike for both low- and high-intensity treatment.   
Some patients who found stepped care somewhat acceptable disliked GSH and 
liked CBT; others rated GSH positively but did not like or held a mixed opinion 
of high-intensity treatment.  Positive views of stepped care reflected a good 
experience of GSH alone but were also held in relation to GSH that had not 
‘worked’ but was nonetheless viewed positively followed by CBT that was 
enjoyed.   
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Table 30. Summary – patient experience of the stepped care intervention 
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Table 30. Summary – patient experience of the stepped care intervention (continued from previous) 
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Typologies of the degree of acceptability to patients 
The degree to which stepped care was acceptable to patients was also 
summarised using typologies (Figure 11).  Nine typologies were derived from 
the experiences of stepped care among the twelve patients analysed and are 
displayed along a continuum of acceptability.  Typologies that appear to the left 
of the figure represent the views of patients for whom stepped care was 
completely unacceptable; typologies that appear to the right represent the views 
of patients for whom stepped care was highly acceptable.  The derivation of 
nine typologies from twelve patients analysed is further evidence of the 
heterogeneity in patients’ views of stepped care.  Stepped care was both highly 
acceptable and completely unacceptable with a range of opinion in-between. 
 
Figure 11 overleaf 
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Figure 11. Typologies of patient attitude to stepped care arrayed by acceptability 
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6.11.8 Cross-cutting themes shaping patient acceptability 
Across all of how patients felt before treatment, on ending therapy, about GSH, 
being monitored and (where applicable) stepping up and CBT, three ‘cross-
cutting’ themes were derived from inferential analysis that appeared to influence 
the degree to which the intervention was acceptable to patients.  The themes 
were: ‘needing something more’, ‘you’re on your own’ and ‘self-efficacy’. 
‘Needing something more’ 
The theme ‘needing something more’ was often but not exclusively evident in 
patients’ response to starting therapy with low-intensity treatment.  It describes 
a sense that the treatment offered was somehow inadequate or unsuitable.  
Patients felt that high-intensity treatment was more appropriate either because 
of how unwell they felt (the severity of their symptoms) or because of specific 
problems that they wanted to address for which they believed low-intensity 
therapy would be less effective.  Features of high-intensity treatment were 
perceived to be more appropriate: greater support and the increased length of 
therapy. 
At first I didn’t think it was for me, I would have preferred to have had 
the other one because it was a case of I was possessive.  The 
problem that I thought I had was with being jealous and possessive, 
not trusting people or not trusting the person I was in the relationship 
with.  So I felt at the time it would have been better me going on to 
the second course straight away.  (Patient 058) 
Well it was a step in the right direction, literally, if I can use the words, 
‘step in the right direction.’  So I wanted to give it a go but I just felt it 
didn’t go into enough depth...  I wasn’t at a stage where I could 
actually help myself.  I would say you have to be quite well to be able 
to help yourself, and at that point I don’t think I was that well.  (Patient 
062) 
Maybe I felt I needed that face-to-face or whatever it was, someone 
external to really help me, that’s how vulnerable I was feeling at the 
time, that maybe I thought that wouldn’t quite be enough, just to be 
getting a few things through the post…   And I thought I would need 
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it, at the beginning, because I thought I was really down in the, you 
know, really down, and would need that extra ten weeks.  (Patient 
063) 
Once in low-intensity treatment, the same sentiment was expressed.  Patients 
felt that they were too poorly to read or do ‘homework’ or that they required 
more than ‘simplistic’ GSH. 
It does surprise me that anyone who’s really anxious and depressed 
would want to do all that homework.  (Patient 007) 
I was in too bad a state, I think, to just do something as simple as 
Guided Self Help at the time…  It really ended up not being for me.  I 
wasn’t in a state of mind to do homework every week.  (Patient 014) 
A more exceptional view was that high-intensity therapy was inadequate given 
specific needs.  One patient felt that it was unable to help with her long-standing 
issues around bereavement. 
‘You’re on your own’ 
The second cross-cutting theme, ‘you’re on your own’, describes patients’ 
feelings of not being well understood or supported throughout therapy but rather 
of being ‘on their own’ with their problems, distant to and perhaps different from 
others.  Again, this sentiment was typically evident in how patients described 
low-intensity treatment.  Patients did not relate to the Wellbeing Course material 
or felt that it was not relevant to them, disliked phone calls and were unhappy 
with the nature of the therapeutic support that was ‘confined’ to thirty minutes, 
aimed to get people through the course but only with reference to that material. 
I mean, no disrespect, I’ve forgotten his name, I think it was [therapist 
name] I used to speak to, I mean, he was doing his job, he wasn’t, as 
far as I understand, a therapist of any kind, if he was I apologise, but 
that’s the way I understood it at the time, but I did feel it was all a little 
bit like it was being read off a sheet.  (Patient 014) 
Other people may want to be more independent and do it all 
themselves - but I kind of felt I needed somebody alongside me.  
(Patient 062) 
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Feelings of being ‘on your own’ were also evident in how patients talked about 
the shortcomings of being monitored.  Perceived inaccuracies in scores or a 
lack of detailed assessment or feedback in areas that were important to patients 
contributed to a sense that the patient was not as well supported as they might 
be.   
‘Self-efficacy’ 
The third cross-cutting theme that appeared to shape the degree to which 
stepped care was acceptable to patients was ‘self-efficacy’.  This theme was 
associated with higher levels of acceptance of low-intensity therapy.  It 
describes how patients felt good about and wanted to be responsible for helping 
themselves.  The sentiment applied to how they felt about therapy but also their 
hopes for what could be achieved once treatment had finished. 
In treatment, patients wanted to learn how they could help themselves and put 
this into practice.  Scores on the PHQ-9 were used by patients to identify areas 
for individual improvement.  The theme also included examples of how patients 
took initiative in (or responsibility for) their own learning in the ways they 
described adapting, using and applying Wellbeing Course material to suit.  
Under this theme, therapeutic support was viewed as an aid to enable one’s 
own learning.  One patient for whom stepped care was highly acceptable 
exemplified how self-efficacy shaped her very positive views of GSH: 
I think having, having, knowing that I was giving, was given umm 
material, I was given tools I can use pretty much for the rest of my life 
with the help of someone else there but it’s me doing it.  I thought that 
was brilliant.  (Patient 027) 
Being able to see you’re making progress [on the PHQ-9] or you don’t 
so what do I have to change, I found that quite helpful for myself.  
(Patient 027) 
I know I can tackle it [my depression].  I might not be successful on 
my own but I know I can at least be starting to tackle if it comes back 
again, on my own.  And learning that by reading it - that was 
important… It was still helpful for me to see that I can make the start 
by myself and I can… use the methods I’ve been given.  (Patient 027) 
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Summary – cross-cutting themes 
Three cross-cutting themes were identified that appeared to shape the 
degree to which stepped care was acceptable to patients.  Negative views 
of low-intensity therapy were associated with a sense of ‘needing 
something more’ and ‘you’re on your own’.  Patients felt that low-intensity 
therapy was inappropriate because of how unwell they were or because of 
specific problems they wanted to address.  Feeling poorly supported and 
different to patients whose experiences were described in the Wellbeing 
Course material, contributed to a sense of isolation.  On the other hand, 
positive views of low-intensity treatment were associated with ‘self-efficacy’ 
– the degree to which patients assumed responsibility for getting better.  
Self-efficacy was evident in how people engaged with GSH and their 
thoughts and feelings about ending treatment. 
 
 
Section 6.12 overleaf 
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6.12 Acceptability of stepped care to therapists 
As well as patient data on acceptability, therapists’ views of stepped care were 
analysed.  Analysis indicated that therapists’ views of stepped care could be 
described by four themes: ‘low-intensity therapy’, ‘monitoring’, ‘stepping’, and 
‘high-intensity therapy’.  All of themes comprised several sub-themes.  Themes 
and sub-themes were descriptive and are listed in Box 5. 
Box 5. Key themes (numbered 1 to 4) and sub-themes describing the 
acceptability of stepped care to therapists 
1. Low-intensity therapy 
Appropriateness 
Anticipated benefits of treatment 
Wellbeing Course material 
Therapeutic support 
Timings 
Option to have CBT following GSH 
2. Monitoring 
The PHQ-9 
Using patients’ scores 
Monitoring depression but not anxiety 
3. Stepping 
Stepping criteria 
When to apply the criteria 
Discharging patients following low-intensity therapy 
Stepping up 
Changing therapists 
4. Cognitive Behaviour Therapy 
Connections between GSH and CBT 
Ending CBT 
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6.12.1 Theme one – low-intensity therapy 
The theme ‘low-intensity therapy’ describes therapists’ views and experiences 
of delivering GSH as part of the stepped care intervention.  The theme 
encompassed interviewees’ views of the appropriateness of GSH, the 
anticipated benefits of low-intensity treatment for patients, views of the 
Wellbeing Course material, the nature of the support therapists offered and the 
timings of therapy i.e. session duration (30 mins), pace (weekly) and total length 
(six weeks).  It also covered therapists’ description of how the option to have 
CBT influenced their delivery of GSH. 
Appropriateness 
At the beginning of the study, therapists’ views of the appropriateness of low-
intensity therapy were divided.  One therapist viewed GSH as appropriate for all 
patients.  Others (with no previous experience of stepped care) viewed GSH as 
inappropriate for people with severe depression as well as patients who 
presented with more complicated, multiple and entrenched difficulties. 
Guided Self Help… means they have to help themselves.  And I think 
part of my understanding of depression is it’s very difficult to be self-
disciplined.  So when you’re tasked with helping yourself essentially, I 
get nervous about how much pressure that puts on people.  These 
were some of my concerns when people showed up with severe, or 
what we’d call a severe level of depression.  (Therapist 01) 
However, views of the appropriateness of low-intensity treatment changed in 
response to positive experiences of GSH for patients with severe depression.  
Low-intensity therapy came to be seen as a useful first step for people with 
entrenched and complex problems although there remained a concern that 
GSH would be less effective for patients with severe depression particularly 
where they lacked motivation.  For the same reason, the effectiveness of high-
intensity CBT for severely depressed patients was also doubted. 
I think I was, yeah, surprisingly all right with it, really…  I started to 
see the Guided Self-Help, if there was a sense that a person was 
more complex or had more entrenched difficulties that it could be a 
useful first step in terms of psychoeducation.  (Therapist 03) 
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So I see motivation, you know, as kind of negatively or inversely 
correlated with depression scores - so the higher your depression 
score the lower your level of motivation.  And yes, that was a bit of a 
concern for me, going through the Guided Self-Help course.  But as I 
‘m saying that, I’m thinking about the type of commitment needed 
from a – within high intensity CBT and it is really quite intense as 
well… I think the dilemma’s the same, or presents itself in both low 
intensity and high intensity, people that need this stuff the most 
probably find it more difficult to do, unfortunately.  (Therapist 01) 
The therapists were also uncertain about the appropriateness of GSH for other 
groups of patients: who, from around the second session, did not understand or 
engage with the cognitive element of the Wellbeing Course; who said that they 
found the Course too basic; patients with a strong preference for CBT; those 
who did not respond week on week; a patient with bulimia; a patient with 
dyslexia and drinking problems who had entered a period of crisis whilst in 
treatment.   
Anticipated benefits of treatment 
Despite concerns regarding the appropriateness of GSH, therapists expected 
(at least some) patients to benefit from low-intensity therapy.  It was anticipated 
that gains might be limited by the nature of therapy.  There was a perception 
that the Wellbeing Course would expose people to a good number of evidence-
based strategies, techniques etc. for depression and anxiety; patients would 
learn something useful but would not benefit from everything covered.  
Compared with CBT, one therapist thought that patients would pick up fewer 
skills and techniques and that for this reason, GSH would bring about less 
symptom reduction.  However, in practise, the therapist who held this belief was 
surprised by the amount of improvement shown by GSH patients. 
I was expecting that [in GSH] people would get some sort of psycho-
education, that they would pick up some skills, but they may not pick 
up the spectrum of skills that were offered, that they might kind of find 
one or two tools that were of value to them.  But that over that 
duration, I probably hadn’t anticipated such symptom reduction.  
(Therapist 03) 
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Wellbeing Course material 
Therapists’ views of the Wellbeing Course material were largely positive: it was 
perceived as well written and researched; course material was judged suitable 
for a wide range of people with different abilities.  However, there was a 
concern that there was too much material, too much repetition therein and for 
some, the material may be patronising - one therapist wondered if it was 
targeted at a lower level than required.  
‘Do It Yourself Guides’ were rated as particularly helpful; the therapists thought 
that patients sometimes referred to them because they were a useful summary 
of material covered elsewhere and could save time reading.  There was a 
suggestion that more examples (stories, case studies) might be included to help 
people with interpersonal difficulties.  Of all of the course components, the 
therapists were most critical of the additional resources.  There was a 
perception that they were valued less and used less by patients; therapists 
found it difficult to incorporate the resources into sessions. 
What I didn’t get a huge sense of was that people made a huge 
amount or attached much value to the additional resources.  They 
came up a lot less.  I would sort of signpost people to them if there 
were particular issues so, for example, with sleep or – but I do 
wonder whether those additional resources could potentially be 
slightly surplus.  (Therapist 03) 
The therapists also queried the order in which the Wellbeing Course material 
was delivered.  There was a feeling that a different order may have been useful 
for some as would flexibility to adapt the order for individual patients although 
the therapist who made this suggestion wondered if changes would influence 
effectiveness and therefore undermine the basis on which the WB course was 
administered as a first treatment step.  
One other means to improve how the course material was delivered was 
proposed.  One of the therapists wondered if the content could be more 
explicitly linked to patients’ therapeutic goals. 
I’m wondering if a more explicit link with goals would have been 
helpful.  We didn’t routinely do this, it wasn’t required of us, but I 
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would actually ask people to tell me what they would like to achieve 
as a result of doing the course… having a little bit more of a 
motivational framework whereby you could actually link [GSH] to a 
value or an activity or to something they really wanted to do, get a 
better job, whatever, may have been helpful.  (Therapist 02) 
Therapeutic support 
Before the start of the trial, therapists’ held different views about conducting 
therapy by phone.  One therapist felt uncertain about supporting patients by 
phone; for another, phone calls presented no significant problem.  Views also 
changed.  Once STEPS was underway, the therapist who had been unsure 
about phone calls came to view them as sufficient for the type of support she 
was required to give. 
I guess I was kind of, by the time I came to actually start doing the 
therapy, so we’d had a kind of lead-up, we’d had quite a lot of 
preparation, so in that time I might have been ‘Mmn, I’m not sure 
about providing therapy by phone’.  By the time it actually came to 
start I was open, curious and willing, and quite happy to have 
different modes.  (Therapist 03) 
However, all of the therapists identified limitations of therapy by phone: the 
absence of non-verbal communication (although this was perceived to be less 
of a problem in low-intensity CBT than it might have been in other therapies) 
and the potential for a loss of rapport between the patient and their therapist.  
Likewise, all of the therapists described benefits: phone calls helped one 
therapist to distinguish her role as a GSH therapist from that of a CBT therapist; 
calls were perceived to fit patients’ lifestyles; outside of the current study, 
therapy could be delivered without a physical location (premises) for business. 
There’s something about it being over the phone that I think, 
conceptually, was quite helpful for me as I came predominantly from 
a CBT, face-to-face therapist, that made this distinction, so you aren’t 
a CBT therapist, you’re on the end of the phone, you’re a Guided 
Self-Helper.  So there was a conceptual thing that was quite helpful, 
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probably, for me around, ‘This is a different form of therapy’.  
(Therapist 03) 
A small number of factors were described that helped to facilitate calls and thus 
make them more acceptable to therapists: meeting with the patient face to face 
at session one; the development of a typical format for calls which meant that 
they were straightforward to manage; having a limited amount of information 
about the patient prior to therapy. 
With regard to the type of support that therapists were required to deliver by 
phone, this was perceived to be different to that required in high-intensity CBT.  
The ‘Guided Self Help-er’ did not have to gather and interpret information about 
the patient but was required to help people use and engage with their reading / 
reflection on that.  This had sometimes caused frustration.  A therapist who was 
used to delivering high-intensity therapy had sometimes wanted to cover 
cognitive techniques in more depth, find out more about people and personalise 
their treatment. 
I found it sometimes, for the more severe individuals, I found it a little 
bit restricting, frustrating, that I couldn’t find out a little bit more, 
couldn’t talk to them a little bit more about, you know, more in depth 
about some of these techniques that they were learning through 
Guided Self-Help, but also a little bit more about themselves and how 
to tailor the programme for them.  But I say that as a therapist.  
(Therapist 01) 
Timings 
Opinions on the length of sessions (thirty minutes) were divided.  Some 
therapists felt that 30 minutes was usually sufficient; others that it was too brief.  
Therapists mentioned several disadvantages of the brief contact with patients:  
it did not allow them to incorporate use of the additional resources; difficulties 
arose around the balance of time spent on how things had been in the last week 
and looking ahead; clock-watching may have affected therapeutic rapport. 
I think the difficulty was how much retro and how much forward 
planning, you know… how much time do you spend on what they did, 
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particularly if it was a difficulty or a barrier, versus, I’ve got to move 
you on to this week’s [material].  (Therapist 02) 
I was, in fact, clock watching for some clients, like ‘Oh God!  Errgh, 
it’s now 23 minutes and this woman’s telling me a story’.  So yes, I 
found it a little bit restricting on that end.  Not that there’s like a, you 
know, like something’s gonna go off and the thirty minutes mark, but 
obviously yeah, you wanna to keep to the thirty minutes, otherwise if 
you’re going on for forty five, an hour, it’s pretty high intensity.  
(Therapist 01) 
To help limit the impact of such difficulties, there was a feeling that it was very 
important to set out ground rules regarding the length and nature of sessions so 
that patients knew what to expect.  There was also a sense that once patients 
got used to the format of sessions, they were straightforward to manage.  
The pace of GSH (being sent course material each week) could also be 
challenging: when patients missed a session, had a difficult week, or found it 
difficult to do homework this put pressure on the therapist.   There was a belief 
that this was impossible to resolve without greater flexibility.  One therapist was 
initially negative about the total length of GSH; it was assumed that people 
would need more than six sessions.  However this view was ultimately replaced 
with a perception that six weeks was sufficient.  Advantages of the relatively 
short timeframe described by therapists were: six weeks gave people 
permission to get what they could out of GSH as well as a sense that they had 
done well if they could learn and apply something (rather than everything); the 
total length of GSH was used as an incentive to keep people in treatment when 
they did not engage in  therapy.   
The fear if you just don’t have that buy-in, you’re just not gonna try, 
we’re gonna send you the material, you’re just not gonna read it, 
you’re not gonna do the DIY guide etc.  So what I’ve attempted to do 
when somebody comes in and tells me that is keep encouraging 
them to try it out, just try it out and we can talk after six sessions or 
after a few sessions, we’ll talk and see what your other options are at 
that point.  (Therapist 01) 
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One of the therapists doubted the requirement for session six at least for some 
patients: it wasn’t modularised and was short; the purpose of session six was 
unclear; patients sometimes indicated that they felt ready to end therapy at 
session five. 
Option to have CBT following GSH 
The option to offer patients CBT at the end of unsuccessful GSH helped make 
stepped care more acceptable to therapists.  Therapists were reassured 
knowing CBT could follow unsuccessful GSH and they felt more comfortable 
about encouraging patients to stick with GSH.  One of the therapists said that it 
had made him more open-minded to delivering low intensity treatment and less 
risk-averse knowing CBT could follow; he could be more experimental with 
patients. 
It also gives you, as a therapist, a bit of a cushion, because ‘You 
know what’, you say to yourself, ‘If they don’t do very well on Guided 
Self-Help, yes, I can stand by the idea that there are other options 
and this is not something that I’m just saying.  This is actually true 
that there are other options and they can step up and that’s fine.’  So 
yeah, so it made me a little bit more – I guess it made me a little bit… 
less risk-averse I think about just trying out what Guided Self-Help 
has to offer.  (Therapist 01) 
Summary – low-intensity therapy 
Therapists’ views of low-intensity therapy were described by six sub-
themes: appropriateness, anticipated benefits of treatment, the Wellbeing 
Course material, therapeutic support, timings and the option for patients to 
have CBT following GSH. 
Two therapists initially considered low-intensity treatment inappropriate for 
some patients but came to see GSH as a useful first step for patients with 
complex and entrenched difficulties.  For patients with severe depression, 
there remained a concern that GSH would be less effective.  The 
Wellbeing Course material was regarded positively although there was a 
perception that the Additional Resources may not have been very useful 
and the therapists wondered if the order of material could be changed; one 
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of the therapists queried if course content could be more explicitly linked to 
patients’ therapeutic goals.  Phone calls presented no major problems.  
The length of GSH sessions (30 minutes) caused some difficulty but was 
felt to be manageable and there was a perception that the total number of 
sessions (six) helped motivate patients although one of the therapists 
doubted the need for session six for some patients.  The pace of sessions 
(one a week) could sometimes be challenging.   The option for CBT to 
follow GSH made low-intensity therapy more acceptable. 
6.12.2 Theme two – monitoring 
The theme of ‘monitoring’ describes therapists’ views and opinions of routinely 
assessing patients’ symptoms of depression.  It encompasses what therapists 
thought of the PHQ-9, how scores were used and a specific issue around 
monitoring anxiety. 
The PHQ-9 
Views of the PHQ-9 were divided.  Whilst all of the therapists were comfortable 
using a symptom checklist to monitor symptoms of depression, two of the 
interviewees were critical of the PHQ-9.  Criticisms included that it asks patients 
on how many days they have experienced a given symptom in the last fortnight 
but does not reflect the intensity of symptoms or capture for how long symptoms 
are experienced on a given day.  There was also uncertainty about how well the 
PHQ-9 would detect change over a seven day period.  In addition, the PHQ-9 
was thought to be subject to recall bias and insensitive to change because of a 
lack of range of scores.  Practical problems arose in that one therapist found the 
PHQ-9 repetitive and time-consuming to administer.  However, this difficulty 
was successfully addressed: the PHQ-9 was sent out with Wellbeing Course 
material for patients to complete prior to phone calls. 
I was getting some feedback from people about, you know - ‘I still do 
worry in the evening but it’s not four hours any more’.  The PHQ-9’s 
not going to pick that up because it’s still happening every day.  Or, 
yeah, ‘I still have times when I feel worthless, but not half as bad, not 
half as intensely as I used to.’  You won’t pick that up with a PHQ-9 
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‘cause it doesn’t measure intensity, it’s only frequency.   (Therapist 
03) 
Although it’s quick and dirty, right, you just – there are nine items…  I 
don’t think the range – there’s something about seeing your scores 
really drop versus drop one or two points.  (Therapist 01) 
Despite finding ways to administer the PHQ-9 that made it more acceptable, 
one of the interviewees was sufficiently concerned by its limitations to query 
whether it should be used to decide if patients required further treatment on end 
GSH.  Another therapist advised that he would have chosen an alternative 
checklist for monitoring. 
Using patients’ scores 
All of the interviewees were able to describe ways in which they had used 
patients’ scores.  Patients’ response to item nine was used to help detect risk of 
suicide and one of the therapists described how he used scores to signpost 
patients to the additional resources of the Wellbeing Course.  More generally, 
scores were used to mark patients’ progress, reinforce success and flag specific 
problems when symptoms got worse.  There was a perception that sharing 
scores with patients was very important. 
Monitoring depression but not anxiety 
Therapists thought that it may have been important to administer the GAD-7 
(Spitzer et al., 2006) as well as the PHQ-9.  Indeed, one therapist sometimes 
asked patients to complete both measures.  Suggested reasons for monitoring 
anxiety as well as depression were that patients presented with both disorders; 
the Wellbeing Course addressed anxiety and depression; information on anxiety 
and depression was useful to help determine the order in which GSH material 
should be delivered. 
Whilst we’re on the questionnaires, though, what I was aware of is 
the PHQ-9 clocks symptoms of depression and the Wellbeing course 
very much equally targets anxiety and depression, and I wonder 
whether actually it would be important to include the GAD, because I 
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had a lot of people presenting with concurrent anxiety that was a big 
as or as much of an issue as low mood.   (Therapist 03) 
Summary – monitoring 
All of the therapists were comfortable using a symptom checklist to monitor 
patients’ symptoms of depression and scores were used in therapy.  
However, two of the therapists were highly critical of the PHQ-9.  One 
therapist queried whether it should be used to determine patients’ next 
treatment step following GSH.  The therapists also felt that we should 
monitor symptoms of anxiety as well as depression. 
6.12.3 Theme three – stepping 
The theme ‘stepping’ covered what therapist thought of the stepping criteria, 
how they had applied the criteria in practice and feelings about ending patients’ 
treatment after GSH as well as stepping up patients to CBT.  The theme also 
encompassed views of changing patients’ therapist from low- to high-intensity 
treatment. 
Stepping criteria 
Views of the stepping criteria were largely positive albeit with scope to improve.  
Therapists thought that the criteria ‘got people in the right ballpark’ for discharge 
or step up and that they worked for the majority (around 70%) of patients.  
However, the criteria were perceived to work less well for one group: patients 
with low pre-treatment scores (less than 10) on the PHQ9 who were eligible for 
discharge at the end of GSH without having made much, if any, improvement.   
I did face a couple of people, as I was saying earlier that had come in 
with an initial very low score and didn’t really move too much.  And 
I’m like ‘OK, is this progress or is this -?  I’m thinking of a client, two 
clients, that showed up with a nine and she ended up with, like, a 
seven.  Which is a clear discharge, but in terms of treatment 
progress, how much is that?  (Therapist 01) 
Suggested ways to improve the criteria were: requiring patients with low pre-
treatment scores to reduce their scores further; amending the criteria for all to 
give priority to progress over cut-off; lowering the cut-off at which patients were 
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recommended for discharge from less than ten to less than five to reduce risk of 
relapse. 
One of the therapists noted that the stepping criteria did not offer guidance on 
when to step patients ‘out’ of treatment prior to the end of therapy e.g. where 
problems were uncovered that may be more appropriate to address in a 
different service or using a different treatment. 
It could well be that actually you see this and you think ‘Oh no, this 
needs, this definitely needs Dialectical Behaviour Therapy, there’s 
sort of personality disorder issues here, why are we doing the 
Beckian CBT model with them?  … Once they’re randomised it’s so 
hard to get them out, you know, you’d rather sort of like keep them in 
than get them out, then they’re in!  (Therapist 02) 
When to apply the criteria 
One of therapists had felt uncertain about when to apply the stepping criteria.  
He described how patients’ progress and the outcome of treatment were often 
discussed at the fifth session of GSH as part of relapse prevention planning.  
Indeed, for patients who responded to GSH, it was often clear by session five 
that they had made good progress and some patients said that they were ready 
to end therapy at this point.  In such circumstances, the need to wait to apply 
the stepping criteria was unclear.  On the other hand, the same therapist 
observed that it could sometimes be helpful to administer the stepping criteria at 
session six.   Patients’ PHQ-9 scores could sometimes increase between 
sessions five and six; the decision to step up became clearer. 
Discharging patients following low-intensity therapy 
In circumstances where the stepping criteria were applied and led to patients 
being discharged at the end of GSH, therapists generally felt comfortable with 
this decision.  They observed that patients themselves were often very positive 
about the progress they had made.  However, the therapists were unsure about 
ending treatment for patients who were at or just below cut-off at session six 
(and might, therefore, be at increased risk of relapse) and for patients with low 
pre-treatment scores.  The therapists wanted to offer (all) patients follow-up on 
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end GSH.  Offering follow-up was perceived as good practice for any therapy 
but a priority for GSH. 
It’s the same sort of thing that I was telling you about earlier, I think, 
for seventy five percent of the people that I saw it made perfect 
sense, whatever at the end of treatment, yeah, because they’re 
scoring at a three or a two.  For the other people, especially that one 
case that I’m thinking of, the woman showing up at a nine, 
discharging at a seven, then I go, ‘Oh, I don’t know’, yeah.   
(Therapist 01) 
No, I think, yeah, yes, I think it makes more sense at this stage of the 
game to, especially, if you only had resources to do it [offer follow-up)  
for one of those people I would do it for the Guided Self-Help people, 
because we don’t know much about it at this stage in terms of 
relapse.  (Therapist 01) 
Stepping up 
When patients did not respond to GSH, all of the therapists worried that this 
would negatively affect patients.  Interviewees were concerned that at least 
some patients would feel upset and as if they had failed.  The therapists 
themselves were also disappointed that GSH had not ‘worked’ although one 
therapist observed that he felt less responsible for patients’ ‘failure’ than he 
might do having delivered other therapies.   
There’s not so much pressure on the therapist to feel I really didn’t 
work 100% on this because you’re reactive as a coach… if you’ve got 
someone who you’re coaching and, for a football team, but they really 
aren’t a very fast runner, they’re not going to make the team, but you 
don’t feel personally responsible for the fact that they don’t run very 
fast!  So that lessens the pressure on the therapist or the practitioner, 
to actually in some way take that responsibility, burden, so much, you 
know, it’s either, well, the course wasn’t right for them.  (Therapist 02) 
Therapists’ main concern with stepping up patients was with regard to how they 
might respond to CBT.  There was a suggestion that some patients who 
stepped up may approach CBT with unhelpful preconceptions.  They may not 
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see the onus being on them to actively engage in treatment or they may not 
believe in particular skills, for example.  Patients who did not engage or do well 
in GSH were of particular concern given that CBT involved a commitment to 
‘more of the same’ offered more intensively.    There was also an assumption 
that patients who did not engage in GSH might include those with severe 
symptoms of depression who were vulnerable to a lack of motivation and would 
therefore be likely to fail in CBT just as they had failed to engage in GSH.  The 
option to provide an alternative to CBT was considered. 
Yeah, so if they make a big improvement, but not good enough, 
within a low intensity treatment may be this person can actually 
benefit from high intensity, because it’s just giving them that extra 
push.  Whereas if somebody is just, you know, kind of hanging 
around and moderately severe, no change throughout the six weeks, 
they’re doing the work, still no change, I don’t know, I don’t know if 
high intensity is the way to go.  (Therapist 02) 
Often I would say things like, ‘What you’ll find is that it’s exactly – 
you’ll be doing the same sort of Cognitive Behaviour Therapy format, 
it will be much more intense, it will be more in depth, you’ll have to 
turn up more regularly, there’ll be a lot of homework.’  And sometimes 
I would be saying that for them to make another determination 
whether they wanted it, because if they hadn’t done homework very 
well doing this, what was the point?  (Therapist 02) 
Changing therapists 
Changing patients’ therapist from GSH to CBT was perceived to work well.  
Therapists identified a number of advantages including that it brought a fresh 
pair of eyes to someone’s problems, patients could make a fresh start, the CBT 
therapist was not affected by how much the patient did or did not do in GSH, 
staying with the same therapist would still have required a more detailed patient 
assessment at the start of CBT which may have felt artificial.  A disadvantage of 
changing therapists was seen as the potential for a loss of rapport. 
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Summary – stepping 
Although the therapists thought that the stepping criteria worked for the majority 
of patients, the clinical algorithm was criticised for patients with low pre-
treatment scores who made little progress during therapy.  The therapists also 
suggested that the cut-off score at which patients were recommended for 
discharge might be lowered to less than five to reduce risk of relapse.  There 
was some uncertainty about when to administer the criteria (session five or six) 
and one of the therapists wanted more guidance on when to end the treatment 
of patients who may be better served by an alternative.  The therapists also 
wanted to offer a follow-up appointment to all patients who were discharged at 
the end of GSH. Therapists were concerned that some patients who progressed 
to CBT may not respond because they did not engage with a low-intensity form 
of the same treatment.  Changing therapists from low- to high-intensity therapy 
was seen as positive. 
6.12.4 Theme four – Cognitive Behaviour Therapy 
The theme ‘Cognitive Behaviour Therapy’ described therapists’ views and 
experiences of delivering CBT as part of stepped care.  It comprised what 
therapists thought of the connection between GSH and CBT and how they felt 
about patients ending CBT. 
Connections between GSH and CBT 
In terms of the link between GSH and CBT, therapists felt that neither they nor 
their patients connected the two treatments.  Therapists described how patients 
saw GSH and CBT as separate and different.  There was a view that how 
STEPS was explained to patients contributed to the lack of connection made 
between low- and high-intensity therapies.   
Patients that are stepping up, it was a little bit strange at some points 
because, although you think that you can just, you know, refer back 
to course material because they just kind of know this stuff from the 
low intensity, I think there’s a bit of a disconnect between this type of 
treatment and the other type of treatment, so it’s not as seamless as 
you think it might be.  It’s a completely different type of treatment I 
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think, as it is, you know, it’s not advertised to be – more of the same.  
(Therapist 01) 
Similarly, therapists’ own delivery of CBT was not much, if at all, influenced by 
patients’ prior experience of low-intensity therapy.  One therapist felt that she 
had started CBT from scratch; another described asking patients at the start of 
high-intensity treatment what they had found most engaging in GSH for an idea 
of what he needed to work on in CBT and how patients might approach it.  He 
did not, however, refer back to patients’ GSH relapse prevention plan or to the 
content of the Wellbeing Course.  All of the therapists were interested in the 
potential to make more and better use of patients’ prior experience of GSH. 
Ending CBT 
What to do for patients who made little progress in low- and high-intensity 
treatment evoked different opinions.  Where such patients consistently failed to 
do much work between sessions, one of the therapists was not inclined to keep 
them in treatment.  Based on a Beckian approach to CBT, he had understood 
eight sessions to constitute an adequate dose of therapy after which other 
options should be considered.   
I’m not sure there is much sense in keeping them in, but under the 
protocol conditions we actually felt that we had to… Particularly if 
supervision is saying, you know, you’ve got to try and get them down 
to a lower score on the symptom checklist, you’ll keep going.  And 
that was one of my confusions.  (Therapist 02) 
On the other hand, another therapist felt uncomfortable about discharging 
patients who had made little progress in CBT yet met criteria for discharge. As 
for GSH, it was suggested that follow up after CBT would be useful though not 
essential; one therapist felt that booster sessions were sufficient. 
Summary – Cognitive Behaviour Therapy 
Therapists felt that neither they nor their patients connected Guided Self-Help 
and CBT and all of the therapists wanted to make more use of patients’ prior 
experience of GSH in CBT.  Views of what to do for patients who made little 
progress in CBT varied.  One therapist felt that it may have been appropriate to 
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discharge them soon after session eight; another therapist did not feel 
comfortable about discharging such patients who met criteria for ending CBT. 
 
6.12.5 A summary of the acceptability of stepped care to therapists 
Therapists’ views of low-intensity therapy, monitoring, stepping and the delivery 
of high-intensity treatment in stepped care combine to determine the 
acceptability of the intervention to therapists.  Across all themes, the therapists 
were supportive but identified ways in which stepped care was less acceptable 
and could be improved; views and opinions are summarised in Table 31. 
 
Table 31 overleaf 
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Table 31. Summary – the acceptability of stepped care to therapists 
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6.13 The relationship between acceptability and attendance 
The results of integrated mixed methods analysis exploring how patients’ views 
of stepped care might help explain variability in the number of treatment 
sessions they attend are described in sections 6.13.1 to 6.13.3.  The analyses 
provided information on how treatment adherence data varied among patients 
for whom stepped care was more or less acceptable; the relationship between 
patients’ views of low- and high-intensity treatment and the number of GSH and 
CBT sessions they attended; how the cross-cutting themes that were identified 
from the qualitative analysis and that appeared to shape people’s views of 
stepped related to attendance. 
6.13.1 Attendance and opinion of stepped care 
Table 32 is a joint typologies / statistics display of the number of treatment 
sessions attended by patients for whom stepped care was more and less 
acceptable.  Data is organised by typologies of the degree to which stepped 
care was acceptable: the number of sessions attended by patients for whom 
stepped care was completely unacceptable are presented at the top of the 
table; the number of sessions attended by patients for whom stepped care was 
highly acceptable appear at the bottom.  Data from patients who described 
stepped care as less acceptable are presented in rows of a darker shade.  
Treatment outcome data are included to help appreciate the extent to which 
views of stepped care and outcomes are confounded but are not referred to in 
the following interpretation of how acceptability and attendance were related. 
The results of this analysis indicate that some patients for whom stepped care 
was highly unacceptable attended little or no treatment [ID 007 & 023].  Their 
reasons for declining or dropping out of therapy were treatment-related [007] or 
treatment-related in part [023].  However, other patients for whom stepped care 
was highly unacceptable also completed low-intensity treatment [047, 058] and, 
in one case [047], attended more than the minimum number of eight CBT 
sessions recommended by the National Institute for Health and Care Excellence 
(National Institute for Health and Care Excellence, 2009b). 
Some patients for whom stepped care was more acceptable attended a 
reasonable or very high number of therapy sessions.  This was true for a patient 
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who had mixed feelings about stepped care [028], another patient who enjoyed 
GSH but not CBT [051], patients who did not like GSH but rated CBT positively 
[014, 062] and patients who were initially cautious about GSH but ultimately 
enjoyed it [039, 063].   One other patient for whom stepped care was highly 
acceptable attended fewer than eight CBT sessions following a complete 
course of GSH [027]; the patient’s decision to drop out of CBT was unrelated to 
her views of treatment. 
 
Table 32 overleaf 
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Table 32. Joint typologies / statistics display: treatment adherence data for patients for whom stepped care is more and less acceptable 
 
Notes: rows are coloured coded by the degree to which stepped care was acceptable to patients – darker shades indicate that stepped care was less acceptable (see Figure 11); 
1
 ‘Change in PHQ-9’ is the 
difference between patients’ pre- and post-treatment PHQ-9 scores; 
2
 ‘50% improvement’ refers to the reduction in depressive symptoms pre- to post-treatment – ‘Yes’ indicates that scores fell  by 50% or 
more; 
3
 NA = not applicable; 
4
 Patient 023 believed that he could return to IAPT for high intensity therapy alone. 
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6.13.2 Attendance and opinion of low- and high-intensity therapy 
The relationship between what patients thought of low- and high-intensity 
therapy and levels of attendance at each is apparent from the case-oriented 
display in Table 33.  Mini-summaries of what patients thought of GSH and CBT 
are displayed alongside a plot of the number of high- and low-intensity sessions 
attended by each patient.  The upper half of the table displays data for patients 
who had GSH alone; the lower half of the table displays data for patients who 
had GSH and CBT.  Patient-related outcome data are included but are not 
referred to in the following interpretation. 
In terms of the relationship between views of low-intensity therapy and 
attendance at GSH, some patients viewed GSH negatively.  Of those, three 
patients did not attend or attended very few sessions [ID 007, 023, 031; others 
completed five or six therapy sessions [058, 014, 047, 062].  There was no 
evidence that the negative views of GSH held by patients who attended more 
vs. less treatment were markedly different.  For example, patients who disliked 
GSH and attended more but also less therapy were unhappy with phone calls 
and the Wellbeing Course. 
With respect to attendance at high-intensity therapy and views of CBT, patients 
who had a positive [014, 062], negative [051, 047] and mixed [028] opinion of 
high-intensity treatment attended more than the minimum number of sessions 
recommended by NICE (National Institute for Health and Care Excellence, 
2009b).  Moreover, some patients with a negative or mixed view [051, 028, 047] 
attended a higher number of CBT sessions than other patients who rated high-
intensity therapy positively [027, 014].  One patient [047] attended 15 CBT 
sessions despite a negative view of both low- and high-intensity treatment.  
Following unsuccessful GSH, this person had been excited by the prospect of 
CBT.  By comparison, other patients who had a fairly positive view of GSH but 
disliked CBT [051, 028] attended a smaller number of CBT sessions; they had 
not been excited at the prospect of CBT. 
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Table 33. Case-oriented display of number of GSH & CBT therapy sessions attended and patient experience of each treatment 
GSH alone patients 
 
Notes: 
1
 ‘Change in PHQ-9’ is the difference between patients’ pre- and post-treatment PHQ-9 scores; 
2
 ‘50% improvement’ refers to the reduction in depressive symptoms pre- to post-treatment – ‘Yes’ 
indicates that scores fell  by 50% or more; 
3
 NA = not applicable 
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Patients who had GSH and CBT 
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6.13.3 Cross-cutting themes and attendance 
Table 34 is a joint categories / themes display of views of stepped care among 
groups of patients who attended more vs. less therapy.  Views are incorporated 
with the cross-cutting themes identified from qualitative analysis highlighted 
(see Box 6 below). 
 
Box 6. Colour coding of cross-cutting themes in the joint categories / theme 
display 
Patient demonstrates ‘self-efficacy’ 
Views of therapy convey a sense of being ‘on your own’ 
Patient describes therapy in terms of ‘needing something 
more’ 
 
The display illustrates that patients in all but the lowest category of attendance 
(category A) described ways of thinking about and approaching stepped care 
that demonstrated ‘self-efficacy’.  None of the patients in the lowest category of 
attendance [ID 007, 023, 031] spoke about GSH in a way to suggest that 
feelings of being responsible for getting better, wanting to help themselves and 
to be in control of how to do that were uppermost in shaping their views of 
therapy; responses to GSH were dominated by feeling ‘on your own’ and (to a 
lesser extent) ‘needing something more’.  All of the patients in the lowest 
attendance category were offered GSH alone and had either declined any 
treatment or attended one session. 
Among patients who completed five or six sessions of GSH (classified in 
categories B to E) some described ways of thinking about and engaging in 
stepped care that demonstrated ‘self-efficacy’ [027, 051, 028, 058, 063, 062].  
Others did not [014, 047, 039] suggesting that ‘self-efficacy’ may have helped to 
retain some patients in low-intensity treatment but was not necessary for 
patients to complete all or the majority of GSH sessions. 
With respect to high-intensity CBT, two patients with a positive view of 
treatment attended nine [014] and twenty-one [062] sessions.  The views of 
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patient 062 but not patient 014 demonstrated a degree of ‘self-efficacy’.  Two 
patients with a negative view of treatment attended ten [051] and fifteen [047] 
sessions.  A degree of ‘self-efficacy’ was evident in the approach to treatment 
by patient 051 but not patient 047.  For patients with a positive view of CBT, 
‘self-efficacy’ was associated with increased attendance; for patients with a 
negative view, ‘self-efficacy’ was associated with decreased attendance. 
 
 
Table 34 overleaf 
 
.
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Table 34. Treatment adherence data and views of stepped care with cross-cutting themes highlighted arrayed in categories of 
attendance 
Category ID Treatment % sessions 
attended 
1
 
n 
GSH 
n 
CBT 
The acceptability of stepped care View of GSH / CBT 
A 
 
0-20% of 
sessions 
attended 
007 
023 
031 
GSH alone 
GSH alone 
GSH alone 
 
0 
0 
16.6 
 
0 
0 
1 
 
NA
2
  
NA 
NA 
Unacceptable.  I did not want GSH.  I disliked the idea of homework and phone calls.  I did not relate to 
the WB course material which was inappropriate for someone my age.  I was too poorly to read.  I found 
being monitored unacceptable – I cannot put my emotions into boxes.  (007) 
Unacceptable.  I thought I would need CBT but was prepared to try GSH.  I did not relate to the WB course 
material (it was too ‘generic’ and was not relevant to me).  The idea of therapy by phone was unappealing 
– it felt impersonal.  I knew I could get CBT elsewhere. (023) 
Largely unacceptable. I was put off GSH by the idea of homework but prepared to give it a go.  Although I 
liked the WB course content I found it difficult to read and use material.  My mum became seriously ill.  It 
did not feel relevant to measure my symptoms of depression.  My therapist did not understand.  I 
dropped out due to my mum and work commitments. (031)  
Negative GSH 
 
 
Negative GSH 
 
 
Negative GSH 
B 
 
21-45% 
of 
sessions 
attended 
027 GSH + CBT 
 
 
 
42.3 6 5 Highly acceptable.  I was pleased to be offered GSH – I wanted to help myself and I liked the idea that I 
could help myself.  The WB course material was good and I read around sessions in a way to suit me.  
Although I was initially unsure about phone calls they felt OK.  I had good therapeutic support – my 
therapist helped me to use material. I used my PHQ9 scores constructively.  When I did not get better 
after GSH, I felt a failure and did not want CBT but my family and friends helped me see it as an 
opportunity.  I enjoyed CBT.  Changing therapists was good.  I finished therapy when I moved location.  On 
ending treatment, I was really pleased to have the GSH material and felt confident that I could begin to 
help myself. (027)   
Positive GSH & CBT 
C 
 
46-65% 
of 
sessions 
attended 
014 
051 
GSH + CBT 
GSH + CBT 
 
 
53.8 
61.5 
5 
6 
9 
10 
Somewhat acceptable.  I was pleased to be offered GSH but did not really like it.  The WB course was 
inadequate given what I needed; I was too poorly to read at home.  Phone calls did not feel very personal 
and I was not well supported by my therapist.  I did not mind my symptoms of depression being 
monitored although I was critical of the PHQ9.  When I did not get better after GSH, I felt I had failed 
STEPS.  I was still keen to have CBT and I found that therapy in person was good; I had a good relationship 
with my therapist.  What I learnt in CBT helped. (014) 
Somewhat acceptable.  I was pleased to be offered GSH.  I mostly liked the WB course.  I read material in 
a way that suited me.  I did not like phone calls but tolerated them.  I had good therapeutic support.  
Sessions were the right length.  It was helpful to monitor my depressive symptoms.  When I did not get 
better after GSH, I was not ready to stop.  I was happy to change therapists but I did not have a good 
relationship with the person who took over.  I ‘didn’t get’ CBT and was uncertain about its benefits.  On 
end treatment, I refer to the WB course material. (051) 
Negative GSH 
Positive CBT 
 
 
 
 
Positive GSH 
Negative CBT 
 
Notes: 
1 
% sessions attended = percentage of maximum number of sessions available (6 in GSH, 20 in CBT, 26 for patients who stepped up), attended; 
2
 NA = not applicable
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Category ID Treatment % sessions 
attended 
n 
GSH 
n 
CBT 
The acceptability of stepped care View of GSH / 
CBT 
D 
 
66-85% 
of 
sessions 
attended 
028 
047 
GSH + CBT 
GSH + CBT 
 
 
76.9 
80.8 
6 
6 
14 
15 
Somewhat acceptable.  I was a little cautious about starting therapy with GSH but willing to try.  I didn’t relate to the 
WB course material  – it was patronising.  All the same, I read around sessions in a way to suit me.  I initially disliked 
phone calls (I thought face to face would be more appropriate) but found them OK.  I had good therapeutic support.  
My therapist helped me to use the material.  I understood why my symptoms of depression were monitored and I 
used my scores constructively although I was critical of the PHQ9.  When I did not get better after GSH, I was fed up 
and frustrated.  I felt annoyed and dubious about going on to CBT although I was happy to change therapists.  I found 
that I preferred therapy in person.  Elements of CBT were useful but it didn’t offer me anything new that could help 
with my long standing bereavement issues.  On ending therapy, I felt better equipped to deal with the day to day.  
(028) 
Largely unacceptable.  I had no opinion about starting therapy with GSH but found that I did not relate to the WB 
course material (it was inadequate and patronising).  I tolerated phone calls but disliked them.  Sessions were too 
short.  I was unhappy with my therapist.  I responded constructively to my depressive symptoms being measured 
although I was critical of the PHQ9.  When I did not respond to GSH, I worried that there was something wrong with 
me.  It compounded my loss of faith in professionals.  Nonetheless I was positive about going on to CBT.  I found that I 
preferred therapy face to face but I did not feel well supported.  I did not ‘get it’ – CBT did not offer me anything new 
/ useful and made me feel bad about myself. (047)  
Mixed GSH & 
CBT 
 
 
 
 
 
 
 
 
Negative GSH 
& CBT 
E 
 
86-100% 
of 
sessions 
attended 
039 
058 
063 
062 
GSH alone 
GSH alone 
GSH alone 
GSH + CBT 
100 
100 
100 
100 
6 
6 
6 
6 
NA 
NA 
NA 
21 
Largely acceptable.  I wasn’t sure that GSH would be enough for me (I felt that I needed to off load) but I found I liked 
it.  Some elements of the course material were particularly useful.  I read around sessions and benefited from that.  
Sessions were a bit short.  I understood why my depressive symptoms were monitored and responded well to my 
PHQ9 scores although I was critical of that measure.  On ending GSH, I reflect on the WB course material.  I have 
residual difficulties but GSH helped me with specific problems. (039) 
Largely unacceptable.  I was disappointed and irritated to be offered GSH (I wanted face to face therapy and thought 
it would help me more with my problems) but I liked the WB course material. I found it difficult to read.  I used 
material in a way to suit me.  Phone calls were very problematic; they weren’t enough for me in my state.  Sessions 
were too short.  I did not feel well supported.  The option of CBT kept me in treatment.  I had difficulties being 
completely honest when filling in the PHQ9 but I responded well to my scores.  On end treatment, I go back to course 
material. (058) 
Largely acceptable.  I was disappointed to be offered GSH (I thought I would need face to face therapy and was 
unsure about relying on myself) but found that I liked the WB course material.  I read around sessions in a way that 
suited me and I was motivated to apply what I learnt.  Phone calls were OK.  I sometimes wanted a bit more flexibility 
to focus on my difficulties.  Sessions were sometimes too short although six in total was fine.  I was concerned that 
symptoms of anxiety were not monitored alongside depression but I used my PHQ9 scores constructively.  I made 
definite gains as a result of GSH. (063) 
Somewhat acceptable.  I did not particularly want GSH; I thought I needed CBT.  I did not relate to the WB course 
material and had difficulty reading.  Phone calls were convenient and OK.  Sessions were too short to allow me to 
open up.  I wanted more therapeutic support.  I was critical of the PHQ9 but responded well to my scores.  I saw GSH 
as a means to access CBT.  I felt matter of fact about not getting better and looked forward to CBT.  Therapy in person 
was good and I was well supported.  Sessions were sometimes too short.  Some elements of CBT were particularly 
helpful and on end treatment I felt that I had tools to retrain my brain.  I would benefit from ongoing support e.g. a 
personal coach for 2 years. (62)  
Positive GSH 
 
 
 
 
Negative GSH 
 
 
 
 
 
Positive GSH 
 
 
 
 
 
Negative GSH 
Positive CBT 
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6.13.4 A summary of the relationship between acceptability and 
attendance 
Two types of mixed methods analysis were used to explore the relationship 
between what patients thought of stepped care and therapeutic attendance: a 
joint display (of typologies / statistics and categories / themes) and a case-
oriented display.  Key results were that among patients for whom stepped care 
was highly unacceptable, some attended very few or no therapy sessions 
whereas others completed treatment.  Likewise, in terms of low-intensity 
therapy, among patients with a negative view of GSH, some declined or 
dropped out of therapy; others completed treatment.  For patients who declined 
GSH or dropped out early there was no sense of self-efficacy in how they talked 
about stepped care. Once in high-intensity treatment, patients tended to remain 
in therapy regardless of their views of CBT; one patient remained in treatment 
despite a negative view of both GSH and CBT. For patients with a positive view 
of CBT, self-efficacy was associated with increased therapeutic attendance.  
However, for patients with a negative view, self-efficacy was associated with 
decreased attendance.  
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6.14 A summary of STEPS feasibility study results 
The STEPS study was designed to address five research questions: 
(1) What is the quantifiable performance of recruitment and retention methods 
which may be used in a fully powered trial?; (2) What proportion of people who 
receive stepped care step up from low-intensity to high-intensity treatment or 
are discharged following low-intensity psychological therapy?; (3) What is the 
variability in patient outcomes following stepped care or intensive psychological 
therapy alone and how do they correlate with patients’ baseline scores?; (4) To 
what extent are potential recruitment methods considered appropriate by trial 
participants (patients), study therapists and other health professionals and 
administrators and how do people’s views combine with numeric data on the 
performance of trial recruitment methods?; (5) How acceptable is stepped care 
to patients and therapists and how do patients’ views explain variability in the 
number of treatment sessions they attend? 
Study results were described in Parts I to III of this chapter.  Results are 
summarised in sections 6.14.1 to 6.14.5 with respect to each research question.   
Implications of the results are discussed in full in Chapter Seven, sections 7.14 
and 7.15. 
6.14.1 The quantifiable performance of recruitment and retention methods 
(Q1) 
Quantitative data indicated that trial recruitment methods and procedures 
performed reasonably well.  The total number of participants was within the 
target range and 2.9% of patients approached were recruited.  Moreover, the 
performance of retention procedures was strong.  Based on the 95% confidence 
intervals for the recruitment and retention rates, it is estimated that in a future 
trial, the randomisation rate would be between 2.2% and 3.5% and the retention 
rate would be between 83.8% and 97.8%.  In terms of a future trial, it may also 
be possible to obtain a higher participation rate: pilot trial recruitment was 
negatively affected by finite therapist capacity and a higher recruitment rate may 
be achieved by increasing the limit of five working days from when patients 
return a permission form to complete recruitment procedures.   
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6.14.2 The proportion of stepped care patients who were discharged vs. 
stepped up (Q2) 
Quantitative data on patient progress through stepped care was collected to 
help estimate the clinic resource required in a future trial.  A third (11/33; 33.3%) 
of patients received high-intensity CBT; the remainder (22/33, 66.7%) were 
discharged from treatment following GSH.  Based on the 95% confidence 
interval for the percentage of patients who received CBT, it can be inferred that 
in a fully-powered evaluation the percentage of patients who would step up from 
low- to high-intensity treatment would be between 17.9% and 51.8%. 
6.14.3 Variability in patient outcomes and how they correlate with baseline 
scores (Q3) 
The standard deviation of patient scores on the BDI-I (the primary outcome in a 
future trial) and other continuous outcomes was calculated to inform the sample 
size calculation for a fully-powered evaluation of stepped care vs. high-intensity 
CBT alone.  An estimate of the correlation between patients’ baseline and six-
month follow-up scores was made to allow the sample size calculation to be 
refined to take account of the added precision gained from adjusting for 
baseline scores when comparing treatment outcomes between the intervention 
and control groups. 
At six months’ follow-up, the pooled standard deviation on the BDI-I was 10.0 
and the standard deviation on the BDI-I for the stepped care and CBT alone 
groups was 9.6 and 10.5, respectively.  The magnitude of the correlation 
(calculated using Spearman’s Rho) between patients’ baseline and follow-up 
scores on the BDI-I was 0.49 for all patients, 0.44 in the stepped care group and 
0.52 in the CBT alone group. 
6.14.4 The appropriateness of recruitment methods and procedures (Q4) 
Data on the appropriateness of recruitment was collected from patients, 
therapists and IAPT staff.  Mixed methods analysis was subsequently used to 
compare qualitative and quantitative recruitment data and point to procedures 
that could remain unchanged or might be modified in a future trial. 
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The appropriateness of recruitment to patients and therapists 
Qualitative analysis suggested that recruitment methods and procedures were 
mostly appropriate to patients and therapists.  Although some patients were 
critical of STEPS study information and had found the prospect of attending a 
baseline interview after their IAPT assessment difficult, analysis did not reveal 
any major problem with recruitment.   On the other hand, there were a small 
number of aspects that were considered less appropriate by patients and / or 
therapists that could be modified in a future trial.  Of those, mixed methods 
analysis underlined that it may be advantageous to respond to patient concerns 
about the prospect of a baseline interview following an IAPT assessment.  
Mixed methods analysis also indicated that allowing more than five days from 
when patients return a permission form to complete recruitment procedures 
could increase the participation rate but may be unpopular with patients and 
therapists (as well as IAPT staff). 
The appropriateness of recruitment to IAPT personnel 
Although IAPT personnel were supportive of research in general and STEPS in 
particular, recruitment caused several difficulties for staff and was therefore 
considered somewhat inappropriate.  Difficulties arose out of a concern that 
some methods and procedures could harm patients whilst others had been 
practically challenging to implement.  
With respect to the potential to harm patients, two issues were particularly 
troubling: the possibility that patients who were interested in STEPS but 
returned to IAPT might drop out of treatment and passing on permission forms 
for patients who may be unsuitable or ineligible to take part.  The need to 
address the concern of IAPT staff regarding patients who return to IAPT was 
underlined by the results of the mixed methods analysis.  In terms of 
procedures that were practically challenging to implement, several issues were 
identified around handling patient permission forms.  Mixed methods analysis 
highlighted that it may be advantageous to provide more support around asking 
patients for their form as this may improve the recruitment rate in a future trial.   
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6.14.5 The acceptability of stepped care and its relationship with 
attendance (Q5) 
A large amount of qualitative data was obtained on the acceptability of the 
stepped care intervention to patients and therapists.  In addition, mixed 
methods analysis was conducted to explore the relationship between the 
acceptability of the intervention to patients and their attendance at therapy. 
The acceptability of stepped care to patients 
Qualitative analysis of the patient data revealed that there was no single 
experience or pattern of experiences of stepped care from which it was possible 
to define acceptability.  Stepped care was both highly unacceptable and 
acceptable to patients with a wide range of opinion in between.  Consistent with 
this interpretation, patients had different views of the high- and low-intensity 
components and there was no single experience in response to unsuccessful 
GSH.  It was not possible to identify ways in which the stepped care clinical 
protocol might be modified that would reliably improve patient experience. 
The acceptability of stepped care to therapists 
Despite reservations about the appropriateness of the intervention for some 
patients, therapists found the stepped care clinical protocol broadly acceptable.  
Interviewees were largely happy with the Wellbeing Course material, therapy by 
phone and the timings of GSH; the use of a symptom checklist for monitoring 
was also acceptable and the stepping criteria were perceived to have worked 
for most patients.  Changing patients’ therapist from low- to high-intensity 
therapy was viewed positively. 
Nonetheless therapist experience highlighted several ways in which each core 
component of the intervention (low-intensity therapy, high-intensity therapy, 
monitoring and stepping) might be modified.   Potential modifications to low-
intensity therapy include the option to drop session six of GSH, change the 
order in which Wellbeing Course material was delivered and reconsider the use 
of Additional Resources.  In terms of monitoring, the use of the PHQ-9 was 
heavily criticised and it may be advantageous to monitor anxiety alongside 
depression.  The therapists also wondered if the stepping criteria might be 
modified for patients who met criteria for discharge but had made relatively little 
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progress and to reduce risk of relapse.  All of the therapists wanted to increase 
the use of patient experience of GSH in CBT.  
The relationship between acceptability and attendance 
Mixed methods analysis of patient data found that there was no simple 
relationship between the acceptability of stepped care and therapeutic 
attendance.  However, self-efficacy (feeling good about and wanting to be 
responsible for getting better) had a role in patient engagement.   Groups of 
patients were identified for whom low-intensity therapy was less acceptable that 
declined or dropped out of therapy vs. remained in treatment.  Self-efficacy was 
also related to patient commitment to high-intensity therapy.  
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CHAPTER 7.  DISCUSSION AND CONCLUSIONS 
This thesis aimed to further the development and evaluation of stepped care by 
conducting a systematic review (Chapter Four) and mixed methods feasibility 
study (Chapters Five and Six) to prepare for a fully-powered RCT of stepped 
care vs. high-intensity psychological therapy alone for the treatment of 
depression in adults.   
Specific objectives of the systematic review were to: (1) determine whether 
existing evidence is sufficient to conclude that stepped care is equivalent to long 
term, intensive psychological therapy for all; (2) investigate heterogeneity in trial 
findings by exploring aspects of study design and elements of the intervention 
that may be associated with more or less effect.  Specific objectives of the 
feasibility study were to: (1) gather enough information on recruitment, 
retention, step ups and treatment effects to design a fully-powered clinical trial 
or to determine that such a trial is not feasible; (2) explore patients’ and 
therapists’ views of stepped care and the ways in which patients’ views relate to 
how much they engage in therapy to inform a stepped care clinical protocol for 
a proposed randomised trial.  There were five related feasibility study research 
questions (Chapter Five, section 5.1). 
In line with the underpinning methodological framework for this programme of 
work (Chapter Three) and to conclude, findings from both studies are now 
discussed in a single chapter.  The general discussion is organised as follows.  
First the reader is oriented to the purpose of the PhD programme of research, 
what was done and found (section 7.1). Study results are then described with 
respect to the aim and objectives of the systematic review and each of the five 
feasibility study research questions (section 7.2).  The strengths and limitations 
of the systematic review are considered in section 7.3, followed by clinical 
implications (section 7.4) and directions for future research (section 7.5).  The 
strengths and limitations of STEPS feasibility study, directions for future 
research and clinical implications are subsequently described in sections 7.6 to 
7.8.  The chapter ends with a brief description of the key conclusions that have 
arisen from my doctoral programme of work (section 7.9). 
Sections 7.3 to 7.5 incorporate material that has previously been published in 
the report of the original systematic review (van Straten et al., 2014). 
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7.1 Overview of thesis 
This thesis assessed evidence on the effectiveness of stepped care for the 
treatment of depression in adults.  Relative to care as usual, stepped care was 
found to improve depression in the short and medium term however there was 
insufficient evidence to establish whether stepped care is equivalent to high-
intensity psychotherapy for all.  This led to a mixed methods feasibility study in 
preparation for a fully-powered RCT of stepped care vs. high-intensity 
psychological therapy alone.  Data were collected to assess the feasibility and 
appropriateness of pilot trial recruitment and retention, the acceptability of the 
stepped care intervention and how patient experience related to attendance.  
Data were also collected to estimate the sample size and clinic resource 
needed in a future trial. 
The performance of retention procedures was strong and recruitment methods 
and procedures worked reasonably well with scope to improve the participation 
rate and the appropriateness of recruitment to IAPT staff.  The stepped care 
intervention was broadly acceptable to therapists and, although no single 
experience defined patient acceptability, self-efficacy was found to have a role 
in patient engagement.  Several ways to modify the clinical protocol were 
apparent from therapist experience.  Data on the variability in patient outcomes, 
the correlation between patient baseline and follow-up scores and the 
proportion of stepped care patients who step up (33%) are now available to 
estimate the sample size and clinic resource needed in a future trial. 
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7.2 Summary of results 
The effectiveness of stepped care 
The aim of the systematic review was to assess the clinical effectiveness of 
stepped care treatment for depression in adults.   Twenty-one RCTs involving 
6364 patients were included.  The results of primary analyses demonstrated 
that stepped care is more effective than usual care for the treatment of 
depression immediately after treatment (Cohen’s d=0.40) and in the medium 
term (d=0.36 at six to nine months).  The quality of included studies was good 
and there was little evidence of publication bias.  
Stepped care vs. high-intensity therapy alone  
The systematic review also addressed a specific objective to determine whether 
there is sufficient evidence to establish the equivalence of stepped care and 
high-intensity psychological therapy alone.  Meta-analyses exclusively 
compared stepped care and care as usual.  There was insufficient evidence to 
establish whether stepped care is equivalent to long-term intensive 
psychological therapy for all. 
Extent of heterogeneity 
The second objective of the review was to assess heterogeneity by exploring 
aspects of study design and elements of the intervention that may be 
associated with more or less effect.  Considerable clinical and methodological 
heterogeneity was observed in terms of participants, interventions and study 
design.  Sub-group analyses found that the effect of stepped care treatment 
based on no clear intensity order (d=0.40) was significantly greater than the 
effect of stepped care defined by increasing intensity (d = 0.15, p<0.01). 
Performance of recruitment and retention methods 
The results of the systematic review led to a mixed methods feasibility study to 
prepare for a fully-powered trial of stepped care vs. high-intensity psychological 
therapy alone.  As part of this study, quantitative data were collected to evaluate 
the performance of pilot trial recruitment and retention methods.  Recruitment 
methods performed reasonably well.  The target number of participants was 
recruited and the participation rate was 2.9%.  Based on the 95% confidence 
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interval for this parameter, it was estimated that in a future trial the 
randomisation rate would be between 2.2% and 3.5%.  Although this level of 
recruitment may be acceptable, numeric data also indicated that it may be 
possible to obtain a higher recruitment rate.  The performance of retention 
procedures was strong.   
Stepping rate 
The feasibility study also addressed a specific research question to establish 
what proportion of people who receive stepped care step up from low- to high-
intensity treatment.  A third of patients who were offered stepped care 
progressed from low- to high-intensity therapy.  Based on the 95% confidence 
interval, it was estimated that between 17.9% and 51.8% of participants in a 
future trial would step up. 
Variability in outcome and correlation with baseline data 
A separate feasibility study question concerned the variability in patient-related 
outcomes following stepped care or intensive psychological therapy alone and 
the correlation between patient baseline and follow up data.  The pooled 
standard deviation of patient scores on the BDI-I (the primary outcome in a 
future trial) at six months was 10.0.  Equivalent figures for patients in the 
stepped care and CBT alone groups were 9.6 and 10.5.  The magnitude of the 
correlation between baseline and follow-up BDI-I data was 0.49 for all patients, 
0.44 in the stepped care group and 0.52 in the CBT alone group.  This 
information can now inform the sample size calculation for a future trial. 
Appropriateness of recruitment  
As part of the feasibility study, semi-structured interviews were conducted to 
assess the appropriateness of pilot trial recruitment methods and procedures.  
Analysis revealed that methods were largely appropriate to patients and 
therapists but much less appropriate to IAPT staff.  Difficulties for IAPT staff 
arose out of a concern that some procedures could harm patients whilst others 
had been practically challenging to implement.   Qualitative and mixed methods 
analysis highlighted ways in which recruitment could be modified to improve 
appropriateness to IAPT staff and to counter a smaller number of patient and 
therapist concerns. 
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Acceptability of stepped care 
Semi-structured interviews also explored the acceptability of the stepped care 
intervention to patients and therapists.  There was no single experience or 
pattern of experiences to define acceptability to patients and, consistent with 
this interpretation, it was not possible to identify ways in which the intervention 
could be modified that would reliably improve how it was received.  On the other 
hand, despite reservations about the suitability of stepped care for some 
patients, therapists found the intervention broadly acceptable.  In addition, 
therapist experience identified several ways in which each of the core 
components of the stepped care clinical protocol (low- intensity, high-intensity 
treatment, monitoring and stepping) could be modified that might improve the 
degree to which it is considered acceptable. 
Acceptability and attendance 
STEPS feasibility study addressed a specific mixed methods question on the 
relationship between patient experience and attendance.  There was no simple 
relationship between acceptability and attendance however self-efficacy had a 
role in patient engagement.  Groups of patients were identified for whom low-
intensity therapy was less acceptable that either declined or dropped out of 
therapy vs. remained in treatment.  Self-efficacy was also related to patient 
attendance at high-intensity therapy. 
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7.3 Strengths and limitations of the systematic review 
A key strength of the original systematic review was that it was the first to 
describe all available RCTs on stepped care treatment for depression in adults.  
However, the included number of studies was small (n=14).  Although the 
updated review included a larger number of studies (n=21), only two thirds were 
suitable for meta-analysis.  Other system-level interventions for improving 
mental health in primary care have been evaluated a good deal more; a recent 
Cochrane review of collaborative care for depression and anxiety included 79 
RCTs (Archer et al., 2012).  The small number of studies made it difficult to 
perform sub-group analyses and, combined with substantial levels of clinical 
and methodological heterogeneity, might limit the degree to which results can 
be considered to generalise. 
7.3.1 Setting and participants 
The majority of the included studies were conducted in the US and the 
Netherlands; three were conducted in developing countries (Araya et al., 2003; 
Oladeji et al., 2015a; Patel et al., 2010).  One of the three (Araya et al., 2003) 
had a very high effect size (0.9).  Although the results of sub-group analyses 
found no significant difference in the effect of stepped care delivered in different 
countries, given the limited evidence base and the influence of one study with a 
high effect size, the main findings of meta-analyses on the effectiveness of 
stepped care for the treatment of depression in adults may need to be 
interpreted with more caution when considering less developed nations.   
Research into stepped care has been conducted on patients with diverse 
disorders.  In addition to depression, some of the included studies recruited 
participants with other mental health problems (typically anxiety) and physical 
health conditions (Acute Coronary Syndrome, diabetes, cancer or visual 
impairment).  Clinical diagnosis of depression was not necessary and a wide 
range of depressive symptoms and/or disorders (sub-threshold, minor and 
major depression) were included.   
To apply an argument made by Archer et al. (2012) in the review of 
collaborative care, studies of patients that use diagnostic criteria to determine 
eligibility are often prioritised over those that use self-report outcome measures 
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or clinician judgement, particularly as evidence-based guidelines often exclude 
the latter from their reviews of the literature. However, whilst positive effects 
may be more likely when interventions target a specific diagnostic group (Roth 
& Fonaghy, 2005), studies where interventions are offered based on levels of 
symptoms rather than clinical diagnosis may be more representative of routine 
practice (Archer et al., 2012). 
7.3.2 Definition and implementation of stepped care 
As originally defined, stepped care refers to the organisation of successive 
treatments in terms of increasing intensity (Davison, 2000).  Whilst the concept 
of intensity readily applies to psychological therapies, it is difficult to 
characterise pharmacological (and perhaps physical treatments) as intensive or 
otherwise.  Nonetheless studies of stepped care, explicitly labelled as such, 
frequently encompass medication and implement a version of this system that is 
not organised by progressive intensity: at each step, patients switch or add 
treatments of different modalities (pharmacological, psychological); patients 
may start with intensive psychotherapy (Araya et al., 2003; Ell et al., 2008; 
Katon et al., 2004).   
Given the importance pharmacotherapy in the treatment of depression and the 
number of trials of stepped care defined in this way, inclusion criteria were set 
to permit studies of stepped care defined by progressive intensity and more 
than one treatment modality. Although this was considered the most 
comprehensive definition of stepped care reflecting current clinical practice, it 
led to substantial variation in what was delivered as part of the intervention.  
Several studies were included that evaluated stepped care combined with 
collaborative care [studies 2, 7, 8, 10, 11].  Among the fourteen studies included 
in meta-analyses, five evaluated stepped care defined by progressive intensity 
[11, 12, 15, 16, 18] and nine evaluated stepped care that was in no clear 
intensity order [2, 4, 5, 7-10, 13, 17]. Our decision to include studies of stepped 
care defined by different treatment modalities is debateable: findings based on 
one definition of stepped care may not generalise to the other; in studies of 
stepped and collaborative care it is impossible to assess the value of each 
intervention; other researchers may choose to review or conduct future 
research on stepped care in line with how it was originally conceived. 
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The delivery of stepped care also varied in many other respects.  In terms of 
providers, some studies included just one or two healthcare professionals whilst 
others included a team of three, four or five personnel.   Treatment was 
provided by less and more qualified staff: residential home staff, study 
researchers, lay health counsellors vs. psychiatrists, GPs and psychologists.  
There was variation in the number of treatment steps (between two and four), 
duration (14 weeks to 12 months), stepping criteria (measures, cut-off scores 
and reference to improvement) and in the delivery of the same treatments 
across different studies e.g. a watchful waiting period that ranged from two 
weeks to three months.  Variation in the delivery of stepped care complicates 
the interpretation of results. 
7.3.3 Stepped care for the prevention of depression 
Five of the included studies evaluated stepped care for the prevention of 
depression; four evaluated stepped care for indicated prevention, one for 
relapse prevention.  Results were mixed.  Promising results reported in three 
studies conducted in the US and Europe were not replicated elsewhere (De 
Xing Zhang et al., 2014).  Although it has been argued that prevention has 
potential to contribute most in reducing the global burden of depression 
(Cuijpers, Beekman, & Reynolds, 2012), the size of the evidence base currently 
precludes a conclusive interpretation of the potential benefits of stepped care 
for the prevention of depression - in any country. 
7.3.4 Usual care comparator 
All of the included studies except for one compared stepped care with treatment 
as usual.  A limitation of this review is that the implementation of usual care 
varies and included studies did not clearly describe key elements.  Usual care 
sometimes included a level of enhancement (training and education of primary 
care physicians, informing patients of their depression scores, distribution of 
treatment guidelines for practitioners and educational material for patients).  
Evidence for these interventions delivered in isolation is limited (Bower & 
Gilbody, 2005a) but they could result in a lower treatment effect (Archer et al., 
2012). 
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7.3.5 The design of included studies 
Although most studies were patient randomised, four used cluster 
randomisation, all of which were included in meta-analyses.  Cluster trials are 
recommended for testing system-level interventions (Ukoumunne, Gulliford, 
Chinn, Sterne, & Burney, 1999) avoiding ‘contamination’ across the control and 
intervention groups when patients are managed in the same setting.  However, 
one of the main consequences of a cluster design is that participants in any one 
cluster tend to respond in a similar manner.  As a result, their data can no 
longer be considered independent.  Many cluster trials fail to allow for this in 
their analysis and studies in which clustering is ignored result in artificially 
narrow confidence intervals that, in the context of a meta-analysis, afford them 
more weight than is appropriate (Higgins, Deeks, & Altman, 2010). 
All of the cluster trials in the review provided an estimate of effect from an 
analysis that was reported to properly account for the study design.  However, 
cluster trials also generally require larger patient samples and may be 
vulnerable to other sources of bias (selective patient recruitment after cluster 
randomisation, baseline imbalance, loss of clusters) (Higgins et al., 2010).  As 
such, effect sizes may have been over- or underestimated.  Sensitivity analyses 
to explore the pooled effects of stepped care excluding cluster trials were not 
performed but will be included in the published update of the original review. 
7.3.6 Quality of the evidence 
Data from a relatively small number of studies were included in the review, 
producing estimates of the effects of stepped care that lacked precision.  
Ninety-five percent confidence intervals around estimates of the effect at all 
points were wide, most notably in the short- (2-4 months) and long-term (18 
months). 
There was also substantial statistical heterogeneity.  In the review update, the 
value of the I2 statistic for the effect of stepped care immediately after treatment 
estimated using the average (combined) effect in each individual study was 
77%; ‘substantial’ according to recommended criteria (Deeks et al., 2008).  At 
six to nine months it was 59% indicating ‘moderate’ heterogeneity (Deeks et al., 
2008).  Random-effects models were used in all analyses as, in contrast to 
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fixed-effects models, random-effects meta-analysis does not assume that all 
studies are estimating the same intervention effect (see also Chapter Four, 
section 4.2.2). 
Risk of bias assessment identified two studies [that were at high or unclear risk 
on the majority of criteria suggested by the Cochrane Handbook (Higgins & 
Altman, 2008).   Both studies were excluded from meta-analysis.  In the 
remaining trials, most criteria were rated at low risk of bias indicating that the 
large majority of studies were of good quality.  Estimates of effect from high-
quality studies of psychotherapy for adult depression have been found to be 
smaller than estimates obtained from lower-quality studies (Cuijpers, van 
Straten, Bohlmeijer, Hollon, & Andersson, 2010). 
Although studies were unable to blind patients or study personnel (clinicians) 
and may be susceptible to bias in this regard, this reflects the reality of 
conducting complex intervention trials in practice; blinding is not always 
possible (Centre for Reviews and Dissemination, 2008; Higgins & Altman, 
2008).  Risk of bias with respect to blinding of outcome assessors was rated as 
low; the majority of studies used self-report outcome data.   As estimates of the 
effect of psychotherapy on depression in adults from self-report data have been 
found to be lower than those calculated using data obtained from clinician rated 
instruments (Cuijpers, Li, Hofmann, & Andersson, 2010), this may have led to a 
relatively conservative estimate of effect in the current review.   
There was little evidence of publication bias from funnel plots and Duval and 
Tweedie’s trim and fill procedure (Duval & Tweedie, 2000).  However, we did 
not search ‘grey literature’.  Adding unpublished studies to published studies of 
psychological treatment for depression has been found to reduce effects 
(Driessen, Hollon, Bockting, Cuijpers, & Turner, 2015).  It is possible that a 
more comprehensive search of the literature would result in a reduced estimate 
of the effect of stepped care. 
7.3.7 Other potential biases in the review methods and procedures 
Sub-group analyses investigated differences in the effectiveness of stepped 
care by country, type of stepped care (IMPACT based, yes / no; progressive 
intensity, yes / no), physical health comorbidity and diagnostic status at 
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inclusion.  Sub-group analyses were not conducted for other methodological 
and clinical factors that may have had a bearing on outcome and for which data 
were extracted e.g. randomisation (cluster / individual), control (enhanced usual 
care vs. usual care) or for which we were unable to extract data (e.g. proportion 
of patients who stepped up). 
Exploration of the impact of different variables on the effects of stepped care 
would benefit from a multivariate approach such as a meta-regression analysis.  
Unlike sub-group analyses, this could assess the relative importance of a series 
of factors on the effect of stepped care but would require extensive imputation 
of missing data.  However, the results of a meta-regression would still need to 
be interpreted with caution.  Meta-regression and sub-group analyses are 
entirely observational in nature.  Results are subject to confounding and 
susceptible to aggregation bias (where differences on a factor of interest that 
are observed within a single study are no longer apparent by looking at effects 
associated with the ‘average’ of that factor across several studies) (Deeks et al., 
2008). 
The effects of stepped care were studied at different time points using time from 
randomisation.  Included interventions were sometimes delivered over several 
months (up to one year).  Long term effects (at 12 months and beyond) do not 
entirely reflect persistent effects of the intervention but will encompass the 
short-term effects of longer interventions.  In the original review, the estimate of 
the effect of stepped care at 18 months was based on one comparison.  
Estimates of the long term effect of stepped care need to be interpreted with 
caution. 
7.3.8 Agreement and disagreement with other reviews 
Only one other published review has examined the effectiveness of stepped 
care treatment for depression in adults (Firth, Barkham, & Kellett, 2015).  Unlike 
the current review, this review was not limited to RCTs; included studies were 
both controlled and uncontrolled.  Estimates of the effect of stepped care in the 
current review obtained from randomised controlled trials alone are at lower risk 
of confounding and thus more trustworthy.   
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Although Firth et al mainly used a narrative synthesis to examine outcomes, the 
standardised mean difference between stepped and usual care was estimated 
for five RCTs: Araya et al. (2003), Davidson et al. (2010), Ell et al. (2008), Patel 
et al. (2010), Seekles et al. (2011).  Across studies, the median effect size was 
d=0.41.  This figure was similar to estimates of effect immediately after 
treatment and at six months in the current review.  As all five of the studies for 
which Firth et al. calculated an effect size were included in meta-analyses in the 
current review, this might be expected. 
7.4 Clinical implications of the review 
7.4.1 Magnitude of effect 
Although this review has provided reasonable evidence of the effectiveness of 
stepped care treatment vs. usual care for improving depression outcomes, the 
clinical relevance of the magnitude of the effects is more difficult to interpret.  
The size of the effect immediately after treatment (d = 0.38) and at six to nine 
months (d = 0.35) was modest according to current conventions (Cohen, 1988; 
Lipsey, 1990).  Moreover, to draw on an argument developed by Archer et al. 
(2012), although there is a lack of consensus on ‘minimally clinically important 
differences’ in mental health, a standardised mean difference of 0.5 has 
previously been adopted as a criteria in the UK; effects observed in the current 
review are less than this. 
However, the benefits of stepped care treatment for adult depression are similar 
to those reported for collaborative care (effect size 0.34 from 30 comparisons) 
(Archer et al., 2012), psychological therapies in general (provided in both low 
and high intensity forms; effect size 0.42 from 175 comparisons) and for 
individual CBT (excluding GSH; effect size 0.41 from 41 comparisons) 
(Cuijpers, Smit, Bohlmeijer, Hollon, & Andersson, 2010).   The majority of meta-
analyses of low-intensity psychotherapy also demonstrate comparable effects 
(range 0.42 to 0.56) (Bower et al., 2013; Gellatly et al., 2007; Richards & 
Richardson, 2012). 
One meta-analysis of low-intensity treatment reported a greater effect size (0.88 
across 22 studies) (Andrews et al., 2010).  Included trials were limited to those 
of patients who met diagnostic criteria for depression and / or anxiety.  Results 
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of individual patient-data meta-analysis have found that patients in receipt of 
low-intensity treatment who are more severely depressed demonstrate larger 
effects than those who are less severely depressed (although the magnitude of 
the interaction is small) (Bower et al., 2013).  Greater effects of self-help 
treatment have also been demonstrated in patients with an existing problem 
compared with those at risk for depression (Gellatly et al., 2007).  The higher 
effect size reported by Andrews et al. (2010) may reflect the patient population 
included in that study. 
7.4.2 Progressive intensity vs. no clear intensity order 
The National Institute for Health and Care Excellence (NICE) currently 
recommends a stepped care framework for the management of depression in 
adults that is defined by increasing intensity  (National Collaborating Centre for 
Mental Health, 2010), albeit with the option to stratify patient care initially.  In 
this review, greater effects were demonstrated for stepped care of no clear 
intensity order (d = 0.40) than for models of increasing intensity (d = 0.15).  In 
models of no clear intensity order, at each step, patients switched or added 
treatments of different modalities (psychological, pharmacological). The result 
implies that it may be more effective to treat depression using a clinical 
algorithm that explicitly encompasses medication and psychotherapy than by 
offering patients low- and then high-intensity psychological therapy. 
Evidence to support this conclusion is weak.  As noted above, sub-group 
analyses are observational in nature and at risk of aggregation bias.  Moreover, 
in the updated review, only three studies evaluated stepped care of progressive 
intensity and seven of the nine studies that evaluated stepped care of no clear 
intensity order were based on the IMPACT model.  The effects of stepped care 
in studies that were IMPACT and non-IMPACT based were similar.  This means 
that the difference in the results between the two sub-group analyses (IMPACT 
- yes/no; increasing intensity - yes/no) was based on two studies [IDs 2 & 17], 
one of which had a very large effect size (0.84 at six to nine months).  At 
present, there is insufficient evidence to conclude with any degree of certainty 
that stepped care models of no clear intensity order are more effective than 
stepped care defined by increasing intensity. 
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7.4.3 Combined pharmacotherapy and psychotherapy in stepped care 
The majority of studies in the systematic review, including trials that evaluated 
stepped care models of psychological therapies organised by increasing 
intensity, incorporated medication alongside psychotherapy as part of the 
stepped care intervention.  However, fewer studies implemented a version of 
stepped care where patients received pharmacotherapy and psychological 
treatment at the same time; combined treatment was not often incorporated in 
step one.  Meta-analysis has demonstrated superior effects for combined 
pharmacotherapy and psychological treatment vs. pharmacotherapy alone 
where the magnitude of the difference was moderately large and clinically 
meaningful in favour of combined treatment (Cuijpers et al., 2014).  Results also 
suggested that the effects of psychotherapy and pharmacotherapy were largely 
independent of each other, with both contributing about equally to the effects of 
combined treatment (Cuijpers et al., 2014).  Based on these results, it is 
suggested that the role for pharmacotherapy and psychotherapy in stepped 
care may yet require further consideration.  Patients are likely to be interested in 
the advantages of combined treatment when considering how they engage in 
stepped care.  
7.5 Directions for future research following the systematic review 
7.5.1 A fully-powered evaluation 
Evidence for the effectiveness of stepped care treatment for depression relative 
to usual care is increasing.   Seven new studies were included in the updated 
review, six of which compared stepped care with usual care.  Yet comparisons 
of stepped care and usual care do not establish the effectiveness of stepped 
care compared with the system that it was designed to replace: long-term, 
intensive psychological therapy alone.   
The clinical effects of CBT in the treatment of adult depression are well 
established, if over-estimated (Cuijpers, Berking, et al., 2013; Cuijpers, Hollon, 
et al., 2013; Cuijpers, Smit, et al., 2010).  However, providers of publicly-funded 
and private healthcare systems must balance clinical effects with costs of 
treatment.  To repeat an argument introduced in Chapter Two, as an alternative 
to long-term intensive CBT, stepped care is assumed to deliver similar patient 
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benefit for less cost.  In a publicly funded healthcare system, providing high-
quality depression treatment at less cost may enable more people to access 
care.  Although stepped care has been widely implemented on this basis, the 
results of the systematic review confirm that the equivalence and efficiency of 
stepped care vs. high-intensity therapy alone have not been tested. 
To determine if stepped care delivers treatment that is equivalent in clinical 
effect but more efficient compared with the traditional provision of psychological 
therapies, a rigorous evaluation of the effectiveness of stepped care vs. 
intensive psychological therapy alone is still required.  An appropriately 
powered, non-inferiority randomised controlled trial of stepped care 
encompassing psychotherapies of increasing intensity compared with intensive 
CBT alone is recommended; cost-effectiveness analyses should be 
incorporated.  
7.5.2 Other areas for future research 
Reporting standards 
The central tenet of stepped care on which the assumption of increased 
efficiency rests is that for many patients, low-intensity treatment is sufficient.  In 
the current review, a limited number of trials provided data on the proportion of 
patients recovered after step one treatment.  Data that were available were 
difficult to interpret.  Stepping criteria varied between studies as well as the 
number of patients who dropped out of treatment.  The number of patients who 
met criteria for progression and the actual percentage who accepted additional 
treatment were not reported.  This is important information within stepped care 
as there is a risk that some patients choose not to start a second high-intensity 
treatment after failure of the first.  Minimum reporting standards for stepped 
care trials are recommended.  Data to include in the report of a clinical trial on 
stepped care for depression are listed in Box 7. 
 
Box 7 overleaf 
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Box 7. Recommended reporting standards on stepped care 
 
 
Further research to identify elements of stepped care associated with 
more and less effect 
Exploration of the moderators and mediators of stepped care (Kraemer, Wilson, 
Fairburn, & Agras, 2002) could provide a better understanding of who is most 
likely to benefit from stepped care and the elements of the model associated 
with more and less effect.  A process evaluation should be incorporated in a 
fully-powered trial of stepped care compared with high-intensity psychological 
therapy alone.  Prior to a fully-powered evaluation, meta-regression analysis 
might be undertaken to assess the relative importance of a series of factors with 
potential to influence the effectiveness of stepped care.  
Testing stepped care defined by increasing intensity vs. stepped care of 
no clear intensity order 
Sub-group analyses indicated that stepped care of no clear intensity order may 
be favourable compared with stepped care of increasing intensity but results 
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were in no way conclusive.   Going forward, stepped care involving 
pharmacological and psychological treatments will remain important.  The 
advantages of combined anti-depressant medication and psychotherapy may 
not yet have been realised in stepped care clinical protocols.  An appropriately 
powered, non-inferiority RCT of stepped care for depression defined by 
increasing intensity versus stepped care involving different treatment modalities 
is recommended that should also consider the role for combined treatment in 
both. 
Evaluation of stepped care for the prevention of depression 
As already noted, five of the twenty-one studies included in the current review 
evaluated the effectiveness of stepped care for the prevention of depression.  
Given the potential importance of prevention in reducing the global burden of 
depression (Cuijpers, Beekman, et al., 2012), additional RCTs to compare 
stepped care with other treatment for the prevention of depression are also 
recommended. 
A randomised controlled trial of stepped vs. matched care 
A large RCT of stepped care vs. CBT alone would establish the effectiveness of 
stepped care treatment compared with the system that it was designed to 
replace however NICE (2010) has recommended the conduct of a fully-powered 
trial of stepped vs. matched care.  Also referred to as personalised medicine, 
matched care involves selecting the best treatment available treatment for a 
given individual (Simon & Perlis, 2010).  As such, it requires that individual 
differences that predict differential response to different treatments are known 
and can be combined for clinical decision making (Huibers et al., 2015).    
At the time of the original systematic review of stepped care, the development 
of personalised medicine for the treatment of depression had only just begun 
(Cuijpers, Reynolds, et al., 2012).  Yet within the last two years, DeRubeis et al. 
(2014) developed a method for integrating predictive information that, applied 
retrospectively, was able to identify an optimal treatment for patients that when 
received would have led to superior clinical outcomes (DeRubeis et al., 2014; 
Huibers et al., 2015).  This method, known as the Personalised Advantage 
Index (PAI), holds great promise for matched care but will need to be tested 
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prospectively (DeRubeis et al., 2014; Huibers et al., 2015).  If the results of 
prospective research yield similar effects to that obtained from the retrospective 
application of the PAI, this method could rival and potentially out-perform 
stepped care as a system for the organisation of treatment for depression.   
Once the results of prospective studies are known, a non-inferiority randomised 
controlled trial of stepped care for depression compared with a matched care 
control utilising the PAI should be undertaken to determine the relative clinical 
and cost-effectiveness of both. 
 
Section 7.6 overleaf 
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7.6 Strengths and limitations of the feasibility study 
Following the results of the systematic review, STEPS provided robust and 
relevant evidence on the feasibility of a fully-powered RCT of stepped care 
compared with intensive psychological therapy alone.  The strengths and 
weaknesses of this study are now described followed by directions for future 
research and clinical implications. 
7.6.1 Study design 
The aim, specific objectives and research questions of STEPS were 
commensurate with the definition of a feasibility study provided by the National 
Institute for Health Research Trials and Studies (2015) and endorsed by Arain 
and colleagues (Arain et al., 2010).  Key clinical, methodological and procedural 
uncertainties associated with the conduct of a large trial were addressed using 
appropriate quantitative, qualitative and mixed methods.  Results support 
inferences about the suitability of a stepped care clinical protocol and pilot trial 
methods and procedures for a fully-powered evaluation.  Findings have been 
described in line with guidelines for reporting the results of feasibility studies 
(Thabane et al., 2010). 
7.6.2 Methodological framework 
A key strength of the feasibility study is its clear and explicit commitment to 
mixed methods.  The study has been described in line with recommendations 
for Good Reporting of a Mixed Methods Study (O'Cathain, Murphy, & Nicholl, 
2008).  Key decisions on the level of interaction, priority, timing and mixing of 
the quantitative and qualitative strands were reached.  This was reflected in the 
implementation of an embedded mixed methods study design (Creswell & 
Plano Clark, 2011).  Techniques for integrated mixed methods analysis were 
also incorporated in new ways that have the potential to extend and strengthen 
how mixed methods are typically utilised in Health Services Research (see also 
section 7.7.5). 
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7.6.3 Quantitative components 
Precision of key parameters of interest 
Quantitative data were collected on recruitment, retention and treatment.  
Margins of error associated with the recruitment rate, retention rate and the 
variability in the primary outcome (for a future trial i.e. BDI-I) were similar to or 
less than the margins of error for the same parameters associated with the 
recruitment of 75/1500 and 60/2000 people.  Margins of error associated with 
the recruitment of 75/1500 and 60/2000 people were considered acceptable for 
the purpose of this study (J. J. Hill et al., 2014).  Key parameters have thus 
been calculated with an acceptable level of precision to help determine 
feasibility and the sample size required for a fully-powered evaluation.   
Primary outcome in large trial 
Quantitative outcome data were collected at six months post-baseline.  
Treatment was designed to last up to 24 weeks.  However, 15% (10/66) of 
patients provided follow-up data prior to the completion of treatment.  Of those, 
one patient completed treatment at 11 months post-baseline; the remainder 
completed treatment within nine months of randomisation.  In a fully-powered 
evaluation, the primary outcome may need to be collected at 12 months post-
baseline to ensure that all patients had completed treatment although data 
collection at nine months may obtain post-treatment data from the large majority 
of interviewees.  Data on retention, variability in treatment outcomes and the 
correlation between baseline and follow-up scores collected at six months may 
not be an accurate estimate of retention, variability and correlations at a later 
time point. 
IAPT treatment received by non-participants 
IAPT personnel were concerned that patients who were sent study information 
and returned a ‘permission’ form but did not join STEPS would subsequently 
drop out of IAPT treatment.  Although IAPT routinely collect data on the 
treatment received by patients who are referred to their service, we did not have 
ethical approval to obtain and analyse this information.  We do not know, 
therefore, how many patients dropped out of IAPT therapy after they did not 
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take part in STEPS.  This information is not available to help respond to the 
concerns of IAPT staff. 
7.6.4 Qualitative components 
Number of patient interviews 
Qualitative data were analysed from twelve patients.  Six of the analysed 
patients had been offered or received low-intensity therapy alone and six had 
received both low- and high-intensity treatment.  Four of the analysed patients 
had declined any treatment or dropped out early; the remainder completed 
treatment.  As noted in Chapter Five (section 5.5.2), data suggest that the 
majority of themes developed in a qualitative analysis can be obtained from the 
analysis of six transcripts (Guest et al., 2006).  On this basis it is suggested that 
the analysis of twelve patient interviews had potential to generate a good 
understanding of the degree to which the stepped care intervention and 
recruitment procedures were acceptable to STEPS patients. 
Patient experience of stepped care 
Although the analysis of patient data incorporated an adequate number of 
interviews, the degree to which patients’ views of stepped care in the pilot trial 
might reflect the views of patients in a fully powered evaluation could be 
debated.  Patients’ views of stepped care in this study were generated in 
response to therapy delivered by three trial therapists working at the University 
of Exeter Mood Disorders Centre AccEPT Clinic.  In a fully-powered evaluation, 
trial treatments would likely be delivered by IAPT therapists working mainly from 
IAPT premises and GP surgeries.  Differences in the delivery of stepped care in 
different settings by different therapists might shape how it is received by 
patients.  
However, stepped care as delivered in the feasibility study was highly 
protocolised.  Patients received a standard set of GSH material; stepping 
criteria were closely defined; therapists utilised a detailed clinical protocol for 
high-intensity CBT and were supervised by highly qualified and experienced 
senior academic clinicians.  By providing expert supervision and using the same 
(or a similar) highly protocolised form of stepped care in a future trial, 
opportunities for the delivery of stepped care to vary greatly from the feasibility 
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study would be constrained.  Qualitative data revealed that feasibility study 
patients endorsed or were concerned by some elements of stepped care that 
were not overly susceptible to the influence of different therapists or settings 
e.g. the use of the PHQ-9.  Provided the stepped care clinical protocol for a 
fully-powered evaluation was not very different to the protocol for the feasibility 
study, it is reasonable to expect that patient experience of both would be 
similar. 
Patient data on recruitment 
Qualitative patient data on recruitment may need to be interpreted with caution.  
Views on recruitment were obtained from trial participants yet a large majority of 
patients (92%) who were sent study information did not respond and around two 
thirds of patients who returned a permission form did not take part.  IAPT 
personnel were concerned that patients who were sent study information with 
their IAPT assessment appointment letter may be overwhelmed or confused by 
the material that they received.  Qualitative patient data suggested that study 
information was well received but we do not know if this was true for people 
who did not respond.  If participants’ views of recruitment are different to those 
of non-participants, modifying recruitment procedures in a future trial in ways 
that respond to the results of the patient interviews may not increase the appeal 
of those procedures to all potential participants. 
Therapist experience and number of interviews 
Three AccEPT Clinic therapists were interviewed.  This comprised all of the 
AccEPT Clinic therapists who delivered stepped care.  Involving a larger 
number of therapists may have generated new and different results on the 
acceptability of stepped care but this was not possible with the resource 
available. 
In addition, we did not employ therapists who will deliver the intervention in a 
large trial.  Trial therapists were a dedicated team of three research clinicians: a 
specialist mental health nurse who had previously been employed as a 
Psychological Wellbeing Practitioner; a trainee Clinical Psychologist with a 
strong clinical and research interest in adult CBT; a qualified Clinical 
Psychologist, accredited by the British Association of Behavioural and Cognitive 
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Psychotherapy and with over ten years’ experience of high-intensity CBT.    In a 
fully-powered RCT, it is likely that trial treatments would be delivered by low- 
and perhaps high-intensity IAPT therapists.  Therapists in this study and those 
in a fully-powered evaluation may differ in terms of their interest in research and 
their prior knowledge, experience and understanding of stepped care, 
depression and the efficacy of CBT.  The views of therapists in the current study 
may not reflect the views of therapists in a large trial. 
However, this conclusion may not be wholly justified.  Pilot trial therapists varied 
in their opinion of stepped care: a therapist who had previously worked in an 
IAPT service as a Psychological Wellbeing Practitioner strongly endorsed low-
intensity therapy; the Clinical Psychologists were more sceptical about the 
benefits of GSH for some patients.  In the same way, low- and high-intensity 
IAPT therapists might vary in their opinion of the intervention.  Variation in 
therapists’ views in this study may help to anticipate aspects of stepped care 
that could be more and less acceptable to different IAPT therapists in a large 
trial. 
IAPT staff experience 
The views of IAPT staff on recruitment were from three employees: a manager, 
Psychological Wellbeing Practitioner and Administrator.  Although the range of 
views expressed by these individuals might be limited by their small number, 
personnel were purposively selected who had different roles in recruitment and 
were well placed to provide a good understanding of the degree to which 
procedures were considered appropriate to the wider staff.  Interviews 
generated a large amount of qualitative data on a wide range of relevant topics 
to inform a fully-powered evaluation. 
Framework analysis 
All of the in-depth interviews with patients, therapists and IAPT staff were 
analysed using a framework approach (Pope, Ziebland, & Mays, 2000; 
Spencer, Ritchie, O'Connor, et al., 2014).  Their views of recruitment and the 
stepped care intervention were described by a number of themes; themes 
sometimes comprised multiple sub-themes.  In this way, framework analysis 
handled data on a very large number of related topics and the derivation of 
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each theme and sub-theme could be readily traced.  By coding and analysing 
the results of the patient, therapist and IAPT staff interviews separately, it was 
possible to develop a detailed description of the ways in which recruitment and 
the stepped care intervention were more and less appropriate / acceptable to 
different groups of people who will be involved in a fully-powered evaluation.   
However, there were potential limitations to framework analysis applied in this 
way.  By indexing, sorting, charting and then engaging in a process of 
abstraction and interpretation, the context and meaning of individual narratives 
may have sometimes been lost.  Contradictions and inconsistencies in 
individual’s recount of their experiences may not have been captured well; the 
analysis may not have readily reflected how patients’ views of acceptability 
changed over time. 
7.6.5 Strengths and limitations of mixed methods analysis 
Three forms of analysis were undertaken in the current study: quantitative, 
qualitative and integrated mixed methods.  A key strength of the integrated 
mixed methods analysis is that it combined different data types in ways that 
were rigorous and transparent.   Quantitative and qualitative data on recruitment 
were compared methodically; the results of mixed methods analysis to explore 
how attendance and acceptability might relate were robust for being systematic 
and clear.  In this way, mixed methods analysis supported a set of conclusions 
that can be easily understood and readily interrogated.  Compared with studies 
where mixed data types are reflected on in the Discussion, the risk of reaching 
selective, spurious or biased conclusions about what one type of data mean in 
relation to the other is likely to be reduced. 
Comparing mixed data on recruitment 
Comparing different data types in a side-by-side summary table of recruitment 
produced mixed results.  Although qualitative and quantitative recruitment were 
systematically compared and clearly pointed to aspects of trial design that could 
be modified or remain unchanged in a future trial, it was sometimes difficult to 
interpret the level of synergy and disparity between interviewees’ views of 
recruitment and numeric data from the STEPS CONSORT diagram.  What one 
type of data meant in relation to the other was not always immediately clear.   
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A possible reason for this is that quantitative data on attrition were compared 
with qualitative data from trial participants only.  The views of non-respondents 
and those who were interested in taking part but did not complete recruitment 
and join STEPS were unavailable to include in the side-by-side summary table.  
Thus, it was sometimes necessary to make inferences about the behaviour of 
non-trial participants based on participants’ views of recruitment and, as a 
result, it was not always possible to make strong conclusions about what the 
quantitative data meant in relation to the qualitative. 
Another limitation of the mixed methods analysis on recruitment that may have 
led to difficulty interpreting synergy and conflict was that the included data were 
aggregated.  Statistics for the sample as a whole were compared with summary 
statements on recruitment experience.  From this information, it was sometimes 
difficult to make sense of the complexity and variation in people’s views in 
relation to the number of people completing (or exiting) each step of 
recruitment.  By combining quantitative and qualitative recruitment data in a 
side by side summary table at the level of the individual participant it may have 
been possible to generate stronger and perhaps more meaningful conclusions 
about synergy and disparity which may have led to a deeper understanding of 
the feasibility and appropriateness of recruitment.  
Integrating data on acceptability and attendance 
Although combining different types of information on recruitment led to mixed 
results, mixed methods analysis on the relationship between acceptability and 
attendance readily generated insights that may not have been possible from a 
less rigorous integration or, indeed, a more straightforward comparison of 
quantitative and qualitative information.  A key part of the success of this 
analysis, and an aspect that differentiated it from the mixed methods analysis 
on recruitment was that, in integrating quantitative and qualitative data, 
information was manipulated.  Individuals were grouped into categories; patient 
experience was represented using typologies; data were also ordered - as in 
the case-oriented display.  By folding together data that had been manipulated 
in some way, it became possible to spot new relationships between attendance 
and acceptability.  Changes in how quantitative and qualitative data was 
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presented helped identify new and different patterns in the relationship between 
these two factors. 
A limitation of the mixed methods analysis on attendance and acceptability 
arose with respect to the number and range of cases included in the analysis.  
In the same way that very few authors have tried to operationalise the number 
of interviews to include in a qualitative analysis, as yet, there is no practical 
guidance on how much data is appropriate to include in integrated mixed 
methods analysis.  Moreover, whilst qualitative analysis typically aims to 
achieve ‘saturation’(Morse, 1995), an equivalent concept has not yet been 
proposed for mixed methods analysis.  Sample size requirements are, however, 
likely to be influenced by the purpose of analysis and, related, the degree to 
which it is important to understand heterogeneity. 
In the STEPS study, quantitative and qualitative data were analysed for twelve 
patients.  Of those, six patients had received low-intensity therapy alone and six 
had low- and high-intensity treatment.  In addition, only four of the analysed 
patients had declined any therapy or dropped out of treatment, three of whom 
had GSH alone and one who had low- and high-intensity treatment.   As such, 
the results on how views of stepped care might relate to attendance were based 
on a limited amount of data from people who did not complete therapy and, in 
particular, the results on how views of each of low- and high-intensity therapy 
might relate to attendance at GSH and CBT drew on the experience of very few 
people who did not engage in treatment.   Results may not generalise or reflect 
the relationship between acceptability and attendance in full.  Whilst discrete 
groups of patients were identified for whom acceptability and attendance related 
in different ways, other relationships are possible. 
7.6.6 Other potential limitations 
Generalisability of the stepped care clinical protocol  
A stepped care clinical protocol was developed for the current study that was 
true to stepped care principles.  However, we do not know how the 
effectiveness of this intervention compares with stepped care implemented in 
other ways.  The feasibility trial may have prepared to evaluate a ‘sub-optimal’ 
form of stepped care. 
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The basis for this conclusion is weak.  The intervention included treatments for 
which there is strong evidence of effect (Titov et al., 2013; Titov et al., 2014; 
Titov et al., 2012).  High-intensity CBT was delivered by experienced therapists 
following a treatment protocol based on the standard manuals published by 
Beck and colleagues (Beck et al., 1979) and used in two other recent mental 
health trials (Rhodes et al., 2014; Wiles et al., 2013).  The systematic review of 
stepped care found considerable variety in the implementation of stepped care 
but only one significant difference between sub-groups of studies requiring 
further investigation.  Differences in the implementation of stepped care are not 
necessarily associated with (statistically significant) differences in effects.  On 
this basis, there is no ‘good reason’ to anticipate that the stepped care clinical 
protocol tested in the feasibility study would necessarily be less effective than 
stepped care implemented in other ways.  
7.7 Directions for future research following the feasibility study 
The mixed methods feasibility study addressed key clinical, methodological and 
procedural uncertainties concerning the feasibility and conduct of a fully-
powered randomised controlled trial of stepped care vs. intensive psychological 
therapy alone.  Data have implications for a future trial in terms of: (i) 
recruitment, (ii) the clinic resource and sample size and, (iii) the stepped care 
clinical protocol.  Findings also point to the potential for a programme of work on 
mixed methods as well as research that could be embedded in a future trial of 
stepped care vs. high-intensity therapy alone. 
7.7.1 Recruitment in a future trial 
Feasibility of recruitment in a large trial 
Although it was possible to recruit to target in the current study, the participation 
rate of 2.9% was lower than expected and could only be achieved by extending 
the recruitment period albeit by two months only.  However, several 
investigations underline that the recruitment of patients into RCTs can be 
extremely difficult (Charlson & Horwitz, 1984; Haidich & Ioannidis, 2001; 
McDonald et al., 2006).  In a study of 114 trials supported by the UK Medical 
Research Council and the Health Technology Assessment Programme, less 
than a third achieved their original recruitment target and half were awarded an 
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extension (McDonald et al., 2006).  Other stepped care trials set in primary care 
report participation rates that are similar to or less than that observed in the 
current study (Huijbregts et al., 2013; Seekles et al., 2011; Stoop et al., 2015; 
Unutzer et al., 2002).  In this context, the performance of STEPS recruitment 
methods and procedures may be considered more acceptable. 
Opportunities to improve the recruitment rate 
Yet for procedures to be used in a future trial with greater confidence, it might 
still be important to refine them in ways that could improve the participation rate.  
A number of systematic reviews have focused on strategies to enhance 
recruitment (Caldwell, Hamilton, Tan, & Craig, 2010; Treweek et al., 2013; 
Watson & Torgerson, 2006).  Interventions that could help to improve 
recruitment include telephone contact on patient non-response to written 
invitation and the use of opt-out rather than opt-in procedures whereby patients 
are contacted unless they withdraw the use of their details (Treweek et al., 
2013). However, the application of such techniques in a large stepped care trial 
would need careful consideration.  The use of such strategies may present 
methodological and ethical challenges (Bower et al., 2014; Treweek et al., 
2013) and data on the feasibility of recruitment incorporating the use of these 
techniques was not collected as part of the current study. 
Opportunities to improve recruitment evident from STEPS feasibility study 
data 
On the other hand, STEPS feasibility study data also highlighted ways to 
improve the participation rate.  Two opportunities were identified by quantifying 
the performance of trial methods and procedures: (1) increase the limit of five 
working days from when patients return a permission form to complete 
procedures; (2) secure adequate clinical resource to treat trial participants.  In 
addition, based on previous examples of the use of qualitative research to 
identify and overcome barriers to recruitment and the promise of such methods 
for improving recruitment rates (Bower et al., 2014; Fletcher, Gheorghe, Moore, 
Wilson, & Damery, 2012), there might also be potential to improve the 
randomisation rate in a future trial by addressing ways in which STEPS 
methods and procedures were considered less appropriate to IAPT staff. 
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Difficulties for IAPT personnel arose out of a concern that some methods and 
procedures could harm patients whilst others had been practically challenging 
to implement.   These difficulties map onto two high level themes (‘perceived 
patient barriers’ and ‘effects on clinical practice) that have been found to 
influence clinicians’ support for recruitment in several other studies (Fletcher et 
al., 2012).  Although there is very little evidence on how best to overcome such 
concerns, two studies have investigated the use of qualitative methods to 
improve recruitment in a prostate cancer trial and implemented several 
strategies that subsequently corresponded with improvement in the number of 
patients recruited: presentation of study design to recruiters, initiation for new 
staff, regular training for all staff involved in recruitment, documents providing 
tips and advice and personalised individual feedback to recruiters (Donovan et 
al., 2009; Donovan et al., 2002).  The same strategies, deployed to address the 
concerns of IAPT staff, can be considered for a future stepped care trial and 
may help to improve the randomisation rate. 
Possible modifications to STEPS recruitment methods and procedures that 
incorporate some of these strategies are summarised in Box 8.  Options for 
increasing the recruitment rate that arose from the quantitative data analysis (as 
noted above) are also included.  Suggested changes mostly address ways in 
which recruitment was less appropriate to IAPT staff.  However, other 
modifications are proposed that respond to a smaller number of concerns raised 
by patients and therapists. 
 
Box 8 overleaf 
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Box 8. Possible modifications to pilot trial recruitment methods and procedures 
in response to patient, therapist and IAPT staff concerns 
Problem with recruitment 
 
Suggested action 
Ways to increase the participation rate evident from quantitative data 
 
Insufficient therapist resource 
 
 
 
 
 
Attrition associated with limit of 
five working days from when 
patients return their form to 
complete recruitment 
 
 
Secure adequate clinic resource in a future trial 
 Use STEPS data on the clinic resource required for stepped care to 
support a funding application for a future trial that would employ a 
sufficient number of therapists for the target number of patients to 
be recruited and treated in a reasonable timeframe 
 
Consider raising the limit of five working days to complete recruitment 
procedures 
 Discuss potential impact on IAPT services (re 28 day performance 
target to start treatment after assessment) and patients who 
welcomed the pace of recruitment  
 
Ways to improve the appropriateness of recruitment to IAPT staff - addressing perceived patient 
harms 
 
Patients may drop out of 
therapy on return to IAPT 
 
 
IAPT therapists were reluctant 
to pass on permission forms 
for patients who may be 
ineligible / unsuitable 
 
 
Obtain STEPS data on treatment outcomes for patients who returned to 
IAPT.  Alternatively, in a future trial, monitor patient treatment on return 
to IAPT; provide feedback to recruiters 
 
Reconsider IAPT therapist involvement in recruitment; present study 
design to recruiters and provide more information on study recruitment 
via training and guidance documents 
 
Ways to improve the appropriateness of recruitment to IAPT staff – addressing effects on clinical 
practice 
 
Impact of recruitment on 
format of IAPT assessment 
appointment 
 
Responding to patient 
questions 
 
Variation in the degree to 
which recruiters were 
proactive in asking patients for 
their permission forms 
 
Administrative Team workload 
 
 
Trial participants did not count 
towards service performance 
target to treat 15% of 
depressed / anxious 
population 
 
 
Initial and regular training for all staff involved in recruitment and 
documents providing tips and advice.  Training and documents to include 
guidance on changing the format of an IAPT assessment appointment, 
responding to questions and asking patients for their permission forms 
 
 
 
Personalised individual feedback to recruiters / recruitment teams on 
number patients recruited 
 
 
 
Consider securing financial support for administrative work on 
recruitment as part of a funding application for a future trial 
 
Review ways in which trial participants might count towards 15% target 
Discuss potential target conflict with IAPT services who may be involved 
in future trial. 
 
Ways to improve the appropriateness of recruitment to therapists 
 
Trial participants included a 
patient with bulimia and 
another patient who was 
dependent on alcohol 
 
Unreliable communication of 
clinic info from baseline 
interview 
 
 
Review study inclusion criteria and how they are implemented 
 Also review criteria for when to discharge patients from treatment 
(see Box 9) 
 
 
Review procedures for summarising and passing on relevant clinic 
information from patient baseline interviews with therapists 
305 
Ways to improve the appropriateness of recruitment to patients 
 
Study documents contained 
too much information 
 
Difficulty attending a baseline 
interview after an IAPT 
assessment 
 
 
Modify the content and format of the Patient Information Sheet (PIS) and 
Study Summary Sheet 
 
Offer patients the opportunity to complete a baseline interview by phone 
in PIS 
 
Possible modifications to study inclusion criteria 
One of the concerns included in Box 8 was raised by therapists and focused on 
STEPS’ study inclusion criteria.  Although criteria excluded patients who were 
alcohol or drug dependent, once in treatment it became clear that one 
participant was alcohol dependent.  Another participant had bulimia.  Study 
inclusion criteria were not designed to exclude patients with bulimia however 
there was a concern that it may have been more appropriate for this person to 
receive specialist care.  To optimise recruitment in a large trial, it will be 
important to critically reflect on and potentially modify feasibility study inclusion 
criteria and / or how they are implemented. 
With respect to which patients to include, feasibility study data speak to a 
general tension in the design of RCTs involving depressed adults: whether and 
in what circumstances to include depressed persons with comorbid mental 
health problems.  Although it may be important for the internal validity of a 
future trial to recruit a tightly defined sample, this may reduce external validity 
as many depressed adults present with comorbid mental health problems 
(McManus et al., 2009).  Clinically, it may be difficult to determine for whom trial 
treatment is appropriate: a comorbid condition may require priority treatment; on 
the other hand it may be sufficient for some patients to access treatment for a 
comorbid condition alongside depression trial treatment.  To help determine 
study inclusion criteria for a large trial, treatment guidelines for other mental 
health disorders and the evidence to support them should be appraised and in 
deciding on criteria, equipoise (genuine uncertainty over which of the 
intervention and control will be more effective) should be maintained for all 
participants. 
In terms of the implementation of inclusion criteria in a large trial, to help reliably 
exclude patients who are alcohol or drug dependent, the SCID-5 – Structured 
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Clinical Interview for DSM-V (First, Williams, Karg, & Spitzer, 2015) – could be 
used as an alternative to the CIS-R (Lewis et al., 1992).  The CIS-R is a 
relatively brief diagnostic interview that can be administered by a non-clinically 
qualified professional for the diagnosis of depression.  Likewise, the SCID-5 is a 
recognised diagnostic interview schedule that can be used by a non-clinically 
qualified professional to diagnose depression but from which selected modules 
can also be used to identify patients with other comorbid conditions.  Use of the 
SCID-5 in a future trial may help reliably identify patients who do not meet 
inclusion criteria and thereby minimise randomisations in error. 
Use of an alternative recruitment method 
The suggested modifications to recruitment in Box 8 represent one means to 
improve the acceptability of recruitment in a large trial and perhaps increase the 
recruitment rate.  However, given the modest pilot trial recruitment rate, the 
level of dissatisfaction with recruitment among IAPT staff and the work that may 
be required to address concerns, the use of an alternative recruitment method 
in a large trial should also be considered. 
Case-note screening in which patients are recruited by searching the electronic 
case records of general practices (or other services) for patients with 
depression, identifying potential participants from depression classification 
codes, has been successfully used in other large depression trials (Richards et 
al., 2016; Richards et al., 2013).  Use of this method in a future stepped care 
trial would avoid the need to involve IAPT staff but would rely on the willingness 
of General Practitioners and other practice staff to assist.  A relatively large 
number of GP surgeries would need to be engaged and, in an area where 
surgeries were already involved in other (potentially large) research projects, 
support for a fully-powered stepped care trial may be reduced. 
By recruiting via IAPT, STEPS minimised burden on local General Practices 
known to be involved in other projects.  This recruitment method also accessed 
a patient sample that was considered reasonably representative of people who 
utilise stepped care services in routine clinical practice.  This advantage would 
extend to a large trial adopting a similar recruitment method.  Recruitment via 
IAPT would also be appropriate for a future trial given that the fully-powered 
evaluation would involve an active treatment control.  Thus, patients who had 
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been referred for psychological therapy would be offered a suitable form of 
CBT.  When deciding on the recruitment method for a future trial, the merits of 
recruitment via IAPT should be considered alongside difficulties involving IAPT 
staff and the pros and cons of case-note screening. 
7.7.2 Sample size in a future trial 
Pilot trial data were collected on the variability in patient outcomes and the 
correlation between baseline and follow-up scores.  This information was 
obtained to inform an estimate of the sample size required for a fully-powered 
evaluation.  From baseline to six month follow-up, the mean reduction in STEPS 
patients’ depressive symptoms (on the BDI-I – the primary outcome in a future 
trial) was 13.4 in the stepped care group and 13.6 in the high-intensity therapy 
alone group.  At follow-up, the standard deviation in patients’ depressive 
symptoms was 10.0 across groups, 9.6 in the stepped care group and 10.5 in 
the high-intensity therapy alone group.  Based on the assumption that stepped 
care is equivalent to offering all patients long-term, intensive psychological 
therapy alone, a two-arm non-inferiority trial is recommended to evaluate the 
relative effectiveness of these systems.  Accordingly, this trial should be 
powered on the basis of clinical non-inferiority (Jones, Jarvis, Lewis, & Ebbutt, 
1996). 
Specific methods have been proposed for the calculation of non-inferiority 
margins i.e. the number of score units by which an intervention can perform 
worse than a control and not be considered inferior (European Medicines 
Agency Committee for Medicinal Products for Human Use (CHMP), 2005; 
Snappin, 2000).  By applying such methods, it is possible to calculate the non-
inferiority margin for a fully-powered evaluation of stepped care vs. high-
intensity therapy alone using the effect size of historical trials comparing 
stepped care versus controls.  Based on the (updated) systematic review of 
stepped care reported in this thesis, stepped care was superior to care as usual 
by a mean of 0.4 standard deviation units (95% confidence interval 0.22 to 0.57) 
or a mean of 5.1 (2.8 to 7.3) BDI-I units (assuming an SD of 12.8 from Beck and 
colleagues (Beck, Steer, & Brown, 1996).  Non-inferiority margins can be 
calculated as 0.5 x mean control effect size (that is, 0.5 x 5.1 = 2.55) or as the 
lower limit of the 95% confidence interval for the effect (that is, 2.8) (European 
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Medicines Agency Committee for Medicinal Products for Human Use (CHMP), 
2005; Snappin, 2000). 
Additional calculations can also be performed that acknowledge the unreliability 
of the estimate of the relative effect of stepped care in the systematic review.   
Excluding the results of one trial (Araya et al., 2003) with a very large effect 
size, stepped care was superior to care as usual by a mean of 0.35 standard 
deviation units (95% confidence interval 0.17 to 0.52) – or 4.5 (2.2 to 6.7) BDI-I 
units, assuming a SD of 12.8 (Beck et al., 1996).  Based on this sensitivity 
analysis, the non-inferiority margin can be calculated as 2.25 (that is 0.5 x 4.5) 
or 2.2, the lower limit of the associated 95% confidence interval. 
It is also possible to estimate the non-inferiority margin using the published 
minimal clinically important difference (MCID) for the BDI.  Button et al. (2015) 
have found that the BDI-II MCID is dependent on initial (pre-treatment) 
depression severity.  For a sample of patients with ‘more typical’ (rather than 
treatment resistant) depression, they estimated a MCID of a 17.5% reduction in 
BDI-II scores from baseline.  Assuming that the 17.5% reduction is a valid 
percentage with which to estimate the MCID between trial arms at follow-up, the 
non-inferiority margin for a large stepped care trial can be calculated as 17.5% 
of the STEPS’ six month mean control group score on the BDI-I.  That is 17.5% 
of 14 i.e. 2.5 BDI-I units. To help ensure an adequate test of the non-inferiority 
of stepped care vs. high-intensity therapy alone, a number of scenarios have 
subsequently been used to estimate the sample size required in a future trial 
that allow for the potential uncertainty in the non-inferiority margin (  
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Table 35).  Based on STEPS pilot trial data on the variability in patient 
outcomes all of the scenarios use a standard deviation of 10.0 in the primary 
outcome.  In addition, although STEPS study data suggested that the retention 
rate will be between 83.8% and 97.8%, scenarios allow for 20% attrition. 
 
  
310 
Table 35. Sample size estimation for a future trial 
 
Approach MCID 
1
 
Power Sample size per group 
after 20% attrition 
LCI StC – UC effect size 
2
 2.8 90% 337 
50% StC – UC effect size 2.55 90% 405 
BDI-II MCID 2.5 90% 421 
50% StC – UC ES, Araya omitted 2.25 90% 520 
LCI StC  - UC ES, Araya omitted 2.2 90% 544 
LCI StC – UC effect size 2.8 80% 252 
50% StC – UC effect size 2.55 80% 303 
BDI-II MCID 2.5 80% 315 
50% StC - UC ES, Araya omitted 2.25 80% 389 
LCI StC  - UC ES, Araya omitted 2.2 80% 406 
 
Notes.  
1
 MCID= Minimal Clinically Important Difference (non-inferiority margin) - calculated using BDI-I SD 
of 12.8 from Beck et al 1996; 
2
 LCI=Lowest confidence interval limit of the stepped care vs. usual care 
effect size. 
 
Selecting a relatively conservative non-inferiority margin and power of 80%, a 
total of 606 participants would need to be recruited in a future trial to detect a 
between group non-inferiority margin of 2.55 in BDI-I units at a one-sided alpha, 
allowing for 20% attrition.  Applying the level of attrition observed at each stage 
of pilot trial recruitment (Figure 10), it is subsequently estimated that, in a fully-
powered evaluation, a total of 21,090 patients would need to be invited to 
participate in order to recruit to target (Figure 12).  Equivalent data could be 
estimated based on the alternative scenarios in   
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Table 35 and combined with the estimates provided here, should be used to 
select a target sample size for a future trial. 
 
Figure 12. Estimated recruitment and retention in a fully-powered non-inferiority 
trial of stepped care vs. high-intensity therapy alone to achieve a target sample 
size of n=606 
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7.7.3 Resource required in a future trial 
Pilot trial data on the clinic and research resource required to conduct STEPS 
can be used to estimate the resource required for a fully-powered RCT with a 
target sample size of 606 participants.  Sixty-six STEPS participants were 
recruited in 11 months via one IAPT service; patients were subsequently treated 
by 1.5 Full Time Equivalent (FTE) therapists.  The total treatment period was 
1.75 years.  Based on this data, it is estimated that to recruit 606 patients in 
approximately one year would require nine IAPT services of a similar size; 
patient treatment could be completed in 1.75 years by 13.5 FTE therapists. 
  The exact number of therapist hours required in a future trial will, in part, 
depend on the proportion of stepped care patients who step up.  Pilot trial data 
revealed that a third of STEPS patients progressed from low- to high-intensity 
treatment.  Based on the 95% confidence interval for this percentage it was 
inferred that in a future trial, the percentage of patients who would step up 
would be between 17.9% and 51.8%.    Additional therapist hours would be 
needed to accommodate a higher step up rate.  Given that pilot trial recruitment 
was negatively affected by a lack of therapist resource (a higher number of 
potential participants were available than the AccEPT Clinic had capacity to 
treat) it is suggested that engaging more than 13.5 FTE therapists in a large trial 
would help to avoid difficulties in recruitment, reduce the recruitment (and 
treatment) period and ensure adequate clinic resource to accommodate a 
higher step up rate. 
In terms of the research resource required in a large RCT, STEPS engaged one 
full-time researcher to recruit 66 participants and collect six month follow-up 
data from 91% of patients; recruitment and data collection were complete within 
1.5 years.  Based on this data, it can be inferred that a large trial would require 
nine FTE researchers to recruit and follow-up 606 participants.  If primary 
outcome data was collected at twelve instead of six months (see section 7.6.3), 
researchers would need to be employed for at least two years. 
 7.7.4 Stepped care clinical protocol in a future trial 
Qualitative analysis on acceptability found that although the stepped care 
intervention was broadly acceptable to therapists, there was no single 
313 
experience or pattern of experiences to define patient acceptability.   Across the 
small number of other qualitative studies that have been completed on stepped 
care, heterogeneity is not atypical: attitudes towards stepped care in routine 
clinical practice have been found to vary (Parry et al., 2011; Richards et al., 
2010); another stepped care trial reported variation in the level of patient 
satisfaction with the intervention (Shinde et al., 2013).  In this context, it is 
suggested that heterogeneity alone should not prevent the conduct of a large 
RCT using the STEPS clinical protocol.  However, in terms of the suitability of 
the stepped care clinical protocol for use in a large trial, it is also relevant to 
appraise patients’ and therapists’ views of the intervention in relation to the four 
possible problems with stepped care that have been highlighted by a number of 
authors (Chapter Two, section 2.5.). 
(1) The appropriateness of low-intensity therapy 
Consistent with authors’ suggestion that patients and professionals may feel 
that the provision of low-intensity therapy is inappropriate (Bilsker et al., 2012; 
Scogin et al., 2003), some STEPS patients doubted the suitability of low-
intensity therapy given the severity of their symptoms and / or the nature of their 
difficulties.  Therapists also expressed reservations regarding the suitability of 
low-intensity treatment for patients with severe depression and complex or 
entrenched difficulties.  However, other patients viewed low-intensity therapy 
positively and were not greatly troubled by the degree to which it might be 
suitable.  Furthermore, patient views of low-intensity treatment could change; 
those who were cautious about the appropriateness of GSH sometimes came to 
view it positively.  In addition, despite their reservations, STEPS therapists 
viewed the intervention as appropriate for the majority of patients.  It is therefore 
suggested that concerns regarding the suitability of low-intensity therapy were 
not so strong or entrenched to prevent the conduct of a future trial incorporating 
the use of low-intensity therapy as tested in STEPS. 
(2) Unsuccessful low-intensity treatment and (3) patient choice 
Other features of stepped care thought to be problematic include the 
consequences of unsuccessful low-intensity treatment (Kellett & Matthews, 
2008; Scogin et al., 2003) and restricted patient choice (Lovell & Bee, 2008).  
With respect to unsuccessful low-intensity treatment, although some patients 
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experienced difficult and negative feelings when they did not respond to GSH, it 
is noteworthy that, despite this experience, unsuccessful low-intensity therapy 
did not deter patients from high-intensity CBT.   Rather, with support from 
family, friends and therapists, patients who had negative feelings came to view 
the option to have high-intensity therapy, positively.  Furthermore, in terms of 
patient choice, this did not emerge as a significant concern.  Whilst some 
people expressed a preference for high-intensity treatment, most patients did 
not object strongly to the prospect of low-intensity therapy and although 
therapists were sometimes uncertain about the suitability of high-intensity CBT 
for patients who did not engage in low-intensity CBT, patients did not ask for a 
wider choice of high-intensity therapies after unsuccessful GSH.  Patient 
experience of unsuccessful low-intensity therapy and restricted choice offer no 
reason to modify or decide against using the stepped care intervention in a 
large trial. 
(4) Stepping criteria 
Gellatly (2011) proposed that inconsistency around therapists’ decision to step 
patients up or out of treatment following low-intensity therapy may stem from a 
tension between the desire to tailor or individualise treatment and standardised 
guidelines for deciding which patients have high-intensity therapy and when.  
Although STEPS therapist experience highlighted uncertainties about the 
stepping criteria, concern did not obviously reflect a desire to tailor patient 
treatment.  Rather, therapists queried how well the criteria worked for all 
patients or a distinct group, specifically, (i) the appropriateness of criteria for 
patients with low pre-treatment scores, (ii) whether criteria were sufficient to 
help prevent risk of relapse and recurrence, and (iii) the focus on symptoms of 
depression but not anxiety.  For this reason, although it might still be important 
to address therapist questions (see below) it is not obvious that greater freedom 
in how criteria are applied is needed for decision making to be more acceptable.  
The stepped care clinical protocol can be used in a future trial without changes 
to address a tension between the desire to tailor treatment and standardised 
guidelines. 
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Possible changes to a stepped care clinical protocol for a large trial 
Based on patient data, it was not possible to identify ways in which the stepped 
care clinical protocol could be modified that would reliably improve acceptability.  
Only one aspect generated reasonable consensus: patients and therapists 
raised issue with use of the PHQ-9 for monitoring symptoms of depression.  As 
such, it may be possible to address this issue in a future trial (see Box 9).  
However, modifying other aspects of stepped care might improve the 
intervention for some patients but make it less acceptable to others.  Patient 
experience does not offer a clear basis for changes to the stepped care 
intervention in a large trial. 
In contrast, although the stepped care intervention was broadly acceptable to 
therapists, therapist experience highlighted elements of each of high- and low-
intensity treatment, monitoring and stepping that could be modified in a large 
trial - or that at least require further consideration.  In terms of how to respond to 
one particular aspect of therapist experience – stepping criteria – due to a lack 
of evidence on the performance of different criteria, changes that would reliably 
improve patient outcomes and therefore acceptability to therapists, cannot be 
identified.  Long-term outcomes for patients who begin treatment with low PHQ-
9 scores and are discharged despite relatively little progress are unclear.  
Although the presence of residual symptoms has been implicated in the risk of 
relapse and recurrence of depression (Beevers, Keitner, Ryan, & Miller, 2003; 
Bockting, Spinhoven, Koeter, Wouters, & Schene, 2006; Faravelli, Ambonetti, 
Pallanti, & Pazzagli, 1986), the relationship between residual symptoms and 
relapse is also unclear (Burcusa & Iacono, 2007).  Rather than modify stepping 
criteria, it may be sufficient to discuss related uncertainties with trial therapists 
to help promote their understanding and acceptance of existing criteria for use 
in a large trial.  This and other suggestions for how to respond to therapist 
experience are outlined in Box 9.  Several ways in which the stepped care 
clinical protocol might be modified are proposed. 
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Box 9. Possible modifications to the stepped care clinical protocol and other 
action in response to therapist experience 
 
Therapist experience 
 
 
Suggested modification / action 
Low-intensity therapy 
 
A different order to the WB course may have been 
helpful for some patients as would flexibility to 
tailor the order for individuals 
 
Patients did not use or value Additional 
Resources; there was not enough time to talk 
about the resources in therapy 
 
No particular issue prompted this suggested 
modification 
 
 
Session six was not modularised and was not 
needed by some patients 
 
 
When patients missed sessions, had a difficult 
week or did not do homework this was difficult for 
the therapist to accommodate 
 
Review the order in which Wellbeing Course material 
is delivered and the option for therapists to vary the 
order for individual patients 
 
Reconsider how best to incorporate the use of 
Additional Resources 
 
 
Consider linking course material to patients’ 
therapeutic goals 
 
Review the need for session six; revisit its structure 
and content (see also ‘monitoring and stepping’, 
point three) 
 
Consider flexibility for therapists to defer patient 
sessions; agree circumstances in which this may be 
appropriate 
 
 
Box 9 continued overleaf 
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Therapist experience 
 
Suggested modification / action 
Monitoring and stepping 
 
The PHQ-9 was time-consuming to deliver and did 
not always accurately reflect patient experience 
 
 
 
 
 
Patients presented with anxiety as well as 
depression which may have been important to 
monitor 
 
Patient progress was often discussed at session 
five; the need apply stepping criteria in session six 
was unclear 
 
 
The suitability of stepping criteria for patients with 
low pre-treatment scores who made little progress 
and in terms of preventing relapse and recurrence 
was unclear 
 
Trial participants included a patient with bulimia 
and another patient who was dependent on 
alcohol 
 
High-intensity CBT may be unsuitable for patients 
who did not engage with low-intensity CBT 
 
 
Uncertainty re long-term outcomes for patients 
discharged from low-intensity therapy 
 
 
Administer the PHQ-9 with course material for 
patients to complete prior to phone calls.  Consider 
additional measures and other ways of recording 
patient progress alongside the PHQ-9 plus how this 
information may or not be used to inform stepping 
decisions 
 
Consider monitoring anxiety alongside depression 
and how this information may or not be used to 
inform stepping decisions 
 
Subject to a review session six (see ‘low-intensity 
therapy, point four), continue to administer stepping 
criteria at session six but allow flexibility to apply 
criteria at session five 
 
Present stepping criteria to therapists as part of trial 
orientation and provide more information via 
supervision and guidance documents 
 
 
Review criteria for when to discharge patients from 
therapy 
 
 
Consider presenting feasibility study data on 
acceptability and role of self-efficacy in patient 
engagement to illustrate different patient experience 
 
Consider offering follow-up appointments to all 
patients discharged at the end of GSH  
High-intensity therapy 
 
Patient experience of GSH was not used in high-
intensity CBT 
 
 
 
 
Uncertainty re how best to support patients who 
made little progress in high-intensity CBT 
 
Develop a pro-forma / separate forms for patients 
and therapists that capture patient experience of 
GSH and how this might influence CBT.  Discuss 
other options for making more use of GSH in CBT, 
with STEPS therapists 
 
Consider presenting feasibility study data on 
acceptability of high-intensity therapy to illustrate 
different patient experience of stepped care among 
those for whom high-intensity therapy is less 
acceptable 
 
7.7.5 Research that could be embedded in a future trial 
In addition to changes to the stepped care clinical protocol, directions for future 
research are recommended that could be embedded in a fully-powered RCT of 
stepped care vs. high-intensity psychological therapy alone for the treatment of 
depression in adults.  
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Testing the relationship between acceptability and attendance 
STEPS found that self-efficacy had a role in patient engagement.   The role for 
self-efficacy in low-intensity therapy is also evident in other qualitative research 
(Farrand et al., 2007) and the concept can be likened to that of self-liberation 
which has been used by Critis-Christoph and Connolly Gibbons (2002) to 
describe a belief held by patients as they prepare to modify their behaviour that 
they, “Have the personal determinism to change… and the commitment and 
recommitment to act on this belief,” (p306).  However, although others may 
have captured the role for self-efficacy (or a related concept) in patient attitude 
to treatment and its implications for behaviour change, our understanding of the 
role of self-efficacy in therapeutic attendance, or indeed patient outcomes, is at 
an early stage.  STEPS feasibility study data offered insight into how patient 
engagement and self-efficacy may relate among a small number of participants 
who received stepped care yet findings are in no way conclusive. 
To improve our understanding of the role for self-efficacy in patient experience, 
self-efficacy data should be collected as part of a fully-powered RCT of stepped 
care vs. high-intensity therapy alone.  In addition, the trial should incorporate a 
process evaluation to investigate mechanisms of change in stepped care and 
the influence of context on patient outcomes.  As part of the process evaluation, 
analyses should investigate the relationship between self-efficacy, therapeutic 
attendance and patient outcomes.   
Generating evidence on effective strategies for improving recruitment 
Given the dearth of evidence available to inform the development of effective 
recruitment methods and procedures, there may be an opportunity for a large 
trial of stepped care to include an embedded trial to test the effectiveness of an 
adapted recruitment strategy.  An adapted strategy could respond to the 
barriers to recruitment identified from qualitative research.  The Systematic 
Techniques for Assisting Recruitment to Trials (START) programme has been 
funded by the UK Medical Research Council to support the routine adoption of 
embedded trials to test recruitment interventions in host trials (Rick et al., 2014).  
Health services researchers involved in planning a large stepped care trial 
should refer to the outputs of that programme which are expected to include 
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guidelines for the design, analysis and reporting of embedded recruitment 
studies. 
7.7.6 Improving the use of mixed methods in health services research 
Although the use of mixed methods may be reasonably common in health 
services research, STEPS is unusual for conducting mixed methods analysis.  
Mixed methods studies typically employ multiple methods but undertake 
quantitative and qualitative strands of work in parallel; data is only integrated at 
the point of discussion (Borglin, 2015).  In contrast, STEPS demonstrated how 
different data types can be combined with rigour at the point of analysis and, in 
response to a mixed methods question, generate new insights that may not 
have been possible from a more straightforward comparison of quantitative and 
qualitative data.  In this regard, STEPS provides an original example of how it is 
possible to formulate a mixed methods research question and take full 
advantage of existing techniques that truly integrate data in the development 
and evaluation of complex interventions.  
Yet more generally, very little guidance is available for the health service 
research community to follow on how to integrate data throughout study 
designs, including during analysis.  In addition,  standards for the reporting of 
mixed methods studies and how to assess the quality of published studies have 
only fairly recently received attention  (Borglin, 2015) and despite attempts to 
improve reporting (O'Cathain et al., 2008), the quality of published articles on 
mixed methods research is often sub-optimal (Wisdom et al., 2012).  The 
shortage of guidance to assist researchers, those responsible for reviewing 
grant applications as well as studies that have been written up for publication, 
means that current limitations in the quality and conduct of mixed methods may 
be more likely to persist.  Without the transfer of knowledge, it is possible that 
mixed methods studies will continue to be undertaken that fail to maximise the 
potential of integrated mixed methods analysis. 
To improve the use and utility, therefore, of mixed methods research, a 
programme of work is recommended to provide the health services research 
community with practical guidance and information in the design, conduct and 
appraisal of mixed methods studies.  Consistent with an approach that has 
previously been used to develop process evaluation guidance (Moore et al., 
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2014), this programme of work might encompass a workshop of participants 
with a strong interest and experience in mixed methods, literature review and 
the identification of and detailed reflection on high-quality case studies of mixed 
methods research.   
7.8 Clinical implications of the feasibility study 
STEPS feasibility study was undertaken to inform the conduct, design and 
development of a fully-powered evaluation of stepped care compared with high-
intensity psychological therapy alone.  However, results on acceptability may be 
of immediate interest to patients, clinicians and health service providers.  Pilot 
trial findings on the resource saving associated with the delivery of stepped care 
vs. high-intensity CBT alone may also be of interest. 
Clinical implications of data on acceptability  
The three cross-cutting themes on the acceptability of stepped care, one of 
which may have a role in patient engagement, provide a way of exploring what 
people think of this system.  Likewise, the themes and sub-themes used to 
describe STEPS patient experience offer a framework for patients and 
therapists to consider how people might feel about each core component of this 
intervention (see Box 10). 
 
Box 10. A framework for exploring patient views of stepped care 
1. Guided Self-Help 
 
How does the person feel about the idea of starting with low-intensity therapy knowing 
high-intensity therapy could follow? 
To what extent might the patient relate to any written material 
How do they feel about reading and using material on their own? 
o What is the person’s reading ability / organisational skills? 
o How much time do they have? 
o Is the person likely to approach reading in a way to suit themselves? 
How does the patient feel about therapy by phone? 
What is the person hoping for from their therapist? 
How do they feel about the length and pace of sessions and the total duration of low-
intensity therapy? 
 
Box 10. continued overleaf  
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2. Monitoring 
 
What does the patient think about their symptoms of depression (and anxiety) being 
routinely monitored using a checklist? 
How might they use their scores? 
How might the person react if a score did not tally with how they were feeling? 
What do they make of the specific questionnaire(s) for monitoring? 
3. Stepping 
 
How does the patient think they might respond to unsuccessful low-intensity therapy? 
And then feel about going on to high-intensity therapy? 
If applicable, what does the patient think about the prospect of changing therapist?  
4. Cognitive Behaviour Therapy 
 
How does the person feel about meeting with their therapist face to face? 
What would be important from the therapeutic relationship? 
What does the patient think about the length and pace of sessions and the possible 
duration of high-intensity therapy? 
 
By using this framework and exploring the degree to which patients 
demonstrate a sense self-efficacy, being ‘on their own’ and ‘needing something 
more’ before treatment, it may be possible to anticipate patients for whom 
stepped care may be less acceptable.  Based on this information (and perhaps 
the results of further research on the role of self-efficacy in patient engagement 
and treatment outcomes) it may also be possible to develop a clinical algorithm 
for stratifying stepped care such that patients for whom low-intensity therapy is 
least acceptable (and who may be less likely to accept and remain in treatment) 
are immediately allocated high-intensity psychological therapy.  Moreover, if the 
results of further research confirm a relationship between self-efficacy and 
patient outcomes, it may ultimately be possible to incorporate an assessment of 
self-efficacy alongside other factors that are currently being considered as part 
of a clinical algorithm to personalise the care of patients with depression 
(DeRubeis et al., 2014; Huibers et al., 2015). 
In the immediate future, clinicians may want to consider how the findings on 
acceptability reported in this study, might apply to their own clinical practice.  In 
this regard, the data may apply to a greater or less extent depending on the 
level of similarity and difference between the form of stepped care implemented 
in STEPS and that implemented elsewhere.  By supplying a detailed description 
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of the feasibility study intervention, information is available to help clinicians 
interpret how findings on acceptability might relate to their work. 
Possible resource saving associated with the delivery of stepped care vs. 
high-intensity CBT alone 
As concluded earlier in this chapter (see 7.5.1) a fully-powered RCT 
incorporating cost-effectiveness analyses is required to establish, with certainty, 
if stepped care delivers treatment that is equivalent in clinical effect but more 
efficient compared with the traditional provision of psychological therapies.  
STEPS was not powered to detect clinically meaningful differences in the 
effectiveness of stepped care vs high-intensity CBT alone; it does not provide 
robust evidence on the clinic resource required to deliver stepped care.  
However, pilot trial data on receipt of the intervention and control (Table 17) can 
be used to estimate the therapist time that was required to deliver stepped care 
and high-intensity CBT alone and the patient journeys undertaken to attend 
treatment. 
Per patient, participants randomised to receive high-intensity CBT alone spent 
an average of 7.3 hours in treatment; on average, stepped care participants 
spent 5.9 hours in therapy.  Assuming that an hour of patient contact required 
an additional hour of therapist ‘admin’ time, the total therapist time to deliver 
therapy was 14.6 hours per CBT alone patient and 11.8 hours per stepped care 
participant.  Relative to CBT alone, per stepped care patient this represented an 
average saving of 2.8 therapist hours – or approximately 20% (2.8 / 14.6). 
With respect to patient journeys, pilot trial data on the number of CBT sessions 
attended (all of which were delivered in person at the MDC AccEPT Clinic) and 
the number of GSH patient contacts (one of which was routinely conducted face 
to face at the MDC) can be used to estimate patient travel.  Per participant, 
patients randomised to CBT alone attended a mean number of 8.8 therapy 
sessions for which they made 17.6 journeys to or from the AccEPT Clinic.  Per 
participant, stepped care patients attended a mean number of 4.3 high-intensity 
CBT sessions and 0.9 GSH sessions at the AccEPT Clinic – 5.2 sessions in 
total.  The mean number of journeys to or from stepped care was therefore 
estimated to be 10.4.  Compared with travel for patients who received CBT 
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alone, per stepped care participant, this represented an average saving of 7.2 
journeys – or approximately 40% (7.2 / 17.6) of the travel involved. 
 
Continued overleaf 
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7.9 Conclusions 
This thesis has encompassed a systematic review of stepped care treatment for 
depression and a mixed methods feasibility study to prepare for a fully-powered 
evaluation of stepped care compared with high-intensity psychological 
treatment alone.   
Key conclusions from the systematic review 
The systematic review found that, relative to usual care, stepped care is 
associated with significant improvements in depression outcomes.  However, 
there is a dearth of evidence on the effectiveness of this system compared with 
the provision of long-term intensive psychological therapies for all.  In the 
absence of robust, empirical research on the effect of stepped care vs. high-
intensity therapy alone it is not possible to conclude, with certainty, that stepped 
care should remain the dominant model of treatment organisation in the UK and 
elsewhere.    A non-inferiority randomised controlled trial should be undertaken 
to establish whether stepped care is not substantially inferior to high-intensity 
CBT in terms of clinical effect.  Cost-effectiveness analyses should be 
incorporated to determine the relative efficiency of both systems. 
Key conclusions from STEPS feasibility study 
Data from STEPS feasibility study suggests that a fully-powered evaluation of 
stepped care vs. high-intensity therapy alone is feasible albeit with scope to 
improve the performance of pilot trial recruitment methods and procedures and 
the acceptability of the stepped care intervention.  Recruitment methods and 
procedures should be modified in ways that address perceived patient barriers 
and effects on clinical practice reported by IAPT staff.  Changes to the 
intervention should reflect therapist experience of each key component of 
stepped care.  A funding application for a fully-powered evaluation of stepped 
care vs. high-intensity CBT alone can subsequently be prepared that should 
plan to recruit upwards of 600 participants and obtain adequate therapist 
resource to treat all patients.  Trial design should combine the definitive 
evaluation of stepped care with a process evaluation to investigate the role of 
self-efficacy in patient engagement and outcome.  
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Key conclusions from the mixed methods analysis 
By applying mixed methods analysis, STEPS provided an example of how it is 
possible take full advantage of existing techniques that truly integrate data in 
the development and evaluation of complex interventions.  To help improve the 
use and utility of mixed methods going forward, a programme of work is 
recommended that will provide the health services research community with 
practical guidance and information on mixed methods research. 
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Appendices 
 
 Appendix I: Meta-analysis computational formulae 
 
 Appendix II: Feasibility study recruitment 
 
 Appendix III: Feasibility study data collection 
 
 Appendix IV: Qualitative analysis of semi-structured interviews 
 
 Appendix V: Feasibility study management
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Appendix I: Meta-analysis computational formulae 
1. Standardised Mean Difference (Cohen’s d) 
(i) Given mean, SD and n in each group 
Raw difference in means (RawDiff) = Mean1 - Mean2 
Pooled (within groups) standard deviation (SDP) = Sqr ((((N1 - 1) * SD12 + (N2 - 1) * SD22) / (N1 + N2 - 2))) 
Standardized difference in means = RawDiff / SDP 
 
(ii) Given a 2 x 2 table of events 
Nomenclature for 2 x 2 table of events: 
 Events Non-Events N 
Intervention A B n1 
Control C D n2 
 
Compute the Log Odds Ratio and then convert to d 
 
Odds Ratio = A*D / B*C 
Log Odds Ratio = ln (Odds Ratio) 
d  = Sqr (3) * Log Odds Ratio / PI 
 
(PI (mathematical constant) = 3.142) 
 
(iii) Given difference in means between independent groups, n in each group 
and p 
pObs = pEntered / tails 
df = N1 + N2 - 2 
t = Abs (t for p, df) 
HarmonicN = (2 * N1 * N2) / (N1 + N2) 
d = t / (Sqr(HarmonicN) / Sqr(2)) 
 
(iv) Given difference in means between independent groups and associated CI 
Compute the SD of the (raw) difference in means (RawDiff SD) and then convert the raw difference (RawDiff) to 
d 
 
RawDiff SD = Sqr((N1 * N2) / (N1 + N2)) * RawDiffSE 
d = RawDiff / RawDiffSD 
 
2. Pooled effect using random effects model 
Pooled effect = weighted average of the intervention effects (Cohen’s d) estimated in each individual study 
Compute a weight for each study (W i) and then the pooled effect 
 
Wi = 1 / V*Yi 
(V*Yi = within-study variance for each study + between studies variance) 
Weighted average = sum of (estimate x weight) / sum of weights i.e.  Σ diWi / ΣWi 
 
3. Q statistic 
Q = sum of (the difference between each study effect and the pooled effect, squared x the weight for each study) 
Q = Σ Wi (di – M)
2 
 
Wi = study weight ; di = individual study effect; M = pooled effect 
 
4. I2 statistic 
I2 = (Q – df / Q) * 100% 
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Appendix II: Feasibility study recruitment 
 
This appendix provides a copy of supporting documents used for feasibility 
study recruitment, specifically: 
 
 Study summary sheet 
 ‘Permission for researcher to contact’ form 
 Patient Information Sheet 
 ‘Information for Clinic’ form 
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STEPS study summary sheet 
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‘Permission for researcher to contact’ form 
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Participant Information Sheet 
  
STEPS (Development and Evaluation of Stepped Care:  
A Mixed Method Feasibility Study) 
 
 
You are being invited to take part in a research study.  Before you decide 
whether you want to take part or not it is important for you to understand why 
the research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
What is the purpose of the study? 
Depression causes misery to many people and is a major health problem in the 
UK.  Although drug and psychological treatments are effective, we are less 
certain about how to organize these.  A system for depression treatment called 
‘stepped care’ requires that almost all patients receive a ‘low intensity’ 
psychological treatment such as guided self-help and only those patients who 
do not respond are given more intensive treatment such as cognitive behaviour 
therapy (CBT).  Although this way of organising treatment is widely used in the 
UK, we do not know if it is acceptable to patients and to clinicians and whether it 
is more efficient than alternatives.  By carrying out a large clinical trial to 
compare the cost and outcome of stepped care with offering almost all patients 
intensive psychological therapy, we hope to find out which system is most 
effective for depression treatment.  However, before we can do this, we need to 
test our methods and procedures in a small trial.  We also need to speak with 
patients and clinicians to find out what they think about stepped care. 
Why have I been invited? 
Your local IAPT service is taking part in this study and you have recently been 
referred to them for treatment.  The letter from the service asks you to consider 
taking part in the research because you may have some of the depression 
symptoms we are treating in this study.  If you decide to take part one of our 
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research team will go through this information sheet with you and answer any 
questions you have. You will also be asked some questions by the researcher 
to see if you are eligible to be included for the treatments being tested. If you 
are already taking medication for depression you would still be eligible however 
if you are already receiving psychological treatment (‘talking therapy’) for 
depression then you would not.  Although you would need to be excluded from 
taking part in this specific study, you will still be treated by the IAPT service and 
your treatment with them would not be delayed.  
Do I have to take part? 
No. It is entirely up to you to decide whether or not to take part.  If you do 
decide to take part you will be asked to sign a consent form. You will still be still 
free to withdraw at any time and without giving a reason. A decision to withdraw 
or not to take part will not affect the care you receive in any way. 
What is being tested? 
We are running a small clinical trial to compare two systems used to organize 
depression treatment – stepped care and offering patients intensive talking 
therapy (psychological therapy).  Stepped care will involve two psychological 
therapies for depression – guided self-help and CBT which are recommended 
by the UK National Institute for Health and Clinical Excellence (NICE) for the 
treatment of depression.  Intensive psychological therapy will involve CBT only.  
NICE has recommended that a large trial be carried out to test stepped care but 
before we can do this, we need to find out how big such a trial needs to be and 
how many people we need to approach to take part.  We also need to know 
what patients and clinicians think about stepped care.  A small trial will allow us 
to develop our trial methods and we will use qualitative interviews to find out if 
stepped care is acceptable to people. 
Guided self help is based on the idea that it can sometimes be easier and 
helpful for people to learn about depression and how they can manage its 
symptoms by reading useful material whilst being supported by a therapist.  The 
therapist aims to be available to you and encourage you to read.  The treatment 
involves learning about the symptoms of depression, how to challenge unhelpful 
thoughts, and managing physical symptoms and behaviours that can maintain 
the symptoms of depression.   
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Cognitive Behaviour Therapy (CBT) is based on the idea that certain ways of 
thinking can trigger, or fuel, certain mental health problems such as depression. 
The therapist helps you to understand your thought patterns. In particular, to 
identify any harmful or unhelpful ideas or thoughts which you have that can 
make you depressed. The aim is then to change your ways of thinking to avoid 
these ideas and to help your thought patterns to be more realistic and helpful, to 
achieve changes in the way that you think, feel and behave. 
What will happen to me if I take part? 
If you decide you might like to take part and return your ‘Permission for 
Researcher to Contact’ form, a researcher will telephone you and ask some 
questions to see if you are potentially eligible and to explain the study in more 
detail, but only after you have agreed to be contacted by us and we have 
allowed you time to think about whether you want to take part or not.  If you are 
potentially eligible to take part, we will then arrange to speak with you on the 
phone or meet with you at your home to ask you some more questions that will 
tell us if you are eligible.  Alternatively, if we cannot speak on the phone or meet 
at your home, we will arrange to meet with you at the University of Exeter.  You 
can ask us about the study at any time.  If we confirm that you are eligible and 
you agree to take part you will receive stepped care or CBT alone. However, if 
after you have spoken with the researcher and answered some questions it is 
found that you are not eligible to take part, we are really sorry if it causes you 
disappointment and thank you for your interest and time that you have given. If 
you are not eligible to take part we would refer you back to your local IAPT 
service to continue treatment in the normal way. 
If you are eligible to take part we need to explain that this study is a randomised 
controlled trial which means that once you have been interviewed by a 
researcher and have decided you would like to take part, the decision about 
whether you receive stepped care or CBT alone is made completely by chance. 
In this trial half of our participants will receive stepped care and half CBT alone. 
We will allocate you to either stepped care or CBT by assigning you a personal 
identification number, known only to the research team, which will be entered 
into a secure computer system that picks the numbers at random and allocates 
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them to one of the treatments at random.  We will let your local IAPT service 
know that you are participating in this study. 
If you are allocated to stepped care, you will receive a minimum of six sessions 
of 30 minutes duration with a trained therapist once a week, spread over 6 
weeks.  The therapist will see you face to face or speak with you over the phone 
and help you read material about depression and what you can do to reduce 
and manage depressive symptoms.  If at the end of the six week period, you 
require more intensive therapy, you will go on to receive between eight and 
twenty sessions of CBT with a trained therapist who will deliver your treatment 
in the same way as for people who only receive CBT.  If you are allocated to 
CBT alone, you will receive between eight and twenty sessions of 50 minutes 
duration with a therapist, spread over up to four months.  You will receive face 
to face sessions, with the option of the session being conducted up to twice 
weekly over the first two months and then weekly thereafter. 
Once you have been allocated to stepped care or CBT alone and receive all of 
the treatment sessions, you will be seen again for a follow-up appointment with 
a researcher at six months to complete a number of questionnaires. Overall, 
your involvement in the study will be for a maximum of six months although the 
research study will last for two years. 
What information do you need from me? 
If you agree to take part in the research the first thing we will want to do is find 
out about you. We will need to ask about your current and past mental health as 
well as your life more generally. We will ask you some questions about how you 
have been feeling recently and there will be a few questionnaires that we would 
like you to fill out.  You will also be able to ask any questions you may have 
about the study. This meeting will take about two hours.  We expect that the 
follow-up appointment will take no more than around 45 minutes and we will 
collect some more questionnaires from you at this appointment. 
We are also interested in finding out about people’s experiences of taking part 
in the trial and what they think of stepped care and will be giving a small number 
of people the opportunity to describe their experiences. We will ask some of the 
participants who are allocated to stepped care to attend a longer interview of up 
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to 60 minutes after they have completed treatment and we would like to audio 
or video record this.  The interview would be conducted over the phone or face 
to face at your home.  Alternatively, if you cannot speak on the phone or meet a 
study researcher at your home, we will arrange to meet with you at the 
University of Exeter.  There is a separate part to the consent form to allow for 
the interview and you do not have to agree to it if you do not want to.  If you 
choose not to take part in the interview, you can still take part in the trial and it 
will not affect the standard of care you receive. If you agree, the recordings will 
be given a code and securely stored for a maximum of nine years before being 
destroyed.  We will also make typed copies of the recorded conversations. We 
will ensure all information in these copies is anonymous by removing all named 
references to you or your family and friends.  
So that we can select people for interview depending on how much therapy they 
receive, we will would like to keep track of how many and which therapy 
sessions you attend.  This information will be recorded by your therapist and will 
be shared with the research team.  The number of sessions you attend will not 
affect your care or your on-going involvement in the trial. 
Will I have to do anything differently? 
No, there are no restrictions in your lifestyle from taking part in this research. 
You should continue to follow the advice of your GP if they remain involved in 
your care. 
Will I be paid to take part? 
No.  We cannot pay people to attend appointments with their therapist and we 
will not reimburse travel expenses for these.  Occasionally, it may be necessary 
for people to attend additional interviews with a study researcher at the 
University of Exeter for which we will pay travel expenses. 
Are there any side effects, disadvantages and risks of taking part? 
We are not aware of any side effects, disadvantages or risks to you of taking 
part in this research. 
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What are the possible benefits of taking part? 
Many people find that guided self-help and/or CBT are helpful as both have 
been shown to have a positive effect for some people with depression. We hope 
that you will find the treatment you are given will help you. However, we cannot 
guarantee that you will benefit from the treatments. The information we get from 
this study may help us to treat future patients with depression better. 
 
What happens when the research study stops? 
We will encourage you to continue to see your GP who will treat you as s/he 
feels is best for you and with your agreement.  We may also encourage you to 
re-contact your local IAPT service who will treat you in the usual way.  
What if something goes wrong or I have a complaint? 
We do not expect any harm coming to you from being in this study. However, if 
you wished to complain, or had any concerns about any aspect of the way you 
have been approached or were treated during the course of this study, the 
normal National Health Service complaints mechanisms are available to you 
through the Patient Advice and Liaison Service (PALS) on 0800 0730741.   
Alternatively, you may prefer to raise the matter with the Mood Disorder Centre 
AccEPT Clinic.  Written complaints should be sent to the AccEPT clinic 
complaints manager, Holly Sugg, AccEPT Clinic Administrator, at: Washington 
Singer Laboratories, School of Psychology, University of Exeter, Perry Road, 
Exeter, EX4 4QG.  If you are eligible, agree to take part and are unhappy with 
the care or treatment you receive, you can also raise the matter (in writing or by 
speaking) with your clinic therapist. 
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the research will be kept 
strictly confidential. Any information about you that is collected from the 
questionnaires or interviews will have your name and address removed so that 
you cannot be recognised from it. As your GP may be involved in your 
treatment, s/he will be informed of your progress as part of the research study, 
with your permission.  Should your condition worsen to a point where it is felt by 
either a researcher or a clinician that you may be a danger to yourself or others, 
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your GP will be informed of this; with or without your permission.  However, this 
is the only time we would ever break confidentially. 
Who is organising and funding the research? 
The study researcher is funded by the University of Exeter who also sponsor 
this research.  This is not a commercially funded industry study.  This means 
that the IAPT service which invited you to express your interest and the 
research team will not receive any extra money for conducting this study. 
Who has reviewed the study? 
All research involving NHS patients is looked at by an independent group of 
people called a Research Ethics Committee to protect your safety, rights well-
being and dignity. The study has been reviewed and given a favourable opinion 
by the South West - Frenchay Research Ethics Committee. 
 
Further Information – Next Steps 
 
Please look at the ‘Participant Flow Chart’ which sets out the assessment and 
treatment process in a way which we hope you find helpful.  If you would like to 
know more about the study you should complete your ‘Permission for 
Researcher to Contact’ form and bring it with you to your DAS Assessment 
Appointment.  We will then contact you and invite you to ask us any questions 
you may have.  If you want to take part and are potentially eligible, an 
appointment will be arranged at a time to suit you, for you to come and see 
Jacqueline Hill who is the study researcher.  During this meeting you will also 
have the chance to ask questions and we will ask you for more information to 
find out if you are eligible.  Last, if you are eligible and want to take part, we will 
ask you to sign a form to say so and then get you to fill out some questionnaires 
about yourself.  We will complete this process within five working days of your 
Assessment Appointment. 
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If you need further information to help you decide, please contact Jacqueline 
Hill at the address below.  
 
Thank you for reading this and for considering taking part in this study. 
 
Contact for Further Information 
 
If you need further information about this study please contact: 
 
Jacqueline J. Hill, STEPS Study Researcher 
Sir Henry Wellcome Building for Mood Disorders Research 
University of Exeter, The Queen’s Drive 
Exeter, EX4 4QQ 
 
Email: j.j.hill@exeter.ac.uk 
Office telephone: 01392 725273 
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STEPS Participant Information for Clinic Form 
To be completed at end baseline for eligible and willing patients 
 
TRIAL ID:  
 
 
Date Randomised:  
 
 
PREFERRED DAY(S) / TIME(S) FOR THERAPY:  
 
 
Demographics 
 
Marital Status:  
Number of Children: 
Ethnic Group:  
Level of Education:  
Age:  
Housing:  
Employment:  
 
CIS-R results 
 
Probable primary diagnosis:  
Probable secondary diagnosis:  
Total Score:  
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History of Depression and Treatment 
 
Previously diagnosed with depression in the past:  
If YES, number of previous episodes:  
Duration of current episode: 
Currently prescribed anti-depressant medication: 
 
 
Questionnaire Data 
 
BDI-I Total Score:  
BDI-I Level of Depression:  
GAD-7 Total Score:  
GAD-7 Level of Difficulty:  
 
 
Risk 
 
Risk Protocol Enacted:  
 
If YES: 
Date:  
Time point:  
Level of Risk:  
 
Previous suicide attempt: YES/NO 
 
 
Other Useful Information 
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Appendix III: Feasibility study data collection 
 
This appendix provides a copy of feasibility study questionnaires, therapy 
session record forms and interview topic guides used to collect data: 
 
 Baseline Case Report Form 
 Guided Self-Help session record 
 Cognitive Behaviour Therapy session record 
 Patient Health Questionnaire (PHQ-9)  
 Patient topic guide 
 Therapist topic guide 
 IAPT manager topic guide ** 
 
 
** Administrator and PWP guides not included - available on request
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Baseline Case Report Form (CRF) 
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  347 
 
  348 
 
  349 
 
  350 
 
  351 
 
  352 
 
  353 
 
  354 
 
  355 
 
  356 
 
  357 
 
  358 
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Participant Session Record 
Guided Self-Help 
 
Participant 
ID: 
Date of 
contact: 
Session 
number: 
PHQ9 
Score: 
 
Adverse Event: 
Circle all that 
apply 
 
YES  /  NO 
Serious 
 
Against the appropriate lesson, indicate key themes covered 
Lesson One  
 
 
 
Lesson Two 
 
 
 
Lesson Three 
 
 
 
Lesson four 
 
 
 
Lesson Five 
 
 
 
Action Following (including summary of any GP contact): 
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Participant Session Record 
Cognitive Behaviour Therapy 
 
Participant ID:   
Therapist: 
Date of session:  
Session number:  
 
Adverse Event (please circle all that apply):      YES 
/ NO / Serious 
 
Themes covered - please tick all that apply  
Assessment/rationale  
Descriptive conceptualisation  
Goal setting & first interventions  
Behavioural experiments  
Behavioural intervention: activity and mastery  
Behavioural intervention: activity scheduling  
Identifying and responding to negative thoughts  
Cross-sectional case formulation  
Session summary  
Patient feedback on session  
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PHQ-9 
 
     Over the last 2 weeks, how often have you been 
bothered by any of the following problems? 
(Use  to indicate your answer) 
 
 
Not at 
all 
 
 
Several 
days 
More 
than 
half the 
days 
 
Nearly 
every 
 day 
1.  Little interest or pleasure in doing things.......……… 0 1 2 3 
2.  Feeling down, depressed, or hopeless.………..…… 0 1 2 3 
3.  Trouble falling or staying asleep, or sleeping too 
much..................................................………..…….. 
 
0 
 
1 
 
2 
 
3 
4.  Feeling tired or having little energy......……...……… 0 1 2 3 
5.  Poor appetite or overeating.......................……….… 0 1 2 3 
6.  Feeling bad about yourself — or that you are a failure or 
have let yourself or your family down…… 
 
0 
 
1 
 
2 
 
3 
7.  Trouble concentrating on things, such as reading the 
newspaper or watching television.…………….. 
 
0 
 
1 
 
2 
 
3 
8.  Moving or speaking so slowly that other people could 
have noticed?  Or the opposite — being so fidgety or 
restless that you have been moving .around a lot more 
than usual..............……………. 
 
 
 
0 
 
 
 
1 
 
 
 
2 
 
 
 
3 
9.  Thoughts that you would be better off dead or of hurting 
yourself in some way......………………….. 
 
0 
 
1 
 
2 
 
3 
 
                              (For office coding: Total Score _____  =   ___   +   ___   +   ___ ) 
 
 
If you checked off any problems, how difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people? 
 
Not difficult  
at all 
Somewhat 
 difficult 
Very 
difficult 
Extremely 
difficult  
    
 
From the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (PRIME-MD PHQ). The PHQ was developed by Drs. 
Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues. For research information, contact Dr. Spitzer at 
rls8@columbia.edu.  PRIME-MD® is a trademark of Pfizer Inc. Copyright© 1999 Pfizer Inc.  All rights reserved.  Reproduced 
with permission 
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TRIAL ID 
 
DATE 
 
LOCATION 
 
 
 
The development of stepped care: a mixed method 
feasibility study 
 
 
Views and experiences of stepped care: 
Qualitative interview topic guide 
 
 
PATIENTS 
 
 
 What are patients’ views about the acceptability of stepped care? 
 What did people think of the Wellbeing Course? 
 What were people’s reactions to our trial methods and procedures? 
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Introduction 
 
Thank you very much for meeting with me today.  We really appreciate your 
time. 
You may remember that we’d like to know what you think about the treatment 
you’ve received as part of this study.  We’d also like to hear your views of how 
we have set up and run the study so I’ll be asking you some questions about 
that, too. 
Compared with when I last met with you, this interview will be a bit different.  
We’d like to know what you think about things.  This means that I will ask you 
questions for you to tell me your views and opinions – how things have been 
from your perspective.  Sometimes, I might follow up something you say with a 
few more questions to make sure that I fully understand it. 
Before we begin, are you still happy for our interview to be audio-recorded?  I’ll 
let you know when I start recording. 
You may remember that everything you say is kept strictly confidential with one 
exception and that’s if you tell me anything which makes me think you may be 
at risk of harming yourself or someone else.  Is that OK? 
Is there anything that you would like to ask before we begin?   
As we go through the questions, if anything is unclear, please do ask me to 
explain. 
Ready to begin? 
I’m going to start recording now. 
Switch on recorder and introduce the recording by stating the date and time of 
the interview and the interviewee’s first name.  
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ACCEPTABILITY OF STEPPED CARE 
 
Thoughts and feelings before treatment 
 
I’m interested in why you sought treatment for depression / anxiety.  What led 
you to seek help? 
What did you expect from treatment? 
Were there any problems with which you particularly wanted help?  What 
were they? 
How did you feel when you were offered stepped care? 
 
Experiences of therapy 
 
What did you think about Guided Self Help? 
 Of the material you received? 
 About meeting with your therapist 
o Face to face or by phone 
o How often you met or spoke 
o The length of each session 
 The total length of time you were in therapy – received GSH (max 6 weeks) 
 
What did you think about CBT? 
 The course content? 
 About meeting with your therapist 
o Face to face for all / most sessions 
o How often you met 
o The length of each session 
 The length of time you were in therapy – received CBT (max 4 months) 
 
What was useful / not useful about your treatment? 
How well did the therapy help you with the problems you wanted to work 
on? 
Why did you decline any treatment / stop early? 
How could your treatment have been improved? 
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Experiences of stepped care 
 
What do you understand by the term stepped care? 
 
What did you think about starting with Guided Self Help? 
 Knowing you may get CBT – or not? 
 Compared with only having CBT? 
 
How did you feel about going on to CBT? 
 What did you think about changing therapists? 
 
How did you feel about your symptoms of depression being assessed? 
 How often this happened 
 Using a symptom checklist 
 How the information was used (to decide if you stop treatment after GSH or go 
on to CBT) 
 
How did you feel when your treatment ended? 
 What, if anything, further should be done to help people who respond well to 
GSH and do not have CBT? 
 
 
FEASIBILITY AND APPROPRIATENESS OF TRIAL PROCEDURES 
 
Your views and opinions of how this study has been set up and run are also 
important to us. 
 
Recruitment 
 
First, I’d like you to think about how you came to join this study so what 
happened before you started treatment… 
 
When did you decide to take part? 
What did you think about the written information you received (summary sheet 
and PIS)? 
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How did you feel about how long it took for me to contact you after you returned 
your form? 
 
What did you think about meeting with your DAS therapist and then with me? 
 How did you find talking about your feelings / reasons for seeking treatment 
again? 
 
In study support 
 
Now I would like to know about how things were once you joined the study… 
 
What did you think of how long it took the clinic team to contact you after we 
met for your baseline interview? 
How easy was it to schedule therapy appointments? 
Did you receive all of the GSH material?  If not, what went wrong? 
How well have we addressed any questions or concerns you may have had 
since starting therapy? 
 
General 
 
What, if anything, could have been done differently to improve the running of 
the study? 
 
FINISH 
 
Finally, are there any other comments that you would like to make about taking 
part? 
 
Thank you. 
 
Stop recording and tell the patient that the recorder has been switched off.  
Explain that the patient will receive a short summary of the results of the 
interviews once completed plus a feedback form for their comment. 
Remind the patient that the research team will be in touch to arrange their six 
month follow up appointment. 
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PATIENT INTERIVEW CHECKLIST 
 
INTERVIEW NOTES TRIAL ID 
DATE 
LOCATION 
 
 
 
⃝ 
⃝ 
⃝ 
 
Before treatment 
 
How they came to treatment 
Expectations and problems to be 
addressed 
View of being offered stepped care 
 
 
 
 
⃝ 
⃝ 
⃝ 
⃝ 
 
 
 
 
⃝ 
⃝ 
⃝ 
⃝ 
 
 
 
 
 
⃝ 
 
 
 
 
 
⃝ 
 
 
Recruitment 
 
When decided to take part 
Summary and PIS 
Five day turnaround 
Meeting DAS therapist and then me 
 
 
In study 
 
Time for clinic to contact after baseline 
Arranging therapy 
Being sent GSH material 
Addressing questions / concerns 
 
 
General 
 
How could we improve how the study 
is run? 
 
 
END 
 
Any other comments on taking part? 
 
 
 
 
 
 
⃝ 
 
 
 
 
 
⃝ 
 
 
 
 
 
 
⃝ 
⃝ 
⃝ 
 
 
Experience of therapy 
 
Guided Self Help 
Material 
Meeting mode, frequency and length of 
each contact 
Total time in therapy 
 
CBT 
Course content 
Meeting mode, frequency and length of 
each contact 
Total time in therapy 
 
 
What was useful / not about therapy 
How well were problems addressed 
Reasons for declining / stopping treatment 
How to improve therapy 
 
 
 
 
⃝ 
⃝ 
⃝ 
 
⃝ 
 
 
 
 
⃝ 
 
 
 
Experiences of stepped care 
 
What’s meant by stepped care 
Starting with GSH 
Going on to CBT 
 
Being monitored 
How often 
Check list 
How the info was used 
 
Ending treatment 
Additional support for patients who do not 
have CBT 
 
 
 
 
OTHER 
 
Arising from interview… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  368 
 
 
 
 
THERAPIST ID 
 
DATE 
 
LOCATION 
 
 
 
The development of stepped care: a mixed method 
feasibility study 
 
 
Views and experiences of stepped care: 
Qualitative interview topic guide 
 
 
THERAPISTS 
 
 What are therapists’ views about the acceptability of stepped care? 
 What do therapists think of the Wellbeing Course? 
 What were their reactions to our trial methods and procedures? 
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Introduction 
Thank you very much for meeting with me today.  I really appreciate your time.  
As you know, I would like to find out what you think about the stepped care 
you’ve delivered as part of this study.  I’d also like to hear your views of how we 
have set up and run STEPS so I’ll be asking you some questions about that too.  
I have broad questions that will help structure the interview but I will also be led 
by what you say.  Sometimes I might follow up something you tell me with more 
questions to help me understand it in full. 
Is that OK? 
Before we begin, I would like to acknowledge that it may sometimes be difficult 
for you to provide honest feedback.  However, it is important for me to 
understand what did and didn’t work well.  The information you provide will be 
used to help develop a large clinical trial on stepped care.  Everything you say 
is kept strictly confidential.  This means that if I quoted something you said in a 
report or paper, I would not attribute the quote to you.  Nor will I, without your 
permission, include a quote that would directly identify you by something you 
said.  However, because a very small number of therapists have been involved 
in STEPS, it may be possible for a reader who is familiar with the project to 
attribute quotes and/or views, to you or your colleagues. 
Do you have any concerns? 
I will now ask you to complete a consent form.  By signing it you will give me 
permission to speak with you and to use the information you provide.  Run 
through consent form and invite questions. 
Is there anything that you would like to ask before we begin?   
As we go through the interview, if any of my questions are unclear, please do 
ask me to explain. 
Ready to begin? 
I’m going to start recording now. 
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Switch on recorder and introduce the recording by stating the date and time of 
the interview and the interviewee’s first name. 
 
1. UNDERSTANDING OF STEPPED CARE 
 
To help me understand what you think of stepped care, I would like to 
know how you define it.  Please describe stepped care to me.  
 
Explore: 
 
Definition of low and high intensity therapy 
The role of systematic monitoring to inform next treatment step 
Previous experience of stepped care 
 
2. LOW INTENSITY THERAPY 
 
I would now like to ask you about the stepped care you have implemented 
as part of this study.  First, please tell me what you thought of the 
Wellbeing Course. 
 
Explore: 
 
What they thought about the course material 
How they felt about conducting sessions by phone 
The frequency and length of each session and the total duration of the course 
How they expected patients to benefit from GSH 
Views on starting every StC patient with GSH - knowing patients may (or not) 
get CBT 
By comparison, what they thought of giving patients CBT alone 
Any patients or circumstances where it felt inappropriate to begin with GSH and 
how they handled that 
Reasons why patients declined GSH or dropped out early and how they felt 
about this 
Ways in which the WB course and how it was delivered could be improved 
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3. MONITORING 
 
You monitored stepped care patients’ symptoms of depression and used 
this information to help decide if people ended treatment or ‘stepped up’ 
following GSH.  What were your views and experience of this?  
 
Explore: 
 
How they felt about monitoring patients every week / session and how they 
used this information 
Their views on using a symptom checklist to monitor progress 
What they thought of the stepping criteria and how criteria were applied in 
practice 
The extent to which patients were involved in deciding to end treatment / step 
up 
Any patients for whom or circumstances in which the criteria felt wrong or were 
difficult to implement and how they handled this 
How they felt when patients ended treatment following GSH and what, if any, 
additional support they wanted to offer 
 
4. HIGH INTENSITY THERAPY 
 
About one third of patients ‘stepped up’ following GSH.  Please tell me 
what you thought about patients going on to CBT and the therapy they 
received. 
 
Explore: 
 
How they felt about patients stepping up and any concerns this raised 
Views on patients changing therapists and how they facilitated this transition 
What they thought of the frequency, length of sessions and total duration of 
CBT treatment - given that patients had already completed the WB course 
Views on patients’ total time in treatment following step up i.e. 6 to 8 months 
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Any reasons patients gave for declining CBT or dropping out early after 
completing GSH 
How they felt when patients who had stepped up ended CBT and how this was 
influenced by patients’ progress 
What more, if any, support they wanted to offer on end CBT 
 
Please tell me about anything else that feels important to feedback on 
your experience of stepped care. 
 
Patients for whom stepped care worked especially well or not and why 
How (else) we could improve how stepped care is delivered 
 
5. FEASIBILITY AND APPROPRIATENESS OF TRIAL PROCEDURES 
 
Your views and opinions of how this study has been set up and run are 
also important to us… 
 
Explore: 
 
What they thought of the STEPS orientation day [SHOW AGENDA]. 
Views on the Clinic handbook [SHOW HANDBOOK] including how much and 
what ways it was used 
How well we coordinated patients’ care on randomisation (allocated therapists 
and arranged first treatment sessions) 
Problems scheduling therapy sessions or sending patients GSH material 
Views and experiences of record keeping and file management including how 
they found filling in session records and patient contact logs 
How they felt about SAE and risk procedures 
Views on STEPS’ DNA protocol and letters to people who withdrew from 
therapy 
How they felt about clinical supervision 
 
Please tell me about anything else that feels important to feedback on the 
set up and running of STEPS 
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What might be done to improve how the study is run 
Any other comments about the research 
 
THANK YOU 
 
 
Stop recording and tell the therapist that the recorder has been switched off. 
 
Explain that the therapist will receive a short summary of the interview to check 
for accuracy. 
 
Then, once the results of all of the interviews with the therapists are combined, 
they will receive a brief summary and feedback form for comment.  This will be 
in a few months’ time. 
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THERAPIST INTERVIEW CHECKLIST 
 
THERAPIST ID; DATE AND LOCATION OF INTERVIEW: 
 
 
 
 
⃝ 
 
⃝ 
 
 
 
 
 
⃝ 
 
 
 
 
 
 
⃝ 
 
 
 
 
⃝ 
 
 
 
 
 
⃝ 
 
 
⃝ 
 
 
 
⃝ 
 
 
 
 
 
 
⃝ 
 
 
Stepped Care 
 
Understanding of stepped care 
 
Wellbeing Course 
Material 
Session mode, frequency and length  
Total time in GSH 
Any improvements 
 
Starting with GSH 
Knowing patients may (or not) have CBT 
Compared with only giving CBT 
Patients for whom this felt inappropriate 
How they expected patients to benefit 
Why people dropped out 
 
Monitoring 
How they felt about weekly monitoring 
Using a check list 
How info was used 
 
Stepping criteria 
Implementation in practice 
Patient involvement 
Patients for whom criteria felt wrong 
Circumstances where criteria felt wrong 
 
Ending treatment after GSH 
Additional support 
 
Stepping up 
Views on stepping up patients 
Changing therapists 
 
CBT 
Meeting mode, frequency and length of each 
contact 
Total time in CBT 
Total time in StC for patients who step up 
Why patients dropped out 
 
Ending treatment after CBT 
Additional support 
 
 
 
⃝ 
 
 
 
⃝ 
 
 
 
 
 
 
 
 
 
 
 
 
⃝ 
 
 
 
 
 
⃝ 
 
 
 
Study methods / procedures 
 
Set up 
Orientation day 
Clinic handbook 
 
In study 
Patient care on randomisation 
Arranging therapy 
Sending GSH material 
Record keeping / file management 
SAEs 
Risk 
DNA protocol and with-drawls 
Clinical Supervision 
 
 
END 
 
Any other comments 
On stepped care 
About study 
 
OTHER 
 
Arising from interview 
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INTERVIEWEE 
 
DATE 
 
LOCATION 
 
 
 
 
The development of stepped care: a mixed method 
feasibility study 
 
 
Feasibility and appropriateness of recruitment 
Qualitative interview topic guide 
 
IAPT MANAGER 
 
 To what extent were recruitment procedures implemented 
 What facilitated / hindered recruitment 
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INTRODUCTION 
 
Thank you very much for meeting with me today.  I really appreciate your time.  
As you know, I would like to find out what you think about STEPS.  Specifically, 
what you think about recruitment and how it involved DAS.  I have some broad 
questions that will help structure the interview but I will also be led by what you 
say.  Sometimes I might follow up something you tell me with more questions to 
help me understand it in full. 
Is that OK? 
Before we get going I would like to acknowledge that it may sometimes be 
awkward for you to share your views.  However, it is important for me to 
understand what did and didn’t work well.  The information you provide will be 
used to help develop a large clinical trial on stepped care.   I would also like to 
share a summary of what I learn from today with my colleagues: your views 
would be combined with those of other interviewees; I would not pass on 
confidential patient information; I would not attribute a specific view or quote to 
you.  However, because I will interview a small number of DAS personnel, it 
may be possible for someone who is familiar with STEPS and Exeter DAS to 
attribute what is said, to you.  Nonetheless, your feedback and that of your 
colleagues will be very useful. 
Please can you tell me if you have any concerns? 
I will now ask you to complete a consent form.  This will give me permission to 
speak with you and to use the information you provide. 
Run though the consent form; invite questions.  On completion, explain that we 
are ready to proceed. 
Is there anything that you would like to ask me before we begin? 
If any of my questions are unclear during the interview, please do ask me to 
explain. 
I am going to start recording now. 
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Switch on recorder and introduce the recording by stating the date, time and 
the interviewee’s first name. 
 
1. RESEARCH AND THE ROLE OF THE NHS 
To help me understand what you think about STEPS, I would like to know 
what you think about research in general. 
Explore: 
 
Positive and negative views 
The role of the NHS / DAS and research 
Previous experience of research – negative or positive 
 
2. SET UP 
I would now like to ask you about STEPS - first our work to agree how to 
recruit patients.    This involved a number of meetings.  We considered at 
what point to approach patients and a number of other concerns were 
raised.  Please tell me what you thought about this process. 
Explore: 
To what extent were concerns raised addressed 
Any other concerns 
What she thought about interaction with the research team 
How she felt about the agreed procedures 
 
3. IMPLEMENTATION 
We are also interested in how the agreed procedures worked in practice.  
Please can you tell me about your experiences of this? 
Explore: 
How did she communicate what was required of her team – therapists, admin – 
how did they react  
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Any problems 
What worked well 
What facilitated or hindered recruitment 
How she felt about interaction with the research team 
 
 
4. THERAPIST REACTION 
 
Please can you tell me (a bit more) about your and others’ experience of 
handling permission forms? 
 
Explore: 
 
What it felt like asking people for forms 
Anyone who did not ask patients about STEPS 
Types of patient or situations where people were not asked about STEPS 
 
5. PATIENT REACTION 
Drawing on your own and others’ experience, please tell us how patients 
responded when being asked if they wanted to return a permission form. 
Explore: 
What patients asked – any concerns 
How did therapists feel about and respond to these questions 
Reasons patients gave for deciding not to return a permission form 
Views on the IAPT letter and STEPS summary sheet 
 
6. END 
 
Please tell me about anything else which has been important in your 
experience of STEPS that we have not already discussed. 
 
Any other comments 
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What, if anything, would you have liked to have done differently? 
 
 
THANK YOU 
 
Stop recording and tell the interviewee that the recorder has been switched off. 
 
Explain that within a few weeks or so she will receive a short summary of the 
interview to check. 
Then, once all of the interviews with DAS have been completed, a summary of 
what we have learnt, again for feedback and comment. This will be in a few 
months’ time. 
 
At the end of the study (end 2015) we will share what we have learnt from 
STEPS as a whole. 
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Appendix IV: Qualitative analysis 
 
This appendix provides a copy of material related to the qualitative analysis of 
feasibility study interview data, specifically: 
 
 Sample patient interview field note 
 Transcription template 
 Example thematic framework 
 Example chart 
 Sample of abstraction 
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Sample Patient Interview Field Note 
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STEPS Qualitative Interview Transcript Template 
 
Participant Trial XX 
Interviewer Jacqueline J Hill 
Date of interview XX/XX/XXXX 
Mode of interview In person / By phone (delete as appropriate) 
Transcribed by Insert full name 
Date last modified XX/XX/XXXX 
Transcript checked 
by 
Insert name of person who checked transcript and date 
check completed 
 
Transcription conventions: 
{} Interviewer and participant talk at same time 
[] non-verbal utterances e.g. laughter 
Xxx unintelligible 
(…) pause 
Hyphen indicates an abrupt cut off or self-interruption 
Underlining indicates emphasis on the word 
 
 
 
Formatting: Trial transcripts have been formatted so that each exchange of 
conversation is labelled by the identifier for the person (patient, interviewer) who 
is speaking.  Insert what the person says on the line below their identifier.  
Interviewer and patient identifiers have been formatted as ‘heading levels’; what 
people say must be formatted as ‘normal’ text.  Insert a line break after what 
someone says and the next identifier.  The start of the transcript is labelled by 
the interviewee’s identifier – this label is formatted as normal text.  The end of 
the transcript is demarcated by, “END OF TRANSCRIPT” – this has been 
written as normal text.  All formatting should be left as is. 
 
Identifiers:  The interviewer will always be Jacqueline J Hill.  Her identifier is I-
JJ. Patient identifiers contain three pieces of information and they are written in 
the form: PAT-XXX-XXX.  ‘PAT’ stands for patient.  Next, insert the patient’s 
Trial ID.  Last denote whether the patient has had GSH only or both GSH and 
CBT - insert ‘GSH’ or ‘ALL’, respectively.  (JJ will let you know what treatment 
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the patient has received.)  As an example, the identifier for participant Trial01 
who has received GSH and CBT would be ‘PAT-001-ALL’. 
 
File labels: Please save transcripts in the form: Trial ID_ ‘Transcriber’s initials’ 
‘date last modified’. 
E.G. Trial 01_JJ 12 Jan 2014.  Replace (delete / save over) old versions of the 
transcript with the latest version; ensure that file is labelled by the date on which 
the document was last modified.  Please save transcripts here: 
N:\PSY\projects\Stepped Care\B. STEPS\7. Data\3. 
Interviews\Patients\Transcripts\2. Originals  
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[PATIENT IDENTIFIER] 
 
I-JJ 
Insert text here and continue on a new line as required. 
Insert a blank line between the end of this text and the patient’s identifier.  
Ensure that the blank line is formatted as normal text. 
 
PAT-XXX-XXX 
 
Insert text here and continue on a new line as required. 
Insert a blank line between the end of this text and the interviewer’s identifier.  
Ensure that the blank line is formatted as normal text. 
 
I-JJ 
 
 
PAT-XXX-XXX 
 
 
I-JJ 
 
 
PAT-XXX-XXX 
 
 
I-JJ 
 
 
PAT-XXX-XXX 
 
 
I-JJ 
 
 
PAT-XXX-XXX 
 
 
I-JJ 
 
 
END OF INTERVIEW  
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IAPT – Recruitment: Development of Initial Thematic Framework 
 
1. Detected elements, 3-4 September 2015 
 
Feelings about research 
Feelings about STEPS 
Impact of other research on STEPS 
 
Benefit – caseload 
Passing over patients 
Non-interest 
 
Recruitment challenges 
Initial approach / DAS letter 
28 day target 
Five day turnaround 
Returning to DAS – keeping people in treatment 
Workload 
Complexity for patients 
Patient complexity 
Handling forms / assessment 
Record keeping 
Handling risk 
Risk / PTSD 
Literacy 
Non-depressed patients 
Potentially ineligible patients 
Potentially unsuitable patients 
STEPS therapist capacity 
Patients’ questions – how STEPS would help 
Handling patient questions 
Patients’ questions – treatment delay 
Patients’ questions – getting treatment 
Patient queries – scheduling treatment 
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Patient queries – focus of treatment 
Prevalence target 
Returning to DAS 
Treatment delay 
Therapist capacity 
Keeping people in treatment 
 
Receiving treatment at DAS and STEPS 
 
Staff briefing / interaction 
Staff support 
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IAPT Recruitment: development of initial thematic framework continued 
 
2. Elements organised into Initial Thematic Framework, 4 September 2015 
 
 
1. Context 
Feelings about research 
Impact of other research on STEPS 
Feelings about STEPS 
 
2. Administration 
Record keeping 
 
3. Initial approach 
Initial approach 
Complexity for patients  
Literacy 
 
4. At Assessment 
Handling forms 
Patient questions and how they were handled 
Risk / PTSD 
Potentially ineligible or unsuitable patients 
Non-interest 
 
5. Post assessment 
Five day turnaround 
Passing over patients 
Caseload benefit 
Prevalence target 
Receiving treatment at DAS and STEPS 
Therapist capacity 
Returning to DAS (keeping people in treatment / 28 day target) 
Treatment delay 
 
6. Other 
Workload 
Staff briefing and support 
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Development of initial thematic framework continued 
 
3. Elements re-organised into modified Initial Thematic Framework (following 
review of coded material), 6 Sep 2015 
 
 
1. Context 
Feelings about research 
Impact of other research on STEPS 
Feelings about STEPS 
 
2. Initial approach 
Appointment booking 
Appointment letter 
 
3. At Assessment 
Handling forms 
Patient questions 
Risk / PTSD 
Other potentially ineligible / unsuitable patients 
Non-interest 
 
4. Post assessment 
Returning to DAS 
Therapist capacity 
Discharging from DAS 
Other 
 
5. Other 
Record keeping 
Workload 
Staff briefing and support 
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Example Chart: Therapist GSH elements 
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Example of abstraction: therapist experience of stepping criteria 
Detected elements (from chart) organised into dimensions 
  
Elements (criteria / appropriateness) 
 
Dimensions 
 
Criteria got people in the right ballpark (03) 
 
Could not recall patients who met criteria for 
discharge for whom that felt wrong although 
might have been instances where bit more 
ongoing support would be valuable (03) 
 
Did not step up people where thought further 
treatment was not required (03) 
 
Criteria worked brilliantly for majority (around 
70%) people (02) 
 
Criteria worked really well – with patients 
who were mainly clear cut step ups (01) 
 
 
Summary 
 
Wondered about lowering cut off to <5 to 
reduce risk of relapse (03) 
 
 
Reducing risk of relapse 
 
Queried aiming for people who present with 
<10 to reduce their scores further e.g.  to 2 
(03) 
 
Criteria did not work well for patients at or 
below cut-off on start GSH – they may have 
remained at a similar level throughout 
treatment and eligible for progress without 
having made much if any gain.  (02) 
 
Wondered about changing criteria to give 
priority to progress over cut-off tho any 
criteria based on arbitrary cut points (how 
much progress = satisfactory) would likely 
not work for minority (02) 
 
 
Discharging patients who present with 
low scores on start treatment 
 
Criteria did not deal with probs uncovered at 
assessment / during tx (except risk) where it 
may be appropriate to step patients ‘out’ / 
onto a different service (01) 
 
 
Stepping ‘out’ 
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Appendix V: Feasibility study management 
 
This appendix provides a copy of selected material related to the management 
of STEPS feasibility study, specifically: 
 
 Ethics approval letters 
o National Research Ethics Committee South West – Frenchay 
o Devon Partnership NHS Trust 
o University of Exeter, School of Psychology 
 Risk protocol 
 Serious Adverse Event standard operating procedure 
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Ethics approval letter: NRES Committee South West – Frenchay (page 1/4) 
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Ethics approval letter: NRES Committee South West – Frenchay (page 2/4) 
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Ethics approval letter: NRES Committee South West – Frenchay (page 3/4) 
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Ethics approval letter: NRES Committee South West – Frenchay (page 4/4) 
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Ethics approval letter: Devon Partnership NHS Trust 
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Ethics approval letter: University of Exeter, School of Psychology 
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Exploring Risk in Research Assessments 
 
“These are thoughts that people suffering from depression often have but it’s important to make 
sure that you are receiving the right kind of support so I will now ask you some questions that 
will explore these feelings in a little more depth.” 
 
 
PLANS 
 
 
1. Do you know how you would kill yourself? 
 
If yes – details 
 
 
Yes / No 
 
2. Have you made any actual plans to end your life? 
 
If yes – details 
 
 
Yes / No 
 
 
 
ACTIONS 
 
 
3. Have you made any actual preparations to kill yourself? 
 
If yes – details 
 
 
Yes / No 
 
4. Have you ever attempted suicide in the past? 
 
If yes – details 
 
 
Yes / No 
 
 
 
PREVENTION 
 
 
5. Is there anything stopping you killing or harming yourself at the 
moment? 
 
If yes – details 
 
 
 
Yes / No 
 
6. Do you feel that there is any immediate danger that you will harm or kill 
yourself? 
 
If yes – details 
 
 
Yes / No 
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Response Action Tell Participant 
 
All ‘no’ apart from Q5 ‘yes’ 
 
No plans or actions, preventive 
factors 
 
A 
 
Advise speak with GP 
 
I can see that things 
have been very difficult 
for you but it seems to 
me that these thoughts 
about death are not 
ones you would act on.  
Would this be how you 
see things?  (If ‘yes’) 
 
I would advise you to 
make an appointment 
to see your GP to talk 
about these feelings. 
 
 
‘Yes’ for any one of Q1-4 and ‘yes’ 
for Q5 but ‘no’ for Q6 
 
Some plan / action but preventive 
factor and no immediate danger 
 
B1 
 
Advise speak with GP 
 
Write to GP 
 
Things seem to be very 
hard for you right now 
and I think it would be 
helpful if you were to 
speak with your GP 
about these feelings. 
 
I will be writing to your 
GP to tell them that you 
have been here today 
and have been having 
some troubling 
thoughts.  I’d also 
advise you to make an 
appointment to see 
your GP to talk about 
these feelings. 
 
 
‘Yes’ for any one of Q1-4 and ‘yes’ 
for Q5 but ‘no’ for Q6 
 
AND the same at last assessment 
but patient has not spoken with GP 
since 
 
B2 
 
 
 
Advise speak with GP 
 
Telephone GP 
 
Follow up by letter – include the 
statement, “The clinical 
management of this patient 
remains your responsibility but 
it is part of our protocol to 
inform you of any risks disclosed 
to ourselves so that you can 
take account of them in your 
care plan.” 
 
 
I think it’s important that 
your GP knows how 
difficult things are for 
you right now. 
 
I will be telephoning 
your GP to speak with 
him/her and suggest 
that you meet with one 
another.  I also advise 
that you make an 
appointment to see 
your GP to talk about 
these feelings. 
 
‘No’ to Q5 or ‘yes’ to Q6 
 
 
Keep patient with you 
 
 
I am very concerned 
about your safety at this 
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Acute risk 
 
No preventive factors or in 
immediate danger 
 
C 
 
Contact supervisor 
 
Involve GP or other appropriate 
clinician 
 
moment.  I’m not a 
clinician but I would like 
you to talk to one right 
now. 
 
I am going to call your 
GP (other) to let them 
know how you are 
feeling and to arrange 
for you to receive 
immediate help. 
 
 
For patients who remain in IAPT or who have been discharged but are at acute risk 
of suicide – “I will also tell IAPT that you have been having some troubling thoughts. This 
will include a description of the action I have suggested or taken to help support you.” 
 
 
If the patient is at acute risk of suicide, contact the first or second supervisor for 
STEPS: 
 
Professor David 
Richards 
 [Telephone Number] [Telephone Number] 
Professor Willem Kuyken [Telephone Number] [Telephone Number] 
 
Other MDC staff qualified to cover risk are: 
 
Barney Dunn [Telephone Number] [Telephone Number] 
Anke Karl [Telephone Number] [Telephone Number] 
Natalia Lawrence [Telephone Number] [Telephone Number] 
Heather O’Mahen [Telephone Number] [Telephone Number] 
Kim Wright [Telephone Number] [Telephone Number] 
Ed Watkins [Telephone Number] [Telephone Number] 
 
 
Use the emergency numbers below, in order of preference: 
 
 
GP – ask for a home visit or get an appointment (If 
out of hours call Devon Doctors on 0845 6710270) 
 
 
Ask participant for GP 
details 
 
DPT Mental Wellbeing & Access - offer specialist 
assessment, consultation and advice between 8am – 
 
01392 823172 
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6pm (Mon-Fri) and links with other network function 
teams to respond outside of these hours. 
 
 
Crisis Resolution Home Treatment Team - this 
number is to make urgent referral to the Crisis Team 
and should not be given out to participants / 
members of the public under any circumstances.  
The participant’s GP can also make an urgent 
referral to the Crisis Team and should be the first 
port of call. 
 
 
[Telephone Number] 
 
Ambulance / A&E, Exeter 
Royal Devon & Exeter Hospital, Barrack Road, 
Exeter, EX2 5DW 
 
 
 
999 
 
 
 
As soon as possible after identification of risk and action following, 
complete a report using the template following. 
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STEPS Risk Assessment Form: A significant risk has been identified for 
the participant below and the STEPS Risk Protocol has been enacted. 
 
Date risk protocol enacted:                                                      Participant ID: 
Time Point: Telephone screen / Baseline / 6 month / other, please specify: 
 
Risk protocol has identified level of risk as:     A                B1                B2                
C 
Suicide Risk Information: 
Report which questionnaire and the score that gave cause for concern and attach copy 
of risk assessment.  Include whether the participant has reported any of the following: 
 Current suicidal ideation 
 Suicide plans 
 Active preparations to commit suicide 
 
 Protective factors or lack of them 
 Regular contact with GP? 
 
 
 
 
 
 
 
Clinical supervisor contacted:  Y / N                                        Date: 
Name of supervisor:                                                                    
Actions taken: 
 
 
 
Additional relevant information: 
 
 
Researcher Name: 
 
 
Date: Signature: 
Clinical Supervisor Name: 
 
Date: Signature: 
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STEPS Adverse & Serious Adverse Event SOP 
 
Adverse Event 
 
An Adverse Event (AE) is any untoward or unintended medical occurrence or 
response, whether it is causally related to the trial treatments or not. 
 
Adverse Events may be disclosed by a participant, their GP, next of kin or another 
person involved in the patient’s care. 
 
Serious Adverse Event 
 
An adverse event can be further classified as a Serious Adverse Event (SAE) if the 
event is: 
 Fatal 
 Life threatening 
 Requires hospitalisation or prolongs existing hospitalisation 
 Results in significant or persistent disability or incapacity 
 Results in congenital abnormality or birth defect 
 Leads to any other condition, judged significant by a clinician. 
 
Immediate Action for Reporting an SAE 
 
If you are alerted to an SAE please contact Jacqueline J Hill (JJ) immediately. 
 
An immediate report (within 24 hours of a SAE coming to light) must be made orally or 
in writing to the research sponsor (University of Exeter).  Therefore, telephone JJ 
(01392 725273) immediately.  If you are unable to speak to her and have left answer 
phone messages, it is important that you also email and text her. 
 
Complete an Adverse & Serious Adverse Event Recording Form and email 
(j.j.hill@exeter.ac.uk) or hand a copy to JJ immediately.  If you do not receive a 
response, please call or find JJ in person to confirm receipt.  If you are unable to 
contact JJ, please email a copy of the completed form to Professor David Richards 
(d.a.richards@exeter.ac.uk); please call or find Dave in person to confirm receipt. 
 
The immediate report must be followed by a detailed written report of the event. This 
report must be sent to the Frenchay National Research Ethics Service Committee – 
South West and the STEPS External Adviser (Professor Chris Dickens) within 15 days of 
JJ becoming aware of the event. This will be handled by JJ. 
 
General guidelines for completing an Adverse & Serious Adverse Event Recording 
Form 
 
Ask the participant (or person disclosing the event) the start and end date/time of the 
event. If they cannot remember then enter as accurate an estimate as possible.  
Document the outcome of the event and any actions taken.  
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Please do not write the participant’s name on the form; identify the participant using 
their Trial ID. 
 
As STEPS is a non-CTIMP (Clinical Trial of an Investigational Medicinal Product) we are 
not required to log non-serious AE’s, however the Adverse Event & Serious Adverse 
Event Recording Form allows researchers to record AE’s when it is not immediately 
clear if it falls into the SAE category.   Hence, if you are uncertain whether an AE meets 
criteria for an SAE, please complete the Adverse & Serious Adverse Event Recording 
Form and follow the procedure for reporting an SAE. 
 
Routine hospitalisations and planned surgery involving a hospital stay are classified as 
SAEs.   This would include, for example, hospitalisation for a cataract operation, hip 
replacement or cancer treatment. 
 
At 6 month follow-up assessments, any SAE that might have occurred since the 
previous visit should be elicited from the participant. 
 
SAE’s and risk 
 
Risk issues may sometimes meet criteria for a SAE and should be handled as such.  ALL 
instances where the risk protocol is enacted must be recorded in the usual manner on 
the Risk Form and countersigned by the site lead or a nominated deputy. 
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Adverse & Serious Adverse Event Recording Form 
 
Date of incident:        Participant ID:                
Details of incident: 
 
 
 
 
Outcome: 
 
 
 
 
Please indicate type (tick all that 
apply): 
Fatality:                                                       
Life-threatening:                                         
Hospitalisation or prolongation of         
hospitalisation:                  
 
 
Persistent or significant disability or incapacity 
Congenital anomaly or birth defect:                         
Other:                                                                             
Additional relevant information: 
 
 
 
 
 
Action taken by research team (if any): 
 
 
 
 
Name of Therapist / 
Researcher (BLOCK 
CAPITALS): 
 
Date: Signature: 
Name of Researcher / Chief 
Investigator  (BLOCK 
CAPITALS): 
Date: Signature: 
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Serious Adverse Event (SAE) Report Form 
 
The Chief Investigator should report any SAE to the sponsor within 24 hours, 
orally or in writing. The immediate report must be followed by a detailed written 
report on the event, using the form below. A copy of this form must also be sent 
to the Frenchay NRES Committee – South WEst and STEPS’ External Adviser 
within 15 days of the CI becoming aware of the event. 
 
1. Details of Chief Investigator 
 
Name: Prof David A Richards 
Address: University of Exeter Medical School 
Haighton Building 
University of Exeter 
St Luke’s Campus 
Heavitree 
Exeter 
EX1 2LU 
Telephone: 01392 724615 
Email: D.A.Richards@exeter.ac.uk  
 
 
2. Details of Study 
 
Full title of study: STEPS (The development and evaluation of 
stepped care treatment for depression: a mixed 
method feasibility study) 
Name of main REC: Frenchay National Research Ethics Service 
Committee – South West 
REC reference: 12/SW/0140 
Research sponsor: University of Exeter 
Sponsor’s reference for this 
report (if applicable): 
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3. Type of Event 
 
Please categorise this event, ticking all appropriate options: 
Fatality: 
 
Life threatening:    
 
Hospitalisation or Pro-
longation of hospitalisation:    
 
Persistent or 
significant disability 
or incapacity:   
 
Congenital anomaly 
or birth defect:     
Other:    
 
 
 
4. Circumstances of the Event 
 
Date of event:  
Location of event:  
Describe the 
circumstances of the 
event (attach further 
details if required): 
 
 
 
 
 
 
What is your assessment 
of the implications, if any, 
for the safety of study 
participants and how will 
these be addressed? 
 
 
 
 
 
 
 
 
5. Declaration 
 
Name of Chief 
Investigator: 
(BLOCK CAPITALS) 
 
Date of submission:  
 
Signature:  
   408 
 
6. Acknowledgement of Receipt by REC 
 
The Frenchay NRES Committee – South West acknowledges receipt of the 
above. 
 
Name: 
(BLOCK CAPITALS) 
 
Position on REC: 
 
 
Date: 
 
 
Signature: 
 
 
 
Signed original to be sent back to the Chief Investigator; copy to be kept for 
information by REC.   
 
 
 
 
 
  
   409 
References 
A. P. A. Presidential Task Force on Evidence-Based Practice. (2006). Evidence-based practice in 
psychology. Am Psychol, 61(4), 271-285. doi: 10.1037/0003-066X.61.4.271 
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental 
Disorders (DSM-V) (Fifth ed.). Arlington, VA: American Psychiatric Association. 
Anderson, L. M., Petticrew, M., Chandler, J., Grimshaw, J., Tugwell, P., O'Neill, J., . . . Shemilt, I. 
(2013). Introducing a series of methodological articles on considering complexity in 
systematic reviews of interventions. J Clin Epidemiol, 66(11), 1205-1208. doi: 
10.1016/j.jclinepi.2013.07.005 
Andrews, G., Cuijpers, P., Craske, M. G., McEvoy, P., & Titov, N. (2010). Computer therapy for 
the anxiety and depressive disorders is effective, acceptable and practical health care: 
a meta-analysis. PLoS One, 5(10), e13196. doi: 10.1371/journal.pone.0013196 
Andrews, G., & World Health Organisation Collaborating Centre for Classification in Mental 
Health. (2006). Tolkien II - A needs-based, costed, stepped-care model for mental 
health services: recommendations, executive summaries, clinical pathways, treatment 
flowcharts, costing structures. Sydney, N.S.W.: World Health Organization, 
Collaborating Centre for Classification in Mental Health. 
Angst, J., Gamma, A., Rossler, W., Ajdacic, V., & Klein, D. N. (2009). Long-term depression 
versus episodic major depression: results from the prospective Zurich study of a 
community sample. J Affect Disord, 115(1-2), 112-121. doi: 10.1016/j.jad.2008.09.023 
Antman, E. M., Lau, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992). A Comparison of 
Results of Metaanalyses of Randomized Control Trials and Recommendations of 
Clinical Experts - Treatments for Myocardial-Infarction. Jama-Journal of the American 
Medical Association, 268(2), 240-248. doi: DOI 10.1001/jama.268.2.240 
Apil, S., Hoencamp, E., Haffmans, P. M. J., & Spinhoven, P. (2012). A stepped care relapse 
prevention program for depression in older people: a randomized controlled trial. 
International Journal of Geriatric Psychiatry, 27(6), 583-591. doi: 10.1002/gps.2756 
Apil, S., Spinhoven, P., Haffmans, P. M., & Hoencamp, E. (2014). Two-year follow-up of a 
randomized controlled trial of stepped care cognitive behavioral therapy to prevent 
recurrence of depression in an older population. Int J Geriatr Psychiatry, 29(3), 317-
325. doi: 10.1002/gps.4010 
Arain, M., Campbell, M. J., Cooper, C. L., & Lancaster, G. A. (2010). What is a pilot or feasibility 
study? A review of current practice and editorial policy. BMC Med Res Methodol, 10, 
67. doi: 10.1186/1471-2288-10-67 
Araya, R., Rojas, G., Fritsch, R., Gaete, J., Rojas, M., Simon, G., & Peters, T. J. (2003). Treating 
depression in primary care in low-income women in Santiago, Chile: a randomised 
controlled trial. The Lancet, 361(9362), 995-1000. doi: 10.1016/s0140-6736(03)12825-
5 
Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., . . . Coventry, P. (2012). 
Collaborative care for depression and anxiety problems. Cochrane Database of 
Systematic Reviews(10). doi: 10.1002/14651858.CD006525.pub2 
Arthur, S., Mitchell, M., Lewis, J., & McNaughton Nicholls, C. (2014). Designing fieldwork. In J. 
Ritchie, J. Lewis, C. McNaughton Nicholls & R. Ormston (Eds.), Qualitative Research 
Practice Second Edition. London, UK: Sage. 
Barkham, M., Rees, A., Stiles, W. B., Shapiro, D. A., Hardy, G. E., & Reynolds, S. (1996). Dose-
effect relations in time-limited psychotherapy for depression. J Consult Clin Psychol, 
64(5), 927-935.  
Barkham, M., Stiles, W. B., Connell, J., Twigg, E., Leach, C., Lucock, M., . . . Angus, L. (2008). 
Effects of psychological therapies in randomized trials and practice-based studies. 
British Journal of Clinical Psychology, 47(4), 397-415. doi: 10.1348/014466508X311713 
   410 
Beck, A. T., Rush, A. J., Shaw, B., & Emery, G. (1979). Cognitive Therapy of Depression: A 
Treatment Manual. New York: Guilford Press. 
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San 
Antonio TX: Psychological Corporation. 
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for 
measuring depression. Archives of General Psychiatry, 4, 561-571.  
Beevers, C. G., Keitner, G. I., Ryan, C. E., & Miller, I. W. (2003). Cognitive predictors of symptom 
return following depression treatment. J Abnorm Psychol, 112(3), 488-496.  
Bennett-Levy, J., Richards, D., & Farrand, P. (2010). Low intensity CBT interventions: a 
revolution in mental health care. In J. Bennett-Levy, D. Richards, P. Farrand, H. 
Christensen, K. M. Griffiths, D. J. Kavanagh, B. Klein, M. A. Lau, J. Proudfoot, L. 
Ritterband, J. White & C. Williams (Eds.), Low Intensity CBT Interventions (pp. 3-18.). 
Oxford: Oxford University Press. 
Bertaux, D. (1981). From the life-history approach to the transformation of sociological 
practice. In D. Bertaux (Ed.), Biography and society: the life history approach in the 
social sciences (pp. 29-45). London: Sage. 
Bilsker, D., Goldner, E. M., & Anderson, E. (2012). Supported Self-Management: A Simple, 
Effective Way to Improve Depression Care. Canadian Journal of Psychiatry-Revue 
Canadienne De Psychiatrie, 57(4), 203-209.  
Boaz, A., Baeza, J., Fraser, A., & for the European Implementation Score Collaborative Group 
(EIS). (2011). Effective implementation of research into practice: an overview of 
systematic reviews of the health literature. BMC Res Notes, 4, 212. doi: 10.1186/1756-
0500-4-212 
Bockting, C. L., Spinhoven, P., Koeter, M. W., Wouters, L. F., & Schene, A. H. (2006). Prediction 
of recurrence in recurrent depression and the influence of consecutive episodes on 
vulnerability for depression: a 2-year prospective study. J Clin Psychiatry, 67(5), 747-
755.  
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). Introduction to meta-
analysis. Chichester, UK: John Wiley & Sons Ltd. 
Borglin, G. (2015). The value of mixed methods for researching complex interventions. In D. A. 
Richards & I. R. Hallberg (Eds.), Complex interventions in health: an overview of 
research methods (pp. 29-45). Oxon, New York: Routledge. 
Borson, S., Scanlan, J., Brush, M., Vitaliano, P., & Dokmak, A. (2000). The Mini-Cog: a cognitive 
'vital signs' measure for dementia screening in multi-lingual elderly. International 
Journal of Geriatric Psychiatry, 15(11), 1021-1027. doi: 10.1002/1099-
1166(200011)15:11<1021::aid-gps234>3.0.co;2-6 
Bosmans, J. E., Dozeman, E., van Marwijk, H. W., van Schaik, D. J., Stek, M. L., Beekman, A. T., 
& van der Horst, H. E. (2014). Cost-effectiveness of a stepped care programme to 
prevent depression and anxiety in residents in homes for the older people: a 
randomised controlled trial. Int J Geriatr Psychiatry, 29(2), 182-190. doi: 
10.1002/gps.3987 
Bot, M., Pouwer, F., Ormel, J., Slaets, J. P., & de Jonge, P. (2010). Predictors of incident major 
depression in diabetic outpatients with subthreshold depression. Diabet Med, 27(11), 
1295-1301. doi: 10.1111/j.1464-5491.2010.03119.x 
Bower, P., Brueton, V., Gamble, C., Treweek, S., Smith, C. T., Young, B., & Williamson, P. (2014). 
Interventions to improve recruitment and retention in clinical trials: a survey and 
workshop to assess current practice and future priorities. Trials, 15(1), 399. doi: 
10.1186/1745-6215-15-399 
Bower, P., & Gilbody, S. (2005a). Managing common mental health disorders in primary care: 
conceptual models and evidence base. British Medical Journal, 330(7495), 839-842. 
doi: 10.1136/bmj.330.7495.839 
   411 
Bower, P., & Gilbody, S. (2005b). Stepped care in psychological therapies: access, effectiveness 
and efficiency: narrative literature review. British Journal of Psychiatry, 186, 11-17. doi: 
10.1192/bjp.186.1.11 
Bower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D., Gilbody, S., . . . Liu, E. T.-H. 
(2013). Influence of initial severity of depression on effectiveness of low intensity 
interventions: meta-analysis of individual patient data. British Medical Journal, 346. 
doi: 10.1136/bmj.f540 
Bowling, A. (2005). Measuring health: a review of quality of life measurement scales. 
Maidenhead: McGraw-Hill Education. 
Bromley, C., & Hewton, J. (2005). Trends in attitudes to health care 1983 to 2003: report based 
on results from the British Social Attitudes Surveys. London, United Kingdom: National 
Centre for Social Research. 
Burcusa, S. L., & Iacono, W. G. (2007). Risk for recurrence in depression. Clin Psychol Rev, 27(8), 
959-985. doi: 10.1016/j.cpr.2007.02.005 
Button, K. S., Kounali, D., Thomas, L., Wiles, N. J., Peters, T. J., Welton, N. J., . . . Lewis, G. 
(2015). Minimal clinically important difference on the Beck Depression Inventory--II 
according to the patient's perspective. Psychol Med, 45(15), 3269-3279. doi: 
10.1017/s0033291715001270 
Caldwell, P. H. Y., Hamilton, S., Tan, A., & Craig, J. (2010). Strategies for Increasing Recruitment 
to Randomised Controlled Trials: Systematic Review. PLoS Med, 7(11), e1000368. doi: 
10.1371/journal.pmed.1000368 
Campbell, M., Fitzpatrick, R., Haines, A., Kinmonth, A. L., Sandercock, P., Spiegelhalter, D., & 
Tyrer, P. (2000). Framework for design and evaluation of complex interventions to 
improve health. BMJ, 321(7262), 694-696.  
Centre for Reviews and Dissemination. (2008). Systematic Reviews. York: York Publishing 
Services Ltd. 
Chalmers, I. (1989). Evaluating the effects of care during pregnancy and childbirth. In I. 
Chalmers, M. Enkin & M. J. N. C. Keirse (Eds.), Effective care in pregnancy and 
childbirth. Oxford: Oxford University Press. 
Chalmers, I., & Glasziou, P. (2009). Avoidable waste in the production and reporting of 
research evidence. Lancet, 374(9683), 86-89. doi: 10.1016/S0140-6736(09)60329-9 
Charlson, M. E., & Horwitz, R. I. (1984). Applying results of randomised trials to clinical 
practice: impact of losses before randomisation. Br Med J (Clin Res Ed), 289(6454), 
1281-1284.  
Clark, D. M. (2011). Implementing NICE guidelines for the psychological treatment of 
depression and anxiety disorders: the IAPT experience. Int Rev Psychiatry, 23(4), 318-
327. doi: 10.3109/09540261.2011.606803 
Clark, D. M. (2013). Developing and disseminating effective psychological treatments: Science, 
practice and economics. Canadian Psychology, 54(1), 12-21. doi: 
http://dx.doi.org/10.1037/a0031258 
Clark, D. M., Layard, R., Smithies, R., Richards, D., Suckling, R., & Wright, B. (2009). Improving 
access to psychological therapy: Initial evaluation of two UK demonstration sites. 
Behaviour Research & Therapy, 47(11), 910-920. doi: 
http://dx.doi.org/10.1016/j.brat.2009.07.010 
Clarke, G., Lynch, F., Spofford, M., & DeBar, L. (2006). Trends influencing future delivery of 
mental health services in large healthcare systems. Clinical Psychology-Science and 
Practice, 13(3), 287-292. doi: 10.1111/j.1468-2850.2006.00040.x 
Cohen, J. A. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, 
New Jersey: Erlbaum. 
Collins, R., & MacMahon, S. (2001). Reliable assessment of the effects of treatment on 
mortality and major morbidity, I: clinical trials. Lancet, 357(9253), 373-380. doi: 
10.1016/S0140-6736(00)03651-5 
   412 
Cooper, H., & Hedges, L. V. (1994). The handbook of research synthesis. New York: Russell Sage 
Foundation Press. 
Corbin, J. M., & Strauss, A. (2008). Basics of qualitative research: techniques and procedures for 
developing grounded theory. Thousand Oaks, New Dehli, London, Singapore: Sage. 
Coupe, N., Anderson, E., Gask, L., Sykes, P., Richards, D., & Chew-Graham, C. (2014). 
Facilitating professional liaison in collaborative care for depression in UK primary care; 
a qualitative study utilising normalisation process theory. BMC Fam Pract, 15, 78. doi: 
10.1186/1471-2296-15-78 
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008). Developing 
and evaluating complex interventions: the new Medical Research Council guidance. 
BMJ, 337, a1655. doi: 10.1136/bmj.a1655 
Creswell, J. W. (2003). Research design: qualitative, quantitative and mixed methods 
approaches. Thousand Oaks, CA: Sage. 
Creswell, J. W. (2013). Qualitative inquiry and research design: choosing among five 
approaches (3rd ed.). Los Angeles: SAGE Publications. 
Creswell, J. W., & Plano Clark, V. L. (2007). Designing and conducting mixed methods research 
(1st ed.). Thousand Oaks, CA: Sage. 
Creswell, J. W., & Plano Clark, V. L. (2011). Designing and conducting mixed methods research 
(2nd ed.). Thousand Oaks, California: Sage Publications, Inc. 
Creswell, J. W., Plano Clark, V. L., Gutmann, M., & Hanson, W. (2003). Advanced mixed 
methods research designs. In A. Tashakkori & C. Teddlie (Eds.), Handbook of mixed 
methods in social and behavioural research (pp. 209-240). Thousand Oaks, CA: Sage. 
Critis-Christoph, P., & Connolly Gibbons, M. B. (2002). Relational interpretations. In J. C. 
Norcross (Ed.), Psychotherapy relationships that work. Oxford, New York: Oxford 
University Press. 
Cuijpers, P., Andersson, G., Donker, T., & van Straten, A. (2011). Psychological treatment of 
depression: results of a series of meta-analyses. Nord J Psychiatry, 65(6), 354-364. doi: 
10.3109/08039488.2011.596570 
Cuijpers, P., Beekman, A. T., & Reynolds, C. F., 3rd. (2012). Preventing depression: a global 
priority. Jama, 307(10), 1033-1034. doi: 10.1001/jama.2012.271 
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013). A 
meta-analysis of cognitive-behavioural therapy for adult depression, alone and in 
comparison with other treatments. Canadian Journal of Psychiatry - Revue Canadienne 
de Psychiatrie, 58(7), 376-385.  
Cuijpers, P., Donker, T., van Straten, A., Li, J., & Andersson, G. (2010). Is guided self-help as 
effective as face-to-face psychotherapy for depression and anxiety disorders? A 
systematic review and meta-analysis of comparative outcome studies. Psychological 
Medicine, 40(12), 1943-1957. doi: 10.1017/s0033291710000772 
Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M., & Andersson, G. (2013). 
Does cognitive behaviour therapy have an enduring effect that is superior to keeping 
patients on continuation pharmacotherapy? A meta-analysis. Bmj Open, 3(4). doi: 
10.1136/bmjopen-2012-002542 
Cuijpers, P., Li, J., Hofmann, S. G., & Andersson, G. (2010). Self-reported versus clinician-rated 
symptoms of depression as outcome measures in psychotherapy research on 
depression: a meta-analysis. Clin Psychol Rev, 30(6), 768-778. doi: 
10.1016/j.cpr.2010.06.001 
Cuijpers, P., Reynolds, C. F., 3rd, Donker, T., Li, J., Andersson, G., & Beekman, A. (2012). 
Personalized treatment of adult depression: medication, psychotherapy, or both? A 
systematic review. Depress Anxiety, 29(10), 855-864. doi: 10.1002/da.21985 
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F., 3rd. 
(2014). Adding psychotherapy to antidepressant medication in depression and anxiety 
disorders: a meta-analysis. World Psychiatry, 13(1), 56-67. doi: 10.1002/wps.20089 
   413 
Cuijpers, P., Smit, F., Bohlmeijer, E., Hollon, S. D., & Andersson, G. (2010). Efficacy of cognitive-
behavioural therapy and other psychological treatments for adult depression: meta-
analytic study of publication bias. Br J Psychiatry, 196(3), 173-178. doi: 
10.1192/bjp.bp.109.066001 
Cuijpers, P., van Straten, A., Bohlmeijer, E., Hollon, S. D., & Andersson, G. (2010). The effects of 
psychotherapy for adult depression are overestimated: a meta-analysis of study 
quality and effect size. Psychol Med, 40(2), 211-223. doi: 10.1017/s0033291709006114 
Cuijpers, P., van Straten, A., Smit, F., Mihalopoulos, C., & Beekman, A. (2008). Preventing the 
onset of depressive disorders: a meta-analytic review of psychological interventions. 
Am J Psychiatry, 165(10), 1272-1280. doi: 10.1176/appi.ajp.2008.07091422 
Cuijpers, P., van Straten, A., van Oppen, P., & Andersson, G. (2008). Are psychological and 
pharmacologic interventions equally effective in the treatment of adult depressive 
disorders? A meta-analysis of comparative studies. J Clin Psychiatry, 69(11), 1675-
1685; quiz 1839-1641.  
Datta, J., & Petticrew, M. (2013). Challenges to evaluating complex interventions: a content 
analysis of published papers. Bmc Public Health, 13, 568. doi: 10.1186/1471-2458-13-
568 
Davidson, K. W., Bigger, J. T., Burg, M. M., Carney, R. M., Chaplin, W. F., Czajkowski, S., . . . Ye, 
S. (2013). Centralized, stepped, patient preference-based treatment for patients with 
post- Acute Coronary Syndrome depression: CODIACS Vanguard randomized 
controlled trial. JAMA Intern Med, 173(11), 997-1004. doi: 
10.1001/jamainternmed.2013.915 
Davidson, K. W., Rieckmann, N., Clemow, L., Schwartz, J. E., Shimbo, D., Medina, V., . . . Burg, 
M. M. (2010). Enhanced depression care for patients with Acute Coronary Syndrome 
and persistent depressive symptoms. Archives of Internal Medicine, 170(7), 600-608.  
Davison, G. C. (2000). Stepped care: doing more with less? Journal of Consulting and Clinical 
Psychology, 68(4), 580-585. doi: 10.1037//0022-006x.68.4.580 
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008). Analysing data and undertaking meta-
analyses. In J. P. T. Higgins & S. Green (Eds.), Cochrane Handbook for Systematic 
Reviews of Interventions. Chichester, UK: John Wiley & Sons Ltd. 
Delgadillo, J., Gellatly, J., & Stephenson-Bellwood, S. (2015). Decision making in stepped care: 
how do therapists decide whether to prolong treatment or not? Behav Cogn 
Psychother, 43(3), 328-341. doi: 10.1017/S135246581300091X 
Department of Health. (1997). The new NHS: modern, dependable. London: The Stationery 
Office. 
Department of Health. (1999). A national service framework for mental health. London: 
Stationery Office. 
Department of Health. (2008). IAPT implementation plan: national guidelines for regional 
delivery. UK. 
Department of Health. (2009). Technical guidance for IAPT key performance indicators. Version 
3.0. London, United Kingdom: Department of Health. 
Department of Health. (2012). IAPT three year report: the first million patients. United 
Kingdom: Department of Health. 
Department of Health Mental Health Division Improving Access to Psychological Therapies 
Programme. (2008). The IAPT Pathfinders: Achievements and Challenges. London, 
United Kingdom: Department of Health. 
DeRubeis, R. J., Cohen, Z. D., Forand, N. R., Fournier, J. C., Gelfand, L. A., & Lorenzo-Luaces, L. 
(2014). The Personalized Advantage Index: translating research on prediction into 
individualized treatment recommendations. A demonstration. PLoS One, 9(1), e83875. 
doi: 10.1371/journal.pone.0083875 
   414 
Di Bona, L., Saxon, D., Barkham, M., Dent-Brown, K., & Parry, G. (2014). Predictors of patient 
non-attendance at Improving Access to Psychological Therapy services demonstration 
sites. J Affect Disord, 169, 157-164. doi: 10.1016/j.jad.2014.08.005 
Donovan, J. L., Athene Lane, J., Peters, T. J., Brindle, L., Salter, E., Gillatt, D., . . . Hamdy, F. C. 
(2009). Development of a complex intervention improved randomization and informed 
consent in a randomized controlled trial. J Clin Epidemiol, 62(1), 29-36. doi: 
http://dx.doi.org/10.1016/j.jclinepi.2008.02.010 
Donovan, J. L., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., . . . Hamdy, F. C. (2002). 
Improving design and conduct of randomised trials by embedding them in qualitative 
research: ProtecT (prostate testing for cancer and treatment) study. British Medical 
Journal, 325, 766-770.  
Dozeman, E., van Marwijk, H. W., van Schaik, D. J., Smit, F., Stek, M. L., van der Horst, H. E., . . . 
Beekman, A. T. (2012). Contradictory effects for prevention of depression and anxiety 
in residents in homes for the elderly: a pragmatic randomized controlled trial. 
International Psychogeriatrics, 24(8), 1242-1251. doi: 10.1017/S1041610212000178 
Driessen, E., Hollon, S. D., Bockting, C. L., Cuijpers, P., & Turner, E. H. (2015). Does Publication 
Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive 
Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-
Funded Trials. PLoS One, 10(9), e0137864. doi: 10.1371/journal.pone.0137864 
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B. J., & Stoddart, G. L. (2005). 
Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford 
University Press. 
Duval, S., & Tweedie, R. (2000). Trim and fill: a simple funnel-plot-based method of testing and 
adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455-463.  
Eaton, W. W., Shao, H., Nestadt, G., Lee, H. B., Bienvenu, O. J., & Zandi, P. (2008). Population-
based study of first onset and chronicity in major depressive disorder. Arch Gen 
Psychiatry, 65(5), 513-520. doi: 10.1001/archpsyc.65.5.513 
Eccles, M., Grimshaw, J., Campbell, M., & Ramsay, C. (2003). Research designs for studies 
evaluating the effectiveness of change and improvement strategies. Qual Saf Health 
Care, 12(1), 47-52.  
Ekers, D., & Webster, L. (2013). An overview of the effectiveness of psychological therapy for 
depression and stepped care service delivery models. Journal of Research in Nursing, 
18(2), 171-184. doi: http://dx.doi.org/10.1177/1744987112466254 
Ell, K., Katon, W., Xie, B., Lee, P. J., Kapetanovic, S., Guterman, J., & Chou, C. P. (2010). 
Collaborative care management of major depression among low-income, 
predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes 
Care, 33(4), 706-713. doi: 10.2337/dc09-1711 
Ell, K., Xie, B., Quon, B., Quinn, D. I., Dwight-Johnson, M., & Lee, P. J. (2008). Randomized 
controlled trial of collaborative care management of depression among low-income 
patients with cancer. Journal of Clinical Oncology, 26(27), 4488-4496. doi: 
10.1200/JCO.2008.16.6371 
Elliot, R. A., & Payne, K. (2005). Essentials of economic evaluation in healthcare. London: The 
Pharmaceutical Press. 
European Medicines Agency Committee for Medicinal Products for Human Use (CHMP). 
(2005). Guideline on the choice of the non-inferiority margin. London: European 
Medicines Agency. 
Evans, I., Thornton, H., Chalmers, I., & Glasziou, P. (2011). Testing treatments: better research 
for better healthcare.  Second edition. London, United Kingdom: Pinter & Martin Ltd. 
Faravelli, C., Ambonetti, A., Pallanti, S., & Pazzagli, A. (1986). Depressive relapses and 
incomplete recovery from index episode. Am J Psychiatry, 143(7), 888-891. doi: 
10.1176/ajp.143.7.888 
   415 
Farrand, P., Duncan, F., & Byng, R. (2007). Impact of graduate mental health workers upon 
primary care mental health: a qualitative study. Health & Social Care in the 
Community, 15(5), 486-493.  
Fava, M., Uebelacker, L. A., Alpert, J. E., Nierenberg, A. A., Pava, J. A., & Rosenbaum, J. F. 
(1997). Major depressive subtypes and treatment response. Biol Psychiatry, 42(7), 568-
576. doi: 10.1016/s0006-3223(96)00440-4 
First, M. B., Williams, J. B., Karg, R. S., & Spitzer, R. L. (2015). Stuctured Clinical Interview for 
DSM-5 Disorders, SCID-5-RV, Research Version. Arlington, VA: American Psychiatric 
Association. 
Firth, N., Barkham, M., & Kellett, S. (2015). The clinical effectiveness of stepped care systems 
for depression in working age adults: A systematic review. J Affect Disord, 170, 119-
130. doi: 10.1016/j.jad.2014.08.030 
Fletcher, B., Gheorghe, A., Moore, D., Wilson, S., & Damery, S. (2012). Improving the 
recruitment activity of clinicians in randomised controlled trials: a systematic review. 
Bmj Open, 2(1). doi: 10.1136/bmjopen-2011-000496 
Fournier, J. C., DeRubeis, R. J., Shelton, R. C., Hollon, S. D., Amsterdam, J. D., & Gallop, R. 
(2009). Prediction of response to medication and cognitive therapy in the treatment of 
moderate to severe depression. Journal of Consulting and Clinical Psychology, 77(4), 
775-787. doi: 10.1037/a0015401 
Franx, G., Oud, M., de Lange, J., Wensing, M., & Grol, R. (2012). Implementing a stepped-care 
approach in primary care: results of a qualitative study. Implementation Science, 7. doi: 
10.1186/1748-5908-7-8 
Gask, L. (2005). Overt and covert barriers to the integration of primary and specialist mental 
health care. Social Science & Medicine, 61(8), 1785-1794. doi: 
http://dx.doi.org/10.1016/j.socscimed.2005.03.038 
Gellatly, J. (2011). Decision making in stepped care for common mental health problems. (PhD), 
University of Manchester.    
Gellatly, J., Bower, P., Hennessy, S., Richards, D., Gilbody, S., & Lovell, K. (2007). What makes 
self-help interventions effective in the management of depressive symptoms? Meta-
analysis and meta-regression. Psychological Medicine, 37(9), 1217-1228. doi: 
10.1017/s0033291707000062 
Giangregorio, L., & Thabane, L. (2015). Pilot and feasibility studies for complex interventions. In 
D. A. Richards & I. R. Hallberg (Eds.), Complex Interventions in Health: An Overvivew of 
Research Methods. Abingdon, Oxon: Routledge. 
Gilbody, S., Richards, D., & Barkham, M. (2007). Diagnosing depression in primary care using 
self-completed instruments: UK validation of PHQ–9 and CORE–OM. The British Journal 
of General Practice, 57(541), 650-652.  
Gjerdingen, D., Katon, W., & Rich, D. E. (2008). Stepped care treatment of postpartum 
depression: a primary care-based management model. Womens Health Issues, 18(1), 
44-52. doi: http://dx.doi.org/10.1016/j.whi.2007.09.001 
Glaser, B., & Strauss, A. (1967). The discovery of grounded theory: strategies for qualitative 
research. New York: Aldine Publishing Company. 
Glover, G., Webb, M., & Evison, F. (2010). Improving Access to Psychological Therapies: a 
review of the progress made by sites in the first roll-out year. Durham (GB): North East 
Public Health Observatory. 
Green, K. E., & Iverson, K. M. (2009). Computerized Cognitive-Behavioral Therapy in a Stepped 
Care Model of Treatment. Professional Psychology: Research and Practice, 40(1), 96-
103. doi: 10.1037/a0012847 
Green, S., Higgins, J. P. T., Alderson, P., Clarke, M., Mulrow, C. D., & Oxman, A. D. (2008). 
Introduction. In J. P. T. Higgins & S. Green (Eds.), Cochrane Handbook for Systematic 
Reviews of Interventions. Chichester: John Wiley & Sons Ltd. 
   416 
Greene, J. C., & Caracelli, V. J. (1997). Defining and describing the paradigm issue in mixed-
method evaluation. New Directions for Evaluation, 1997(74), 5-17. doi: 
10.1002/ev.1068 
Griffiths, P., & Norman, I. (2013). Qualitative or quantitative? Developing and evaluating 
complex interventions: time to end the paradigm war. Int J Nurs Stud, 50(5), 583-584. 
doi: 10.1016/j.ijnurstu.2012.09.008 
Guest, G., Bunce, A., & Johnson, L. (2006). How Many Interviews Are Enough?: An Experiment 
with Data Saturation and Variability. Field Methods, 18(1), 59-82. doi: 
10.1177/1525822x05279903 
Gulliford, M., Figueroa-Munoz, J., Morgan, M., Hughes, D., Gibson, B., Beech, R., & Hudson, M. 
(2002). What does 'access to health care' mean? J Health Serv Res Policy, 7(3), 186-
188.  
Gunn, J., Diggens, J., Hegarty, K., & Blashki, G. (2006). A systematic review of complex system 
interventions designed to increase recovery from depression in primary care. BMC 
Health Services Research., 6(88). doi: 10.1186/1472-6963-6-88 
Gyani, A., Shafran, R., Layard, R., & Clark, D. M. (2013). Enhancing recovery rates: lessons from 
year one of IAPT. Behav Res Ther, 51(9), 597-606. doi: 10.1016/j.brat.2013.06.004 
Haaga, D. A. F. (2000). Introduction to the special section on stepped care models in 
psychotherapy. Journal of Consulting & Clinical Psychology, 68(4), 547-548.  
Haidich, A. B., & Ioannidis, J. P. (2001). Patterns of patient enrollment in randomized controlled 
trials. J Clin Epidemiol, 54(9), 877-883.  
Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. San Diego: Academic 
Press. 
Helfrich, C. D., Li, Y. F., Sharp, N. D., & Sales, A. E. (2009). Organizational readiness to change 
assessment (ORCA): development of an instrument based on the Promoting Action on 
Research in Health Services (PARIHS) framework. Implement Sci, 4, 38. doi: 
10.1186/1748-5908-4-38 
Hermens, M. L. M., Muntingh, A., Franx, G., van Splunteren, P. T., & Nuyen, J. (2014). Stepped 
care for depression is easy to recommend, but harder to implement: results of an 
explorative study within primary care in the Netherlands. Bmc Family Practice, 15, 12. 
doi: 10.1186/1471-2296-15-5 
Higgins, J. P. T., & Altman, D. G. (2008). Assessing risk of bias in included studies. In J. P. T. 
Higgins & S. Green (Eds.), Cochrane Handbook for Systematic Reviews of Interventions. 
Chichester, UK: John Wiley & Sons Ltd. 
Higgins, J. P. T., Deeks, J. J., & Altman, D. G. (2010). Special topics in statistics. In J. P. T. Higgins 
& S. Green (Eds.), Cochrane Handbook for Systematic Reviews of Interventions. 
Chichester, UK: John Wiley & Sons Ltd. 
Hill, A. B. (1965). The Environment and Disease: Association or Causation? Proc R Soc Med, 58, 
295-300.  
Hill, J. J., Kuyken, W., & Richards, D. (2014). Developing stepped care treatment for depression 
(STEPS): study protocol for a pilot randomised controlled trial. Trials, 15(1), 452. doi: 
10.1186/1745-6215-15-452 
Howard, K. I., Kopta, S. M., Krause, M. S., & Orlinsky, D. E. (1986). The dose-effect relationship 
in psychotherapy. Am Psychol, 41(2), 159-164.  
Howick, J., Glasziou, P., & Aronson, J. K. (2009). The evolution of evidence hierarchies: what 
can Bradford Hill's 'guidelines for causation' contribute? J R Soc Med, 102(5), 186-194. 
doi: 10.1258/jrsm.2009.090020 
Huibers, M. J., Cohen, Z. D., Lemmens, L. H., Arntz, A., Peeters, F. P., Cuijpers, P., & DeRubeis, 
R. J. (2015). Predicting Optimal Outcomes in Cognitive Therapy or Interpersonal 
Psychotherapy for Depressed Individuals Using the Personalized Advantage Index 
Approach. PLoS One, 10(11), e0140771. doi: 10.1371/journal.pone.0140771 
   417 
Huijbregts, K. M., de Jong, F. J., van Marwijk, H. W., Beekman, A. T., Ader, H. J., Hakkaart-van 
Roijen, L., . . . van der Feltz-Cornelis, C. M. (2013). A target-driven collaborative care 
model for Major Depressive Disorder is effective in primary care in the Netherlands. A 
randomized clinical trial from the depression initiative. J Affect Disord, 146(3), 328-
337. doi: 10.1016/j.jad.2012.09.015 
Hunkeler, E. M., Katon, W., Tang, L., Williams, J. W., Jr., Kroenke, K., Lin, E. H., . . . Unutzer, J. 
(2006). Long term outcomes from the IMPACT randomised trial for depressed elderly 
patients in primary care. BMJ, 332(7536), 259-263. doi: 10.1136/bmj.38683.710255.BE 
Institute of Medicine. (2001a). Crossing the quality chasm: A new health system for the 21st 
century. Washington, DC: National Academies Press. 
Institute of Medicine. (2001b). Crossing the quality chasm: a new health system for the 
twenty-first century. Washington, U.S.: National Academy Press. 
Ipsos MORI. (2006). Understanding public and patient attitudes to the NHS: research review 
prepared for the Healthcare Comission. London, United Kindgom: Healthcare 
Commission. 
Joffe, R. T., & Levitt, A. J. (1995). Antidepressant failure: Augmentation or substitution? Journal 
of Psychiatry & Neuroscience, 20(1), 7-9.  
Johnson, R. B., & Onwuegbuzie, A. J. (2004). Mixed Methods Research: A Research Paradigm 
Whose Time Has Come. Educational Researcher, 33(7), 14-26. doi: 
10.3102/0013189x033007014 
Johnson, R. B., Onwuegbuzie, A. J., & Turner, L. A. (2007). Towards a definition of mixed 
method research. Journal of Mixed Methods Research, 1(2), 112-133.  
Johnston, O., Kumar, S., Kendall, K., Peveler, R., Gabbay, J., & Kendrick, T. (2007). Qualitative 
study of depression management in primary care: GP and patient goals, and the value 
of listening. Br J Gen Pract, 57(544), 872-879. doi: 10.3399/096016407782318026 
Jones, B., Jarvis, P., Lewis, J. A., & Ebbutt, A. F. (1996). Trials to assess equivalence: the 
importance of rigorous methods. BMJ, 313(7048), 36-39. doi: 
10.1136/bmj.313.7048.36 
Kasper, S., Schindler, S., & Neumeister, A. (1996). Risk of suicide in depression and its 
implication for psychopharmacological treatment. Int Clin Psychopharmacol, 11(2), 71-
79.  
Katon, W., & Ludman, E. J. (2003). Improving services for women with depression in primary 
care settings. Psychology of Women Quarterly, 27(2), 114-120. doi: 
http://dx.doi.org/10.1111/1471-6402.00091 
Katon, W., Von Korff, M., Lin, E., & Simon, G. (2001). Rethinking practitioner roles in chronic 
illness: the specialist, primary care physician, and the practice nurse. General Hospital 
Psychiatry, 23(3), 138-144.  
Katon, W., Von Korff, M., Lin, E., Simon, G., Walker, E., Unutzer, J., . . . Ludman, E. (1999). 
Stepped collaborative care for primary care patients with persistent symptoms of 
depression: a randomized trial. Arch Gen Psychiatry, 56(12), 1109-1115.  
Katon, W., Von Korff, M., Lin, E. H. B., Simon, G., Ludman, E., Russo, J., . . . Bush, T. (2004). The 
Pathways Study.  A randomized trial of collaborative care in patients with diabetes and 
depression. Archives of General Psychiatry, 61, 1042-1049.  
Katz, S. J., Kessler, R. C., Frank, R. G., Leaf, P., Lin, E., & Edlund, M. (1997). The use of outpatient 
mental health services in the United States and Ontario: the impact of mental 
morbidity and perceived need for care. Am J Public Health, 87(7), 1136-1143.  
Kellett, S., & Matthews, L. (2008). Reflecting on the clinical, organisational and methodological 
implications of the Doncaster IAPT site: a commentary on Richards and Suckling. 
Clinical Psychology Forum, 181, 29-30.  
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). 
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National 
   418 
Comorbidity Survey Replication. Arch Gen Psychiatry, 62(6), 593-602. doi: 
10.1001/archpsyc.62.6.593 
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., . . . Zaslavsky, A. 
M. (2005). Prevalence and Treatment of Mental Disorders, 1990 to 2003. The New 
England Journal of Medicine, 352(24), 2515-2523. doi: 
http://dx.doi.org/10.1056/NEJMsa043266 
Kettles, A. M., Creswell, J. W., & Zhang, W. (2011). Mixed methods research in mental health 
nursing. J Psychiatr Ment Health Nurs, 18(6), 535-542. doi: 10.1111/j.1365-
2850.2011.01701.x 
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002). Mediators and moderators 
of treatment effects in randomized clinical trials. Arch Gen Psychiatry, 59(10), 877-883.  
Krebber, A. M., Jansen, F., Witte, B. I., Cuijpers, P., De Bree, R., Becker-Commissaris, A., . . . 
verdonck-de Leeuw, I. M. (2015). Stepped care targeting psychological distress in head 
and neck and lung cancer patients: a randomized controlled trial. In submission.  
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: validity of a brief depression 
severity measure. Journal of General Internal Medicine, 16(9), 606-613. doi: 
10.1046/j.1525-1497.2001.016009606.x 
L'Abbe, K. A., Detsky, A. S., & O'Rourke, K. (1987). Meta-analysis in clinical research. Ann Intern 
Med, 107(2), 224-233.  
Lancaster, G. A., Dodd, S., & Williamson, P. R. (2004). Design and analysis of pilot studies: 
recommendations for good practice. J Eval Clin Pract, 10(2), 307-312. doi: 
10.1111/j.2002.384.doc.x 
Landreville, P., Landry, J., Baillargeon, L., Guérette, A., & Matteau, É. (2001). Older Adults' 
Acceptance of Psychological and Pharmacological Treatments for Depression. The 
Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 56(5), 
P285-P291. doi: 10.1093/geronb/56.5.P285 
Lecrubier, Y. (2001). Prescribing patterns for depression and anxiety worldwide. J Clin 
Psychiatry, 62 Suppl 13, 31-36; discussion 37-38.  
Lewis, G., Pelosi, A. J., Araya, R., & Dunn, G. (1992). Measuring psychiatric disorder in the 
community: a standardized assessment for use by lay interviewers. Psychological 
Medicine, 22(2), 465-486.  
Li, S., Marquart, J. M., & Zercher, C. (2000). Conceptual issues and analytic strategies in mixed-
methods studies of preschool inclusion. Journal of Early Intervention, 23(2), 116-132.  
Lilienfeld, S. O., Ritschel, L. A., Lynn, S. J., Cautin, R. L., & Latzman, R. D. (2013). Why many 
clinical psychologists are resistant to evidence-based practice: root causes and 
constructive remedies. Clin Psychol Rev, 33(7), 883-900. doi: 
10.1016/j.cpr.2012.09.008 
Lipsey, M. W. (1990). Design sensitivity.  Statistical power for experimental research. Newbury 
Park, California: SAGE Publications Inc. 
Lipsey, M. W., & Wilson, D. B. (1993). The efficacy of psychological, educational and 
behavioural treatment: confirmation from meta-analysis. American Psychologist, 
48(12), 1181-1209.  
Lovell, K., & Bee, P. (2008). Implementing the NICE OCD/BDD guidelines. Psychology and 
Psychotherapy-Theory Research and Practice, 81, 365-376. doi: 
10.1348/147608308x320107 
Lovell, K., & Richards, D. (2000). Multiple Access Points and Levels of Entry (MAPLE): ensuring 
choice, accessibility and equity for CBT services. Behavioural and Cognitive 
Psychotherapy, 28(04), 379-391. doi: doi:null 
Mathers, C., Boerma, T., & Ma Fat, D. (2008). The Global Burden of Disease: 2004 update. 
Switzerland: World Health Organisation. 
   419 
May, C. R., Mair, F., Finch, T., MacFarlane, A., Dowrick, C., Treweek, S., . . . Montori, V. M. 
(2009). Development of a theory of implementation and integration: Normalization 
Process Theory. Implement Sci, 4, 29. doi: 10.1186/1748-5908-4-29 
McCormack, B., McCarthy, G., Wright, J., Slater, P., & Coffey, A. (2009). Development and 
testing of the Context Assessment Index (CAI). Worldviews Evid Based Nurs, 6(1), 27-
35. doi: 10.1111/j.1741-6787.2008.00130.x 
McDonald, A. M., Knight, R. C., Campbell, M. K., Entwistle, V. A., Grant, A. M., Cook, J. A., . . . 
Snowdon, C. (2006). What influences recruitment to randomised controlled trials? A 
review of trials funded by two UK funding agencies. Trials, 7, 9. doi: 10.1186/1745-
6215-7-9 
McEntarffer, R. (2003). Strengths based mentoring in teacher education: a mixed methods 
study. (Masters thesis Masters thesis), University of Nebraska-Lincoln.    
McManus, S., Meltzer, H., Brugha, T., Bebbington, P., & Jenkins, R. (2009). Adult psychiatric 
morbidity in England, 2007: results of a household survey. London: The NHS 
Information Centre for Health & Social Care. 
McMillan, D., Gilbody, S., & Richards, D. (2010). Defining successful treatment outcome in 
depression using the PHQ-9: a comparison of methods. J Affect Disord, 127(1-3), 122-
129. doi: 10.1016/j.jad.2010.04.030 
Mendlinger, S., & Cwikel, J. (2008). Spiraling between qualitative and quantitative data on 
women's health behaviours: a double helix model for mixed methods. Qualitative 
Health Research, 18(2), 280-293.  
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: an expanded sourcebook. 
(Second ed.). London: Sage. 
Mitchell, C., Dwyer, R., Hagan, T., & Mathers, N. (2011). Impact of the QOF and the NICE 
guideline in the diagnosis and management of depression: a qualitative study. British 
Journal of General Practice, 61(586), e279-289. doi: 
http://dx.doi.org/10.3399/bjgp11X572472 
Moffitt, T. E., Caspi, A., Taylor, A., Kokaua, J., Milne, B. J., Polanczyk, G., & Poulton, R. (2010). 
How common are common mental disorders? Evidence that lifetime prevalence rates 
are doubled by prospective versus retrospective ascertainment. Psychological 
Medicine, 40(6), 899-909. doi: 10.1017/s0033291709991036 
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., . . . Altman, 
D. G. (2010). CONSORT 2010 explanation and elaboration: updated guidelines for 
reporting parallel group randomised trials. BMJ, 340, c869. doi: 10.1136/bmj.c869 
Moore, G., Audrey, S., Barker, M., Bond, L., Bonell, C., Cooper, C., . . . Baird, J. (2014). Process 
evaluation in complex public health intervention studies: the need for guidance. J 
Epidemiol Community Health, 68(2), 101-102. doi: 10.1136/jech-2013-202869 
Morse, J. M. (1994). Designing qualitative research. In N. K. Denzin & Y. S. Lincoln (Eds.), 
Handbook of qualitative research. London: SAGE Publications. 
Morse, J. M. (1995). The Significance of Saturation. Qualitative Health Research, 5(2), 147-149. 
doi: 10.1177/104973239500500201 
Murphy, S. A., Collins, L. M., & Rush, A. J. (2007). Customizing treatment to the patient: 
Adaptive treatment strategies. Drug and Alcohol Dependence, 88(SUPPL. 2), S1-S3. doi: 
http://dx.doi.org/10.1016/j.drugalcdep.2006.12.007 
National Collaborating Centre for Mental Health. (2010). Depression: The NICE guideline on the 
treatment and management of depression in adults.  Updated edition. Clinical 
guideline 90. London: The British Psychological Society and The Royal College of 
Psychiatrists. 
National Institute for Health and Care Excellence. (2009a). Depression in adults with a chronic 
physical health problem: treatment and management. Clinical guideline 91. London, 
United Kingdom: National Institute for Health and Care Excellence. 
   420 
National Institute for Health and Care Excellence. (2009b). Depression in adults: the treatment 
and management of depression in adults.  NICE clinical guideline 90. London: National 
Institute for Health and Care Excellence. 
National Institute for Health and Care Excellence. (2011). Common mental health disorders: 
identification and pathways to care.  NICE clinical guideline 123. 
National Institute for Health Research. (2016). from http://www.nihr.ac.uk/funding/pgfar-
patient-and-public-involvement.htm 
National Institute for Health Research Evaluation, T. a. S. C. C. (2015). The National Institute for 
Health Research Evaluation Trials and Studies Coordinating Centre (NETSCC) glossary.   
Retrieved 19 May 2015, from http://www.netscc.ac.uk/glossary/ 
Newman, M. G. (2000). Recommendations for a cost-offset model of psychotherapy allocation 
using Generalized Anxiety Disorder as an example. Journal of Consulting & Clinical 
Psychology, 68(4), 549-555.  
O'Cathain, A., Murphy, E., & Nicholl, J. (2008). The quality of mixed methods studies in health 
services research. J Health Serv Res Policy, 13(2), 92-98.  
Oladeji, B. D., Kola, L., Abiona, T., Montgomery, A. A., Araya, R., & Gureje, O. (2015a). A pilot 
randomized controlled trial of a stepped care intervention package for depression in 
primary care in Nigeria. Bmc Psychiatry, 15, 11. doi: 10.1186/s12888-015-0483-0 
Oladeji, B. D., Kola, L., Abiona, T., Montgomery, A. A., Araya, R., & Gureje, O. (2015b). A pilot 
randomized controlled trial of a stepped care intervention package for depression in 
primary care in Nigeria. BMC Psychiatry, 15, 96. doi: 10.1186/s12888-015-0483-0 
Oosterbaan, D. B., Verbraak, M., Terluin, B., Hoogendoorn, A. W., Peyrot, W. J., Muntingh, A., 
& Balkom, A. (2013). Collaborative stepped care v. Care as usual for common mental 
disorders: 8-month, cluster randomised controlled trial. British Journal of Psychiatry, 
203(2), 132-139.  doi:http://dx.doi.org/10.1192/bjp.bp.112.125211 
Ormel, J., Bartel, M., & Nolen, W. A. (2003). [Undertreatment of depression; causes and 
recommendations]. Nederlands Tijdschrift voor Geneeskunde, 147(21), 1005-1009.  
Otto, M. W., Pollack, M. H., & Maki, K. M. (2000). Empirically supported treatments for Panic 
Disorder: costs, benefits, and stepped care. Journal of Consulting & Clinical Psychology, 
68(4), 556-563.  
Oxman, A. D. (1993). Meta-statistics: help or hindrance? ACP Journal Club, 118. doi: 
10.7326/ACPJC-1993-118-3-A13  
Oxman, A. D., & Guyatt, G. H. (1993). The science of reviewing research. Ann N Y Acad Sci, 703, 
125-133; discussion 133-124.  
Parry, G., Barkham, M., Brazier, J., Dent-Brown, K., Hardy, G., Kendrick, T., . . . Lovell, K. (2011). 
An evaluation of a new service model: Improving Access to Psychological Therapies 
demonstration sites 2006-2009. Final report.: NIHR Service Delivery and Organisation 
programme. 
Partridge, N., & Scadding, J. (2004). The James Lind Alliance: patients and clinicians should 
jointly identify their priorities for clinical trials. Lancet, 364(9449), 1923-1924. doi: 
10.1016/S0140-6736(04)17494-1 
Patel, V., Weiss, H. A., Neerja, C., Smita, N., Sulochana, P., Chatterjee, S., . . . Kirkwood, B. R. 
(2010). Effectiveness of an intervention led by lay health counsellors for depressive 
and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised 
controlled trial. The Lancet, 376, 2086-20895. doi: 10.1016/S0140-6736(10)61508-5 
Patten, S. B., Bilsker, D., & Goldner, E. (2008). The evolving understanding of major depression 
epidemiology: implications for practice and policy. Canadian Journal of Psychiatry - 
Revue Canadienne de Psychiatrie, 53(10), 689-695.  
Patton, M. Q. (1988). Paradigms and pragmatism. In D. M. Fetterman (Ed.), Qualitative 
approaches to evaluation in education: the silent scientific revolution. New York: 
Praeger. 
   421 
Pilling, S., & Burbeck, R. (2006). Cognitive behavioural therapy and the effective treatment of 
depresion: report for the Department of Health in support of the submission to the 
Comprehensive Spending Review. London: National Collaborating Centre for Mental 
Health, Univeristy College London. 
Pope, C., Ziebland, S., & Mays, N. (2000). Qualitative research in health care: analysing 
qualitative data. British Medical Journal, 320(7227), 114-116. doi: 
10.1136/bmj.320.7227.114 
Public Health Service Agency for Healthcare Policy and Research. (1993). Depression in primary 
care: detection and diagnosis. Rockville MD: US Department of Health and Human 
Services. 
Rhodes, S., Richards, D., Ekers, D., McMillan, D., SByford, S., Farrand, P. A., . . . Wright, K. A. 
(2014). Cost and outcome of behavioural activation versus cognitive behaviour therapy 
for depression (COBRA): study protocol for a randomised controlled trial. Trials, 15, 29.  
Richards, D. (2011). Prevalence and clinical course of depression: A review. Clin Psychol Rev, 
31(7), 1117-1125. doi: http://dx.doi.org/10.1016/j.cpr.2011.07.004 
Richards, D. (2012). Stepped Care: A Method to Deliver Increased Access to Psychological 
Therapies. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 57(4), 
210-215.  
Richards, D. (2015a). The complex interventions framework. In D. A. Richards & I. R. Hallberg 
(Eds.), Complex interventions in health: an overview of research methods. Oxon, New 
York: Routledge. 
Richards, D. (2015b). Patient and public involvement in interventions research. In D. A. 
Richards & I. R. Hallberg (Eds.), Complex interventions in health: an overview of 
research methods. Oxon, New York: Routledge. 
Richards, D., & Borglin, G. (2011). Implementation of psychological therapies for anxiety and 
depression in routine practice: Two year prospective cohort study. J Affect Disord, 
133(1-2), 51-60. doi: 10.1016/j.jad.2011.03.024 
Richards, D., Bower, P., Pagel, C., Weaver, A., Utley, M., Cape, J., . . . Vasilakis, C. (2012). 
Delivering stepped care: an analysis of implementation in routine practice. 
Implementation Science, 7. doi: 10.1186/1748-5908-7-3 
Richards, D., Ekers, D., McMillan, D., Taylor, R. S., Byford, S., Warren, F. C., . . . Finning, K. 
(2016). Cost and Outcome of Behavioural Activation versus Cognitive Behavioural 
Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial. The 
Lancet. doi: 10.1016/S0140-6736(16)31140-0 
Richards, D., Hill, J. J., Gask, L., Lovell, K., Chew-Graham, C., Bower, P., . . . Barkham, M. (2013). 
Clinical effectiveness of collaborative care for depression in UK primary care (CADET): 
cluster randomised controlled trial. British Medical Journal, 347, f4913. doi: 
10.1136/bmj.f4913 
Richards, D., & Richardson, T. (2012). Computer-based psychological treatments for 
depression: a systematic review and meta-analysis. Clin Psychol Rev, 32(4), 329-342. 
doi: 10.1016/j.cpr.2012.02.004 
Richards, D., & Suckling, R. (2009). Improving access to psychological therapies: Phase IV 
prospective cohort study. British Journal of Clinical Psychology, 48, 377-396. doi: 
10.1348/014466509x405178 
Richards, D., Weaver, A., Utley, M., Bower, P., Cape, J., Gallivan, S., . . . Vasilakis, C. (2010). 
Developing evidence-based and acceptable stepped care systems in mental health 
care: an operational research project. Final report: NIHR Service Delivery and 
Organisation programme. 
Rick, J., Graffy, J., Knapp, P., Small, N., Collier, D. J., Eldridge, S., . . . Bower, P. (2014). 
Systematic techniques for assisting recruitment to trials (START): study protocol for 
embedded, randomized controlled trials. Trials, 15(1), 407. doi: 10.1186/1745-6215-
15-407 
   422 
Robins, L. N., Locke, B. Z., & Regier, D. A. (1991). An overview of psychiatric disorders in 
America. In R. L. N. & D. A. Regier (Eds.), Psychiatric disorders in America: the 
epidemiologic catchment area study (pp. 328-366). New York: Free Press. 
Robinson, K. A., & Goodman, S. N. (2011). A systematic examination of the citation of prior 
research in reports of randomized, controlled trials. Ann Intern Med, 154(1), 50-55. 
doi: 10.7326/0003-4819-154-1-201101040-00007 
Rosenthal, M. H. (2003). The challenge of comorbid disorders in patients with depression. J Am 
Osteopath Assoc, 103(8 Suppl 4), S10-15.  
Roth, A., & Fonaghy, P. (2005). What works for whom?  A critical review of psychotherapy 
research (Second ed.). London: Guilford Press. 
Sackett, D. L., Richardson, W. S., Rosenberg, W., & Haynes, R. B. (1997). Evidence-based 
medicine: How to practice and teach EBM. New York, Edinburgh, London, Madrid, 
Melbourne, San Francisco, Tokyo: Churchill Livingstone. 
Sackett, D. L., Rosenberg, W., Gray, J., Haynes, R. B., & Richardson, W. S. (1996). Evidence 
based medicine: what it is and what it isn't. British Medical Journal, 312(7023), 71-72. 
doi: 10.1136/bmj.312.7023.71 
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987). Meta-
analyses of randomized controlled trials. N Engl J Med, 316(8), 450-455. doi: 
10.1056/nejm198702193160806 
Schensul, J. J., & Le Compte, M. D. (2010). Designing and conducting ethnographic research: an 
introduction. (2nd ed.). Lanham, New York, Toronto, Plymouth (UK): Altamira Press: 
Rowan & Littlefield Publishers Inc. 
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: updated guidelines 
for reporting parallel group randomised trials. British Medical Journal, 340, c332. doi: 
10.1136/bmj.c332 
Schulz, K. F., Chalmers, I., Grimes, D. A., & Altman, D. G. (1994). Assessing the quality of 
randomization from reports of controlled trials published in obstetrics and gynecology 
journals. Jama, 272(2), 125-128.  
Schulz, K. F., Chalmers, I., Hayes, R. J., & Altman, D. G. (1995). Empirical evidence of bias. 
Dimensions of methodological quality associated with estimates of treatment effects 
in controlled trials. Jama, 273(5), 408-412.  
Scogin, F. R., Hanson, A., & Welsh, D. (2003). Self-administered treatment in stepped-care 
models of depression treatment. Journal of Clinical Psychology, 59(3), 341-349. doi: 
10.1002/jclp.10133 
Seekles, W., van Straten, A., Beekman, A., van Marwijk, H., & Cuijpers, P. (2011). Stepped care 
treatment for depression and anxiety in primary care. a randomized controlled trial. 
Trials, 12, 171. doi: 10.1186/1745-6215-12-171 
Sharan, P., & Saxena, S. (1998). Treatment-resistant depression: clinical significance, concept 
and management. National Medical Journal of India, 11(2), 69-79.  
Shinde, S., Andrew, G., Bangash, O., Cohen, A., Kirkwood, B., & Patel, V. (2013). The impact of a 
lay counselor led collaborative care intervention for common mental disorders in 
public and private primary care: A qualitative evaluation nested in the MANAS trial in 
Goa, India. Social Science & Medicine, 88, 48-55. doi: 
http://dx.doi.org/10.1016/j.socscimed.2013.04.002 
Silverman, W. A. (1985). Human experimentation: a guided step into the unknown. Oxford: 
Oxford University Press. 
Simon, G. E., & Perlis, R. H. (2010). Personalized Medicine for Depression: Can We Match 
Patients With Treatments? American Journal of Psychiatry, 167(12), 1445-1455. doi: 
doi:10.1176/appi.ajp.2010.09111680 
Snappin, S. M. (2000). Noninferiority trials. Curr Controlled Trials Cardiovasc Med, 1, 19-21.  
Sobell, M. B., & Sobell, L. C. (2000). Stepped care as a heuristic approach to the treatment of 
alcohol problems. Journal of Consulting & Clinical Psychology, 68(4), 573-579.  
   423 
Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., . . . Endicott, J. 
(2000). Multiple recurrences of major depressive disorder. Am J Psychiatry, 157(2), 
229-233. doi: 10.1176/appi.ajp.157.2.229 
Spencer, L., Ritchie, J., O'Connor, W., Morrell, G., & Ormston, R. (2014). Analysis in practice. In 
J. Ritchie, J. Lewis, C. McNaughton Nicholls & R. Ormston (Eds.), Qualitative Research 
Practice. Los Angeles, London, Mew Delhi, Singapore, Washington DC.: Sage. 
Spencer, L., Ritchie, J., Ormston, R., O'Connor, W., & Barnard, M. (2014). Analysis: principles 
and processes. In J. Ritchie, J. Lewis, C. Mc Naughton Nicholls & R. Ormston (Eds.), 
Qualitative research rractice: a guide for social science students and researchers. Los 
Angeles, London, New Dehli, Singapore, Washington DC: SAGE. 
Spijker, J., van Vliet, I. M., Meeuwissen, J. A. C., & van Balkom, A. J. L. M. (2010). Update of the 
multidisciplinary guidelines for anxiety and depression. [Herziening van de 
multidisciplinaire richtlijnen angst en depressie.]. Tijdschrift voor psychiatrie, 52(10), 
715-718.  
Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing 
generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166(10), 1092-
1097. doi: 10.1001/archinte.166.10.1092 
Spring, B. (2007). Evidence-based practice in clinical psychology: what it is, why it matters; 
what you need to know. J Clin Psychol, 63(7), 611-631. doi: 10.1002/jclp.20373 
Stiles, W. B., Barkham, M., Mellor-Clark, J., & Connell, J. (2008). Effectiveness of cognitive-
behavioural, person-centred, and psychodynamic therapies in UK primary-care routine 
practice: replication in a larger sample. Psychological Medicine, 38(05), 677-688. doi: 
doi:10.1017/S0033291707001511 
Stoop, C. H., Nefs, G., Pommer, A. M., Pop, V. J. M., & Pouwer, F. (2015). Effectiveness of a 
stepped care intervention for anxiety and depression in people with diabetes, asthma 
or COPD in primary care: A randomized controlled trial. J Affect Disord, 184, 269-276. 
doi: http://dx.doi.org/10.1016/j.jad.2015.05.063 
Tang, L., Song, J., Belin, T. R., & Unutzer, J. (2005). A comparison of imputation methods in a 
longitudinal randomized clinical trial. Stat Med, 24(14), 2111-2128. doi: 
10.1002/sim.2099 
Tashakkori, A., & Teddlie, C. (1998). Mixed methodology: combining qualitative and 
quantitative approaches. Thousand Oaks, CA: Sage. 
Taylor, M. (2011). Interviewing. In I. Holloway (Ed.), Qualitative Research in Health Care (pp. 
29-55). Maidenhead: Open University Press. 
ten Have, M., de Graaf, R., Vollebergh, W., & Beekman, A. (2004). What depressive symptoms 
are associated with the use of care services? Results from the Netherlands Mental 
Health Survey and Incidence Study (NEMESIS). J Affect Disord, 80(2-3), 239-248.  
Thabane, L., Ma, J., Chu, R., Cheng, J., Ismaila, A., Rios, L. P., . . . Goldsmith, C. H. (2010). A 
tutorial on pilot studies: the what, why and how. BMC Med Res Methodol, 10, 1. doi: 
10.1186/1471-2288-10-1 
The Centre for Economic Performance Mental Health Policy Group. (2006). The depresssion 
report.  A new deal for depression and anxiety disorders. London: School of Economics 
and Political Science Centre for Economic Performance. 
The Cochrane Collaboration. (2011). Cochrane Handbook for Systematic Reviews of 
Interventions Version 5.1.0 (updated March 2011) (J. P. T. Higgins & S. Green Eds.): 
Wiley-Blackwell. 
Thornton, H. (2009). What roles for patients? In A. Edwards & G. Elwyn (Eds.), Shared decision-
making in health care: achieving evidence-based patient choice (Second ed.). Oxford: 
Oxford University Press. 
Titov, N., Dear, B. F., Johnston, L., Lorian, C., Zou, J., Wootton, B., . . . Rapee, R. M. (2013). 
Improving adherence and clinical outcomes in self-guided internet treatment for 
   424 
anxiety and depression: randomised controlled trial. PLoS One, 8(7), e62873. doi: 
10.1371/journal.pone.0062873 
Titov, N., Dear, B. F., Johnston, L., McEvoy, P. M., Wootton, B., Terides, M. D., . . . Rapee, R. M. 
(2014). Improving adherence and clinical outcomes in self-guided internet treatment 
for anxiety and depression: a 12-month follow-up of a randomised controlled trial. 
PLoS One, 9(2), e89591. doi: 10.1371/journal.pone.0089591 
Titov, N., Dear, B. F., Johnston, L., & Terides, M. (2012). Transdiagnostic internet treatment for 
anxiety and depression. Spanish Journal of Clinical Psychology, 17(3), 237-260.  
Torgerson, D. J., & Torgerson, C. J. (2008). Designing randomised trials. Basingstoke; New York: 
Palgrave Macmillan. 
Treweek, S., Lockhart, P., Pitkethly, M., Cook, J. A., Kjeldstrom, M., Johansen, M., . . . Mitchell, 
E. D. (2013). Methods to improve recruitment to randomised controlled trials: 
Cochrane systematic review and meta-analysis. Bmj Open, 3(2). doi: 10.1136/bmjopen-
2012-002360 
Ukoumunne, O. C., Gulliford, M. C., Chinn, S., Sterne, J. A., & Burney, P. G. (1999). Methods for 
evaluating area-wide and organisation-based interventions in health and health care: a 
systematic review. Health Technol Assess, 3(5), iii-92.  
Ulfelder, H. (1980). The stilbestrol disorders in historical perspective. Cancer, 45(12), 3008-
3011.  
Unutzer, J., Katon, W., Callahan, C. M., Williams, J. W., Hunkeler, E., Harpole, L., . . . 
Investigators, I. (2002). Collaborative care management of late-life depression in the 
primary care setting: a randomized controlled trial. Journal of the American Medical 
Association, 288(22), 2836-2845. doi: 10.1001/jama.288.22.2836 
Unutzer, J., Katon, W., Ming-Yu, F., Schoenbaum, M. C., Lin, E. H., Della Penna, R. D., & Powers, 
D. (2008). Long-term cost effects of collaborative care for late-life depression. The 
American Journal of Managed Care, 14, 95-100.  
van't Veer-Tazelaar, P. J., van Marwijk, H. W. J., van Oppen, P., van Hout, H. P. J., van der Horst, 
H. E., Cuijpers, P., . . . Beekman, A. T. F. (2009). Stepped-care prevention of anxiety and 
depression in late life: a randomized controlled trial. Archives of General Psychiatry, 
66(3), 297-304.  
van Achterberg, T. (2015). Introduction to Section 4. In D. A. Richards & I. R. Hallberg (Eds.), 
Complex interventions in health: an overview of research methods. Oxon, New York: 
Routledge. 
van Beljouw, I. M. J., Laurant, M. G. H., Heerings, M., Stek, M. L., van Marwijk, H. W. J., & van 
Exel, E. (2014). Implementing an outreaching, preference-led stepped care 
intervention programme to reduce late life depressive symptoms: results of a mixed-
methods study. Implementation Science, 9, 13. doi: 10.1186/s13012-014-0107-y 
Van Beljouw, I. M. J., Van Exel, E., Van De Ven, P. M., Joling, K. J., Dhondt, T. D. F., Stek, M. L., & 
Van Marwijk, H. W. J. (2015). Does an outreaching stepped care program reduce 
depressive symptoms in community-dwelling older adults? A randomized 
implementation trial. American journal of geriatric psychiatry, 23(8), 807-817.  
van der Aa, H. P. A., van Rens, G. H. M. B., Comijs, H. C., Margrain, T. H., Gallindo-Garre, F., 
Twisk, J. W. R., & van Nispen, R. M. A. (2015). Stepped care for depression and anxiety 
in visually impaired older adults: multicentre randomised controlled trial. BMJ, 351. 
doi: 10.1136/bmj.h6127 
van Dijk, S. E. M., Pols, A. D., Adriaanse, M. C., Bosmans, J. E., Elders, P. J. M., van Marwijk, H. 
W. J., & van Tulder, M. W. (2013). Cost-effectiveness of a stepped-care intervention to 
prevent major depression in patients with type 2 diabetes mellitus and/or coronary 
heart disease and subthreshold depression: design of a cluster-randomized controlled 
trial. Bmc Psychiatry, 13. doi: 10.1186/1471-244x-13-128 
van Schaik, D. J., Dozeman, E., van Marwijk, H. W., Stek, M. L., Smit, F., Beekman, A. T., & van 
der Horst, H. E. (2014). Preventing depression in homes for older adults: are effects 
   425 
sustained over 2 years? International Journal of Geriatric Psychiatry, 29(2), 191-197. 
doi: 10.1002/gps.3989 
van Straten, A., Hill, J., Richards, D., & Cuijpers, P. (2014). Stepped care treatment delivery for 
depression: a systematic review and meta-analysis. Psychol Med, 45(2), 231-246. doi: 
10.1017/s0033291714000701 
Van Weel-Baumgarten, E. M., Van Gelderen, M. G., Grundmeijer, H. G. L. M., Licht-Strunk, E., 
Van Marjwik, H. W. J., Van Rijswijk, H. C. A. M., & al., e. (2012). The NHG guideline 
depression (second revision of the NHG guideline depressive disorder) [in Dutch]. 
Huisartsen en Werenschap, 55, 252-259.  
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007). Reducing relapse and recurrence 
in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's 
effects. J Consult Clin Psychol, 75(3), 475-488. doi: 10.1037/0022-006x.75.3.475 
Von Korff, M., Katon, W., Unutzer, J., Wells, K., & Wagner, E. H. (2001). Improving depression 
care: barriers, solutions, and research needs. Journal of Family Practice, 50(6), E1.  
Von Korff, M., & Tiemens, B. (2000). Individualized stepped care of chronic illness. Western 
Journal of Medicine, 172(2), 133-137. doi: 10.1136/ewjm.172.2.133 
Wagner, E. H., Austin, B. T., Davis, C., Hindmarsh, M., Schaefer, J., & Bonomi, A. (2001). 
Improving chronic illness care: translating evidence into action. Health Aff (Millwood), 
20(6), 64-78.  
Ware, J. E., Kosinski, M., Bjorner, J. B., Turner-Bowker, D. M., Gandek, B., & Maruish, M. E. 
(2007). User's manual for the SF-36v2 Health Survey (2nd ed.). Lincoln RI: Quality 
Metric Incorporated. 
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. 
Conceptual framework and item selection. Medical Care, 30(6), 473-483.  
Watson, J. M., & Torgerson, D. J. (2006). Increasing recruitment to randomised trials: a review 
of randomised controlled trials. BMC Med Res Methodol, 6, 34. doi: 10.1186/1471-
2288-6-34 
Wells, K. B., Katon, W., Rogers, B., & Camp, P. (1994). Use of minor tranquilizers and 
antidepressant medications by depressed outpatients: results from the medical 
outcomes study. Am J Psychiatry, 151(5), 694-700. doi: 10.1176/ajp.151.5.694 
Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. 
(2013). Estimating remission from untreated major depression: a systematic review 
and meta-analysis. Psychol Med, 43(8), 1569-1585. doi: 10.1017/s0033291712001717 
Whooley, M. A., Avins, A. L., Miranda, J., & Browner, W. S. (1997). Case-finding instruments for 
depression: two questions are as good as many. Journal of General Internal Medicine, 
12(7), 439-445. doi: 10.1046/j.1525-1497.1997.00076.x 
Wiles, N., Thomas, L., Abel, A., Ridgway, N., Turner, N., Campbell, J., . . . Lewis, G. (2013). 
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care 
based patients with treatment resistant depression: results of the CoBalT randomised 
controlled trial. The Lancet, 381(9864), 375-384. doi: 10.1016/s0140-6736(12)61552-9 
Williams, C., & Martinez, R. (2008). Increasing Access to CBT: Stepped Care and CBT Self-Help 
Models in Practice. Behavioural and Cognitive Psychotherapy, 36(6), 675-683. doi: 
10.1017/s1352465808004864 
Wilson, G. T., Vitousek, K. M., & Loeb, K. L. (2000). Stepped Care Treatment for Eating 
Disorders. Journal of Consulting & Clinical Psychology, 68(4), 564-572.  
Wilson, P., Petticrew, M., Calnan, M., & Nazareth, I. (2008). Why promote the findings of single 
research studies? BMJ, 336(7646), 722. doi: 10.1136/bmj.39525.447361.94 
Wisdom, J. P., Cavaleri, M. A., Onwuegbuzie, A. J., & Green, C. A. (2012). Methodological 
reporting in qualitative, quantitative, and mixed methods health services research 
articles. Health Serv Res, 47(2), 721-745. doi: 10.1111/j.1475-6773.2011.01344.x 
   426 
Wittink, M. N., Barg, F. K., & Gallo, J. J. (2006). Unwritten rules of talking to doctors about 
depression: integrating qualitative and quantitative methods. Annals of Family 
Medicine, 4(4), 302-309.  
World Health Organization. (1992). The ICD-10 classification of mental and behavioural 
disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health 
Organization. 
World Medical Association General Assembly. (2013). World Medical Association Declaration 
of Helsinki: ethical principles for medical research involving human subjects - Fortaleza 
Amendment. Ferney-Voltaire: The World Medical Association. 
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001). The quality of care for 
depressive and anxiety disorders in the United States. Arch Gen Psychiatry, 58(1), 55-
61.  
Zhang, D. X., Lewis, G., Araya, R., Tang, W. K., Mak, W. W. S., Cheung, F. M. C., . . . Wong, S. Y. 
S. (2014). Prevention of anxiety and depression in Chinese: A randomized clinical trial 
testing the effectiveness of a stepped care program in primary care. Journal of 
Affective Disorders, 169, 212-220.  
Zhang, D. X., Lewis, G., Araya, R., Tang, W. K., Mak, W. W. S., Cheung, F. M. C., . . . Wong, S. Y. 
S. (2014). Prevention of anxiety and depression in Chinese: A randomized clinical trial 
testing the effectiveness of a stepped care program in primary care. J Affect Disord, 
169(0), 212-220. doi: http://dx.doi.org/10.1016/j.jad.2014.08.015 
 
 
